[Title 21 CFR II]
[Code of Federal Regulations (annual edition) - April 1, 1996 Edition]
[Title 21 - FOOD AND DRUGS]
[Chapter II - DRUG ENFORCEMENT]
[From the U.S. Government Publishing Office]
21
FOOD AND DRUGS
9
1996-04-01
1996-04-01
false
DRUG ENFORCEMENT
II
CHAPTER II
FOOD AND DRUGS
CHAPTER II--DRUG ENFORCEMENT
PART 1300--[RESERVED]--Table of Contents
PART 1301--REGISTRATION OF MANUFACTURERS, DISTRIBUTORS, AND DISPENSERS OF CONTROLLED SUBSTANCES--Table of Contents
General Information
Sec.
1301.01 Scope of Part 1301.
1301.02 Definitions.
1301.03 Information; special instructions.
Fees for Registration and Reregistration
1301.11 Fee amounts.
1301.12 Time and method of payment; refund.
1301.13 Persons exempt from fee.
Requirements for Registration
1301.21 Persons required to register.
1301.22 Separate registration for independent activities.
1301.23 Separate registrations for separate locations.
1301.24 Exemption of agents and employees; affiliated practitioners.
1301.25 Exemption of certain military and other personnel.
1301.26 Exemption of law enforcement officials.
1301.27 Exemption of civil defense officials.
1301.28 Registration regarding ocean vessels.
1301.29 Provisional registration of narcotic treatment programs;
compounders.
Applications for Registration
1301.31 Time for application for registration; expiration date.
1301.32 Application forms; contents; signature.
1301.33 Research protocols.
1301.34 Filing of application; joint filings.
1301.35 Acceptance for filing; defective applications.
1301.36 Additional information.
1301.37 Amendments to and withdrawal of applications.
1301.38 Special procedures for certain applications.
Action on Applications for Registration: Revocation or Suspension of
Registration
1301.41 Administrative review generally.
1301.42 Action on applications for research in Schedule I substances.
1301.43 Application for bulk manufacture of Sschedule I and II
substances.
1301.44 Certificate of registration; denial of registration.
1301.45 Suspension or revocation of registration.
1301.46 Suspension of registration pending final order.
1301.47 Extension of registration pending final order.
1301.48 Order to show cause.
Hearings
1301.51 Hearings generally.
1301.52 Purpose of hearing.
1301.53 Waiver or modification of rules.
1301.54 Request for hearing or appearance; waiver.
1301.55 Burden of proof.
1301.56 Time and place of hearing.
1301.57 Final order.
Modification, Transfer and Termination of Registration
1301.61 Modification in registration.
1301.62 Termination of registration.
1301.63 Transfer of registration.
Security Requirements
1301.71 Security requirements generally.
1301.72 Physical security controls for nonpractitioners; narcotic
treatment programs and compounders for narcotic treatment
programs; storage areas.
1301.73 Physical security controls for nonpractitioners; compounders
for narcotic treatment programs; manufacturing and compounding
areas.
1301.74 Other security controls for nonpractitioners; narcotic
treatment programs and compounders for narcotic treatment
programs.
1301.75 Physical security controls for practitioners.
1301.76 Other security controls for practitioners.
Employee Screening--Non-Practitioners
1301.90 Employee screening procedures.
1301.91 Employee responsibility to report drug diversion.
1301.92 Illicit activities by employees.
1301.93 Sources of information for employee checks.
Authority: 21 U.S.C. 821, 822, 823, 824, 871(b), 875, 877.
Source: 36 FR 7778, Apr. 24, 1971, unless otherwise noted.
Redesignated at 38 FR 26609, Sept. 24, 1973.
General Information
Sec. 1301.01 Scope of Part 1301.
Procedures governing the registration of manufacturers,
distributors, and dispensers of controlled substances pursuant to
sections 1301 through 1304 of the Act (21 U.S.C. 821-824) are set forth
generally by those sections and specifically by the sections of this
part.
[[Page 5]]
Sec. 1301.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substances Act (84 Stat. 1242;
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act
(84 Stat. 1285; 21 U.S.C. 951).
(b) The term basic class means, as to controlled substances listed
in Schedules I and II:
(1) Each of the opiates, including its isomers, esters, ethers,
salts, and salts of isomers, esters, and ethers whenever the existence
of such isomers, esters, ethers, and salts is possible within the
specific chemical designation, listed in Sec. 1308.11 (b) of this
chapter;
(2) Each of the opium derivatives, including its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation,
listed in Sec. 1308.11(c) of this chapter;
(3) Each of the hallucinogenic substances, including its salts,
isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation, listed in Sec. 1308.11(d) of this chapter;
(4) Each of the following substances, whether produced directly or
indirectly by extraction from substances of vegetable origin, or
independently by means of chemical synthesis, or by a combination of
extraction and chemical synthesis:
(i) Opium, including raw opium, opium extracts, opium fluid
extracts, powdered opium, granulated opium, deodorized opium and
tincture of opium;
(ii) Apomorphine;
(iii) Codeine;
(iv) Etorphine hydrochloride;
(v) Ethylmorphine;
(vi) Hydrocodone;
(vii) Hydromorphone;
(viii) Metopon;
(ix) Morphine;
(x) Oxycodone;
(xi) Oxymorphone;
(xii) Thebaine;
(xiii) Mixed alkaloids of opium listed in Sec. 1308.12(b) (2) of
this chapter;
(xiv) Cocaine; and
(xv) Ecgonine;
(5) Each of the opiates, including its isomers, esters, ethers,
salts, and salts of isomers, esters, and ethers whenever the existence
of such isomers, esters, ethers, and salts is possible within the
specific chemical designation, listed in Sec. 1308.12 (c) of this
chapter; and
(6) Methamphetamine, its salts, isomers, and salts of its isomers;
(7) Amphetamine, its salts, optical isomers, and salts of its
optical isomers;
(8) Phenmetrazine and its salts;
(9) Methylphenidate;
(10) Each of the substances having a depressant effect on the
central nervous system, including its salts, isomers, and salts of
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation, listed in
Sec. 1308.12 (e) of this chapter.
(c) The term Administration means the Drug Enforcement
Administration.
(d) The term compounder means any person engaging in maintenance or
detoxification treatment who also mixes, prepares, packages or changes
the dosage form of a narcotic drug listed in Schedules II, III, IV or V
for use in maintenance or detoxification treatment by another narcotic
treatment program.
(e) The term detoxification treatment means the dispensing, for a
period of time as specified below, of a narcotic drug or narcotic drugs
in decreasing doses to an individual to alleviate adverse physiological
or psychological effects incident to withdrawal from the continuous or
sustained use of a narcotic drug and as a method of bringing the
individual to a narcotic drug-free state within such period of time.
There are two types of detoxification treatment: Short-term
detoxification treatment and long-term detoxification treatment.
(1) Short-term detoxification treatment is for a period not in
excess of 30 days.
(2) Long-term detoxification treatment is for a period more than 30
days but not in excess of 180 days.
(f) The term Administrator means the Administrator of the Drug
Enforcement Administration. The Administrator has been delegated
authority under the Act by the Attorney General (28 CFR 0.100).
[[Page 6]]
(g) The term hearing means any hearing held pursuant to this part
for the granting, denial, revocation, or suspension of a registration
pursuant to sections 303 and 304 of the Act (21 U.S.C. 823-824).
(h) The term maintenance treatment means the dispensing for a period
in excess of twenty-one days, of a narcotic drug or narcotic drugs in
the treatment of an individual for dependence upon heroin or other
morphine-like drug.
(i) The term narcotic treatment program means a program engaged in
maintenance and/or detoxification treatment with narcotic drugs.
(j) The term person includes any individual, corporation, government
or governmental subdivision or agency, business trust, partnership,
association, or other legal entity.
(k) The terms register and registration refer only to registration
required and permitted by section 303 of the Act (21 U.S.C. 823).
(l) The term registrant means any person who is registered pursuant
to either section 303 or section 1008 of the Act (21 U.S.C. 823 or 958).
(m) Any term not defined in this section shall have the definition
set forth in section 102 of the Act (21 U.S.C. 802).
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 12735, July 7, 1971; 36
FR 20687, Oct. 28, 1971. Redesignated at 38 FR 26609, Sept. 24, l973]
Editorial Note: For FR citations affecting Sec. 1301.02, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1301.03 Information; special instructions.
Information regarding procedures under these rules and instructions
supplementing these rules will be furnished upon request by writing to
the Registration Unit, Drug Enforcement Administration, Department of
Justice, Post Office Box 28083, Central Station, Washington, DC 20005.
[36 FR 7778, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 23, 1973,
and amended at 51 FR 5319, Feb. 13, 1986]
Fees for Registration and Reregistration
Sec. 1301.11 Fee amounts.
(a) For each registration or reregistration to manufacture
controlled substances, the registrant shall pay an application fee of
$875 for an annual registration.
(b) For each registration or reregistration to distribute controlled
substances, the registrant shall pay an application fee of $438 for an
annual registration.
(c) For each registration or reregistration to dispense, or to
conduct instructional activities with, controlled substances listed in
Schedules II through V, the registrant shall pay an application fee of
$210 for a three-year registration equating to an annualized fee of $70
per annum.
(d) For each registration or reregistration to conduct research or
instructional activities with a controlled substance listed in Schedule
I, or to conduct research with a controlled substance in Schedules II
through V, the registrant shall pay an application fee of $70 for an
annual registration.
(e) For each registration or reregistration to conduct chemical
analysis with controlled substances listed in any schedule, the
registrant shall pay an application fee of $70 for an annual
registration.
(f) For each registration or reregistration to engage in a narcotic
treatment program, including a compounder, the registrant shall pay an
application fee of $70 for an annual registration.
[58 FR 15274, Mar. 22, 1993]
Sec. 1301.12 Time and method of payment; refund.
Application fees shall be paid at the time when the application for
registration or reregistration is submitted for filing. Payments should
be made in the form of a personal, certified, or cashier's check or
money order made payable to ``Drug Enforcement Administration.''
Payments made in the form of stamps, foreign currency, or third party
endorsed checks will not be
[[Page 7]]
accepted. These application fees are not refundable.
[52 FR 20599, June 2, 1987, as amended at 53 FR 4963, Feb. 19, 1988]
Sec. 1301.13 Persons exempt from fee.
(a) The Administrator shall exempt from payment of an application
fee for registration or reregistration any hospital or other institution
which is operated by an agency of the United States (including the U.S.
Army, Navy, Marine Corps, Air Force, and Coast Guard), of any State, or
any political subdivision or agency thereof.
(b) In order to claim exemption from payment of a registration or
reregistration application fee, the registrant shall have completed the
certification on the appropriate application form, wherein the
registrant's officer certifies to the status and address of the
registrant.
(c) Exemption from payment of a registration or reregistration
application fee does not relieve the registrant of any other
requirements or duties prescribed by law.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18728, Sept. 21, 1971; 38 FR 756, Jan. 4, 1973. Redesignated at 38 FR
26609, Sept. 24, l973 and amended at 53 FR 4963, Feb. 19, 1988; 59 FR
8859, Feb. 24, 1994]
Requirements for Registration
Sec. 1301.21 Persons required to register.
Every person who manufactures, distributes, or dispenses any
controlled substance or who proposes to engage in the manufacture,
distribution, or dispensing of any controlled substance shall obtain
annually a registration unless exempted by law or pursuant to
Secs. 1301.24-1301.29. Only persons actually engaged in such activities
are required to obtain a registration; related or affiliated persons who
are not engaged in such activities are not required to be registered.
(For example, a stockholder or parent corporation of a corporation
manufacturing controlled substances is not required to obtain a
registration.)
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973]
Sec. 1301.22 Separate registration for independent activities.
(a) The following groups of activities are deemed to be independent
of each other:
(1) Manufacturing controlled substances;
(2) Distributing controlled substances;
(3) Dispensing controlled substances listed in Schedules II through
V;
(4) Conducting research with controlled substances listed in
Schedules II through V;
(5) Conducting instructional activities with controlled substances
listed in schedules II through V;
(6) Conducting a narcotic treatment program using any narcotic drug
listed in Schedules II, III, IV or V, however, pursuant to Sec. 1301.24,
employees, agents, or affiliated practitioners, in programs, need not
register separately. Each program site located away from the principal
location and at which place narcotic drugs are stored or dispensed must
be separately registered and obtain narcotic drugs by use of order forms
pursuant to Sec. 1305.03;
(7) Conducting research and instructional activities with controlled
substances listed in Schedule I;
(8) Conducting chemical analysis with controlled substances listed
in any schedule;
(9) Importing controlled substances;
(10) Exporting controlled substances; and
(11) A compounder as defined by Sec. 1301.02(d).
(b) Every person who engages in more than one group of independent
activities shall obtain a separate registration for each group of
activities, except as provided in this paragraph. Any person, when
registered to engage in the group of activities described in each
subparagraph in this paragraph, shall be authorized to engage in the
coincident activities described in that subparagraph without obtaining a
registration to engage in such coincident activities, provided that,
unless specifically exempted, he complies with all requirements and
duties prescribed by law for persons registered to engage in such
coincident activities:
(1) A person registered to manufacture or import any controlled
[[Page 8]]
substance or basic class of controlled substance shall be authorized to
distribute that substance or class, but no other substance or class
which he is not registered to manufacture or import;
(2) A person registered to manufacture any controlled substance
listed in Schedules II through V shall be authorized to conduct chemical
analysis and preclinical research (including quality control analysis)
with narcotic and non-narcotic controlled substances listed in those
schedules in which he is authorized to manufacture;
(3) A person registered to conduct research with a basic class of
controlled substance listed in Schedule I shall be authorized to
manufacture or import such class if and to the extent that such
manufacture or importation is set forth in the research protocol
described in Sec. 1301.33 and to distribute such class to other persons
registered or authorized to conduct research with such class or
registered or authorized to conduct chemical analysis with controlled
substances;
(4) A person registered or authorized to conduct chemical analysis
with controlled substances shall be authorized to manufacture and import
such substances for analytical or instructional purposes, to distribute
such substances to other persons registered or authorized to conduct
chemical analysis or instructional activities or research with such
substances and to persons exempted from registration pursuant to
Sec. 1301.26, to export such substances to persons in other countries
performing chemical analysis or enforcing laws relating to controlled
substances or drugs in those countries, and to conduct instructional
activities with controlled substances; and
(5) A person registered or authorized to conduct research with
controlled substances listed in Schedules II through V shall be
authorized to conduct chemical analysis with controlled substances
listed in those schedules in which he is authorized to conduct research,
to manufacture such substances if and to the extent that such
manufacture is set forth in a statement filed with the application for
registration, to import such substances for research purposes, to
distribute such substances to other persons registered or authorized to
conduct chemical analysis, instructional activities, or research with
such substances and to persons exempted from registration pursuant to
Sec. 1301.26, and to conduct instructional activities with controlled
substances;
(6) A person registered to dispense controlled substances in
Schedules II through V shall be authorized to conduct research and to
conduct instructional activities with those substances, except that a
mid-level practitioner, as defined in Sec. 1304.02(f), may conduct
research coincident to his/her practitioner registration only to the
extent expressly authorized by state statute.
(c) A single registration to engage in any group of independent
activities may include one or more controlled substances listed in the
schedules authorized in that group of independent activities. A person
registered to conduct research with controlled substances listed in
Schedule I may conduct research with any substance listed in Schedule I
for which he has filed and had approved a research protocol.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18728, Sept. 21, 1971;
37 FR 15918, Aug. 8, 1972; 38 FR 756, Jan. 4, 1973. Redesignated at 38
FR 26609, Sept. 24, l973; 58 FR 31175, June 1, 1993]
Editorial Note: For FR citations affecting Sec. 1301.22, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1301.23 Separate registrations for separate locations.
(a) A separate registration is required for each principal place of
business or professional practice at one general physical location where
controlled substances are manufactured, distributed, or dispensed by a
person.
(b) The following locations shall be deemed not to be places where
controlled substances are manufactured, distributed, or dispensed:
(1) A warehouse where controlled substances are stored by or on
behalf of a registered person, unless such substances are distributed
directly from such warehouse to registered locations other than the
registered location from which the substances were delivered or to
persons not required to register by
[[Page 9]]
virtue of subsection 302(c)(2) of the Act (21 U.S.C. 822(c)(2));
(2) An office used by agents of a registrant where sales of
controlled substances are solicited, made, or supervised but which
neither contains such substances (other than substances for display
purposes or lawful distribution as samples only) nor serves as a
distribution point for filling sales orders; and
(3) An office used by a practitioner (who is registered at another
location) where controlled substances are prescribed but neither
administered nor otherwise dispensed as a regular part of the
professional practice of the practitioner at such office, and where no
supplies of controlled substances are maintained.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18728, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973]
Sec. 1301.24 Exemption of agents and employees; affiliated practitioners.
(a) The requirement of registration is waived for any agent or
employee of a person who is registered to engage in any group of
independent activities, if such agent or employee is acting in the usual
course of his business or employment.
(b) An individual practitioner, as defined in section 1304.02 of
this chapter, who is an agent or employee of another individual
practitioner (other than a mid-level practitioner) registered to
dispense controlled substances may, when acting in the normal course of
business or employment, administer or dispense (other than by issuance
of prescription) controlled substances if and to the extent that such
individual practitioner is authorized or permitted to do so by the
jurisdiction in which he or she practices, under the registration of the
employer or principal practitioner in lieu of being registered him/
herself.
(c) An individual practitioner, as defined in Sec. 1304.02 of this
chapter, who is an agent or employee of a hospital or other institution
may, when acting in the normal course of business or employment,
administer, dispense, or prescribe controlled substances under the
registration of the hospital or other institution which is registered in
lieu of being registered him/herself, provided that:
(1) Such dispensing, administering or prescribing is done in the
usual course of his professional practice;
(2) Such individual practitioner is authorized or permitted to do so
by the jurisdiction in which he is practicing;
(3) The hospital or other institution by whom he is employed has
verified that the individual practitioner is so permitted to dispense,
administer, or prescribe drugs within the jurisdiction;
(4) Such individual practitioner is acting only within the scope of
his employment in the hospital or institution;
(5) The hospital or other institution authorizes the individual
practitioner to administer, dispense or prescribe under the hospital
registration and designates a specific internal code number for each
individual practitioner so authorized. The code number shall consist of
numbers, letters, or a combination thereof and shall be a suffix to the
institution's DEA registration number, preceded by a hyphen (e.g.,
AP0123456-10 or AP0123456-A12); and
(6) A current list of internal codes and the corresponding
individual practitioners is kept by the hospital or other institution
and is made available at all times to other registrants and law
enforcement agencies upon request for the purpose of verifying the
authority of the prescribing individual practitioner.
[36 FR 18728, Sept. 21, 1971, as amended at 37 FR 15918, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, l973, and amended at 51 FR 5319,
Feb. 13, 1986; 58 FR 31175, June 1, 1993; 60 FR 36641, July 18, 1995]
Sec. 1301.25 Exemption of certain military and other personnel.
(a) The requirement of registration is waived for any official of
the U.S. Army, Navy, Marine Corps, Air Force, Coast Guard, Public Health
Service, or Bureau of Prisons who is authorized to prescribe, dispense,
or administer, but not to procure or purchase, controlled substances in
the course of his official duties. Such officials shall follow
procedures set forth in part 1306 of this chapter regarding
prescriptions, but shall state the branch of service or
[[Page 10]]
agency (e.g., ``U.S. Army'' or ``Public Health Service'') and the
service identification number of the issuing official in lieu of the
registration number required on prescription forms. The service
identification number for a Public Health Service employee is his Social
Security identification number.
(b) If any official exempted by this section also engages as a
private individual in any activity or group of activities for which
registration is required, such official shall obtain a registration for
such private activities.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18729, Sept. 21, 1971;
38 FR 756, Jan. 4, 1973. Redesignated at 38 FR 26609, Sept. 24, l973]
Sec. 1301.26 Exemption of law enforcement officials.
(a) The requirement of registration is waived for the following
persons in the circumstances described in this section:
(1) Any officer or employee of the Administration, any officer of
the U.S. Customs Service, any officer or employee of the United States
Food and Drug Administration, and any other Federal officer who is
lawfully engaged in the enforcement of any Federal law relating to
controlled substances, drugs or customs, and is duly authorized to
possess controlled substances in the course of his official duties; and
(2) Any officer or employee of any State, or any political
subdivision or agency thereof, who is engaged in the enforcement of any
State or local law relating to controlled substances and is duly
authorized to possess controlled substances in the course of his
official duties.
(b) Any official exempted by this section may, when acting in the
course of his official duties, possess any controlled substance and
distribute any such substance to any other official who is also exempted
by this section and acting in the course of his official duties.
(c) Any official exempted by this section may procure any controlled
substance in the course of an inspection, in accordance with
Sec. 1316.03(d), or in the course of any criminal investigation
involving the person from whom the substance was procured.
(d) In order to enable law enforcement agency laboratories to obtain
and transfer controlled substances for use as standards in chemical
analysis, such laboratories must obtain annually a registration to
conduct chemical analysis. Such laboratories shall be exempted from
payment of a fee for registration. Laboratory personnel, when acting in
the scope of their official duties, are deemed to be officials exempted
by this section and within the activity described in section 515(d) of
the Act (21 U.S.C. 885(d)). For purposes of this paragraph, laboratory
activities shall not include field or other preliminary chemical tests
by officials exempted by this section.
(e) Laboratories of the Administration shall obtain annually a
registration to conduct chemical analysis in accordance with paragraph
(d) of this section. In addition to the activities authorized under a
registration to conduct chemical analysis pursuant to Sec. 1301.22(b)
(4), laboratories of the Administration shall be authorized to
manufacture or import controlled substances for any lawful purpose, to
distribute or export such substances to any person, and to import and
export such substances in emergencies without regard to the requirements
of part 1312 of this chapter if a report concerning the importation or
exportation is made to the Diversion Operations Section of the
Administration within 30 days of such importation or exportation.
[36 FR 7778, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 46 FR 28841, May 29, 1981; 51 FR 5319, Feb. 13, 1986]
Sec. 1301.27 Exemption of civil defense officials.
(a) The requirement of registration is waived for any official of a
civil defense or disaster relief organization who, in the course of his
official duties, is authorized to:
(1) Maintain, and distribute for such maintenance, controlled
substances held for emergency use; or
(2) Procure controlled substances for the purpose of maintaining
supplies for emergency use, provided that all of such procurement is
from the U.S. General Services Administration and in
[[Page 11]]
accordance with the rules of the U.S. Office of Emergency Preparedness.
(b) The requirement of registration is waived for any official of a
civil defense or disaster relief organization during a state of
emergency or disaster within his jurisdiction proclaimed by the
President or by a concurrent resolution of the Congress, which official,
in the course of his official duties, during such emergency or disaster,
is authorized to:
(1) Dispense controlled substances; or
(2) Procure or distribute controlled substances, provided that all
such procurement is on a special ``Civil Defense Emergency Order Form,''
as described in this section.
(c) Civil Defense Emergency Order Forms shall be furnished by the
U.S. Office of Emergency Preparedness and will contain the name of the
civil defense or disaster relief organization. Such forms may be used
and are valid only during a state of emergency or disaster proclaimed by
the President or by a concurrent resolution of the Congress for the area
in which the organization using such forms has civil defense or disaster
relief jurisdiction, who shall state his position and the nature and
legal designation of the emergency or disaster. Such forms may be filled
by any person registered under the Act. The organization shall, upon the
execution of a Civil Defense Emergency Order Form, be deemed to be
registered under the Act for purposes of recordkeeping pursuant to part
1304 of this chapter.
Sec. 1301.28 Registration regarding ocean vessels.
(a) If acquired by and dispensed under the general supervision of a
medical officer described in paragraph (b) of this section, or the
master or first officer of the vessel under the circumstances described
in paragraph (d) of this section, controlled substances may be held for
stocking, be maintained in, and dispensed from medicine chests, first
aid packets, or dispensaries:
(1) On board any vessel engaged in international trade or in trade
between ports of the United States and any merchant vessel belonging to
the U.S. Government;
(2) On board any aircraft operated by an air carrier under a
certificate of permit issued pursuant to the Federal Aviation Act of
1958 (49 U.S.C. 1301); and
(3) In any other entity of fixed or transient location approved by
the Administrator as appropriate for application of this section (e.g.,
emergency kits at field sites of an industrial firm).
(b) A medical officer shall be:
(1) Licensed in a state as a physician;
(2) Employed by the owner or operator of the vessel, aircraft or
other entity; and
(3) Registered under the Act at either of the following locations:
(i) The principal office of the owner or operator of the vessel,
aircraft or other entity or
(ii) At any other location provided that the name, address,
registration number and expiration date as they appear on his
Certificate of Registration (DEA Form 223) for this location are
maintained for inspection at said principal office in a readily
retrievable manner.
(c) A registered medical officer may serve as medical officer for
more than one vessel, aircraft, or other entity under a single
registration, unless he serves as medical officer for more than one
owner or operator, in which case he shall either maintain a separate
registration at the location of the principal office of each such owner
or operator or utilize one or more registrations pursuant to paragraph
(b)(3)(ii) of this section.
(d) If no medical officer is employed by the owner or operator of a
vessel, or in the event such medical officer is not accessible and the
acquisition of controlled substances is required, the master or first
officer of the vessel, who shall not be registered under the Act, may
purchase controlled substances from a registered manufacturer of
distributor, or from an authorized pharmacy as described in paragraph
(f) of this section, by following the procedure outlined below:
(1) The master or first officer of the vessel must personally appear
at the vendor's place of business, present proper identification (e.g.,
Seaman's photographic identification card) and a
[[Page 12]]
written requisition for the controlled substances.
(2) The written requisition must be on the vessel's official
stationery or purchase order form and must include the name and address
of the vendor, the name of the controlled substance, description of the
controlled substance (dosage form, strength and number or volume per
container) number of containers ordered, the name of the vessel, the
vessel's official number and country of registry, the owner or operator
of the vessel, the port at which the vessel is located, signature of the
vessel's officer who is ordering the controlled substances and the date
of the requisition.
(3) The vendor may, after verifying the identification of the
vessel's officer requisitioning the controlled substances, deliver the
control substances to that officer. The transaction shall be documented,
in triplicate, on a record of sale in a format similar to that outlined
in paragraph (d)(4) of this section. The vessel's requisition shall be
attached to copy 1 of the record of sale and filed with the controlled
substances records of the vendor, copy 2 of the record of sale shall be
furnished to the officer of the vessel and retained aboard the vessel,
copy 3 of the record of sale shall be forwarded to the nearest DEA
Division Office within 15 days after the end of the month in which the
sale is made.
(4) The vendor's record of sale should be similar to, and must
include all the information contained in, the below listed format.
Sale of Controlled Substances to Vessels
(Name of registrant)____________________________________________________
(Address of registrant)_________________________________________________
(DEA registration number)_______________________________________________
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Packages
Line No. packages ordered Size of packages Name of product distributed Date distributed
--------------------------------------------------------------------------------------------------------------------------------------------------------
1........................................................ ................. ................. ................. ................. .................
2........................................................ ................. ................. ................. ................. .................
3........................................................ ................. ................. ................. ................. .................
--------------------------------------------------------------------------------------------------------------------------------------------------------
Line numbers may be continued according to needs of the vendor.
Number of lines completed_______________________________________________
Name of vessel _________________________________________________________
Vessel's official number _______________________________________________
Vessel's country of registry____________________________________________
Owner or operator of the vessel_________________________________________
Name and title of vessel's officer who presented the requisition________
Signature of vessel's officer who presented the requisition_____________
(e) Any medical officer described in paragraph (b) of this section
shall, in addition to complying with all requirements and duties
prescribed for registrants generally, prepare an annual report as of the
date on which his registration expires, which shall give in detail an
accounting for each vessel, aircraft, or other entity, and a summary
accounting for all vessels, aircraft, or other entities under his
supervision for all controlled substances purchased, dispensed or
disposed of during the year. The medical officer shall maintain this
report with other records required to be kept under the Act and, upon
request, deliver a copy of the report to the Administration. The medical
officer need not be present when controlled substances are dispensed, if
the person who actually dispensed the controlled substances is
responsible to the medical officer to justify his actions.
(f) Any registered pharmacy which wishes to distribute controlled
substances pursuant to this section shall be authorized to do so,
provided that:
(1) The registered pharmacy notifies the nearest Division Office of
the Administration of its intention to so distribute controlled
substances prior to the initiation of such activity. This notification
shall be by registered mail and shall contain the name, address, and
registration number of the pharmacy as well as the date upon which such
activity will commence; and
(2) Such activity is authorized by state law; and
(3) The total number of dosage units of all controlled substances
distributed by the pharmacy during any calendar year in which the
pharmacy is registered to dispense does not exceed the
[[Page 13]]
limitations imposed upon such distribution by Sec. 1307.11(a)(4) and (b)
of this chapter.
(g) Owners or operators of vessels, aircraft, or other entities
described in this section shall not be deemed to possess or dispense any
controlled substance acquired, stored and dispensed in accordance with
this section.
(h) The Master of a vessel shall prepare a report for each calendar
year which shall give in detail an accounting for all controlled
substances purchased, dispensed, or disposed of during the year. The
Master shall file this report with the medical officer emploxed by the
owner or operator of his vessel, if any, or, if not, he shall maintain
this report with other records required to be kept under the Act and,
upon request, deliver a copy of the report to the Administration.
(i) Controlled substances acquired and possessed in accordance with
this section shall not be distributed to persons not under the general
supervision of the medical officer employed by the owner or operator of
the vessel, aircraft, or other entity, except in accordance with
Sec. 1307.21 of this chapter.
[37 FR 15918, Aug. 8, 1972, as amended at 38 FR 756, Jan. 4, 1973.
Redesignated at 38 FR 26609, Sept. 24, l973, and amended at 41 FR 9546,
Mar. 5, 1976; 50 FR 31589, Aug. 5, 1985]
Sec. 1301.29 Provisional registration of narcotic treatment programs; compounders.
(a) All persons currently approved by the Food and Drug
Administration under Sec. 310.505 (formerly Sec. 130.44) of this title
to conduct a methadone treatment program and who are registered by the
Drug Enforcement Administration under this section will be granted a
Provisional Narcotic Treatment Program Registration.
(b) The provisions of Sec. 1301.45-1301.57 relating to revocation
and suspension of registration, shall apply to a provisional
registration.
(c) Unless sooner revoked or suspended under paragraph (b) of this
section, a provisional registration shall remain in effect until (1) the
date on which such person has registered under this section or has had
his registration denied, or (2) such date as may be prescribed by
written notification to the person from the Drug Enforcement
Administration for the person to become registered to conduct a narcotic
treatment program, whichever occurs first.
[39 FR 37984, Oct. 25, 1974]
Applications for Registration
Sec. 1301.31 Time for application for registration; expiration date.
(a) Any person who is required to be registered and who is not so
registered may apply for registration at any time. No person required to
be registered shall engage in any activity for which registration is
required until the application for registration is granted and a
Certificate of Registration is issued by the Administrator to such
person.
(b) Any person who is registered may apply to be reregistered not
more than 60 days before the expiration date of his registration.
(c) At the time a manufacturer, distributor, researcher, analytical
lab, importer, exporter or narcotic treatment program is first
registered, that business activity shall be assigned to one of twelve
groups, which shall correspond to the months of the year. The expiration
date of the registrations of all registrants within any group will be
the last date of the month designated for that group. In assigning any
of the above business activities to a group, the Administration may
select a group the expiration date of which is less than one year from
the date such business activity was registered. If the business activity
is assigned to a group which has an expiration date less than three
months from the date of which the business activity is registered, the
registration shall not expire until one year from that expiration date;
in all other cases, the registration shall expire on the expiration date
following the date on which the business activity is registered.
(d) At the time a retail pharmacy, hospital/clinic, practitioner or
teaching institution is first registered, that business activity shall
be assigned to one of twelve groups, which shall correspond to the
months of the year. The expiration date of the registrations of all
registrants within any group will be the last day of the month
designated for that group. In assigning any of the
[[Page 14]]
above business activities to a group, the Administration may select a
group the expiration date of which is not less than 28 months nor more
than 39 months from the date such business activity was registered.
After the initial registration period, the registration shall expire 36
months from the initial expiration date.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973, and amended at 52 FR 20599,
June 2, 1987]
Sec. 1301.32 Application forms; contents; signature.
(a) If any person is required to be registered, and is not so
registered and is applying for registration:
(1) To manufacture or distribute controlled substances, he shall
apply on DEA Form 225;
(2) To dispense controlled substances listed in Schedules II through
V, he shall apply on DEA Form 224;
(3) To conduct instructional activities with controlled substances
listed in Schedules II through V, he shall apply on DEA Form 224;
(4) To conduct research with controlled substances listed in
Schedules II through V (other than research described in
Secs. 1301.22(a)(6), he shall apply on DEA Form 225;
(5) To conduct research with narcotic drugs listed in Schedules II
through V, as described in Sec. 1301.22(a)(6), he shall apply on DEA
Form 225;
(6) To conduct research with controlled substances listed in
Schedule I, he shall apply on DEA Form 225, with three copies of a
research protocol as described in Sec. 301.33(a) attached to the form,
or, in the case of a clinical investigation, with three copies of a
certificate of submission of an IND as described in Sec. 1301.33(b)
attached to the form (the researcher also submitting to the Food and
Drug Administration three copies of a Notice of Claimed Investigational
Exemption for a New Drug as required in Sec. 1301.33(b) );
(7) To conduct instructional activities with controlled substances
listed in Schedule I, he shall apply as a researcher on DEA Form 225
with two copies of a statement describing the nature, extent, and
duration of such instructional activities attached to the form;
(8) To conduct chemical analysis with controlled substances listed
in any Schedule, he shall apply on DEA Form 225; and
(9) To conduct a narcotic treatment program, including a compounder,
shall apply on DEA Form 363.
(b) If any person is registered and is applying for reregistration:
(1) To manufacture or distribute controlled substances, he shall
apply on DEA Form 225a;
(2) To dispense controlled substances listed in Schedules II through
V, he shall apply on DEA Form 224a;
(3) To conduct instructional activities with controlled substances
listed i Schedules II through V, he shall apply on DEA Form 224a;
(4) To conduct research with controlled substances listed in
Schedules II through V (other than research described in Sec. 1301.22(a)
(6), he shall apply on DEA Form 225a;
(5) To conduct research with narcotic drugs listed in Schedules II
through V, as described in Sec. 1301.22(a) (6), he shall apply on DEA
Form 225a;
(6) To continue to conduct research with controlled substances
listed in Schedule I under one or more approved research protocols, he
shall apply on DEA Form 225a;
(7) To continue to conduct instructional activities with controlled
substances listed in Schedule I under one or more approved instructional
statements, he shall apply as a researcher on DEA Form 225a;
(8) To conduct chemical analysis with controlled substances listed
in any Schedule, he shall apply on DEA Form 225a; and
(9) To conduct a narcotic treatment program, including a compounder,
shall apply on DEA Form 363a (Renewal Form).
(c) DEA (or BND) Forms 224 and 225 may be obtained at any regional
office of the Administration or by writing to the Registration Unit,
Drug Enforcement Administration, Department of Justice, Post Office Box
28083, Central Station, Washington, DC 20005. DEA Forms 224a, 225a and
363a will be mailed, as applicable, to each registered person
approximately 60 days
[[Page 15]]
before the expiration date of his registration; if any registered person
does not receive such forms within 45 days before the expiration date of
his registration, he must promptly give notice of such fact and request
such forms by writing to the Registration Unit of the Administration at
the foregoing address.
(d) Each application for registration to handle any basic class of
controlled substance listed in Schedule I (except to conduct chemical
analysis with such classes) and each application for registration to
manufacture a basic class of controlled substance listed in Schedule II
shall include the Administration Controlled Substances Code Number, as
set forth in part 1308 of this chapter, for each basic class to be
covered by such registration.
(e) Each application for registration to conduct research with any
basic class of controlled substance listed in Schedule II shall include
the Administration Controlled Substances Code Number, as set forth in
part 1308 of this chapter, for each such basic class to be manufactured
or imported as a coincident activity of that registration. A statement
listing the quantity of each such basic class or controlled substance to
be imported or manufactured during the registration period for which
application is being made shall be included with each such application.
For purposes of this paragraph only, manufacturing is defined as the
production of a controlled substance by synthesis, extraction or by
agricultural/horticultural means.
(f) Each application shall include all information called for in the
form, unless the item is not applicable, in which case this fact shall
be indicated.
(g) Each application, attachment, or other document filed as part of
an application, shall be signed by the applicant, if an individual; by a
partner of the applicant, if a partnership; or by an officer of the
applicant, if a corporation, corporate division, association, trust or
other entity. An applicant may authorize one or more individuals, who
would not otherwise be authorized to do so, to sign applications for the
applicant by filing with the Registration Unit of the Administration a
power of attorney for each such individual. The power of attorney shall
be signed by a person who is authorized to sign applications under this
paragraph and shall contain the signature of the individual being
authorized to sign applications. The power of attornex shall be valid
until revoked by the applicant.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18729, Sept. 21, 1971;
37 FR 15918, Aug. 8, 1972; 37 FR 28712, Dec. 29, 1972. Redesignated at
38 FR 26609, Sept. 24, l973]
Editorial Note: For FR citations affecting Sec. 1301.32, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1301.33 Research protocols.
(a) A protocol to conduct research with controlled substances listed
in Schedule I shall be in the following form and contain the following
information where applicable:
(1) Investigator:
(i) Name, address, and DEA registration number; if any.
(ii) Institutional affiliation.
(iii) Qualifications, including a curriculum vitae and an
appropriate bibliography (list of publications).
(2) Research project:
(i) Title of project.
(ii) Statement of the purpose.
(iii) Name of the controlled substances or substances involved and
the amount of each needed.
(iv) Description of the research to be conducted, including the
number and species of research subjects, the dosage to be administered,
the route and method of administration, and the duration of the project.
(v) Location where the research will be conducted.
(vi) Statement of the security provisions for storing the controlled
substances (in accordance with Sec. 1301.75) and for dispensing the
controlled substances in order to prevent diversion.
(vii) If the investigator desires to manufacture or import any
controlled substance listed in paragraph (a)(2)(iii) of this section, a
statement of the quantity to be manufactured or imported and the sources
of the chemicals to be used or the substance to be imported.
(3) Authority:
(i) Institutional approval.
[[Page 16]]
(ii) Approval of a Human Research Committee for human studies.
(iii) Indication of an approved active Notice of Claimed
Investigational Exemption for a New Drug (number).
(iv) Indication of an approved funded grant (number), if any.
(b) In the case of a clinical investigation with controlled
substances listed in Schedule I, the applicant shall submit three copies
of a Notice of Claimed Investigational Exemption for a New Drug (IND)
together with a statement of the security provisions (as prescribed in
paragraph (a)(2)(v) of this section for a research protocol) to, and
have such submission approved by, the Food and Drug Administration as
required in 21 U.S.C. 355(i) and Sec. 130.3 of this title. Submission of
this Notice and statement to the Food and Drug Administration shall be
in lieu of a research protocol to the Administration as required in
paragraph (a) of this section. The applicant, when applying for
registration with the Administration, shall indicate that such notice
has been submitted to the Food and Drug Administration by submitting to
the Administration with his DEA (or BND) Form 225 three copies of the
following certificate:
I hereby certify that on -------- (Date), pursuant to 21 U.S.C.
355(i) and 21 CFR 130.3, I, ------------------------------ (Name and
Address of IND Sponsor) submitted a Notice of Claimed Investigational
Exemption for a New Drug (IND) to the Food and Drug Administration for:
------------------------------ (Name of Investigational Drug).
------------ (Date)
------------------------------ (Signature of Applicant).
(c) In the event that the registrant desires to increase the
quantity of a controlled substance used for an approved research
project, he shall submit a request to the Registration Unit, Drug
Enforcement Administration, Post Office Box 28083, Central Station,
Washington, DC 20005, by registered mail, return receipt requested. The
request shall contain the following information: DEA registration
number; name of the controlled substance or substances and the quantity
of each authorized in the approved protocol; and the additional quantity
of each desired. Upon return of the receipt, the registrant shall be
authorized to purchase the additional quantity of the controlled
substance or substances specified in the request. The Administration
shall review the letter and forward it to the Food and Drug
Administration together with the Administration comments. The Food and
Drug Administration shall approve or deny the request as an amendment to
the protocol and so notify the registrant. Approval of the letter by the
Food and Drug Administration shall authorize the registrant to use the
additional quantity of the controlled substance in the research project.
(d) In the event the registrant desires to conduct research beyond
the variations provided in the registrant's approved protocol (excluding
any increase in the quantity of the controlled substance requested for
his research project as outlined in paragraph (c) of this section), he
shall submit three copies of a supplemental protocol in accordance with
paragraph (a) of this section describing the new research and omitting
information in the supplemental protocol which has been stated in the
original protocol. Supplemental protocols shall be processed and
approved or denied in the same manner as original research protocols.
[37 FR 28712, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
l973, and amended at 51 FR 5319, Feb. 13, 1986]
Sec. 1301.34 Filing of application; joint filings.
(a) All applications for registration shall be submitted for filing
to the Registration Unit, Drug Enforcement Administration, Department of
Justice, Post Office Box 28083, Central Station, Washington, DC 20005.
The appropriate registration fee and any required attachments must
accompany the application.
(b) Any person required to obtain more than one registration may
submit all applications in one package. Each application must be
complete and should not refer to any accompanying application for
required information.
[36 FR 7778, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 51 FR 5319, Feb. 13, 1986]
[[Page 17]]
Sec. 1301.35 Acceptance for filing; defective applications.
(a) Applications submitted for filing are dated upon receipt. If
found to be complete, the application will be accepted for filing.
Applications failing to comply with the requirements of this part will
not generally be accepted for filing. In the case of minor defects as to
completeness, the Administrator may accept the application for filing
with a request to the applicant for additional information. A defective
application will be returned to the applicant within 10 days following
its receipt with a statement of the reason for not accepting the
application for filing. A defective application may be corrected and
resubmitted for filing at any time; the Administrator shall accept for
filing any application upon resubmission by the applicant, whether
complete or not.
(b) Accepting an application for filing does not preclude any
subsequent request for additional information pursuant to Sec. 1301.36
and has no bearing on whether the application will be granted.
Sec. 1301.36 Additional information.
The Administrator may require an applicant to submit such documents
or written statements of fact relevant to the application as he deems
necessary to determine whether the application should be granted. The
failure of the applicant to provide such documents or statements within
a reasonable time after being requested to do so shall be deemed to be a
waiver by the applicant of an opportunity to present such documents or
facts for consideration by the Administrator in granting or denying the
application.
Sec. 1301.37 Amendments to and withdrawal of applications.
(a) An application may be amended or withdrawn without permission of
the Administrator at any time before the date on which the applicant
receives an order to show cause pursuant to Sec. 1301.48. An application
may be amended or withdrawn with permission of the Administrator at any
time where good cause is shown by the applicant or where the amendment
or withdrawal is in the public interest.
(b) After an application has been accepted for filing, the request
by the applicant that it be returned or the failure of the applicant to
respond to official correspondence regarding the application, when sent
by registered or certified mail, return receipt requested, shall be
deemed to be a withdrawal of the application.
[36 FR 7778, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
as amended at 60 FR 32101, June 20, 1995]
Sec. 1301.38 Special procedures for certain applications.
(a) If, at the time of application for registration of a new
pharmacy, the pharmacy has been issued a license from the appropriate
State licensing agency, the applicant may include with his application
an affidavit as to the existence of the State license in the following
form:
Affidavit for New Pharmacy
I, ----------, the ------------------------ (Title of officer,
official, partner, or other position) of ------------------------
(Corporation, partnership, or sole proprietor), doing business as ------
---------- (Store name) at ---------------- (Number and Street), ------
---------- (City) ---------------- (State) ---------------- (Zip code),
hereby certify that said store was issued a pharmacy permit No. --------
by the ------------------------ (Board of Pharmacy or Licensing Agency)
of the State of -------------------- on ------------ (Date).
This statement is submitted in order to obtain a Drug Enforcement
Administration registration number. I understand that if any information
is false, the Administration may immediately suspend the registration
for this store and commence proceedings to revoke under 21 U.S.C. 824(a)
because of the danger to public health and safety. I further understand
that any false information contained in this affidavit may subject me
personally and the above-named corporation/partnership/business to
prosecution under 21 U.S.C. 843, the penalties for conviction of which
include imprisonment for up to 4 years, a fine of not more than $30,000
or both.
........................................................................
Signature (Person who signs Application for Registration)
State of ------------
County of --------------
Subscribed to and sworn before me this ---------- day of --------------,
19----.
........................................................................
Notary Public
(b) Whenever the ownership of a pharmacy is being transferred from
one
[[Page 18]]
person to another, if the transferee owns at least one other pharmacy
licensed in the same State as the one the ownership of which is being
transferred, the transferee may apply for registration prior to the date
of transfer. The Administrator may register the applicant and authorize
him to obtain controlled substances at the time of transfer. Such
registration shall not authorize the transferee to dispense controlled
substances until the pharmacy has been issued a valid State license. The
transferee shall include with his application the following affidavit:
Affidavit for Transfer of Pharmacy
I, ----------------, the ------------------------ (Title of officer,
official, partner or other position) of ------------------------
(Corporation, partnership, or sole proprietor), doing business as ------
---------- (Store name) hereby certify:
(1) That said company was issued a pharmacy permit No. -------- by
the ------------------------ (Board of Pharmacy of Licensing Agency) of
the State of ---------------- and a DEA Registration Number ----------
for a pharmacy located at -------------------- (Number and Street) ----
------------ (City) ------------------ (State) ---------------- (Zip
Code); and
(2) That said company is acquiring the pharmacy business of --------
-------- (Name of Seller) doing business as ---------------- with DEA
Registration Number ---------- on or about ---------------- (Date of
Transfer) and that said company has applied (or will apply on ----------
------ (Date) for a pharmacy permit from the board of pharmacy (or
licensing agency) of the State of ---------------- to do business as --
-------------- (Store name) at ---------------- (Number and Street) ----
------------ (City) ---------------- (State) ---------------- (Zip
Code).
This statement is submitted in order to obtain a Drug Enforcement
Administration registration number.
I understand that if a DEA registration number is issued, the
pharmacy may acquire controlled substances but may not dispense them
until a pharmacy permit or license is issued by the State board of
pharmacy or licensing agency.
I understand that if any information is false, the Administration
may immediately suspend the registration for this store and commence
proceedings to revoke under 21 U.S.C. 824(a) because of the danger to
public health and safety. I further understand that any false
information contained in this affidavit may subject me personally to
prosecution under 21 U.S.C. 843, the penalties for conviction of which
include imprisonment for up to 4 years, a fine of not more than $30,000
or both.
........................................................................
Signature (Person who signs Application for Registration)
State of ------------
County of --------------
Subscribed to and sworn before me this ------------day of --------------
--, 19----.
........................................................................
Notary Public
(c) The Administrator shall follow the normal procedures for
approving an application to verify the statements in the affidavit. If
the statements prove to be false, the Administrator may revoke the
registration on the basis of section 1304(a)(1) of the Act (21 U.S.C.
824(a)(1)) and suspend the registration immediately by pending
revocation on the basis of section 1304(d) of the Act (21 U.S.C.
824(d)). At the same time, the Administrator may seize and place under
seal all controlled substances possessed by the applicant under section
1304(f) of the Act (21 U.S.C. 824(f)). International misuse of the
affidavit procedure may subject the applicant to prosecution for fraud
under section 403(a)(4) of the Act (21 U.S.C. 843(a)(4)), and obtaining
controlled substances under a registration fraudulently gotten may
subject the applicant to prosecution under section 403(a)(3) of the Act
(21 U.S.C. 843(a)(3)). The penalties for conviction of either offense
include imprisonment for up to 4 years, a fine not exceeding $30,000 or
both.
[38 FR 756, Jan. 4, 1973. Redesignated at 38 FR 26609, Sept. 24, l973]
Action on Applications for Registration: Revocation or Suspension of
Registration
Sec. 1301.41 Administrative review generally.
The Administrator may inspect, or cause to be inspected, the
establishment of an applicant or registrant, pursuant to subpart A of
part 1316 of this chapter. The Administrator shall review, the
application for registration and other information gathered by the
Administrator regarding an applicant in order to determine whether the
applicable standards of section 1303 of the Act (21 U.S.C. 823) have
been met by the applicant.
[[Page 19]]
Sec. 1301.42 Action on applications for research in Schedule I substances.
(a) In the case of an application for registration to conduct
research with controlled substances listed in Schedule I, the
Administrator shall process the application and protocol and forward a
copy of each to the Secretary within 7 days after receipt. The Secretary
shall determine the qualifications and competency of the applicant, as
well as the merits of the protocol (and shall notify the Administrator
of his determination) within 21 days after receipt of the application
and complete protocol, except that in the case of a clinical
investigation, the Secretary shall have 30 days to make such
determination and notify the Administrator. The Secretary, in
determining the merits of the protocol, shall consult with the
Administrator as to effective procedures to safeguard adequately against
diversion of such controlled substances from legitimate medical or
scientific use.
(b) An applicant whose protocol is defective shall be notified by
the Secretary within 21 days after receipt of such protocol from the
Administrator (or in the case of a clinical investigation within 30
days), and he shall be requested to correct the existing defects before
consideration shall be given to his submission.
(c) If the Secretary determines the applicant qualified and
competent and the research protocol meritorious, he shall notify the
Administrator in writing of such determination. The Administrator shall
issue a certificate of registration within 10 days after receipt of this
notice, unless he determines that the certificate of registration should
be denied on a ground specified in section 304(a) of the Act (21 U.S.C.
824(a)). In the case of a supplemental protocol, a replacement
certificate of registration shall be issued by the Administrator.
(d) If the Secretary determines that the protocol is not meritorious
and/or the applicant is not qualified or competent, he shall notify the
Administrator in writing setting forth the reasons for such
determination. If the Administrator determines that grounds exist for
the denial of the application, he shall within 10 days issue an order to
show cause pursuant to Sec. 1301.48 and, if requested by the applicant,
hold a hearing on the application pursuant to Sec. 1301.51. If the
grounds for denial of the application include a determination by the
Secretary, the Secretary or his duly authorized agent shall furnish
testimony and documents pertaining to his determination at such hearing.
(e) Supplemental protocols will be processed in the same manner as
original research protocols. If the processing of an application or
research protocol is delayed beyond the time limits imposed by this
section, the applicant shall be so notified in writing.
[37 FR 28712, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
l973]
Sec. 1301.43 Application for bulk manufacture of Schedule I and II substances.
(a) In the case of an application for registration or reregistration
to manufacture in bulk a basic class of controlled substance listed in
Schedule I or II, the Administrator shall, upon the filing of such
application, publish in the Federal Register a notice naming the
applicant and stating that such applicant has applied to be registered
as a bulk manufacturer of a basic class of narcotic or nonnarcotic
controlled substance, which class shall be identified. A copy of said
notice shall be mailed simultaneously to each person registered as a
bulk manufacturer of that basic class and to any other applicant
therefor. Any such person may, within 60 days from the date of
publication of the notice in the Federal Register, file with the
Administrator written comments on or objections to the issuance of the
proposed registration.
(b) In order to provide adequate competition, the Administrator
shall not be required to limit the number of manufacturers in any basic
class to a number less than that consistent with maintenance of
effective controls against diversion solely because a smaller number is
capable of producing an adequate and uninterrupted supply.
(c) This section shall not apply to the manufacture of basic classes
of controlled substances listed in Schedules I or II as an incident to
research or
[[Page 20]]
chemical analysis as authorized in Sec. 1301.22 (b).
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18729, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973; 60 FR 32101, June 20, 1995]
Sec. 1301.44 Certificate of registration; denial of registration.
(a) The Administrator shall issue a Certificate of Registration (DEA
Form 223) to an applicant if the issuance of registration or
reregistration is required under the applicable provisions of section
303 of the Act (21 U.S.C. 823). In the event that the issuance of
registration or reregistration is not required, the Administrator shall
deny the application. Before denying any application, the Administrator
shall issue an order to show cause pursuant to Sec. 1301.48 and, if
requested by the applicant, shall hold a hearing on the application
pursuant to Sec. 1301.51.
(b) If a hearing is requested by an applicant for registration or
reregistration to manufacture in bulk a basic class of controlled
substance listed in Schedule I or II, notice that a hearing has been
requested shall be published in the Federal Register and shall be mailed
simultaneously to the applicant and to all persons to whom notice of the
application was mailed. Any person entitled to file comments or
objections to the issuance of the proposed registration pursuant to
Sec. 1301.43(a) may participate in the hearing by filing a notice of
appearance in accordance with Sec. 1301.54. Such persons shall have 30
days to file a notice of appearance after the date of publication of the
notice of a request for a hearing in the Federal Register.
(c) The Certificate of Registration (DEA Form 223) shall contain the
name, address, and registration ntmber of the registrant, the activity
authorized by the registration, the schedules and/or Administration
Controlled Substances Code Number (as set forth in part 1308 of this
chapter) of the controlled substances which the registrant is authorized
to handle, the amount of fee paid (or exemption), and the expiration
date of the registration. The registrant shall maintain the certificate
of registration at the registered location in a readily retrievable
manner and shall permit inspection of the certificate by any official,
agent or employee of the Administration or of any Federal, State, or
local agency engaged in enforcement of laws relating to controlled
substances.
[36 FR 7778, Apr. 24, 1971, as amended at 37 FR 15918, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, l973 and amended at 53 FR 4963,
Feb. 19, 1988; 60 FR 32101, June 20, 1995]
Sec. 1301.45 Suspension or revocation of registration.
(a) The Administrator may suspend any registration pursuant to
section 304 (a) of the Act (21 U.S.C. 824(a)) for any period of time he
determines.
(b) The Administrator may revoke any registration pursuant to
section 304 (a) of the Act (21 U.S.C. 824(a)).
(c) Before revoking or suspending any registration, the
Administrator shall issue an order to show cause pursuant to
Sec. 1301.48 and, if requested by the registrant, shall hold a hearing
pursuant to Sec. 1301.51. Notwithstanding the requirements of this
section, however, the Administrator may suspend any registration pending
a final order pursuant to Sec. 1301.46.
(d) Upon service of the order of the Administrator suspending or
revoking registration, the registrant shall immediately deliver his
Certificate of Registration and any order forms in his possession to the
nearest office of the Administration. The suspension or revocation of a
registration shall suspend or revoke any individual manufacturing or
procurement quota fixed for the registrant pursuant to part 303 of this
chapter. Also, upon service of the order of the Administrator revoking
or suspending registration, the registrant shall, as instructed by the
Administrator:
(1) Deliver all controlled substances in his possession to the
nearest office of the Administrator or to authorized agents of the
Administrator; or
(2) Place all controlled substances in his possession under seal as
described in section 304(f) of the Act (21 U.S.C. 824(f)).
(e) In the event that revocation or suspension is limited to a
particular controlled substance or substances, the registrant shall be
given a new
[[Page 21]]
Certificate of Registration for all substances not affected by such
revocation or suspension; no fee shall be required to be paid for the
new Certificate of Registration. The registrant shall deliver the old
Certificate of Registration and, if appropriate, any order forms in his
possession to the nearest office of the Administration. The suspension
or revocation of a registration, when limited to a particular basic
class or classes of controlled substances, shall suspend or revoke any
individual manufacturing or procurement quota fixed for the registrant
for such class or classes pursuant to part 303 of this chapter. Also,
upon service of the order of the Administrator revoking or suspending
registration, the registrant shall, as instructed by the Administrator:
(1) Deliver to the nearest office of the Administration or to
authorized agents of the Administration all of the particular controlled
substance or substances affected by the revocation or suspension which
are in his possession; or
(2) Place all of such substances under seal as described in section
304(f) of the Act (21 U.S.C. 824(f)).
[36 FR 7778, Apr. 24, 1971, as amended at 37 FR 15919, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, l973]
Sec. 1301.46 Suspension of registration pending final order.
(a) The Administrator may suspend any registration simultaneously
with or at any time subsequent to the service upon the registrant of an
order to show cause why such registration should not be revoked or
suspended, in any case where he finds that there is an imminent danger
to the public health or safety. If the Administrator so suspends, he
shall serve with the order to show cause pursuant to Sec. 1301.48 an
order of immediate suspension which shall contain a statement of his
findings regarding the danger to public health or safety.
(b) Upon service of the order of immediate suspension, the
registrant shall promptly return his Certificate of Registration and any
order forms in his possession to the nearest office of the
Administration. The suspension of any registration under this section
shall suspend any quota fixed for the registrant pursuant to part 1303
of this chapter. Also, upon service of the order of the Administrator
immediately suspending registration, the registrant shall, as instructed
by the Administrator:
(1) Deliver all affected controlled substances in his possession to
the nearest office of the Administration or to authorized agents of the
Administration; or
(2) Place all of such substances under seal as described in section
304(f) of the Act (21 U.S.C. 824(f)).
(c) Any suspension shall continue in effect until the conclusion of
all proceedings upon the revocation or suspension, including any
judicial review thereof, unless sooner withdrawn by the Administrator or
dissolved by a court of competent jurisdiction. Any registrant whose
registration is suspended under this section may request a hearing on
the revocation or suspension of his registration at a time earlier than
specified in the order to show cause pursuant to Sec. 1301.48, which
request shall be granted by the Administrator, who shall fix a date for
such hearing as early as reasonably possible.
Sec. 1301.47 Extension of registration pending final order.
In the event that an applicant for reregistration (who is doing
business under a registration previously granted and not revoked or
suspended) has applied for reregistration at least 45 days before the
date on which the existing registration is due to expire, and the
Administrator has issued no order on the application on the date on
which the existing registration is due to expire, the existing
registration of the applicant shall automatically be extended and
continue in effect until the date on which the Administrator so issues
his order. The Administrator may extend any other existing registration
under the circumstances contemplated in this section even though the
registrant failed to apply for reregistration at least 45 days before
expiration of the existing registration, with or without request by the
registrant, if the Administrator finds that such extension is not
inconsistent with the public health and safety.
[[Page 22]]
Sec. 1301.48 Order to show cause.
(a) If, upon examination of the application for registration from
any applicant and other information gathered by the Administration
regarding the applicant, the Administrator is unable to make the
determinations required by the applicable provisions of section 303 of
the Act (21 U.S.C. 823) to register the applicant, the Administrator
shall serve upon the applicant an order to show cause why the
registration should not be denied.
(b) If, upon information gathered by the Administration regarding
any registrant, the Administrator determines that the registration of
such registrant is subject to suspension or revocation pursuant to
section 304 of the Act (21 U.S.C. 824), the Administrator shall serve
upon the registrant an order to show cause why the registration should
not be revoked or suspended.
(c) The order to show cause shall call upon the applicant or
registrant to appear before the Administrator at a time and place stated
in the order, which shall not be less than 30 days after the date of
receipt of the order. The order to show cause shall also contain a
statement of the legal basis for such hearing and for the denial,
revocation, or suspension of registration and a summary of the matters
of fact and law asserted.
(d) Upon receipt of an order to show cause, the applicant or
registrant must, if he desires a hearing, file a request for a hearing
pursuant to Sec. 1301.54. If a hearing is requested, the Administrator
shall hold a hearing at the time and place stated in the order, pursuant
to Sec. 1301.51.
(e) When authorized by the Administrator, any agent of the
Administration may serve the order to show cause.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973]
Hearings
Sec. 1301.51 Hearings generally.
(a) In any case where the Administrator shall hold a hearing on any
registration or application therefor, the procedures for such hearing
shall be governed generally by the adjudication procedures set forth in
the Administrative Procedure Act (5 U.S.C. 551-559) and specifically by
sections 303 and 304 of the Act (21 U.S.C. 823-824), by Secs. 1301.52-
1301.57, and by the procedures for administrative hearings under the Act
set forth in Secs. 1316.41-1316.67 of this chapter.
(b) Any hearing under this part shall be independent of, and not in
lieu of, criminal prosecutions or other proceedings under the Act or any
other law of the United States.
Sec. 1301.52 Purpose of hearing.
If requested by a person entitled to a hearing, the Administrator
shall hold a hearing for the purpose of receiving factual evidence
regarding the issues involved in the denial, revocation, or suspension
of any registration, and the granting of any application for
registration to manufacture in bulk a basic class of controlled
substance listed in Schedule I or II. Extensive argument should not be
offered into evidence but rather presented in opening or closing
statements of counsel or in memoranda or proposed findings of fact and
conclusions of law.
Sec. 1301.53 Waiver or modification of rules.
The Administrator or the presiding officer (with respect to matters
pending before him) may modify or waive any rule in this part by notice
in advance of the hearing, if he determines that no party in the hearing
will be unduly prejudiced and the ends of justice will thereby be
served. Such notice of modification or waiver shall be made a part of
the record of the hearing.
Sec. 1301.54 Request for hearing or appearance; waiver.
(a) Any person entitled to a hearing pursuant to Secs. 1301.42,
1301.44, or 1301.45 and desiring a hearing shall, within 30 days after
the date of receipt of the order to shown cause, file with the
Administrator a written request for a hearing in the form prescribed in
Sec. 1316.47 of this chapter.
(b) Any person entitled to participate in a hearing pursuant to
Sec. 1301.44(b) and desiring to do so shall, within 30 days of the date
of publication of notice of the request for a hearing in the
[[Page 23]]
Federal Register, file with the Administrator a written notice of intent
to participate in such hearing in the form prescribed in Sec. 1316.48 of
this chapter. Any person filing a request for a hearing need not also
file a notice of appearance.
(c) Any person entitled to a hearing or to participate in a hearing
pursuant to Secs. 1301.42, 1301.44, or 1301.45 may, within the period
permitted for filing a request for a hearing or a notice of appearance,
file with the Administrator a waiver of an opportunity for a hearing or
to participate in a hearing, together with a written statement regarding
such person's position on the matters of fact and law involved in such
hearing. Such statement, if admissible, shall be made a part of the
record and shall be considered in light of the lack of opportunity for
cross-examination in determining the weight to be attached to matters of
fact asserted therein.
(d) If any person entitled to a hearing or to participate in a
hearing pursuant to Secs. 1301.42, 1301.44, or 1301.45 fails to file a
request for a hearing or a notice of appearance, or if such person so
files and fails to appear at the hearing, such person shall be deemed to
have waived the opportunity for a hearing or to participate in the
hearing, unless such person shows good cause for such failure.
(e) If all persons entitled to a hearing or to participate in a
hearing waive or are deemed to waive their opportunity for the hearing
or to participate in the hearing, the Administrator may cancel the
hearing, if scheduled, and issue his final order pursuant to
Sec. 1301.57 without a hearing.
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973; 60 FR 32101, June 20, 1995]
Sec. 1301.55 Burden of proof.
(a) At any hearing on an application to manufacture any controlled
substance listed in Schedule I or II, the applicant shall have the
burden of proving that the requirements for such registration pursuant
to section 303(a) of the Act (21 U.S.C. 823(a)) are satisfied. Any other
person participating in the hearing pursuant to Sec. 1301.44(b) shall
have the burden of proving any propositions of fact or law asserted by
such person in the hearing.
(b) At any hearing on the granting or denial of an applicant to be
registered to conduct a narcotic treatment program or as a compounder,
the applicant shall have the burden of proving that the requirements for
each registration pursuant to section 303(g) of the Act (21 U.S.C.
823(g)) are satisfied.
(c) At any other hearing for the denial of a registration, the
Administration shall have the burden of proving that the requirements
for such registration pursuant to section 303 of the Act (21 U.S.C. 823)
are not satisfied.
(d) At any hearing for the revocation or suspension of a
registration, the Administration shall have the burden of proving that
the requirements for such revocation or suspension to section 304 (a) of
the Act (21 U.S.C. 824(a)) are satisfied.
[36 FR 7778, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 41 FR 21448, May 26, 1976; 60 FR 32102, June 20, 1995]
Sec. 1301.56 Time and place of hearing.
The hearing will commence at the place and time designated in the
order to show cause or notice of hearing published in the Federal
Register (unless expedited pursuant to Sec. 1301.46(c)) but thereafter
it may be moved to a different place and may be continued from day to
day or recessed to a later day without notice other than announcement
thereof by the presiding officer at the hearing.
Sec. 1301.57 Final order.
As soon as practicable after the presiding officer has certified the
record to the Administrator, the Administrator shall issue his order on
the granting, denial, revocation, or suspension of registration. In the
event that an application for registration to manufacture in bulk a
basic class of any controlled substance listed in Schedule I or II is
granted, or any application for registration is denied, or any
registration is revoked or suspended, the order shall include the
findings of fact and conclusions of law upon which the order is based.
The order shall specify the date on which it shall take effect. The
Administrator shall serve one copy
[[Page 24]]
of his order upon each party in the hearing.
Modification, Transfer and Termination of Registration
Sec. 1301.61 Modification in registration.
Any registrant may apply to modify his registration to authorize the
handling of additional controlled substances or to change his name or
address, by submitting a letter of request to the Registration Unit,
Drug Enforcement Administration, Department of Justice, Post Office Box
28083, Central Station, Washington, DC 20005. The letter shall contain
the registrant's name, address, and registration number as printud on
the certificate of registration, and the substances and/or schedules to
be added to his registration or the new name or address and shall be
signed in accordance with Sec. 1301.32(f). If the registrant is seeking
to handle additional controlled substances listed in Schedule I for the
purpose of research or instructional activities, he shall attach three
copies of a research protocol describing each research project involving
the additional substances, or two copies of a statement describing the
nature, extent, and duration of such instructional activities, as
appropriate. No fee shall be required to be paid for the modification.
The request for modification shall be handled in the same manner as an
application for registration. If the modification in registration is
approved, the Administrator shall issue a new certificate of
registration (DEA Form 223) to the registrant, who shall maintain it
with the old certificate of registration until expiration.
[36 FR 18729, Sept. 21, 1971, as amended at 37 FR 15919, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, l973, and amended at 51 FR 5319,
Feb. 13, 1986; 53 FR 4963, Feb. 19, 1988]
Sec. 1301.62 Termination of registration.
The registration of any person shall terminate if and when such
person dies, ceases legal existence, or discontinues business or
professional practice. Any registrant who ceases legal existence or
discontinues business or professional practice shall notify the
Administrator promptly of such fact.
[37 FR 15919, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, l973]
Sec. 1301.63 Transfer of registration.
No registration or any authority conferred thereby shall be assigned
or otherwise transferred except upon such conditions as the
Administrator may specifically designate and then only pursuant to his
written consent.
Security Repuirements
Sec. 1301.71 Security requirements generally.
(a) All applicants and registrants shall provide effective controls
and procedures to guard against theft and diversion of controlled
substances. In order to determine whether a registrant has provided
effective controls against diversion, the Administrator shall use the
security requirements set forth in Secs. 1301.72-1301.76 as standards
for the physical security controls and operating procedures necessary to
prevent diversion. Materials and construction which will provide a
structural equivalent to the physical security controls set forth in
Secs. 1301.72, 1301.73 and 1301.75 may be used in lieu of the materials
and construction described in those sections.
(b) Substantial compliance with the standards set forth in
Secs. 1301.72-1301.76 may be deemed sufficient by the Administrator
after evaluation of the overall security system and needs of the
applicant or registrant. In evaluating the overall security system of a
registrant or applicant, the Administrator may consider any of the
following factors as he may deem relevant to the need for strict
compliance with security requirements:
(1) The type of activity conducted (e.g., processing of bulk
chemicals, preparing dosage forms, packaging, labeling, cooperative
buying, etc.);
(2) The type and form of controlled substances handled (e.g., bulk
liquids or dosage units, usable powders or nonusable powders);
(3) The quantity of controlled substances handled;
[[Page 25]]
(4) The location of the premises and the relationship such location
bears on security needs;
(5) The type of building construction comprising the facility and
the general characteristics of the building or buildings;
(6) The type of vault, safe, and secure enclosures or other storage
system (e.g., automatic storage and retrieval system) used;
(7) The type of closures on vaults, safes, and secure enclosures;
(8) The adequacy of key control systems and/or combination lock
control systems;
(9) The adequacy of electric detection and alarm systems, if any
including use of supervised transmittal lines and standby power sources;
(10) The extent of unsupervised public access to the facility,
including the presence and characteristics of perimeter fencing, if any;
(11) The adequacy of supervision over employees having access to
manufacturing and storage areas;
(12) The procedures for handling business guests, visitors,
maintenance personnel, and nonemployee service personnel;
(13) The availability of local police protection or of the
registrant's or applicant's security personnel, and;
(14) The adequacy of the registrant's or applicant's system for
monitoring the receipt, manufacture, distribution, and disposition of
controlled substances in its operations.
(c) When physical security controls become inadequate as a result of
a controlled substance being transferred to a different schedule, or as
a result of a noncontrolled substance being listed on any schedule, or
as a result of a significant increase in the quantity of controlled
substances in the possession of the registrant during normal business
operations, the physical security controls shall be expanded and
extended accordingly. A registrant may adjust physical security controls
within the requirements set forth in Secs. 1301.72-1301.76 when the need
for such controls decreases as a result of a controlled substance being
transferred to a different schedule, or a result of a controlled
substance being removed from control, or as a result of a significant
decrease in the quantity of controlled substances in the possession of
the registrant during normal business operations.
(d) Any registrant or applicant desiring to determine whether a
proposed security system substantially complies with, or is the
structural equivalent of, the requirements set forth in Secs. 1301.72-
1301.76 may submit any plans, blueprints, sketches or other materials
regarding the proposed security system either to the Special Agent in
Charge in the region in which the system will be used, or to the
Diversion Operations Section, Drug Enforcement Administration,
Department of Justice, Washington, DC 20537.
(e) Physical security controls of locations registered under the
Harrison Narcotic Act or the Narcotics Manufacturing Act of 1960 on
April 30, 1971, shall be deemed to comply substantially with the
standards set forth in Secs. 1301.72, 1301.73 and 1301.75. Any new
facilities or work or storage areas constructed or utilized for
controlled substances, which facilities or work or storage areas have
not been previously approved by the Administration, shall not
necessarily be deemed to comply substantially with the standards set
forth in Secs. 1301.72, 1301.73 and 1301.75, notwithstanding that such
facilities or work or storage areas have physical security controls
similar to those previously approved by the Administration.
[36 FR 18729, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
l973, and amended at 46 FR 28841, May 29, 1981; 47 FR 41735, Sept. 22,
1982; 51 FR 5319, Feb. 13, 1986]
Sec. 1301.72 Physical security controls for non-practitioners; narcotic treatment programs and compounders for narcotic treatment programs; storage areas.
(a) Schedules I and II. Raw materials, bulk materials awaiting
further processing, and finished products which are controlled
substances listed in Schedule I or II shall be stored in one of the
following secure storage areas:
(1) Where small quantities permit, a safe or steel cabinet;
(i) Which safe or steel cabinet shall have the following
specifications or the equivalent: 30 man-minutes against
[[Page 26]]
surreptitious entry, 10 man-minutes against forced entry, 20 man-hours
against lock manipulation, and 20 man-hours against radiological
techniques;
(ii) Which safe or steel cabinet, if it weighs less than 750 pounds,
is bolted or cemented to the floor or wall in such a way that it cannot
be readily removed; and
(iii) Which safe or steel cabinet, if necessary, depending upon the
quantities and type of controlled substances stored, is equipped with an
alarm system which, upon attempted unauthorized entry, shall transmit a
signal directly to a central protection company or a local or State
police agency which has a legal duty to respond, or a 24-hour control
station operated by the registrant, or such other protection as the
Administrator may approve.
(2) A vault constructed before, or under construction on, September
1, 1971, which is of substantial construction with a steel door,
combination or key lock, and an alarm system; or
(3) A vault constructed after September 1, 1971:
(i) The walls, floors, and ceilings of which vault are constructed
of at least 8 inches of reinforced concrete or other substantial
masonry, reinforced vertically and horizontally with \1/2\-inch steel
rods tied 6 inches on center, or the structural equivalent to such
reinforced walls, floors, and ceilings;
(ii) The door and frame unit of which vault shall conform to the
following specifications or the equivalent: 30 man-minutes against
surreptitious entry, 10 man-minutes against forced entry, 20 man-hours
against lock manipulation, and 20 man-hours against radiological
techniques;
(iii) Which vault, if operations require it to remain open for
frequent access, is equipped with a ``day-gate'' which is self-closing
and self-locking, or the equivalent, for use during the hours of
operation in which the vault door is open;
(iv) The walls or perimeter of which vault are equipped with an
alarm, which upon unauthorized entry shall transmit a signal directly to
a central station protection company, or a local or State police agency
which has a legal duty to respond, or a 24-hour control station operated
by the registrant, or such other protection as the Administrator may
approve, and, if necessary, holdup buttons at strategic points of entry
to the perimeter area of the vault;
(v) The door of which vault is equipped with contact switches; and
(vi) Which vault has one of the following: Complete electrical
lacing of the walls, floor and ceilings; sensitive ultrasonic equipment
within the vault; a sensitive sound accumulator system; or such other
device designed to detect illegal entry as may be approved by the
Administration.
(b) Schedules III, IV and V. Raw materials, bulk materials awaiting
further processing, and finished products which are controlled
substances listed in Schedules III, IV and V shall be stored in the
following secure storage areas:
(1) A safe or steel cabinet as described in paragraph (a)(1) of this
section;
(2) A vault as described in paragraph (a)(2) or (3) of this section
equipped with an alarm system as described in paragraph (b)(4)(v) of
this section;
(3) A building used for storage of Schedules III through V
controlled substances with perhmeter security which limits access during
working hours and provides security after working hours and meets the
following specifications:
(i) Has an electronic alarm system as described in paragraph
(b)(4)(v) of this section,
(ii) Is equipped with self-closing, self-locking doors constructed
of substantial material commensurate with the type of building
construction, provided, however, a door which is kept clored and locked
at all times when not in use and when in use is kept under direct
observation of a responsible employee or agent of the registrant is
permitted in lieu of a self-closing, self-locking door. Doors may be
sliding or hinged. Regarding hinged doors, where hinges are mounted on
the outside, such hinges shall be sealed, welded or otherwise
constructed to inhibit removal. Locking devices for such doors shall be
either of the multiple-position combination or key lock type and:
(a) In the case of key locks, shall require key control which limits
access to a limited number of employees, or;
[[Page 27]]
(b) In the case of combination locks, the combination shall be
limited to a minimum number of employees and can be changed upon
termination of employment of an employee having knowledge of the
combination;
(4) A cage, located within a building on the premises, meeting the
following specifications:
(i) Having walls constructed of not less than No. 10 gauge steel
fabric mounted on steel posts, which posts are:
(a) At least one inch in diameter;
(b) Set in concrete or installed with lay bolts that are pinned or
brazed; and
(c) Which are placed no more than ten feet apart with horizontal one
and one-half inch reinforcements every sixty inches;
(ii) Having a mesh construction with openings of not more than two
and one-half inches across the square,
(iii) Having a ceiling constructed of the same material, or in the
alternative, a cage shall be erected which reaches and is securely
attached to the structural ceiling of the building. A lighter gauge mesh
may be used for the ceilings of large enclosed areas if walls are at
least 14 feet in height,
(iv) Is equipped with a door constructed of No. 10 gauge steel
fabric on a metal door frame in a metal door flange, and in all other
respects conforms to all the requirements of 21 CFR 1301.72(b)(3)(ii),
and
(v) Is equipped with an alarm system which upon unauthorized entry
shall transmit a signal directly to a central station protection agency
or a local or state police agency, each having a legal duty to respond,
or to a 24-hour control station operated by the registrant, or to such
other source of protection as the Administrator may approve;
(5) An enclosure of masonry or other material, approved in writing
by the Administrator as providing security comparable to a cage;
(6) A building or enclosure within a building which has been
inspected and approved by DEA or its predecessor agency, BNDD, and
continues to provide adequate security against the diversion of Schedule
III through V controlled substances, of which fact written
acknowledgment has been made by the Special Agent in Charge of DEA for
the area in which such building or enclosure is situated;
(7) Such other secure storage areas as may be approved by the
Administrator after considering the factors listed in Sec. 1301.71(b),
(1) through (14);
(8) (i) Schedule III through V controlled substances may be stored
with Schedules I and II controlled substances under security measures
provided by 21 CFR 1301.72(a);
(ii) Non-controlled drugs, substances and other materials may be
stored with Schedule III through V controlled substances in any of the
secure storage areas required by 21 CFR 1301.72(b), provided that
permission for such storage of non-controlled items is obtained in
advance, in writing, from the Special Agent in Charge of DEA for the
area in which such storage area is situated. Any such permission
tendered must be upon the Special Agent in Charge's written
determination that such non-segregated storage does not diminish
security effectiveness for Schedules III through V controlled
substances.
(c) Multiple storage areas. Where several types or classes of
controlled substances are handled separately by the registrant or
applicant for different purposes (e.g., returned goods, or goods in
process), the controlled substances may be stored separately, provided
that each storage area complies with the requirements set forth in this
section.
(d) Accessibility to storage areas. The controlled substances
storage areas shall be accessible only to an absolute minimum number of
specifically authorized employees. When it is necessary for employee
maintenance personnel, nonemployee maintenance personnel, business
guests, or visitors to be present in or pass through controlled
substances storage areas, the registrant shall provide for adequate
observation of the area by an employee specifically authorized in
writing.
[36 FR 18730, Sept. 21, 1971, as amended at 37 FR 15919, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, l973]
Editorial Note: For Federal Register citations affecting
Sec. 1301.72, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
[[Page 28]]
Sec. 1301.73 Physical security controls for non-practitioners; compounders for narcotic treatment programs; manufacturing and compounding areas.
All manufacturing activities (including processing, packaging and
labeling) involving controlled substances listed in any schedule and all
activities of compounders shall be conducted in accordance with the
following:
(a) All in-process substances shall be returned to the controlled
substances storage area at the termination of the process. If the
process is not terminated at the end of a workday (except where a
continuous process or other normal manufacturing operation should not be
interrupted), the processing area or tanks, vessels, bins or bulk
containers containing such substances shall be securely locked, with
adequate security for the area or building. If such security requires an
alarm, such alarm, upon unauthorized entry, shall transmit a signal
directly to a central station protection company, or local or state
police agency which has a legal duty to respond, or a 24-hour control
station operated by the registrant.
(b) Manufacturing activities with controlled substances shall be
conducted in an area or areas of clearly defined limited access which is
under surveillance by an employee or employees designated in writing as
responsible for the area. ``Limited access'' may be provided, in the
absence of physical dividers such as walls or partitions, by traffic
control lines or restricted space designation. The employee designated
as responsible for the area may be engaged in the particular
manufacturing operation being conducted: Provided, That he is able to
provide continuous surveillance of the area in order that unauthorized
persons may not enter or leave the area without his knowledge.
(c) During the production of controlled substances, the
manufacturing areas shall be accessible to only those employees required
for efficient operation. When it is necessary for employee maintenance
personnel, nonemployee maintenance personnel, business guests, or
visitors to be present in or pass through manufacturing areas during
production of controlled substances, the registrant shall provide for
adequate observation of the area by an employee specifically authorized
in writing.
[36 FR 18731, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
l973 and amended at 39 FR 37984, Oct. 25, 1974]
Sec. 1301.74 Other security controls for non-practitioners; narcotic treatment programs and compounders for narcotic treatment programs.
(a) Before distributing a controlled substance to any person who the
registrant does not know to be registered to possess the controlled
substance, the registrant shall make a good faith inquiry either with
the Administration or with the appropriate State controlled substances
registration agency, if any, to determine that the person is registered
to possess the controlled substance.
(b) The registrant shall design and operate a system to disclose to
the registrant suspicious orders of controlled substances. The
registrant shall inform the Field Division Office of the Administration
in his area of suspicious orders when discovered by the registrant.
Suspicious orders include orders of unusual size, orders deviating
substantially from a normal pattern, and orders of unusual frequency.
(c) The registrant shall notify the Field Division Office of the
Administration in his area of any theft or significant loss of any
controlled substances upon discovery of such theft or loss. The supplier
shall be responsible for reporting in-transit losses of controlled
substances by the common or contract carrier selected pursuant to
Sec. 1301.74(e), upon discovery of such theft or loss. The registrant
shall also complete DEA Form 106 regarding such theft or loss. Thefts
must be reported whether or not the controlled substances are
subsequently recovered and/or the responsible parties are identified and
action taken against them.
(d) The registrant shall not distribute any controlled substance
listed in Schedules II through V as a complimentary sample to any
potential or current customer (1) without the prior written request of
the customer, (2) to be used only for satisfying the legitimate medical
needs of patients of the customer, and (3) only in reasonable
quantities. Such request must contain
[[Page 29]]
the name, address, and registration number of the customer and the name
and quantity of the specific controlled substance desired. The request
shall be preserved by the registrant with other records of distribution
of controlled substances. In addition, the requirements of part 1305 of
the chapter shall be complied with for any distribution of a controlled
substance listed in Schedule II. For purposes of this paragraph, the
term ``customer'' includes a person to whom a complimentary sample of a
substance is given in order to encourage the prescribing or recommending
of the substance by the person.
(e) When shipping controlled substances, a registrant is responsible
for selecting common or contract carriers which provide adequate
security to guard against in-transit losses. When storing controlled
substances in a public warehouse, a registrant is responsible for
selecting a warehouseman which will provide adequate security to guard
against storage losses; wherever possible, the registrant shall store
controlled substances in a public warehouse which complies with the
requirements set forth in Sec. 1301.72. In addition, the registrant
shall employ precautions (e.g., assuring that shipping containers do not
indicate that contents are controlled substances) to guard against
storage or in-transit losses.
(f) When distributing controlled substances through agents (e.g.,
detailmen), a registrant is responsible for providing and requiring
adequate security to guard against theft and diversion while the
substances are being stored or handled by the agent or agents.
(g) Before the initial distribution of carfentanil etorphine
hydrochloride and/or diprenorphine to any person, the registrant must
verify that the person is authorized to handle the substances(s) by
contacting the Drug Enforcement Administration.
(h) The acceptance of delivery of narcotic substances by a narcotic
treatment program shall be made only by a licensed practitioner employed
at the facility or other authorized individuals designated in writing.
At the time of delivery, the licensed practitioner or other authorized
individual designated in writing (excluding persons currently or
previously dependent on narcotic drugs), shall sign for the narcotics
and place his specific title (if any) on any invoice. Copies of these
signed invoices shall be kept by the distributor.
(i) Narcotics dispensed or administered at a narcotic treatment
program will be dispensed or administered directly to the patient by
either (1) the licensed practitioner, (2) a registered nurse under the
direction of the licensed practitioner, (3) a licensed practical nurse
under the direction of the licensed practitioner, or (4) a pharmacist
under the direction of the licensed practitioner.
(j) Persons enrolled in a narcotic treatment program will be
required to wait in an area physically separated from the narcotic
storage and dispensing area. This requirement will be enforced by the
program physician and employees.
(k) All narcotic treatment programs must comply with standards
established by the Secretary of Health and Human Services (after
consultation with the Administration) respecting the quantities of
narcotic drugs which may be provided to persons enrolled in a narcotic
treatment program for unsupervised use.
(l) DEA may exercise discretion regarding the degree of security
required in narcotic treatment programs based on such factors as the
location of a program, the number of patients enrolled in a program and
the number of physicians, staff members and security guards. Similarly,
such factors will be taken into consideration when evaluating existing
security or requiring new security at a narcotic treatment program.
[36 FR 7778, Apr. 24, 1971; 36 FR 13386, July 21, 1971, as amended at 36
FR 18731, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24, l973]
Editorial Note: For Federal Register citations affecting
Sec. 1301.74, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
Sec. 1301.75 Physical security controls for practitioners.
(a) Controlled substances listed in Schedule I shall be stored in a
securely
[[Page 30]]
locked, substantially constructed cabinet.
(b) Controlled substances listed in Schedules II, III, IV, and V
shall be stored in a securely locked, substantially constructed cabinet.
However, pharmacies and institutional practitioners (as defined in
Sec. 1304.02(e) of this chapter) may disperse such substances throughout
the stock of noncontrolled substances in such a manner as to obstruct
the theft or diversion of the controlled substances.
(c) This section shall also apply to nonpractitioners authorized to
conduct research or chemical analysis under another registration.
(d) Carfentanil etorphine hydrochloride and diprenorphine shall be
stored in a safe or steel cabinet equivalent to a U.S. Government Class
V security container.
[39 FR 3674, Jan. 29, 1974, as amended at 39 FR 17838, May 21, 1974; 54
FR 33674, Aug. 16, 1989]
Sec. 1301.76 Other security controls for practitioners.
(a) The registrant shall not employ, as an agent or employee who has
access to controlled substances, any person who has been convicted of a
felony offense relating to controlled substances or who, at any time,
had an application for registration with the DEA denied, had a DEA
registration revoked or has surrendered a DEA registration for cause.
For purposes of this subsection, the term ``for cause'' means a
surrender in lieu of, or as a consequence of, any federal or state
administrative, civil or criminal action resulting from an investigation
of the individual's handling of controlled substances.
(b) The registrant shall notify the Field Division Office of the
Administration in his area of the theft or significant loss of any
controlled substances upon discovery of such loss or theft. The
registrant shall also complete DEA (or BND) Form 106 regarding such loss
or theft.
(c) Whenever the registrant distributes a controlled substance
(without being registered as a distributor, as permitted in
Sec. 1301.22(b) and/or Secs. 1307.11-1307.14), he shall comply with the
requirements imposed on nonpractitioners in Sec. 1301.74 (a), (b), and
(e).
[36 FR 7778, Apr. 24, 1971, as amended at 36 FR 18731, Sept. 21, 1971;
37 FR 15919, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, l973;
47 FR 41735, Sept. 22, 1982; 56 FR 36728, Aug. 1, 1991]
Employee Screening--Non- Practitioners
Sec. 1301.90 Employee screening procedures.
It is the position of DEA that the obtaining of certain information
by non-practitioners is vital to fairly assess the likelihood of an
employee committing a drug security breach. The need to know this
information is a matter of business necessity, essential to overall
controlled substances security. In this regard, it is believed that
conviction of crimes and unauthorized use of controlled substances are
activities that are proper subjects for inquiry. It is, therefore,
assumed that the following questions will become a part of an employer's
comprehensive employee screening program:
Question. Within the past five years, have you been convicted of a
felony, or within the past two years, of any misdemeanor or are you
presently formally charged with committing a criminal offense? (Do not
include any traffic violations, juvenile offenses or military
convictions, except by general court-martial.) If the answer is yes,
furnish details of conviction, offense, location, date and sentence.
Question. In the past three years, have you ever knowingly used any
narcotics, amphetamines or barbiturates, other than those prescribed to
you by a physician? If the answer is yes, furnish details.
Advice. An authorization, in writing, that allows inquiries to be
made of courts and law enforcement agencies for possible pending charges
or convictions must be executed by a person who is allowed to work in an
area where access to controlled substances clearly exists. A person must
be advised that any false information or omission of information will
jeopardize his or her position with respect to employment. The
application for employment should inform a person that information
furnished or recovered as a result of any inquiry will not necessarily
preclude employment, but will be considered as part of an overall
evaluation of the person's qualifications. The maintaining of fair
employment practices, the protection of the person's right of privacy,
and the assurance
[[Page 31]]
that the results of such inquiries will be treated by the employer in
confidence will be explained to the employee.
[40 FR 17143, Apr. 17, 1975]
Sec. 1301.91 Employee responsibility to report drug diversion.
Reports of drug diversion by fellow employees is not only a
necessary part of an overall employee security program but also serves
the public interest at large. It is, therefore, the position of DEA that
an employee who has knowledge of drug diversion from his employer by a
fellow employee has an obligation to report such information to a
responsible security official of the employer. The employer shall treat
such information as confidential and shall take all reasonable steps to
protect the confidentiality of the information and the identity of the
employee furnishing information. A failure to report information of drug
diversion will be considered in determining the feasibility of
continuing to allow an employee to work in a drug security area. The
employer shall inform all employees concerning this policy.
[40 FR 17143, Apr. 17, 1975]
Sec. 1301.92 Illicit activities by employees.
It is the position of DEA that employees who possess, sell, use or
divert controlled substances will subject themselves not only to State
or Federal prosecution for any illicit activity, but shall also
immediately become the subject of independent action regarding their
continued employment. The employer will assess the seriousness of the
employee's violation, the position of responsibility held by the
employee, past record of employment, etc., in determining whether to
suspend, transfer, terminate or take other action against the employee.
[40 FR 17143, Apr. 17, 1975]
Sec. 1301.93 Sources of information for employee checks.
DEA recommends that inquiries concerning employees' criminal records
be made as follows:
Local inquiries. Inquiries should be made by name, date and place of
birth, and other identifying information, to local courts and law
enforcement agencies for records of pending charges and convictions.
Local practice may require such inquiries to be made in person, rather
than by mail, and a copy of an authorization from the employee may be
required by certain law enforcement agencies.
DEA inquiries. Inquiries supplying identifying information should
also be furnished to DEA Field Division Offices along with written
consent from the concerned individual for a check of DEA files for
records of convictions. The Regional check will result in a national
check being made by the Field Division Office.
[40 FR 17143, Apr. 17, 1975, as amended at 47 FR 41735, Sept. 22, 1982]
PART 1302--LABELING AND PACKAGING REQUIREMENTS FOR CONTROLLED SUBSTANCES--Table of Contents
Sec.
1302.01 Scope of Part 1302.
1302.02 Definitions.
1302.03 Symbol required; exceptions.
1302.04 Location and size of symbol on label.
1302.05 Location and size of symbol on labeling.
1302.06 Effective dates of labeling requirements.
1302.07 Sealing of controlled substances.
1302.08 Labeling and packaging requirements for imported and exported
substances.
Authority: 21 U.S.C. 821, 825, 871(b), 958(e).
Source: 36 FR 7785, Apr. 24, 1971, unless otherwise noted.
Redesignated at 38 FR 26609, Sept. 24, 1973.
Sec. 1302.01 Scope of Part 1302.
Requirements governing the labeling and packaging of controlled
substances pursuant to sections 1305 and 1008(d) of the Act (21 U.S.C.
825 and 958(d)) are set forth generally by those sections and
specifically by the sections of this part.
[36 FR 13386, July 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
l973]
Sec. 1302.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term commercial container means any bottle, jar, tube,
ampule, or other receptacle in which a substance is held for
distribution or dispensing to an ultimate user, and in addition, any box
or package in which the receptacle is held for distribution or
dispensing to an ultimate user. The term commercial
[[Page 32]]
container does not include any package liner, package insert or other
material kept with or within a commercial container, nor any carton,
crate, drum, or other package in which commercial containers are stored
or are used for shipment of controlled substances.
(b) The term label means any display of written, printed, or graphic
matter placed upon the commercial container of any controlled substance
by any manufacturer of such substance.
(c) The term labeling means all labels and other written, printed,
or graphic matter (1) upon any controlled substance or any of its
commercial containers or wrappers, or (2) accompanying such controlled
substance.
(d) The term manufacture means the producing, preparation,
propagation, compounding, or processing of a drug or other substance or
the packaging or repackaging of such substance, or the labeling or
relabeling of the commercial container of such substance, but does not
include the activities of a practitioner who, as an incident to his
administration or dispensing such substance in the course of his
professional practice, prepares, compounds, packages or labels such
substance. The term manufacturer means a person who manufactures a drug
or other substance, whether under a registration as a manufacturer or
under authority of registration as a researcher or chemical analyst.
(e) Any term not defined in this section shall have the definition
set forth in section 102 of the Act (21 U.S.C. 802) or Sec. 1301.02 of
this chapter.
[36 FR 7785, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1302.03 Symbol required; exceptions.
(a) Each commercial container of a controlled substance (except for
a controlled substance excepted by the Administrator pursuant to
Sec. 1308.31 of this chapter) shall have printed on the label the symbol
designating the schedule in which such controlled substance is listed.
Each such commercial container, if it otherwise has no label, must bear
a label complying with the requirement of this part.
(b) Each manufacturer shall print upon the labeling of each
controlled substance distributed by him the symbol designating the
schedule in which such controlled substance is listed.
(c) The following symbols shall designate the schedule corresponding
thereto:
Schedule
Schedule I................................ CI or C-I.
Schedule II............................... CII or C-II.
Schedule III.............................. CIII or C-III.
Schedule IV............................... CIV or C-IV.
Schedule V................................ CV or C-V.
The word ``schedule'' need not be used. No distinction need be made
between narcotic and nonnarcotic substances.
(d) The symbol is not required on a carton or wrapper in which a
commercial container is held if the symbol is easily legible through
such carton or wrapper.
(e) The symbol is not required on a commercial container too small
or otherwise unable to accommodate a label, if the symbol is printed on
the box or package from which the commercial container is removed upon
dispensing to an ultimate user.
(f) The symbol is not required on a commercial container containing,
or on the labeling of, a controlled substance being utilized in clinical
research involving blind and double blind studies.
[36 FR 7785, Apr. 24, 1971, as amended at 36 FR 18731, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1302.04 Location and size of symbol on label.
(a) The symbol shall be prominently located on the right upper
corner of the principal panel of the label of the commercial container
and/or the panel of the commercial container normally displayed to
dispensers of any controlled substance listed in Schedules I through V.
The symbol must be at least two times as large as the largest type
otherwise printed on the label.
(b) In lieu of locating the symbol in the corner of the label, as
prescribed in paragraph (a) of this section, the symbol may be
overprinted on the label, in which case the symbol must be printed at
least one-half the height of the label and in a contrasting color
providing clear visibility against the background color of the label.
[[Page 33]]
(c) In all cases the symbol shall be clear and large enough to
afford easy identification of the schedule of the controlled substance
upon inspection without removal from the dispenser's shelf.
Sec. 1302.05 Location and size of symbol on labeling.
The symbol shall be prominently located on all labeling other than
labels covered by Sec. 1302.04. In all cases the symbol shall be clear
and large enough to afford prompt identification of the controlled
substance upon inspection of the labeling.
Sec. 1302.06 Effective dates of labeling requirements.
(a) All labels on commercial containers of, and all labeling of, a
controlled substance which is listed in any schedule on May 1, 1971, and
which is packaged after December 1, 1971, shall comply with the
requirements of Sec. 1302.03.
(b) All labels on commercial containers of, and all labeling of, a
controlled substance which either is listed in any schedule on May 1,
1971, and thereafter transferred to another schedule or is added to any
schedule after May 1, 1971, and which is packaged more than 180 days
following the date on which the transfer or addition becomes effective,
shall comply with the requirements of Sec. 1302.03.
(c) The Administrator may, in the case of any controlled substance,
require compliance with the requirements of Sec. 1302.03 within a period
of time shorter than required by this section if he finds that public
health or safety necessitate an earlier effective date.
(d) Until compliance is required under this section, the label on
commercial container containing, and the labeling of, any controlled
substance shall comply with any requirements under Federal law as to
labels of such containers and as to labeling of such substances existing
prior to the effective date prescribed in this section.
Sec. 1302.07 Sealing of controlled substances.
(a) On each bottle, multiple dose vial, or other commercial
container of any controlled substance listed in Schedules I or II or of
any narcotic controlled substance listed in Schedule III or IV, there
shall be securely affixed to the stopper, cap, lid, covering, or wrapper
or such container a seal to disclose upon inspection any tampering or
opening of the container.
(b) Any seal accepted for use under Federal law prior to May 1,
1971, shall be deemed acceptable for use under this section.
[36 FR 7785, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1302.08 Labeling and packaging requirements for imported and exported substances.
(a) The symbol requirements of Secs. 1302.03-1302.06 apply to every
commercial container containing, and to all labeling of, controlled
substances imported into the jurisdiction of and/or the customs
territory of the United States, as defined in Sec. 1311.02 of this
chapter.
(b) The symbol requirements of Secs. 1302.03-1302.06 do not apply to
any commercial containers containing, or any labeling of, a controlled
substance intended for export from the jurisdiction of the United
States, as defined in Sec. 1311.02 of this chapter.
(c) The sealing requirements of Sec. 1302.07 apply to every bottle,
multiple dose vial, or other commercial container of any controlled
substance listed in schedule I or II, or of any narcotic controlled
substance listed in schedule III or IV, imported into, exported from, or
intended for export from, the jurisdiction of and/or the customs
territory of the United States, as defined in Sec. 1311.02 of this
chapter.
[36 FR 18731, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
1973]
PART 1303--QUOTAS--Table of Contents
General Information
Sec.
1303.01 Scope of Part 1303.
1303.02 Definitions.
[[Page 34]]
Aggregate Production and Procurement Quotas
1303.11 Aggregate production quotas.
1303.12 Procurement quotas.
1303.13 Adjustments of aggregate production quotas.
Individual Manufacturing Quotas
1303.21 Individual manufacturing quotas.
1303.22 Procedure for applying for individual manufacturing quotas.
1303.23 Procedure for fixing individual manufacturing quotas.
1303.24 Inventory allowance.
1303.25 Increase in individual manufacturing quotas.
1303.26 Reduction in individual manufacturing quotas.
1303.27 Abandonment of quota.
Hearings
1303.31 Hearings generally.
1303.32 Purpose of hearing.
1303.33 Waiver or modification of rules.
1303.34 Request for hearing or appearance; waiver.
1303.35 Burden of proof.
1303.36 Time and place of hearing.
1303.37 Final order.
Authority: 21 U.S.C. 821, 826, 871(b).
General Information
Sec. 1303.01 Scope of Part 1303.
Procedures governing the establishment of production and
manufacturing quotas on basic classes of controlled substances listed in
schedules I and II pursuant to section 306 of the Act (21 U.S.C. 826)
are governed generally by that section and specifically by the sections
of this part.
[36 FR 7786, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term hearing means any hearing held pursuant to this part
regarding the determination of aggregate production quota or the
issuance, adjustment, suspension, or denial of a procurement quota or an
individual manufacturing quota.
(b) The term inventory means all factory and branch stocks in
finished form of a basic class of controlled substance manufactured or
otherwise acquired by a registrant, whether in bulk, commercial
containers, or contained in pharmaceutical preparations in the
possession of the registrant (including stocks held by the registrant
under separate registration as a manufacturer, importer, exporter, or
distributor).
(c) The term net disposal means, for a stated period, the quantity
of a basic class of controlled substance distributed by the registrant
to another person, plus the quantity of that basic class used by the
registrant in the production of (or converted by the registrant into)
another basic class of controlled substance or a noncontrolled
substance, plus the quantity of that basic class otherwise disposed of
by the registrant, less the quantity of that basic class returned to the
registrant by any purchaser, and less the quantity of that basic class
distributed by the registrant to another registered manufacturer of that
basic class for purposes other than use in the production of, or
conversion into, another basic class of controlled substance or a
noncontrolled substance or in the manufacture of dosage forms of that
basic class.
(d) The term registrant means any person registered pursuant to
section 303 of the Act (21 U.S.C. 823).
(e) Any term not defined in this section shall have the definition
set forth in section 102 of the Act (21 U.S.C. 802) and Sec. 1301.02 of
this chapter.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 37
FR 15919, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973]
Editorial Note: For an interpretation document clarifying
Sec. 1303.02(b), see 40 FR 52844, Nov. 13, 1975.
Aggregate Production and Procurement Quotas
Sec. 1303.11 Aggregate production quotas.
(a) The Administrator shall determine the total quantity of each
basic class of controlled substance listed in Schedule I or II necessary
to be manufactured during the following calendar year to provide for the
estimated medical, scientific, research and industrial needs of the
United States, for lawful export requirements, and for the establishment
and maintenance of reserve stocks.
[[Page 35]]
(b) In making his determinations, the Administrator shall consider
the following factors:
(1) Total net disposal of the class by all manufacturers during the
current and 2 preceding years;
(2) Trends in the national rate of net disposal of the class;
(3) Total actual (or estimated) inventories of the class and of all
substances manufactured from the class, and trends in inventory
accumulation;
(4) Projected demand for such class as indicated by procurement
quotas requested pursuant to Sec. 1303.12; and
(5) Other factors affecting medical, scientific, research, and
industrial needs in the United States and lawful export requirements, as
the Administrator finds relevant, including changes in the currently
accepted medical use in treatment with the class or the substances which
are manufactured from it, the economic and physical availability of raw
materials for use in manufacturing and for inventory purposes, yield and
stability problems, potential disruptions to production (including
possible labor strikes), and recent unforeseen emergencies such as
floods and fires.
(c) The Administrator shall, on or before May 1 of each year,
publish in the Federal Register, general notice of an aggregate
production quota for any basic class determined by him under this
section. A copy of said notice shall be mailed simultaneously to each
person registered as a bulk manufacturer of the basic class. The
Administrator shall permit any interested person to file written
comments on or objections to the proposal and shall designate in the
notice the time during which such filings may be made. The Administrator
may, but shall not be required to, hold a public hearing on one or more
issues raised by the comments and objections filed with him. In the
event the Administrator decides to hold such a hearing, he shall publish
notice of the hearing in the Federal Register, which notice shall
summarize the issues to be heard and shall set the time for the hearing
which shall nnt be less than 30 days after the date of publication of
the notice. After consideration of any comments or objections, or after
a hearing if one is ordered by the Administrator, the Administrator
shall issue and publish in the Federal Register his final order
determining the aggregate production quota for the basic class of
controlled substance. The order shall include the findings of fact and
conclusions of law upon which the order is based. The order shall
specify the date on which it shall take effect. A copy of said order
shall be mailed simultaneously to each person registered as a bulk
manufacturer of the basic class.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15919, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.12 Procurement quotas.
(a) In order to determine the estimated needs for, and to insure an
adequate and uninterrupted supply of, basic classes of controlled
substances listed in Schedules I and II (except raw opium being imported
by the registrant pursuant to an import permit) the Administrator shall
issue procurement quotas authorizing persons to procure and use
quantities of each basic class of such substances for the purpose of
manufacturing such class into dosage forms or into other substances.
(b) Any person who is registered to manufacture controlled
substances listed in any schedule and who desires to use during the next
calendar year any basic class of controlled substances listed in
Schedule I or II (except raw opium being imported by the registrant
pursuant to an import permit) for purposes of manufacturing, shall apply
on DEA (or BND) Form 250 for a procurement quota for such basic class. A
separate application must be made for each basic class desired to be
procured or used. The applicant shall state whether he intends to
manufacture the basic class himself or purchase it from another
manufacturer. The applicant shall state separately each purpose for
which the basic class is desired, the quantity desired for that purpose
during the next calendar year, and the quantities used and estimated to
be used, if any, for that purpose during the current and preceding 2
calendar years. If the purpose is to manufacture the basic class into
dosage form, the applicant shall state the official name, common or
usual name, chemical
[[Page 36]]
name, or brand name of that form. If the purpose is to manufacture
another substance, the applicant shall state the official name, common
or usual name, chemical name, or brand name of the substance, and, if a
controlled substance listed in any schedule, the schedule number and
Administration Controlled Substances Code Number, as set forth in part
1308 of this chapter, of the substance. If the purpose is to manufacture
another basic class of controlled substance listed in Schedule I or II,
the applicant shall also state the quantity of the other basic class
which the applicant has applied to manufacture pursuant to Sec. 1303.22
and the quantity of the first basic class necessary to manufacture a
specified unit of the second basic class. DEA (or BND) Form 250 shall be
filed on or before April 1 of the year preceding the calendar year for
which the procurement quota is being applied. Copies of DEA (or BND)
Form 250 may be obtained from, and shall be filed with, the Drug Control
Section, Drug Enforcement Administration, Department of Justice,
Washington, DC 20537.
(c) The Administrator shall, on or before July 1 of the year
preceding the calendar year during which the quota shall be effective,
issue to each qualified applicant a procurement quota authorizing him to
procure and use:
(1) All quantities of such class necessary to manufacture all
quantities of other basic classes of controlled substances listed in
Schedules I and II which the applicant is authorized to manufacture
pursuant to Sec. 1303.23; and
(2) Such other quantities of such class as the applicant has applied
to procure and use and are consistent with his past use, his estimated
needs, and the total quantity of such class that will be produced.
(d) Any person to whom a procurement quota has been issued may at
any time request an adjustment in the quota by applying to the
Administrator with a statement showing the need for the adjustment. Such
application shall be filed with the Drug Control Section, Drug
Enforcement Administration, Department of Justice, Washington, DC 20537.
The Administrator shall increase or decrease the procurement quota of
such person if and to the extent that he finds, after considering the
factors enumerated in paragraph (c) of this section and any occurrences
since the issuance of the procurement quota, that the need justifies an
adjustment.
(e) The following persons need not obtain a procurement quota:
(1) Any person who is registered to manufacture a basic class of
controlled substance listed in Schedule I or II and who uses all of the
quantity he manufactures in the manufacture of a subsance not controlled
under the Act;
(2) Any person who is registered or authorized to conduct chemical
analysis with controlled substances (for controlled substances to be
used in such analysis only); and
(3) Any person who is registered to conduct research with a basic
class of controlled substance listed in Schedule I or II and who is
authorized to manufacture a quantity of such class pursuant to
Sec. 1301.22(b) of this chapter.
(f) Any person to whom a procurement quota has been issued,
authorizing that person to procure and use a quantity of a basic class
of controlled substances listed in Schedules I or II during the current
calendar year, shall, at or before the time of giving an order to
another manufacturer requiring the distribution of a quantity of such
basic class, certify in writing to such other manufacturer that the
quantity of such basic class ordered does not exceed the person's unused
and available procurement quota of such basic class for the current
calendar year. The written certification shall be executed by the same
individual who signed the DEA Form 222 transmitting the order.
Manufacturers shall not fill an order from persons required to apply for
a procurement quota under paragraph (b) of this section unless the order
is accompanied by a certification as required under this section. The
certification required by this section shall contain the following: The
date of the certification; the name and address of the bulk manufacturer
to whom the certification is directed; a reference to the number of the
DEA Form 222 to which the certification applies; the name of the person
giving the order to which the certification applies; the name of the
basic class specified in the DEA Form 222 to
[[Page 37]]
which the certification applies; the appropriate schedule within which
is listed the basic class specified in the DEA Form 222 to which the
certification applies; a statement that the quantity (expressed in
grams) of the basic class specified in the DEA Form 222 to which the
certification applies does not exceed the unused and available
procurement quota of such basic class, issued to the person giving the
order, for the current calendar year; and the signature of the
individual who signed the DEA Form 222 to which the certification
applies.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18731, Sept. 21, 1971; 37 FR 15919, Aug. 8, 1972. Redesignated at 38
FR 26609, Sept. 24, 1973]
Editorial Note: For FR citations affecting Sec. 1303.12, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1303.13 Adjustments of aggregate production quotas.
(a) The Administrator may at any time increase or reduce the
aggregate production quota for a basic class of controlled substance
listed in Schedule I or II which he has previously fixed pursuant to
Sec. 1303.11.
(b) In determining to adjust the aggregate production quota, the
Administrator shall consider the following factors:
(1) Changes in the demand for that class, changes in the national
rate of net disposal of the class, and changes in the rate of net
disposal of the class by registrants holding individual manufacturing
quotas for that class;
(2) Whether any increased demand for that class, the national and/or
individual rates of net disposal of that class are temporary, short
term, or long term;
(3) Whether any increased demand for that class can be met through
existing inventories, increased individual manufacturing quotas, or
increased importation, without increasing the aggregate production
quota, taking into account production delays and the probability that
other individual manufacturing quotas may be suspended pursuant to
Sec. 1303.24(b);
(4) Whether any decreased demand for that class will result in
excessive inventory accumulation by all persons registered to handle
that class (including manufacturers, distributors, practitioners,
importers, and exporters), notwithstanding the possibility that
individual manufacturing quotas may be suspended pursuant to
Sec. 1303.24(b) or abandoned pursuant to Sec. 1303.27;
(5) Other factors affecting medical, scientific, research, and
industrial needs in the United States and lawful export requirements, as
the Administrator finds relevant, including changes in the currently
accepted medical use in treatment with the class or the substances which
are manufactured from it, the economic and physical availability of raw
materials for use in manufacturing and for inventory purposes, yield and
stability problems, potential disruptions to production (including
possible labor strikes), and recent unforeseen emergencies such as
floods and fires.
(c) The Administrator in the event he determines to increase or
reduce the aggregate production quota for a basic class of controlled
substance, shall publish in the Federal Register general notice of an
adjustment in the aggregate production quota for that class determined
by him under this section. A copy of said notice shall be mailed
simultaneously to each person registered as a bulk manufacturer of the
basic class. The Administrator shall permit any interested person to
file written comments on or objections to the proposal and shall
designate in the notice the time during which such filings may be made.
The Administrator may, but shall not be required to, hold a public
hearing on one or more issues raised by the comments and objections
filed with him. In the event the Administrator decides to hold such a
hearing, he shall publish notice of the hearing in the Federal Register,
which notice shall summarize the issues to be heard and shall set the
time for the hearing, which shall not be less than 10 days after the
date of publication of the notice. After consideration of any comments
or objections, or after a hearing if one is ordered by the
Administrator, the Administrator shall issue and publish in the Federal
Register his final order determining the aggregate production for the
basic class of controlled
[[Page 38]]
substance. The order shall include the findings of fact and conclusions
of law upon which the order is based. The order shall specify the date
on which it shall take effect. A copy of said order shall be mailed
simultaneously to each person registered as a bulk manufacturer of the
basic class.
[37 FR 15919, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973]
Individual Manufacturing Quotas
Sec. 1303.21 Individual manufacturing quotas.
(a) The Administrator shall, on or before July 1 of each year, fix
for and issue to each person who is registered to manufacture a basic
class of controlled substance listed in Schedule I or II, and who
applies for a manufacturing quota, an individual manufacturing quota
authorizing that person to manufacture during the next calendar year a
quantity of that basic class. Any manufacturing quota fixed and issued
by the Administrator shall be subject to his authority to reduce or
limit it at a later date pursuant to Sec. 1303.26 and to his authority
to revoke or suspend it at any time pursuant to Secs. 1301.45 and
1301.46 of this chapter.
(b) No individual manufacturing quota shall be required for
registrants listed in Sec. 1303.12(e).
[36 FR 7786, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.22 Procedure for applying for individual manufacturing quotas.
Any person who is registered to manufacture any basic class of
controlled substance listed in Schedule I or II and who desires to
manufacture a quantity of such class shall apply on DEA (or BND) Form
189 for a manufacturing quota for such quantity of such class. Copies of
DEA (or BND) Form 189 may be obtained from, and shall be filed (on or
before May 1 of the year preceding the calendar year for which the
manufacturing quota is being applied) with, the Drug Control Section,
Drug Enforcement Administration, Department of Justice, Washington, D.C.
20537. A separate application must be made for each basic class desired
to be manufactured. The applicant shall state:
(a) The name and Administration Controlled Substances Code Number,
as set forth in part 1308 of this chapter, of the basic class.
(b) For the basic class in each of the current and preceding 2
calendar years,
(1) The authorized individual manufacturing quota, if any;
(2) The actual or estimated quantity manufactured;
(3) The actual or estimated net disposal;
(4) The actual or estimated inventory allowance pursuant to
Sec. 1303.24; and
(5) The actual or estimated inventory as of December 31;
(c) For the basic class in the next calendar year,
(1) The desired individual manufacturing quota; and
(2) Any additional factors which the applicant finds relevant to the
fixing of his individual manufacturing quota, including the trend of
(and recent changes in) his and the national rates of net disposal, his
production cycle and current inventory position, the econolic and
physical availability of raw materials for use in manufacturing and for
inventory purposes, yield and stability problems, potential disruptions
to production (including possible labor strikes) and recent unforeseen
emergencies such as floods and fires.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 37
FR 15920, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973, and
amended at 46 FR 28841, May 29, 1981; 51 FR 5319, Feb. 13, 1986]
Sec. 1303.23 Procedure for fixing individual manufacturing quotas.
(a) In fixing individual manufacturing quotas for a basic class of
controlled substance listed in Schedule I or II, the Administrator shall
allocate to each applicant who is currently manufacturing such class a
quota equal to 100 percent of the estimated net disposal of that
applicant for the next calendar year, adjusted--
(1) By the amount necessary to increase or reduce the estimated
inventory of the applicant on December 31 of the current year to his
estimated inventory allowance for the next calendar year, pursuant to
Sec. 1303.24, and
(2) By any other factors which the Administrator deems relevant to
the
[[Page 39]]
fixing of the individual manufacturing quota of the applicant, including
the trend of (and recent changes in) his and the national rates of net
disposal, his production cycle and current inventory position, the
economic and physical availability of raw materials for use in
manufacturing and for inventory purposes, yield and stability problems,
potential disruptions to production (including possible labor strikes),
and recent unforeseen emergencies such as floods and fires.
(b) In fixing individual manufacturing quotas for a basic class of
controlled substance listed in Schedule I or II, the Administrator shall
allocate to each applicant who is not currently manufacturing such class
a quota equal to 100 percent of the reasonably estimated net disposal of
that applicant for the next calendar year, as determined by the
Administrator, adjusted--
(1) By the amount necessary to provide the applicant his estimated
inventory allowance for the next calendar year, pursuant to
Sec. 1303.24, and
(2) By any other factors which the Administrator deems relevant to
the fixing of the individual manufacturing quota of the applicant,
including the trend of (and recent changes in) the national rate of net
disposal, his production cycle and current inventory position, the
economic and physical availability of raw materials for use in
manufacturing and for inventory purposes, yield and stability problems,
potential disruptions to production (including possible labor strikes),
and recent unforeseen emergencies such as floods and fires.
(c) The Administrator shall, on or before March 1 of each year,
adjust the individual manufacturing quota allocated for that year to
each applicant in paragraph (a) of this section by the amount necessary
to increase or reduce the actual inventory of the applicant to December
31 of the preceding year to his estimated inventory allowance for the
current calendar year, pursuant to Sec. 1303.24.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.24 Inventory allowance.
(a) For the purpose of determining individual manufacturing quotas
pursuant to Sec. 1303.23, each registered manufacturer shall be allowed
as a part of such quota an amount sufficient to maintain an inventory
equal to,
(1) For current manufacturers, 50 percent of his average estimated
net disposal for the current calendar year and the last preceding
calendar year; or
(2) For new manufacturers, 50 percent of his reasonably estimated
net disposal for the next calendar year as determined by the
Administrator.
(b) During each calendar year each registered manufacturer shall be
allowed to maintain an inventory of a basic class not exceeding 65
percent of his estimated net disposal of that class for that year, as
determined at the time his quota for that year was determined. At any
time the inventory of a basic class held by a manufacturer exceeds 65
percent of his estimated net disposal, his quota for that class is
automatically suspended and shall remain suspended until his inventory
is less than 60 percent of his estimated net disposal. The Administrator
may, upon application and for good cause shown, permit a manufacturer
whose quota is, or is likely to be, suspended pursuant to this paragraph
to continue manufacturing and to accumulate an inventory in excess of 65
percent of his estimated net disposal, upon such conditions and within
such limitations as the Administrator may find necessary or desirable.
(c) If, during a calendar year, a registrant has manufactured the
entire quantity of a basic class allocated to him under an individual
manufacturing quota, and his inventory of that class is less than 40
percent of his estimated net disposal of that class for that year, the
Administrator may, upon application pursuant to Sec. 1303.25, increase
the quota of such registrant sufficiently to allow restoration of the
inventory to 50 percent of the estimated net disposal for that year.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
[[Page 40]]
Sec. 1303.25 Increase in individual manufacturing quotas.
(a) Any registrant who holds an individual manufacturing quota for a
basic class of controlled substance listed in Schedule I or II may file
with the Administrator an application on Administration Form 189 for an
increase in such quota in order for him to meet his estimated net
disposal, inventory and other requirements during the remainder of such
calendar year.
(b) The Administrator, in passing upon a registrant's application
for an increase in his individual manufacturing quota, shall take into
consideration any occurrences since the filing of such registrant's
initial quota application that may require an increased manufacturing
rate by such registrant during the balance of the calendar year. In
passing upon such application the Administrator may also take into
consideration the amount, if any, by which his determination of the
total quantity for the basic class of controlled substance to be
manufactured under Sec. 1303.11 exceeds the aggregate of all the
individual manufacturing quotas for the basic class of controlled
substance, and the equitable distribution of such excess among other
registrants.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.26 Reduction in individual manufacturing quotas.
The Administrator may at any time reduce an individual manufacturing
quota for a basic class of controlled substance listed in Schedule I or
II which he has previously fixed in order to prevent the aggregate of
the individual manufacturing quotas and import permits outstanding or to
be granted from exceeding the aggregate production quota which has been
established for that class pursuant of Sec. 1303.11, as adjusted
pursuant to Sec. 1303.13. If a quota assigned to a new manufacturer
pursuant to Sec. 1303.23(b), or if a quota assigned to any manufacturer
is increased pursuant to Sec. 1303.24(c), or if an import permit issued
to an importer pursuant to part 1312 of this chapter, causes the total
quantity of a basic class to be manufactured and imported during the
year to exceed the aggregate production quota which has been established
for that class pursuant to Sec. 1303.11, as adjusted pursuant to
Sec. 1303.13, the Administrator may proportionately reduce the
individual manufacturing quotas and import permits of all other
registrants to keep the aggregate production quota within the limits
originally established, or, alternatively, the Administrator may reduce
the individual manufacturing quota of any registrant whose quota is
suspended pursuant to Sec. 1303.24(b) or Sec. 1301.45 or Sec. 1301.46 of
this chapter, or is abandoned pursuant to Sec. 1303.27.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.27 Abandonment of quota.
Any manufacturer assigned an individual manufacturing quota for any
basic class pursuant to Sec. 1303.23 may at any time abandon his right
to manufacture all or any part of such quota by filing with the Drug
Control Section a written notice of such abandonment, stating the name
and Administration Controlled Substances Code Number, as set forth in
part 1308 of this chapter, of the substance and the amount which he has
chosen not to manufacture. The Administrator may, in his discretion,
allocate such amount among the other manufacturers in proportion to
their respective quotas.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 46 FR 28841,
May 29, 1981; 51 FR 5319, Feb. 13, 1986]
Hearings
Sec. 1303.31 Hearings generally.
(a) In any case where the Administrator shall hold a hearing
regarding the determination of an aggregate production quota pursuant to
Sec. 1303.11(c), or regarding the adjustment of an aggregate production
quota pursuant to Sec. 1303.13(c), the procedures for such hearing shall
be governed generally by the rule making procedures set forth in the
Administrative Procedure Act (5 U.S.C. 551-559) and specifically by
section 306 of the Act (21 U.S.C. 826), by Secs. 1303.32-1303.37, and by
the procedures for administrative hearings under the
[[Page 41]]
Act set forth in Secs. 1316.41-1316.67 of this chapter.
(b) In any case where the Administrator shall hold a hearing
regarding the issuance, adjustment, suspension, or denial of a
procurement quota pursuant to Sec. 1303.12, or the issuance, adjustment,
suspension, or denial of an individual manufacturing quota pursuant to
Secs. 1303.21-1303.27, the procedures for such hearing shall be governed
generally by the adjudication procedures set forth in the Administrative
Procedures Act (5 U.S.C. 551-559) and specifically by section 306 of the
Act (21 U.S.C. 826), by Secs. 1303.32-1303.37, and by the procedures for
administrative hearings under the Act set forth in Secs. 1316.41-1316.67
of this chapter.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.32 Purpose of hearing.
(a) The Administrator may, in his sole discretion, hold a hearing
for the purpose of receiving factual evidence regarding any one or more
issues (to be specified by him) involved in the determination or
adjustment of any aggregate production quota.
(b) If requested by a person applying for or holding a procurement
quota or an individual manufacturing quota, the Administrator shall hold
a hearing for the purpose of receiving factual evidence regarding the
issues involved in the issuance, adjustment, suspension, or denial of
such quota to such person, but the Administrator need not hold a hearing
on the suspension of a quota pursuant to Sec. 1301.45 or Sec. 1301.46 of
this chapter separate from a hearing on the suspension of registration
pursuant to those sections.
(c) Extensive argument should not be offered into evidence but
rather presented in opening or closing statements of counsel or in
memoranda or proposed findings of fact and conclusions of law.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.33 Waiver or modification of rules.
The Administrator or the presiding officer (with respect to matters
pending before him) may modify or waive any rule in this part by notice
in advance of the hearing, if he determines that no party in the hearing
will be unduly prejudiced and the ends of justice will thereby be
served. Such notice of modification or waiver shall be made a part of
the record of the hearing.
[36 FR 7786, Apr. 24,1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.34 Request for hearing or appearance; waiver.
(a) Any applicant or registrant who desires a hearing on the
issuance, adjustment, suspension, or denial of his procurement and/or
individual manufacturing quota shall, within 30 days after the date of
receipt of the issuance, adjustment, suspension, or denial of such
quota, file with the Administrator a written request for a hearing in
the form prescribed in Sec. 1316.47 of this chapter. Any interested
person who desires a hearing on the determination of an aggregate
production quota shall, within the time prescribed in Sec. 1303.11(c),
file with the Administrator a written request for a hearing in the form
prescribed in Sec. 1316.47 of this chapter, including in the request a
statement of the grounds for a hearing.
(b) Any interested person who desires to participate in a hearing on
the determination or adjustment of an aggregate production quota, which
hearing is ordered by the Administrator pursuant to Sec. 1303.11(c) or
Sec. 1303.13(c) may do so by filing with the Administrator, within 30
days of the date of publication of notice of the hearing in the Federal
Register, a written notice of his intention to participate in such
hearing in the form prescribed in Sec. 1316.48 of this chapter.
(c) Any person entitled to a hearing or to participate in a hearing
pursuant to paragraph (b) of this section, may, within the period
permitted for filing a request for a hearing of notice of appearance,
file with the Administrator a waiver of an opportunity for a hearing or
to participate in a hearing, together with a written statement regarding
his position on the matters of fact and law involved in such hearing.
Such statement, if admissible, shall be made a part of the record and
shall be considered in light of the lack of opportunity for
[[Page 42]]
cross-examination in determining the weight to be attached to matters of
fact asserted therein.
(d) If any person entitled to a hearing or to participate in a
hearing pursuant to paragraph (b) of this section, fails to file a
request for a hearing or notice of appearance, or if he so files and
fails to appear at the hearing, he shall be deemed to have waived his
opportunity for the hearing or to participate in the hearing, unless he
shows good cause for such failure.
(e) If all persons entitled to a hearing or to participate in a
hearing waive or are deemed to waive their opportunity for the hearing
or to participate in the hearing, the Administrator may cancel the
hearing, if scheduled, and issue his final order pursuant to
Sec. 1303.37 without a hearing.
[36 FR 7786, Apr. 24, 1971, as amended at 36 FR 18731, Sept. 21, 1971;
37 FR 15920, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.35 Burden of proof.
(a) At any hearing regarding the determination or adjustment of an
aggregrate production quota, each interested person participating in the
hearing shall have the burden of proving any propositions of fact or law
asserted by him in the hearing.
(b) At any hearing regarding the issuance, adjustment, suspension,
or denial of a procurement or individual manufacturing quota, the
Administration shall have the burden of proving that the requirements of
this part for such issuance, adjustment, suspension, or denial are
satisfied.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.36 Time and place of hearing.
(a) If any applicant or registrant requests a hearing on the
issuance, adjustment, suspension, or denial of his procurement and/or
individual manufacturing quota pursuant to Sec. 1303.34, the
Administrator shall hold such hearing. Notice of the hearing shall be
given to the applicant or registrant of the time and place at least 30
days prior to the hearing, unless the applicant or registrant waives
such notice and requests the hearing be held at an earlier time, in
which case the Administrator shall fix a date for such hearing as early
as reasonably possible.
(b) The hearing will commence at the place and time designated in
the notice given pursuant to paragraph (a) of this section or in the
notice of hearing published in the Federal Register pursuant to
Sec. 1303.11(c) or Sec. 1303.13 (c), but thereafter it may be moved to a
different place and may be continued from day to day or recessed to a
later day without notice other than announcement thereof by the
presiding officer at the hearing.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1303.37 Final order.
As soon as practicable after the presiding officer has certified the
record to the Administrator, the Administrator shall issue his order on
the determination or adjustment of the aggregate production quota or on
the issuance, adjustment, suspension, or denial of the procurement quota
or individual manufacturing quota, as case may be. The order shall
include the findings of fact and conclusions of law upon which the order
is based. The order shall specify the date on which it shall take
effect. The Administrator shall serve one copy of his order upon each
party in the hearing.
[36 FR 7786, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
PART 1304--RECORDS AND REPORTS OF REGISTRANTS--Table of Contents
General Information
Sec.
1304.01 Scope of Part 1304.
1304.02 Definitions.
1304.03 Persons required to keep records and file reports.
1304.04 Maintenance of records and inventories.
Inventory Requirements
1304.11 General requirements for inventories.
1304.12 Initial inventory date.
1304.13 Biennial inventory date.
1304.14 Inventory date for newly controlled substances.
[[Page 43]]
1304.15 Inventories of manufacturers.
1304.16 Inventories of distributors.
1304.17 Inventories of dispensers and researchers.
1304.18 Inventories of importers and exporters.
1304.19 Inventories of chemical analysts.
Continuing Records
1304.21 General requirements for continuing records.
1304.22 Records for manufacturers.
1304.23 Records for distributors.
1304.24 Records for dispensers and researchers.
1304.25 Records for importers.
1304.26 Records for exporters.
1304.27 Records for chemical analysts.
1304.28 Records for maintenance treatment programs and detoxification
treatment programs.
1304.29 Records for treatment programs which compound narcotics for
treatment programs and other locations.
Reports
1304.31 Reports from manufacturers importing opium.
1304.32 Reports of manufacturers importing medicinal coca leaves.
1304.33 Reports from manufacturers importing special coca leaves.
1304.34 Reports generally.
1304.35 Reports from manufacturers of bulk materials or dosage units.
1304.36 Reports from packagers and labelers.
1304.37 Reports from distributors.
1304.38 Reports from manufacturers importing poppy straw or concentrate
of poppy straw.
Authority: 21 U.S.C. 821, 827, 871(b), 958(d), 965, unless otherwire
noted.
General Information
Sec. 1304.01 Scope of Part 1304.
Inventory and other records and reports required under section 307
or section 1008(d) of the Act (21 U.S.C. 827 and 958(d)) shall be in
accordance with, and contain the information required by, those sections
and by the sections of this part.
[36 FR 7789, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substances Act (84 Stat. 1242;
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act
(84 Stat. 1285; 21 U.S.C. 951).
(b) The term commercial container means any bottle, jar, tube,
ampule, or other receptacle in which a substance is held for
distribution or dispensing to an ultimate user, and in addition, any box
or package in which the receptacle is held for distribution or
dispensing to an ultimate user. The term commercial container does not
include any package liner, package insert of other material kept with or
within a commercial container, nor any carton, crate, drum, or other
package in which commercial containers are stored or are used for
shipment of controlled substances.
(c) The term dispenser means an individual practitioner,
institutional practitioner, pharmacy or pharmacist who dispenses a
controlled substance.
(d) The term individual practitioner means a physician, dentist,
veterinarian, or other individual licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which he
practices, to dispense a controlled substance in the course of
professional practice, but does not include a pharmacist, a pharmacy, or
an institutional practitioner.
(e) The term institutional practitioner means a hospital or other
person (other than an individual) licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which it
practices, to dispense a controlled substance in the course of
professional practice, but does not include a pharmacy.
(f) The term mid-level practitioner means an individual practitioner
(as defined in Sec. 1304.02(d)), other than a physician, dentist,
veterinarian, or podiatrist, who is licensed, registered, or otherwise
permitted by the United States or the jurisdiction in which he/she
practices, to dispense a controlled substance in the course of
professional practice. Examples of mid-level practitioners include, but
are not limited to, health care providers such as nurse practitioners,
nurse midwives, nurse anesthetists, clinical nurse specialists and
physician assistants who are authorized to dispense controlled
substances by the state in which they practice.
[[Page 44]]
(g) The term name means the official name, common or usual name,
chemical name, or brand name of a substance.
(h) The term pharmacist means any pharmacist licensed by a State to
dispense controlled substances, and shall include any other person
(e.g., pharmacist intern) authorized by a State to dispense controlled
substances under the supervision of a pharmacist licensed by such State.
(i) The term readily retrievable means that certain records are kept
by automatic data processing systems or other electronic or mechanized
recordkeeping systems in such a manner that they can be separated out
from all other records in a reasonable time and/or records are kept on
which certain items are asterisked, redlined, or in some other manner
visually identifiable apart from other items appearing on the records.
(j) Any term not defined in this section shall have the definition
set forth in sections 102 and 1001 of the Act (21 U.S.C. 802 and 951)
and in Secs. 1301.02 and 1311.02 of this chapter.
[36 FR 7789, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973; 58 FR 31175, June 1, 1993]
Sec. 1304.03 Persons required to keep records and file reports.
(a) Each registrant shall maintain the records and inventories and
shall file the reports required by this part, except as exempted by this
section. Any registrant who is authorized to conduct other activities
without being registered to conduct those activities, either pursuant to
Sec. 1301.22(b) of this chapter or pursuant to Secs. 1307.11-1307.15 of
this chapter, shall maintain the records and inventories and shall file
the reports required by this part for persons registered to conduct such
activities. This latter requirement should not be construed as requiring
stocks of controlled substances being used in various activities under
one registration to be stored separately, nor that separate records are
required for each activity. The intent of the Administration is to
permit the registrant to keep one set of records which are adapted by
the registrant to account for controlled substances used in any
activity. Also, the Administration does not wish to acquire separate
stocks of the same substance to be purchased and stored for separate
activities. Otherwise, there is no advantage gained by permitting
several activities under one registration. Thus, when a researcher
manufactures a controlled item, he must keep a record of the quantity
manufactured; when he distributes a quantity of the item, he must use
and keep invoices or order forms to document the transfer; when he
imports a substance, he keeps as part of his records the documentation
required of an importer; and when substances are used in chemical
analysis, he need not keep a record of this because such a record would
not be required of him under a registration to do chemical analysis. All
of these records may be maintained in one consolidated record system.
Similarly, the researcher may store all of his controlled items in one
place, and every two years take inventory of all items on hand,
regardless of whether the substances were manufactured by him, imported
by him, or purchased domestically by him, of whether the substances will
be administered to subjects, distributed to other researchers, or
destroyed during chemical analysis.
(b) A registered individual practitioner is required to keep
records, as described in Sec. 1304.04, of controlled substances in
Schedules II, III, IV, and V which are dispensed, other than by
prescribing or administering in the lawful course of professional
practice.
(c) A registered individual practitioner is not required to keep
records of controlled substances in Schedules II, III, IV, and V which
are prescribed in the lawful course of professional practice, unless
such substances are prescribed in the course of maintenance or
detoxification treatment of an individual.
(d) A registered individual practitioner is not required to keep
records of controlled substances listed in Schedules II, III, IV and V
which are administered in the lawful course of professional practice
unless the practitioner regularly engages in the dispensing or
administering of controlled substances and charges patients, either
separately or together with charges for
[[Page 45]]
other professional services, for substances so dispensed or
administered. Records are required to be kept for controlled substances
administered in the course of maintenance or detoxification treatment of
an individual.
(e) Each registered mid-level practitioner shall maintain in a
readily retrievable manner those documents required by the state in
which he/she practices which describe the conditions and extent of his/
her authorization to dispense controlled substances and shall make such
documents available for inspection and copying by authorized employees
of the Administration. Examples of such documentation include protocols,
practice guidelines or practice agreements.
(f) A registered person using any controlled substance in research
conducted in conformity with an exemption granted under section 505(i)
or 512(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)
or 360b(j)) at a registered establishment which maintains records in
accordance with either of those sections is not required to keep records
if he notifies the Administration of the name, address, and registration
number of the establishment maintaining such records.
(g) A registered person using any controlled substance in
preclinical research or in teaching at a registered establishment which
maintains records with respect to such substances is not required to
keep records if he notifies the Administration of the name, address, and
registration number of the establishment maintaining such records.
(h) Notice required by paragraphs (f) and (g) of this section shall
be given at the time the person applies for registration or
reregistration and shall be made in the form of an attachment to the
application, which shall be filed with the application.
[36 FR 7790, Apr. 24, 1971, as amended at 36 FR 18731, Sept. 21, 1971;
37 FR 15920, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 50 FR 40523, Oct. 4, 1985; 51 FR 5320, Feb. 13, 1986; 51
FR 26154, July 21, 1986; 58 FR 31175, June 1, 1993]
Sec. 1304.04 Maintenance of records and inventories.
(a) Every inventory and other records required to be kept under this
part shall be kept by the registrant and be available, for at least 2
years from the date of such inventory or records, for inspection and
copying by authorized employees of the Administration, except that
financial and shipping records (such as invoices and packing slips but
not excuted order forms subject to Sec. 1305.13 of this chapter) may be
kept at a central location, rather than at the registered location, if
the registrant has notified the Administration of his intention to keep
central records. Written notification must be submitted by registered or
certified mail, return receipt requested, in triplicate, to the Special
Agent in Charge of the Administration in the area in which the
registrant is located. Unless the registrant is informed by the Special
Agent in Charge that permission to keep central records is denied, the
registrant may maintain central records commencing 14 days after receipt
of his notification by the Special Agent in Charge.
All notifications must include:
(1) The nature of the records to be kept centrally.
(2) The exact location where the records will be kept.
(3) The name, address, DEA registration number and type of DEA
registration of the registrant whose records are being maintained
centrally.
(4) Whether central records will be maintained in a manual, or
computer readable form.
(b) All registrants that are authorized to maintain a central
recordkeeping system shall be subject to the following conditions:
(1) The records to be maintained at the central record location
shall not include executed order forms, prescriptions and/or inventories
which shall be maintained at each registered location.
(2) If the records are kept on microfilm, computer media or in any
form requiring special equipment to render the records easily readable,
the registrant shall provide access to such equipment with the records.
If any
[[Page 46]]
code system is used (other than pricing information), a key to the code
shall be provided to make the records understandable.
(3) The registrant agrees to deliver all or any part of such records
to the registered location within two business days upon receipt of a
written request from the Administration for such records, and if the
Administration chooses to do so in lieu of requiring delivery of such
records to the registered location, to allow authorized employees of the
Administration to inspect such records at the central location upon
request by such employees without a warrant of any kind.
(4) In the event that a registrant fails to comply with these
conditions, the Special Agent in Charge may cancel such central
recordkeeping authorization, and all other central recordkeeping
authorizations held by the registrant without a hearing or other
procedures. In the event of a cancellation of central recordkeeping
authorizations under this paragraph the registrant shall, within the
time specified by the Special Agent in Charge, comply with the
requirements of this section that all records be kept at the registered
location.
(c) Registrants need not notify the Special Agent in Charge or
obtain central recordkeeping approval in order to maintain records on an
in-house computer system.
(d) ARCOS participants who desire authorization to report from other
than their registered locations must obtain a separate central reporting
identifier. Request for central reporting identifiers will be submitted
to: ARCOS Unit, P.O. Box 28293, Central Station, Washington, DC 20005.
(e) All central recordkeeping permits previously issued by the
Administration will expire on September 30, 1980. Registrants who desire
to continue maintaining central records will make notification to the
local Special Agent in Charge as provided in paragraph (a) of this
section.
(f) Each registered manufacturer, distributor, importer, exporter,
narcotic treatment program and compounder for narcotic treatment program
shall maintain inventories and records of controlled substances as
follows:
(1) Inventories and records of controlled substances listed in
Schedules I and II shall be maintained separately from all of the
records of the registrant; and
(2) Inventories and records of controlled substances listed in
Schedules III, IV, and V shall be maintained either separately from all
other records of the registrant or in such form that the information
required is readily retrievable from the ordinary business records of
the registrant.
(g) Each registered individual practitioner required to keep records
and institutional practitioner shall maintain inventories and records of
controlled substances in the manner prescribed in paragraph (f) of this
section.
(h) Each registered pharmacy shall maintain the inventories and
records of controlled substances as follows:
(1) Inventories and records of all controlled substances listed in
Schedules I and II shall be maintained separately from all other records
of the pharmacy, and prescriptions for such substances shall be
maintained in a separate prescription file; and
(2) Inventories and records of controlled substances listed in
Schedules III, IV, and V shall be maintained either separately from all
other records of the pharmacy or in such form that the information
required is readily retrievable from ordinary business records of the
pharmacy, and prescriptions for such substances shall be maintained
either in separate prescription file for controlled substances listed in
Schedules III, IV, and V only or in such form that they are readily
retrievable from the other prescription records of the pharmacy.
Prescriptions will be deemed readily retrievable if, at the time they
are initially filed, the face of the prescription is stamped in red ink
in the lower right corner with the letter ``C'' no less than 1-inch high
and filed either in the prescription file for controlled substances
listed in
[[Page 47]]
Schedules I and II or in the usual consecutively numbered prescription
file for non-controlled substances.
(21 U.S.C. 821 and 871(b); 28 CFR 0.100)
[36 FR 7790, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, l973, and amended at 39 FR 37985,
Oct. 25, 1974; 45 FR 44266, July 1, 1980; 47 FR 41735, Sept. 22, 1982;
51 FR 5320, Feb. 13, 1986]
Inventory Requirements
Sec. 1304.11 General requirements for inventories.
(a) Each inventory shall contain a complete and accurate record of
all controlled substances on hand on the date the inventory is taken.
Controlled substances shall be deemed to be ``on hand'' if they are in
the possession of or under the control of the registrant, including
substances returned by a customer, substances ordered by a customer but
not yet invoiced, substances stored in a warehouse on behalf of the
registrant, and substances in the possession of employees of the
registrant and intended for distribution as complimentary samples.
(b) A separate inventory shall be made by a registrant for each
registered location. In the event controlled substances in the
possession or under the control of the registrant at a location for
which he is not registered, the substances shall be included in the
inventory of the registered location to which they are subject to
control or to which the person possessing the substance is responsible.
Each inventory for a registered location shall be kept at the registered
location.
(c) A separate inventory shall be made by a registrant for each
independent activity for which he is registered, except as provided in
Sec. 1304.18.
(d) A registrant may take an inventory on a date that is within 4
days of his biennial inventory date pursuant to Sec. 1304.13 if he
notifies in advance the Special Agent in Charge of the Administration in
his area of the date on which he will take the inventory. A registrant
may take an inventory either as of the opening of business or as of the
close of business on the inventory date. The registrant shall indicate
on the inventory records whether the inventory is taken as of the
opening or as of the close of business and the date the inventory is
taken.
(e) An inventory must be maintained in a written, typewritten or
printed form. An inventory taken by use of an oral recording device must
be promptly transcribed.
[36 FR 7790, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, l973,
and amended at 47 FR 41735, Sept. 22, 1982]
Sec. 1304.12 Initial inventory date.
(a) Every person required to keep records who is provisionally
registered on May 1, 1971, shall take an inventory of all stocks of
controlled substances on hand on that date in accordance with
Secs. 1304.15-1304.19, as applicable.
(b) Every person required to keep records who is registered after
May 1, 1971, and who was not provisionally registered on that date,
shall take an inventory of all stocks of controlled substances on hand
on the date he first engages in the manufacture, distribution, or
dispensing of controlled substances, in accordance with Secs. 1304.15-
1304.19, as applicable. In the event a person commences business with no
controlled substances on hand, he shall record this fact as his initial
inventory.
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 37
FR 15920, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.13 Biennial inventory date.
Every 2 years following the date on which the initial inventory is
taken by a registrant pursuant to Sec. 1304.12, the registrant shall
take a new inventory of all stocks of controlled substances on hand. The
biennial inventory may be taken (a) on the day of the year on which the
initial inventory was taken or (b) on the registrant's regular general
physical inventory date, if any, which is nearest to and does not vary
by more than 6 months from the biennial date that would otherwise apply
or (c) on any other fixed date which does not vary by more than 6 months
from the biennial date that would otherwise apply. If the registrant
elects to take the biennial inventory on his regular
[[Page 48]]
general physical inventory date or another fixed date, he shall notify
the Administration of this election and of the date on which the
biennial inventory will be taken.
[36 FR 7791, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.14 Inventory date for newly controlled substances.
On the effective date of a rule by the Administrator pursuant to
Secs. 1308.48-1308.49, or Sec. 1308.50 of this chapter adding a
substance to any schedule of controlled substances, which substance was,
immediately prior to that date, not listed on any such schedule, every
registrant required to keep records who possesses that substance shall
take an inventory of all stocks of the substance on hand. Thereafter
such substance shall be included in each inventory made by the
registrant pursuant to Sec. 1304.13.
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.15 Inventories of manufacturers.
Each person registered or authorized (by Sec. 1301.22(b),
Sec. 1307.12, or Sec. 1307.15 of this chapter) to manufacture controlled
substances shall include the following information in his inventory:
(a) For each controlled substance in bulk form to be used in (or
capable of use in) the manufacture of the same or other controlled or
non-controlled substances in finished form:
(1) The name of the substance; and
(2) The total quantity of the substance to the nearest metric unit
weight consistent with unit size (except that for inventories made in
1971, avoirdupois weights may be utilized where metric weights are not
readily available).
(b) For each controlled substance in the process of manufacture on
the inventory date:
(1) The name of the substance;
(2) The quantity of the substance in each batch and/or stage of
manufacture, identified by the batch number or other appropriate
identifying number;
(3) The physical form which the substance is to take upon completion
of the manufacturing process (e.g., granulations, tablets, capsules, or
solutions), identified by the batch number or other appropriate
identifying number, and if possible the finished form of the substance
(e.g., 10-milligram tablet or 10-milligram concentration per fluid ounce
or milliliter) and the number or volume thereof; and
(c) For each controlled substance in finished form:
(1) The name of the substance;
(2) Each finished form of the substance (e.g., 10-milligram tablet
or 10-milligram concentration per fluid ounce or milliliter);
(3) The number of units or volume of each finished form in each
commercial container (e.g., 100-tablet bottle or 3-milliliter vial); and
(4) The number of commercial containers of each such finished form
(e.g. four 100-tablet bottles or six 3-milliliter vials).
(d) For each controlled substance not included in paragraphs (a),
(b) or (c) of this section (e.g., damaged, defective or impure
substances awaiting disposal, substances held for quality control
purposes, or substances maintained for extemporaneous compoundings):
(1) The name of the substance;
(2) The total quantity of the substance to the nearest metric unit
weight or the total number of units of finished form; and
(3) The reason for the substance being maintained by the registrant
and whether such substance is capable of use in the manufacture of any
controlled substance in finished form.
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18732, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.16 Inventories of distributors.
Each person registered or authorized (by Secs. 1301.22(b) or
Secs. 1307.11-1307.14 of this chapter) to distribute controlled
substances shall include in his inventory the same information required
of manufacturers pursuant to Sec. 1304.15 (c) and (d).
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
[[Page 49]]
Sec. 1304.17 Inventories of dispensers and researchers.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to dispense or conduct research with controlled substances and
required to keep records pursuant to Sec. 1304.03 shall include in his
inventory the same information required of manufacturers pursuant to
Sec. 1304.15 (c) and (d). In determining the number of units of each
finished form of a controlled substance in a commercial container which
has been opened, the dispenser shall do as follows:
(a) If the substance is listed in Schedule I or II, he shall make an
exact count or measure of the contents; and
(b) If the substance is listed in Schedule III, IV, or V, he shall
make an estimated count or measure of the contents, unless the container
holds more than 1,000 tablets or capsules in which case he must make an
exact count of the contents.
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.18 Inventories of importers and exporters.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to import or export controlled substances shall include in his
inventory the same information required of manufacturers pursuant to
Sec. 1304.15 (a), (c), and (d). Each such person who is also registered
as a manufacturer or as a distributor shall include in his inventory as
an importer or exporter only those stocks of controlled substances that
are actually separated from his stocks as a manufacturer or as a
distributor (e.g., in transit or in storage for shipment).
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.19 Inventories of chemical analysts.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to conduct chemical analysis with controlled substances shall
include in his inventory the same information required of manufacturers
pursuant to Sec. 1305.15 (a), (c), and (d) as to substances which have
been manufactured, imported, or received by such person. If less than 1
kilogram of any controlled substance (other than a hallucinogenic
controlled substance listed in Schedule I), or less than 20 grams of a
hallucinogenic substance listed in Schedule I (other than lysergic acid
diethylamide), or less than 0.5 gram of lysergic acid diethylamide, is
on hand at the time of inventory, that substance need not be included in
the inventory. Laboratories of the Administrator may possess up to 150
grams of any hallucinogenic substance in Schedule I without regard to a
need for an inventory of those substances. No inventory is required of
known or suspected controlled substances received as evidentiary
materials for analysis.
[36 FR 7791, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Continuing Records
Sec. 1304.21 General requirements for continuing records.
(a) On and after May 1, 1971, every registrant required to keep
records pursuant to Sec. 1304.03 shall maintain on a current basis a
complete and accurate record of each such substance manufactured,
imported, received, sold, delivered, exported, or otherwise disposed of
by him, except that no registrant shall be required to maintain a
perpetual inventory.
(b) Separate records shall be maintained by a registrant for each
registered location except as provided in Sec. 1304.04 (a). In the event
controlled substances are in the possession or under the control of a
registrant at a location for which he is not registered, the substances
shall be included in the records of the registered location to which
they are subject to control or to which the person possessing the
substance is responsible.
(c) Separate records shall be maintained by a registrant for each
independent activity for which he is registered, except as provided in
Secs. 1304.25 and 1304.26.
(d) In recording dates of receipt, importation, distribution,
exportation, or other transfers, the date on which the
[[Page 50]]
controlled substances are actually received, imported, distributed,
exported, or otherwise transferred shall be used as the date of receipt
or distribution of any documents of transfer (e.g., invoices or packing
slips).
[36 FR 7792, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.22 Records for manufacturers.
Each person registered or authorized (by Sec. 1301.22(b) or
Sec. 1307.15 of this chapter) to manufacture controlled substances shall
maintain records with the following information:
(a) For each controlled substance in bulk form to be used in, or
capable of use in, or being used in, the manufacture of the same or
other controlled or noncontrolled substances in finished form,
(1) The name of the substance;
(2) The quantity manufactured in bulk form by the registrant,
including the date, quantity and batch or other identifying number of
each batch manufactured;
(3) The quantity received from other persons, including the date and
quantity of each receipt and the name, address, and registration number
of the other person from whom the substance was received;
(4) The quantity imported directly by the registrant (under a
registration as an importer) for use in manufacture by him, including
the date, quantity, and import permit or declaration number for each
importation;
(5) The quantity used to manufacture the same substance in finished
form, including:
(i) The date and batch or other identifying number of each
manufacture;
(ii) The quantity used in the manufacture;
(iii) The finished form (e.g., 10-milligram tablets or 10-milligram
concentration per fluid ounce or milliliter);
(iv) The number of units of finished form manufactured;
(v) The quantity used in quality control;
(vi) The quantity lost during manufacturing and the causes therefor,
if known;
(vii) The total quantity of the substance contained in the finished
form;
(viii) The theoretical and actual yields; and
(ix) Such other information as is necessary to account for all
controlled substances used in the manufacturing process;
(6) The quantity used to manufacture other controlled and
noncontrolled substances, including the name of each substance
manufactured and the information required in paragraph (a)(5) of this
section;
(7) The quantity distributed in bulk form to other persons,
including the date and quantity of each distribution and the name,
address, and registration number of each person to whom a distribution
was made;
(8) The quantity exported directly by the registrant (under a
registration as an exporter), including the date, quantity, and export
permit or declaration number of each exportation;
(9) The quantity distributed or disposed of in any other manner by
the registrant (e.g., by distribution of complimentary samples or by
destruction), including the date and manner of distribution or disposal,
the name, address, and registration number of the person to whom
distributed, and the quantity distributed or disposed;
(10) The originals of all written certifications of available
procurement quotas submitted by other persons (as required by
Sec. 1303.12(f) of this chapter) relating to each order requiring the
distribution of a basic class of controlled substance listed in Schedule
I or II.
(b) For each controlled substance in finished form,
(1) The name of the substance;
(2) Each finished form (e.g., 10-milligram tablet or 10-milligram
concentration per fluid ounce or milliliter) and the number of units or
volume of finished form in each commercial container (e.g., 100-tablet
bottle or 3-milliliter vial);
(3) The number of containers of each such commercial finished form
manufactured from bulk form by the registrant, including the information
required pursuant to paragraph (a)(5) of this section;
[[Page 51]]
(4) The number of units of finished forms and/or commercial
containers received from other persons, including the date of and number
of units and/or commercial containers in each receipt and the name,
address, and registration number of the person from whom the units were
received;
(5) The number of units of finished forms and/or commercial
containers imported directly by the person (under a registration or
authorization to import), including the date of, the number of units
and/or commercial containers in, and the import permit or declaration
number for, each importation;
(6) The number of units and/or commercial containers manufactured by
the registrant from units in finished form received from others or
imported, including:
(i) The date and batch or other identifying number of each
manufacture;
(ii) The operation performed (e.g., repackaging or relabeling);
(iii) The number of units of finished form used in the manufacture,
the number manufactured and the number lost during manufacture, with the
causes for such losses, if known; and
(iv) Such other information as is necessary to account for all
controlled substances used in the manufacturing process;
(7) The number of commercial containers distributed to other
persons, including the date of and number of containers in each
distribution, and the name, address, and registration number of the
person to whom the containers were distributed;
(8) The number of commercial containers exported directly by the
registrant (under a registration as an exporter), including the date,
number of containers and export permit or declaration number for each
exportation; and
(9) The number of units of finished forms and/or commercial
containers distributed or disposed of in any other manner by the
registrant (e.g., by distribution of complimentary samples or by
destruction), including the date and manner of distribution or disposal,
the name, address, and registration number of the person to whom
distributed, and the quantity in finished form distributed or disposed.
[36 FR 7792, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18732, Sept. 21, 1971; 37 FR 15920, Aug. 8, 1972. Redesignated at 38
FR 26609, Sept. 24, 1973]
Editorial Note: For FR citations affecting Sec. 1304.22, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1304.23 Records for distributors.
Each person registered or authorized (by Sec. 1301.22(b) or
Secs. 1307.11-1307.14 of this chapter) to distribute controlled
substances shall maintain records with the following information for
each controlled substance:
(a) The name of the substance;
(b) Each finished form (e.g., 10-milligram tablet or 10-milligram
concentration per fluid ounce or milliliter) and the number of units or
volume of finished form in each commercial container (e.g., 100-tablet
bottle or 3-milliliter vial);
(c) The number of commercial containers of each such finished form
received from other persons, including the date of and number of
containers in each receipt and the name, address, and registration
number of the person from whom the containers were received;
(d) The number of commercial containers or each such finished form
imported directly by the person (under a registration or authorization
to import), including the date of, the number of commercial containers
in, and the import permit or declaration number for, each importation;
(e) The number of commercial containers of each such finished form
distributed to other persons, including the date of and number of
containers in each distribution and the name, address, and registration
number of the person to whom the containers were distributed;
(f) The number of commercial containers of each such finished form
exported directly by the person (under a registration or authorization
to export), including the date of, the number of commercial containers
in, and the export permit or declaration number for, each exportation;
and
[[Page 52]]
(g) The number of units or volume of finished forms and/or
commercial containers distributed or disposed of in any other manner by
the person (e.g., by distribution as complimentary samples or by
destruction) including the date and manner of distribution or disposal,
the name, address, and registration number of the person to whom
distributed, and the quantity of the substance in finished form
distributed or disposed.
[36 FR 7792, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.24 Records for dispensers and researchers.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to dispense or conduct research with controlled substances and
required to keep records pursuant to Sec. 1304.03 shall maintain records
with the following information for each controlled substance:
(a) The name of the substance;
(b) Each finished form (e.g., 10-milligram tablet or 10-milligram
concentration per fluid ounce or milliliter) and the number of units or
volume of finished form in each commercial container (e.g., 100-tablet
bottle or 3-milliliter vial);
(c) The number of commercial containers of each such finished form
received from other persons, including the date of and number of
containers in each receipt and the name, address, and registration
number of the person from whom the containers were received;
(d) The number of units or volume of such finished form dispensed,
including the name and address of the person to whom it was dispensed,
the date of dispensing, the number of units or volume dispensed, and the
written or typewritten name or initials of the individual who dispensed
or administered the substance on behalf of the dispenser; and
(e) The number of units or volume of such finished forms and/or
commercial containers disposed of in any other manner by the registrant,
including the date and manner of disposal and the quantity of the
substance in finished form disposed.
[36 FR 7793, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.25 Records for importers.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to import controlled substances shall maintain records with the
following information for each controlled substance:
(a) The name of the substance;
(b) The quantity (or number of units or volume in finished form)
imported, including the date, quantity (or number of units or volume),
and import permit or declaration number for each importation;
(c) The quantity (or number of units or volume in finished form)
distributed to other persons, including the date and quantity (or number
of units or volume) of each distribution and the name, address, and
registration number of each person to whom a distribution was made; and
(d) The quantity disposed of in any other manner by the registrant
(except quantities used in manufacturing by an importer under a
registration as a manufacturer, which quantities are to be recorded
pursuant to Sec. 1304.22(a) (4) or (b) (5)), including the date and
manner of disposal and the quantity disposed.
[36 FR 7793, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.26 Records for exporters.
Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to export controlled substances shall maintain records with the
following information for each controlled substance:
(a) The name of the substance;
(b) The quantity (or number of units or volume in finished form)
received from other persons, including the date and quantity (or number
of units or volume) of each receipt and the name, address, and
registration number of each person from whom the substance was received;
(c) The quantity (or number of units or volume in finished form)
exported, including the date, quantity (or number of units or volume),
and the export
[[Page 53]]
permit or declaration number for each exportation, but excluding all
quantities (and numbers of units and volumes) manufactured by an
exporter under a registration as a manufacturer, which quantities (and
numbers of units and volumes) are to be recorded pursuant to
Sec. 1304.22 (a) (8) or (b) (8); and
(d) The quantity disposed of in any other manner by the registrant,
including the date and manner of disposal and the quantity disposed.
[36 FR 7793, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.27 Records for chemical analysts.
(a) Each person registered or authorized (by Sec. 1301.22(b) of this
chapter) to conduct chemical analysis with controlled substances shall
maintain records with the following information (to the extent known and
reasonably ascertainable by him) for each controlled substance:
(1) The name of the substance;
(2) The form or forms in which the substance is received, imported,
or manufactured by the registrant (e.g., powder, granulation, tablet,
capsule, or solution) and the concentration of the substance in such
form (e.g., C.P., U.S.P., N.F., 10-milligram tablet or 10-milligram
concentration per milliliter);
(3) The total number of the forms received, imported or manufactured
(e.g., 100 tablets, thirty 1-milliliter vials, or 10 grams of powder),
including the date and quantity of each receipt, importation, or
manufacture and the name, address, and registration number, if any, of
the person from whom the substance was received;
(4) The quantity distributed, exported, or destroyed in any manner
by the registrant (except quantities used in chemical analysis or other
laboratory work), including the date and manner of distribution,
exportation, or destruction, and the name, address, and registration
number, if any, of each person to whom the substance was distributed or
exported.
(b) Records of controlled substances used in chemical analysis or
other laboratory work are not required.
(c) Records relating to known or suspected controlled substances
received as evidentiary material for analysis are not required under
paragraph (a) of this section.
[36 FR 7793, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18732, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1304.28 Records for maintenance treatment programs and detoxification treatment programs.
(a) Each person registered or authorized (by Sec. 1301.22 of this
chapter) to maintain and/or detoxify controlled substance users in a
narcotic treatment program shall maintain records with the following
information for each narcotic controlled substance:
(1) Name of substance;
(2) Strength of substance;
(3) Dosage form;
(4) Date dispensed;
(5) Adequate identification of patient (consumer);
(6) Amount consumed;
(7) Amount and dosage form taken home by patient; and
(8) Dispenser's initials.
(b) The records required by paragraph (a) of this section will be
maintained in a dispensing log at the narcotic treatment program site
and will be maintained in compliance with Sec. 1304.24 without reference
to Sec. 1304.03.
(c) All sites which compound a bulk narcotic solution from bulk
narcotic powder to liquid for on-site use must keep a separate batch
record of the compounding.
(d) Records of identity, diagnosis, prognosis, or treatment of any
patients which are maintained in connection with the performance of a
narcotic treatment program shall be confidential, except that such
records may be disclosed for purposes and under the circumstances
authorized by part 310 and part 1401 of this title.
[39 FR 37985, Oct. 25, 1974]
Sec. 1304.29 Records for treatment programs which compound narcotics for treatment programs and other locations.
Each person registered or authorized by Sec. 1301.22 of this chapter
to compound
[[Page 54]]
narcotic drugs for off-site use in a narcotic treatment program shall
maintain records which include the following information for each
narcotic drug:
(a) For each narcotic controlled substance in bulk form to be used
in, or capable of use in, or being used in, the compounding of the same
or other noncontrolled substances in finished form:
(1) The name of the substance;
(2) The quantity compounded in bulk form by the registrant,
including the date, quantity and batch or other identifying number of
each batch compounded;
(3) The quantity received from other persons, including the date and
quantity of each receipt and the name, address and registration number
of the other person from whom the substance was received;
(4) The quantity imported directly by the registrant (under a
registration as an importer) for use in compounding by him, including
the date, quantity and import permit or declaration number of each
importation;
(5) The quantity used to compound the same substance in finished
form, including:
(i) The date and batch or other identifying number of each
compounding;
(ii) The quantity used in the compound;
(iii) The finished form (e.g., 10-milligram tablets or 10-milligram
concentration per fluid ounce or milliliter;
(iv) The number of units of finished form compounded;
(v) The quantity used in quality control;
(vi) The quantity lost during compounding and the causes therefore,
if known;
(vii) The total quantity of the substance contained in the finished
form;
(viii) The theoretical and actual yields; and
(ix) Such other information as is necessary to account for all
controlled substances used in the compounding process;
(6) The quantity used to manufacture other controlled and non-
controlled substances; including the name of each substance manufactured
and the information required in paragraph (a)(5) of this section;
(7) The quantity distributed in bulk form to other programs,
including the date and quantity of each distribution and the name,
address and registration number of each program to whom a distribution
was made;
(8) The quantity exported directly by the registrant (under a
registration as an exporter), including the date, quantity, and export
permit or declaration number of each exploration; and
(9) The quantity disposed of by destruction, including the reason,
date and manner of destruction. All other destruction of narcotic
controlled substances will comply with Sec. 1307.22.
(b) For each narcotic controlled substance in finished form:
(1) The name of the substance;
(2) Each finished form (e.g., 10-milligram tablet or 10 milligram
concentration per fluid ounce or milliliter) and the number of units or
volume or finished form in each commercial container (e.g., 100-tablet
bottle or 3-milliliter vial);
(3) The number of containers of each such commercial finished form
compounded from bulk form by the registrant, including the information
required pursuant to paragraph (a)(5) of this section;
(4) The number of units of finished forms and/or commercial
containers received from other persons, including the date of and number
of units and/or commercial containers in each receipt and the name,
address and registration number of the person from whom the units were
received;
(5) The number of units of finished forms and/or commercial
containers imported directly by the person (under a registration or
authorization to import), including the date of, the number of units
and/or commercial containers in, and the import permit or declaration
number for, each importation;
(6) The number of units and/or commercial containers compounded by
the registrant from units in finished form received from others or
imported, including:
(i) The date and batch or other identifying number of each
compounding;
(ii) The operation performed (e.g., repackaging or relabeling);
[[Page 55]]
(iii) The number of units of finished form used in the compound, the
number compounded and the number lost during compounding, with the
causes for such losses, if known; and
(iv) Such other information as is necessary to account for all
controlled substances used in the compounding process;
(7) The number of containers distributed to other programs,
including the date, the number of containers in each distribution, and
the name, address and registration number of the program to whom the
containers were distributed;
(8) The number of commercial containers exported directly by the
registrant (under a registration as an exporter), including the date,
number of containers and export permit or declaration number for each
exportation; and
(9) The number of units of finished forms and/or commercial
containers destroyed in any manner by the registrant, including the
reason, the date and manner of destruction. All other destruction of
narcotic controlled substances will comply with Sec. 1307.22.
[39 FR 37985, Oct. 25, 1974]
Reports
Sec. 1304.31 Reports from manufacturers importing opium.
(a) Every manufacturer importing crude opium shall submit, in
addition to the report on DEA (or BND) Form 234 and its supplements, DEA
(or BND) Form 247 and its supplements, 247a and 247b, accounting for the
importation and for all manufacturing operations performed between
importation and the production in bulk of finished marketable products,
standardized in accordance with the U.S. Pharmacopeia, National
Formulary, or other recognized medical standards. Subsequent manufacture
from such products, including bottling or packaging operations, shall be
accounted for in the quarterly returns on DEA (or BND) Form 234 and its
supplements. DEA (or BND) Form 247 and its supplements shall be
submitted quarterly to the Drug Control Section, Drug Enforcement
Administration, Department of Justice, Washington, DC 20537, on or
before the 15th day of the month immediately following the period for
which it is submitted.
(b) The report of manufacture from crude opium shall consist of
summaries (DEA (or BND) Forms 247 and 247a) with supporting detail
sheets (on DEA (or BND) Form 247b) accounting for original manufacture
from crude opium, production from morphine for further manufacture and
production from manufacturing opium, and also accounting for stocks of
crude opium, manufacturing opium, morphine for further manufacture and
other crude alkaloids.
(c) The detail sheets (DEA (or BND) Form 247b) supporting the
summary of original manufacture from crude opium shall show separately
the crude opium used for the manufacture of opium tinctures and
extracts, crude opium used for the extraction of alkaloids, crude opium
used for the manufacture of controlled substances listed in Schedule V,
and crude opium used for the production of manufacturing opium; and
shall show separately the medicinal opium, alkaloids and salts, opium
tinctures and extracts, controlled substances listed in Schedule V, and
manufacturing opium produced.
(d) Importation of opium shall be reported in summarized entries in
the debit summary of the quarterly report (DEA (or BND) Form 234) and
shall be immediately reported by similar summarized entries in the
credit summary of the quarterly report (DEA (or BND) Form 234) as
transferred to importing manufacturer's report. Such importations shall
further be reported in summary (DEA (or BND) Form 247) and supporting
detail sheets (DEA (or BND) Form 247b). Products manufactured therefrom
shall be reported as produced in accordance with paragraphs (b) and (c)
of this section and, with the exception of manufacturing opium, morphine
for further manufacture, and other crude or unfinished alkaloids, shall
be transferred to the quarterly report (DEA (or BND) Form 234) when
reported produced.
(e) Upon importation of crude opium, samples will be selected and
assays made by the importing manufacturer in the manner and according to
the
[[Page 56]]
method specified in the U.S. Pharmacopoeia. These assays shall be
accounted for in terms of its anhydrous morphine alkaloid content. Where
final assay data is not determined at the time of rendering report, the
report shall be made on the basis of the best data available, subject to
adjustment, and the necessary adjusting entries shall be made on the
next report.
(f) Upon withdrawal of crude opium from customs custody, the
importing manufacturer shall assign to each container an identification
mark or number by which the opium will be associated with the lot assay
and identified in reports.
(g) Where factory procedure is such that partial withdrawals of
opium are made from individual containers, there shall be attached to
each container a stock record card on which shall be kept a complete
record of all withdrawals therefrom.
(h) Opium products and derivatives which are produced for exclusive
use in further manufacturing purposes shall be reported produced when
they come into existence in that form in which they are to be so used.
Medicinal opium, morphine and its salts, or other alkaloids or
derivatives produced exclusively for distribution shall be reported as
produced when manufacture has actually been completed and the finished
marketable product ready for packaging and distribution. Such products
shall be regarded as ready for packaging and distribution as soon as all
processing other than mere packaging has been completed. Medicinal
opium, tinctures, extracts, or other products manufactured partly for
distribution and partly for use in further manufacture will be reported
produced as soon as manufacture is complete and they are ready either
for use in further manufacture or for packaging for distribution.
(i) Subject to Sec. 1303.24(c) of this chapter, no accumulations of
morphine or other narcotic controlled substances in their pure or near-
pure states shall be permitted to remain inactively in process for an
unreasonable time in light of efficient industrial practices. All such
products nearing completion of their respective processes and
approaching a condition of purity shall be carefully protected, promptly
completed, and immediately transferred to finished stocks, and reported
as produced.
(j) In making conversions of opium alkaloids and their salts to
anhydrous morphine the quantity of the particular alkaloid or salt in
avoirdupois ounces shall be multipled by a conversion factor arrived at
by ascertaining the ratio, carried to the fourth decimal place, between
the respective molecular weight of such alkaloid or salt and the
molecular weight of anhydrous morphine (285.16), such weights being
computed to the third decimal place from the chemical formulae of the
substances and the atomic weights of elements, as adopted by the
International Committee on Chemical Elements and published in the latest
edition of the U.S. Pharmacopoeia.
[36 FR 7794, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973.
Redesignated and amended at 51 FR 5319, 5320, Feb. 13, 1986]
Sec. 1304.32 Reports of manufacturers importing medicinal coca leaves.
(a) Every manufacturer importing raw coca leaves for the manufacture
of medicinal products shall submit, in addition to the report on DEA (or
BND) Form 234 and its supplements, DEA (or BND) Form 168 and its
supplements, 168a and 168b, accounting for the importation and for all
manufacturing operations performed between the importation and the
manufacture of bulk or finished products standardized in accordance with
U.S. Pharmacopoeia, National Formulary, or other recognized standards.
Subsequent manufacture from such products, including bottling or
packaging operations, shall be accounted for in quarterly reports on DEA
(or BND) Form 234 and its supplements. Reports on Form 168 and its
supplements shall be submitted quarterly to the Drug Control Section,
Drug Enforcement Administration, Department of Justice, Washington, DC
20537, on or before the 15th day of the month immediately following the
period for which it is submitted.
(b) The report of manufacture from medicinal coca leaves shall
consist of summaries (DEA (or BND) Forms 168 and 168a) with supporting
detail sheets (DEA (or BND) Form 168b) accounting for original
manufacture from such
[[Page 57]]
leaves, conversions or production from manufacturing coca extracts, and
also accounting for stocks of raw coca leaves, manufacturing coca
extracts, and other crude coca alkaloids.
(c) The detail sheets (DEA (or BND) Form 168b) supporting the
summary of original manufacture from medicinal coca leaves, shall show
separately the coca leaves used for the manufacture of manufacturing
coca extracts, coca leaves used for the direct manufacture of marketable
coca tinctures and extracts, and coca leaves used for the extraction of
alkaloids, and shall show separately the coca alkaloids and salts, coca
tinctures and extracts, and manufacturing coca extracts produced.
(d) Importations of medicinal coca leaves shall be reported in
summarized entries in the debit summary of the quarterly report (DEA (or
BND) Form 234) and shall be immediately reported by similar summarized
entries in the credit summary of the quarterly report (DEA (or BND) Form
234) as transferred to importing manufacturer's report. Such
importations shall further be reported in summary (DEA (or BND) Form
168) and supporting detail sheets (DEA (or BND) Form 168b). Products
manufactured therefrom shall be reported as produced in accordance with
paragraph (h) of this section and, with the exception of manufacturing
coca extracts, residues or bases for further manufacture, and other
crude or unfinished alkaloids, shall be transferred to the quarterly
report (DEA (or BND) Form 234) when reported produced.
(e) Upon importation of medicinal coca leaves, samples will be
selected and assays made by the importing manufacturer in accordance
with recognized chemical procedures. These assays shall form the basis
of accounting for such coca leaves, which shall be accounted for in
terms of their cocaine alkaloid content or equivalency or their total
anhydrous coca alkaloid content. Where final assay data is not
determined at the time of submitting the report, the report shall be
made on the basis of the best data available, subject to adjustment, and
the necessary adjusting entries shall be made on the next report.
(f) Upon withdrawal of medicinal coca leaves from customs custody,
the importing manufacturer shall assign to each bale or container an
identification mark or number by which the coca leaves will be
associated with the lot assay and identified in reports.
(g) Where factory procedure is such that partial withdrawals of
medicinal coca leaves are made from individual containers, there shall
be attached to the container a stock record card on which shall be kept
a complete record of withdrawals therefrom.
(h) Manufacturing coca extracts shall be reported as produced when
they come into existence in that form in which they are intended for
exclusive use in further manufacture. Cocaine and its salts, ecgonine
and its salts, or other alkaloids or derivatives produced exclusively
for distribution shall be reported as produced when manufacture has
actually been completed and the finished marketable product is ready for
packaging and distribution. Such products shall be regarded as ready for
packaging and distribution as soon as all processing other than mere
packaging has been completed. Tinctures, extracts, or other products
manufactured partly for distribution and partly for use in further
manufacture shall be reported produced as soon as manufacture is
complete and they are ready either for use in further manufacture or for
packaging for distribution.
(i) No accumulations of cocaine or ecgonine or other narcotic
controlled substances in their pure or near-pure states shall be
permitted to remain inactively in process. All such products nearing
completion of their respective processes and approaching a condition of
purity shall be carefully protected, promptly completed, and immediately
transferred to finished stocks and reported as produced.
(j) In making conversions of coca alkaloids and their salts to
cocaine alkaloid and to anhydrous ecgonine alkaloid, the quantity of the
particular alkaloid or salt in avoirdupois ounces shall be multiplied by
a conversion factor arrived at by ascertaining the ratio, carried to the
fourth decimal place, between the molecular weight of such alkaloid or
salt and the molecular weight of cocaine alkaloid (303.172) or anhydrous
ecgonine alkaloid (185.125), as the case may be, such weights being
[[Page 58]]
computed to the third decimal place from the chemical formulae of the
substances and the atolic weights of elements, as adopted by the
International Committee on Chemical Elements and published in the latest
edition of the U.S. Pharmacopoeia.
[36 FR 7795, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973.
Redesignated and amended at 51 FR 5319, 5320, Feb. 13, 1986]
Sec. 1304.33 Reports from manufacturers importing special coca leaves.
(a) Every manufacturer using special coca leaves imported into the
United States shall submit a quarterly report (DEA (or BND) Form 249)
accounting for all transactions involving such leaves or substances
derived therefrom which contain cocaine or ecgonine, or any salts,
derivatives, or preparations from which cocaine or ecgonine may be
synthesized or made. This report shall be submitted to the Drug Control
Section, Drug Enforcement Administration, Department of Justice,
Washington, DC 20537, on or before the 15th day of the month following
the period for which the report is made. Such report shall include a
report of all importations of special coca leaves (DEA (or BND) Form
249a), a report of all materials entered into the processes of
manufacture (DEA (or BND) Form 249b), a report of the various substances
produced therefrom (DEA (or BND) Forms 249c, 249d, and 249e), a report
of all such substances destroyed (DEA (or BND) Form 249f), and a summary
of operations (DEA (or BND) Form 249g).
(b) The report of importations shall provide in appropriate columns
the following data as to each importation:
(1) The date of the import permit;
(2) The serial number of the import permit;
(3) The name of the foreign consignor;
(4) The address of the foreign consignor;
(5) The foreign port of export;
(6) The number of bales imported;
(7) The serial numbers of the bales imported; and
(8) The quantity imported in avoirdupois pounds.
(c) The report of materials entered into the process of manufacture
shall provide in appropriate columns the following information as to
each lot of leaves dumped:
(1) The lot number of specification, a specification to be assigned
to each dump for identification purposes in order to avoid repeating the
serial numbers of the bales when the lot is subsequently referred to;
(2) The date the leaves entered into the process of manufacture;
(3) The number of bales dumped;
(4) The serial numbers of the bales;
(5) The quantity of leaves entered into the process of manufacture,
stated in avoirdupois pounds;
(6) The quantity of alcohol used for each extraction or wash of the
leaves;
(7) The quantity of water used for each water extraction or
dilution;
(8) The quantity of any other or additional substance introduced at
any stage into the process of manufacture; and
(9) The dry weight of any filter cloth or other absorbent material
to be later removed from the process after saturation.
(d) The reports of substances produced from special coca leaves
shall provide in columns the following information as to each production
lot or dump:
(1) The lot number;
(2) The quantity of ground leaves entered into process, in terms of
avoirdupois ounces and the quantity, in ounces and grains, of alkaloid
contained therein as determined by analysis;
(3) The quantity of substance in process after each distinct step in
the manufacturing process and the total alkaloid contained in each,
stated in ounces and grains;
(4) The quantity of exhausted or spent leaves and the quantity of
each residue removed from process, and the total alkaloid contained in
each, stated in ounces and grains;
(5) The weight of the used filter cloth or other absorbent material
removed after saturation; and
(6) The quantity, in gallons, of finished extract produced.
(e) The report of substances destroyed, shall provide in appropriate
columns the following data as to each lot destroyed:
(1) The lot number;
[[Page 59]]
(2) The quantity of spent leaves, residues, and saturated materials
destroyed, stated separately for each; and
(3) The name of the Government officer witnessing the destruction.
(f) The summary shall include a complete accounting for all
transactions in raw leaves, leaves in process, and residues removed from
production processes.
(1) The summary of raw coca leaves shall include:
(i) The quantity of special coca leaves on hand at the beginning of
the quarter;
(ii) The quantity of special coca leaves imported during the
quarter;
(iii) The quantity of special coca leaves entered into the process
of manufacture during the quarter;
(iv) The quantity of special coca leaves on hand at the end of the
quarter; and
(v) Any other transaction during the quarter which increased or
decreased the quantity of raw coca leaves on hand.
(2) The summary of coca leaves in process shall include:
(i) The quantity of special coca leaves in process at the beginning
of the quarter;
(ii) The quantity of such leaves placed in the process during the
quarter;
(iii) The quantity of such leaves represented by lots completed
during the quarter;
(iv) The quantity of such leaves represented by lots in process at
the end of the quarter; and
(v) Any other transaction during the quarter which increased or
decreased the quantity of leaves in process.
(3) The summary of residues removed from production processes shall
provide in appropriate columns, separately as to spent leaves, each
residue and saturated material, the following information:
(i) The quantity of each, on hand at the beginning of the quarter,
awaiting destruction;
(ii) The quantity of each removed from process during the quarter;
(iii) The quantity of each destroyed during the quarter;
(iv) The quantity of each on hand at the end of the quarter; and
(v) Any other transaction during the quarter affecting the quantity
of such residues on hand.
[36 FR 7795, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 46 FR 28841, May 29, 1981. Redesignated and amended at 51
FR 5319, Feb. 13, 1986]
Sec. 1304.34 Reports generally.
(a) All reports required by Secs. 1304.35--1304.38 shall be filed
with the ARCOS Unit, P.O. Box 28293, Central Station, Washington, DC.
20005.
(b) Reports required by Secs. 1304.35--1304.38 shall be filed on DEA
(or BND) Form 333, or on media which contains the data required by DEA
(or BND) Form 333 and which is acceptable to the ARCOS Unit.
(c) References to DEA (or BND) Form 234 in Secs. 1304.33 and 1304.34
shall be deemed to refer equally to DEA (or BND) Form 333.
[37 FR 28714, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 46 FR 28841, May 29, 1981. Redesignated and amended
at 51 FR 5319, 5320, Feb. 13, 1986]
Sec. 1304.35 Reports from manufacturers of bulk materials or dosage units.
Each person who is registered to manufacture controlled substances
in bulk or dosage form shall report as follows:
(a) Substance covered. Reports shall include data on each
controlled substance listed in Schedules I and II, on each narcotic
controlled substance listed in Schedules III, IV and V, and on each
psychotropic controlled substance listed in Schedules III and IV as
identified below:
Schedule III
(1) Benzphetamine;
(2) Cyclobarbital;
(3) Glutethimide;
(4) Methylprylon; and
(5) Phendimetrazine.
Schedule IV
(1) Barbital;
(2) Diethylproprion (Amfepramone);
(3) Ethchlovynol;
(4) Ethinamate;
(5) Lefetamine (SPA);
(6) Mazindol;
(7) Meprobamate;
(8) Methylphenobarbital;
(9) Phenobarbital;
[[Page 60]]
(10) Phentermine; and
(11) Pipradrol.
Data shall be presented in such a manner as to identify the particular
form, strength, and trade name, if any, of the product containing the
controlled substance for which the report is being made. For this
purpose, persons filing reports shall utilize the National Drug Code
Number assigned to the product under the National Drug Code System of
the Food and Drug Administration.
(b) Transactions reported. Reports shall provide data on each
acquisition to inventory (identifying whether it is, e.g., by purchase
or transfer, return from a customer, recovery of waste material,
manufacture from other materials, or supplied by the Federal Government)
and each reduction from inventory (identifying whether it is, e.g., by
sale or transfer, sampling, use in production, loss through
nonrecoverable waste, theft, destruction, or seizure by Government
agencies). These reports shall be filed every month not later than the
15th day of the month succeeding the month for which it is submitted;
except that a registrant may be given permission to file more frequently
or less frequently (but not less than quarterly), depending on the
number of transactions being reported each time by that registrant.
(c) Inventories reported. Reports shall provide data on the stocks
of each reported controlled substance on hand as of the close of
business on December 31 of each year, indicating whether the substance
is in storage or in process of manufacturing. These reports shall be
filed no later than January 15 of the following year.
(d) Registrants manufacturing etorphine hydrochloride or
diprenorphine shall, on a weekly basis, forward a copy of the order
forms received for these substances to the Administration.
(Approved by the Office of Management and Budget under control number
1117-0003)
[37 FR 28714, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 39 FR 17838, May 21, 1974; 49 FR 37060, Sept. 21,
1984. Redesignated and amended at 51 FR 5320, Feb. 13, 1986]
Sec. 1304.36 Reports from packagers and labelers.
Each person who is registered to manufacture controlled substances
and who only packages, repackages, labels, or relabels such substances
shall report as follows:
(a) Substances covered. Reports shall include data on each
controlled substance listed in Schedule I and II and on each narcotic
controlled substance listed in Schedule III (but not on any material,
compound, mixture, or preparation containing a quantity of a substance
having a stimulant effect on the central nervous system, which material,
compound, mixture, or preparation is listed in Schedule III or on any
narcotic controlled substance listed in Schedule V). Data shall be
presented in such a manner as to identify the particular form, strength,
and trade name, if any, of the product containing the controlled
substance for which the report is being made. For this purpose, persons
filing reports shall utilize the National Drug Code Number assigned to
the product under the National Drug Code System of the Food and Drug
Administration.
(b) Transactions reported. Reports shall provide data on each
acquisition to inventory (identifying whether it is, e.g., by purchase
or transfer, return from a customer, or supply by the Federal Government
and each reduction from inventory (identifying whether it is, e.g., by
sale or transfer, sampling, theft, destruction, or seizure by Government
agencies). These reports shall be filed every month not later than the
15th day of the month succeeding the month for which it is submitted;
except that a registrant may be given permission to file more frequently
or less frequently (but not less than quarterly), depending on the
number of transactions being reported each time by that registrant.
(c) Inventories reported. Reports shall provide data on the stocks
of each reported controlled substance on hand as of the close of
business on December 31 of each year. These reports shall be filed no
later than January 15 of the following year.
(d) Exceptions. A registered institutional practitioner who
repackages or relabels exclusively for distribution to and
[[Page 61]]
dispensing by agents, employees, or affiliated institutional
practitioners of the registrant may be exempted from filing reports
under this section by applying to the ARCOS Unit of the Administration.
(Approved by the Office of Management and Budget under control number
1117-0003)
[37 FR 28714, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 38 FR 34998, Dec. 21, 1973; 46 FR 28841, May 29,
1981; 49 FR 37060, Sept. 21, 1984. Redesignated at 51 FR 5320, Feb. 13,
1986]
Sec. 1304.37 Reports from distributors.
Each person who is registered to distribute controlled substances
shall report as follows:
(a) Substances covered. Reports shall include data on each
controlled substance listed in Schedules I and II and on each narcotic
controlled substance listed in Schedule III (but not on any material,
compound, mixture or preparation containing a quantity of a substance
having a stimulant effect on the central nervous system, which material,
compound, mixture or preparation is listed in Schedule III or on any
narcotic controlled substance listed in Schedule V). Data shall be
presented in such a manner as to identify the particular form, strength,
and trade name, if any, of the product containing the controlled
substance for which the report is being made. For this purpose, persons
filing reports shall utilize the National Drug Code Number assigned to
the product under the National Drug Code System of the Food and Drug
Administration.
(b) Transactions reported. Reports shall provide data on each
acquisition to inventory (identifying whether it is, e.g., by purchase
or transfer, return from a customer, or supply by the Federal
Government) and each reduction from inventory (identifying whether it
is, e.g., by sale or transfer, sampling, theft, destruction, or seizure
by Government agencies). These reports shall be filed every month not
later than the 15th day of the month succeeding the month for which it
is submitted: except that a registrant may be given permission to file
more frequently or less frequently (but not less than quarterly),
depending on the number of transactions being reported each time by that
registrant.
(c) Inventories reported. Reports shall provide data on the stocks
of each reported controlled substance on hand as of the close of
business on December 31 of each year. These reports shall be filed no
later than January 15 of the following year.
(d) Exceptions. A registered institutional practitioner which
distributes exclusively to (for dispensing by) agents, employees, or
affiliated institutional practitioners of the registrant may be exempted
from filing reports under this section by applying to the ARCOS Unit of
the Administration.
[37 FR 28714, Dec. 29, 1972. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 38 FR 34998, Dec. 21, 1973; 46 FR 28841, May 29,
1981. Redesignated at 49 FR 37060, Sept. 21, 1984. Redesignated at 51 FR
5320, Feb. 13, 1986]
Sec. 1304.38 Reports from manufacturers importing poppy straw or concentrate of poppy straw.
(a) Every manufacturer importing poppy straw or concentrate of poppy
straw shall submit in addition to Form 333, Form DEA 247(c) accounting
for the importation and for all manufacturing operations performed
between importation and the production in bulk of finished marketable
products, standardized in accordance with the U.S. Pharmacopeia,
National Formulary, or other recognized medical standards. Subsequent
manufacture from such products, including bottling or packaging
operations, shall be accounted for in the returns on DEA Form 333
(Sec. 1304.38) and its supplements. DEA Form 247(c) shall be submitted
quarterly to the Drug Control Section, Drug Enforcement Administration,
Department of Justice, Washington, DC 20537, on or before the 15th day
of the month immediately following the period for which it is submitted.
(b) The report of manufacture from poppy straw or concentrate of
poppy straw shall consist of summaries with supporting detail sheets
accounting for original manufacture from poppy straw to concentrate, and
from concentrate of poppy straw, production from morphine for further
manufacture and also accounting for all stocks of poppy
[[Page 62]]
straw, concentrate of poppy straw, morphine for further manufacture and
other crude alkaloids.
(c) The detail sheets (DEA 247(c)) supporting the summary of
manufacture from poppy straw or concentrate of poppy straw shall show
separately the amount of poppy straw or concentrate imported, the poppy
straw used for production of concentrate, the concentrate used for
extraction of alkaloids, subsequent manufacture from those alkaloids and
the inventory of poppy straw and concentrate of poppy straw at the close
of the reporting period.
(d) Upon importation of poppy straw or concentrate of poppy straw,
samples will be selected and assays made by the importing manufacturer
in a manner and according to a method previously approved by DEA. Where
final assay data is not determined at the time of rendering report, the
report shall be made on the basis of the best data available, subject to
adjustment, and the necessary adjusting entries shall be made on the
next report.
(e) Upon withdrawal of poppy straw or concentrate of poppy straw
from Customs custody, the importing manufacturer shall assign to each
lot or container an identification number by which the poppy straw or
concentrate will be associated with the lot assay and identified in
reports.
(f) Where factory procedure is such that partial withdrawals of
poppy straw or concentrate are made from individual containers, there
shall be attached to each container a stock record card on which shall
be kept a complete record of all withdrawals therefrom.
(g) Concentrate of poppy straw and derivatives produced for
exclusive use in further manufacturing purposes shall be reported
produced when they come into existence in that form in which they are to
be so used. Alkaloids or derivatives produced exclusively for
distribution shall be reported as produced when manufacture has actually
been completed and the finished marketable product ready for packaging
and distribution. Such products shall be regarded as ready for packaging
and distribution as soon as all processing other than mere packaging has
been completed. Products manufactured partly for distribution and partly
for use in further manufacture will be reported produced as soon as
manufacture is complete and they are ready either for use in further
manufacture or for packaging for distribution.
(h) Subject to Sec. 1303.24(c) of this chapter, no accumulations of
morphine or other narcotic controlled substances in their pure or near-
pure states shall be permitted to remain inactively in process for an
unreasonable time in light of efficient industrial practices. All such
products nearing completion of their respective processes and
approaching a condition of purity shall be carefully protected, promptly
completed, and immediately transferred to finished stocks, and reported
as produced.
(i) In making conversions of concentrate of poppy straw alkaloids
and their salts to anhydrous morphine the quantity of the particular
alkaloid or salt in avoirdupois ounces shall be multiplied by a
conversion factor arrived at by ascertaining the ratio, carried to the
fourth decimal place, between the respective molecular weight of such
alkaloid or salt and the molecular weight of anhydrous morphine
(285.16), such weights being computed to the third decimal place from
the chemical formulae of the substances and the atomic weights of
elements, as adopted by the International Committee on Chemical Elements
and published in the latest edition of the U.S. Pharmacopoeia.
[40 FR 6779, Feb. 14, 1975, as amended at 40 FR 42866, Sept. 17, 1975;
46 FR 28841, May 29, 1981. Redesignated at 49 FR 37060, Sept. 21, 1984.
Redesignated and amended at 51 FR 5319, 5320, Feb. 13, 1986]
PART 1305--ORDER FORMS--Table of Contents
Sec.
1305.01 Scope of Part 1305.
1305.02 Definitions.
1305.03 Distributions requiring order forms.
1305.04 Persons entitled to obtain and execute order forms.
1305.05 Procedure for obtaining order forms.
1305.06 Procedure for executing order forms.
1305.07 Power of attorney.
1305.08 Persons entitled to fill order forms.
1305.09 Procedure for filling order forms.
1305.10 Procedure for endorsing order forms.
1305.11 Unaccepted and defective order forms.
1305.12 Lost and stolen order forms.
[[Page 63]]
1305.13 Preservation of order forms.
1305.14 Return of unused order forms.
1305.15 Cancellation and voiding of order forms.
1305.16 Special procedure for filling certain order forms.
Authority: 21 U.S.C. 821, 828, 871(b), unless otherwise noted.
Source: 36 FR 7796, Apr. 24, 1971, unless otherwise noted.
Redesignated at 38 FR 26609, Sept. 24, 1973.
Sec. 1305.01 Scope of Part 1305.
Procedures governing the issuance, use, and preservation of order
forms pursuant to section 1308 of the Act (21 U.S.C. 828) are set forth
generally by that section and specifically by the sections of this part.
Sec. 1305.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substances Act (84 Stat. 1242;
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act
(84 Stat. 1285; 21 U.S.C. 951).
(b) The term purchaser means any registered person entitled to
obtain and execute order forms pursuant to Sec. 1305.04 and
Sec. 1305.06.
(c) The term supplier means any registered person entitled to fill
order forms pursuant to Sec. 1305.08.
(d) Any term not defined in this section shall have the definition
set forth in section 102 of the Act (21 U.S.C. 802) and Secs. 1301.02
and 1302.02 of this chapter.
Sec. 1305.03 Distributions requiring order forms.
An order form (DEA Form 222) is required for each distribution of a
controlled substance listed in Schedule I or II, except for the
following:
(a) The exportation of such substances from the United States in
conformity with the Act;
(b) The delivery of such substances to or by a common or contract
carrier for carriage in the lawful and usual course of its business, or
to or by a warehouseman for storage in the lawful and usual course of
its business (but excluding such carriage or storage by the owner of the
substance in connection with the distribution to a third person);
(c) The procurement of a sample of such substances by an exempt law
enforcement official pursuant to Sec. 1301.26(b) of this chapter,
provided that the receipt required by that section is used and is
preserved in the manner prescribed in this part for order forms;
(d) The procurement of such substances by a civil defense or
disaster relief organization, pursuant to Sec. 1301.27 of this chapter,
provided that the Civil Defense Emergency Order Form required by that
section is used and is preserved with other records of the registrant;
and
(e) The purchase of such sustances by the master or first officer of
a vessel pursuant to Sec. 1301.28 of this chapter: Provided, That copies
of the record of sale are generated, distributed and preserved by the
vendor according to that section.
(f) The delivery of such substances to a registered analytical
laboratory, or its agent approved by DEA, from an anonymous source for
the analysis of the drug sample, provided the laboratory has obtained a
written waiver of the order form requirement from the Special Agent in
Charge of the Area in which the laboratory is located, which waiver may
be granted upon agreement of the laboratory to conduct its activities in
accordance with Administration guidelines.
[36 FR 7796, Apr. 24, 1971, as amended at 37 FR 15920, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 39 FR 15031,
Apr. 30, 1974; 47 FR 41735, Sept. 22, 1982; 50 FR 31590, Aug. 5, 1985;
51 FR 5320, Feb. 13, 1986; 53 FR 4963, Feb. 19, 1988]
Sec. 1305.04 Persons entitled to obtain and execute order forms.
(a) Order forms may be obtained only by persons who are registered
under section 303 of the Act (21 U.S.C. 823) to handle controlled
substances listed in Schedules I and II, and by persons who are
registered under section 1008 of the Act (21 U.S.C. 958) to export such
substances. Persons not registered to handle controlled substances
listed in Schedule I or II and persons registered only to import
controlled substances listed in any schedule are not entitled to obtain
order forms.
[[Page 64]]
(b) An order form may be executed only on behalf of the registrant
named thereon and only if his registration as to the substances being
purchased has not expired or been revoked or suspended.
Sec. 1305.05 Procedure for obtaining order forms.
(a) Order Forms are issued in mailing envelopes containing either
seven or fourteen forms, each form containing an original duplicate and
triplicate copy (respectively, Copy 1, Copy 2, and Copy 3). A limit,
which is based on the business activity of the registrant, will be
imposed on the number of order forms which will be furnished on any
requisition unless additional forms are specifically requested and a
reasonable need for such additional forms is shown.
(b) Any person applying for a registration which would entitle him
to obtain order forms may requisition such forms by so indicating on the
application form; order forms will be supplied upon the registration of
the applicant. Any person holding a registration entitling him to obtain
order forms may requisition such forms for the first time by contacting
any Division Office or the Registration Unit of the Administration. Any
person already holding order forms may requisition additional forms on
DEA Form 222a which is mailed to a registrant approximately 30 days
after each shipment of order forms to that registrant or by contacting
any Division Office or the Registration Unit of the Administration. All
requisition forms (DEA Form 222a) shall be submitted to the Registration
Unit, Drug Enforcement Administration, Department of Justice, Post
Office Box 28083, Central Station, Washington, DC 20005.
(c) Each requisition shall show the name, address, and registration
number of the registrant and the number of books of order forms desired.
Each requisition shall be signed and dated by the same person who signed
the most recent application for registration or for reregistration, or
by any person authorized to obtain and execute order forms by a power of
attorney pursuant to Sec. 1305.07.
(d) Order forms will be serially numbered and issued with the name,
address and registration number of the registrant, the authorized
activity and schedules of the registrant. This information cannot be
altered or changed by the registrant; any errors must be corrected by
the Registration Unit of the Administration by returning the forms with
notification of the error.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 51 FR 5319,
Feb. 13, 1986; 53 FR 4963, Feb. 19, 1988]
Sec. 1305.06 Procedure for executing order forms.
(a) Order forms shall be prepared and executed by the purchaser
simultaneously in triplicate by means of interleaved carbon sheets which
are part of the DEA Form 222. Order forms shall be prepared by use of a
typewriter, pen, or indelible pencil.
(b) Only one item shall be entered on each numbered line. There are
ten lines on each order form. If one order form is not sufficient to
include all items in an order, additional forms shall be used. Order
forms for carfentanil etorphine hydrochloride and diprenorphine shall
contain only these substances. The total number of items ordered shall
be noted on that form in the space provided.
(c) An item shall consist of one or more commercial or bulk
containers of the same finished or bulk form and quantity of the same
substance; a separate item shall be made for each commercial or bulk
container of different finished or bulk form, quantity or substance. For
each item the form shall show the name of the article ordered, the
finished or bulk form of the article (e.g., 10-milligram tablet, 10-
milligram concentration per fluid ounce or milliliter, or U.S.P.), the
number of units or volume in each commercial or bulk container (e.g.,
100-tablet bottle or 3-milliliter vial) or the quantity or volume of
each bulk container (e.g., 10 kilograms), the number of commercial or
bulk containers ordered, and the name and quantity per unit of the
controlled substance or substances contained in the article if not in
pure
[[Page 65]]
form. The catalogue number of the article may be included at the
discretion of the purchaser.
(d) The name and address of the supplier from whom the controlled
substances are being ordered shall be entered on the form. Only one
supplier may be listed on any one form.
(e) Each order form shall be signed and dated by a person authorized
to sign a requisition for order forms on behalf of the purchaser
pursuant to Sec. 1305.05(c). The name of the purchaser, if different
from the individual signing the order form, shall also be inserted in
the signature space. Unexecuted order forms may be kept and may be
executed at a location other than the registered location printed on the
form, provided that all unexecuted forms are delivered promptly to the
registered location upon an inspection of such location by any officer
authorized to make inspections, or to enforce, any Federal, State, or
local law regarding controlled substances.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 39 FR 17838,
May 21, 1974; 53 FR 4963, Feb. 19, 1988; 54 FR 33674, Aug. 16, 1989]
Sec. 1305.07 Power of attorney.
Any purchaser may authorize one or more individuals, whether or not
located at the registered location of the purchaser, to obtain and
execute order forms on his behalf by executing a power of attorney for
each such individual. The power of attorney shall be signed by the same
person who signed (or was authorized to sign, pursuant to
Sec. 1301.32(f) of this chapter or Sec. 1311.32(f) of this chapter) the
most recent application for registration or reregistration and by the
individual being authorized to obtain and execute order forms. The power
of attorney shall be filed with the executed order forms of the
purchaser, and shall be retained for the same period as any order form
bearing the signature of the attorney. The power of attorney shall be
available for inspection together with other order form records. Any
power of attorney may be revoked at any time by executing a notice of
revocation, signed by the person who signed (or was authorized to sign)
the power of attorney or by a successor, whoever signed the most recent
application for registration or reregistration, and filing it with the
power of attorney being revoked. The form for the power of attorney and
notice of revocation shall be similar to the following:
Power of Attorney for DEA Order Forms
-------------------- (Name of registrant) -------------------- (Address
of registrant) -------------------- (DEA registration number)
I, ------------------------ (name of person granting power), the
undersigned, who is authorized to sign the current application for
registration of the above-named registrant under the Controlled
Substances Act or Controlled Substances Import and Export Act, have
made, constituted, and appointed, and by these presents, do make,
constitute, and appoint ------------------------ (name of attorney-in-
fact), my true and lawful attorney for me in my name, place, and stead,
to execute applications for books of official order forms and to sign
such order forms in requisition for Schedule I and II controlled
substances, in accordance with section 308 of the Controlled Substances
Act (21 U.S.C. 828) and part 305 of Title 21 of the Code of Federal
Regulations. I hereby ratify and confirm all that said attorney shall
lawfully do or cause to be done by virtue hereof.
........................................................................
(Signature of person granting power)
I, ---------------------- (name of attorney-in-fact), hereby affirm
that I am the person named herein as attorney-in-fact and that the
signature affixed hereto is my signature.
........................................................................
(Signature of attorney-in-fact)
Witnesses:
1. ------------------------.
2. -----------------------.
Signed and dated on the ------ day of ----------------, 19----, at
----------------.
Notice of Revocation
The foregoing power of attorney is hereby revojed by the
undersigned, who is authorized to sign the current application for
registration of the above-named registrant under the Controlled
Substances Act of the Controlled Substances Import and Export Act.
Written notice of this revocation has been given to the attorney-in-fact
---------------- this same day.
........................................................................
(Signature of person revoking power)
Witnesses:
1. ------------------------.
2. ------------------------.
[[Page 66]]
Signed and dated on the ------ day of ----------------, 19----, at
----------------.
[37 FR 15921, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1305.08 Persons entitled to fill order forms.
An order form may be filled only by a person registered as a
manufacturer or distributor of controlled substances listed in Schedule
I or II under section 303 of the Act (21 U.S.C. 823) or as an importer
of such substances under section 1008 of the Act (21 U.S.C. 958), except
for the following:
(a) A person registered to dispense such substances under section
303 of the Act, or to export such substances under section 1008 of the
Act, if he is discontinuing business or if his registration is expiring
without reregistration, may dispose of any controlled substances listed
in Schedule I or II in his possession pursuant to order forms in
accordance with Sec. 1307.14 of this chapter;
(b) A person who has obtained any controlled substance in Schedule I
or II by order form may return such substance, or portion thereof, to
the person from whom he obtained the substance or the manufacturer of
the substance pursuant to the order form of the latter person;
(c) A person registered to dispense such substances may distribute
such substances to another dispenser pursuant to, and only in the
circumstances described in, Sec. 1307.11 of this chapter; and
(d) A person registered or authorized to conduct chemical analysis
or research with controlled substances may distribute a controlled
substance listed in Schedule I or II to another person registered or
authorized to conduct chemical analysis, instructional activities, or
research with such substances pursuant to the order form of the latter
person, if such distribution is for the purpose of furthering such
chemical analysis, instructional activities, or research.
(e) A person registered as a compounder of narcotic substances for
use at off-site locations in conjunction with a narcotic treatment
program at the compounding location, who is authorized to handle
Schedule II narcotics, is authorized to fill order forms for
distribution of narcotic drugs to off-site narcotic treatment programs
only.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971; 36
FR 18732, Sept. 21, 1971; 37 FR 15921, Aug. 8, 1972. Redesignated at 38
FR 26609, Sept. 24, 1973]
Editorial Note: For FR citations affecting Sec. 1305.08, see the
List of CFR Sections Affected in the Finding Aids section of this
volume.
Sec. 1305.09 Procedure for filling order forms.
(a) The purchaser shall submit Copy 1 and Copy 2 of the order form
to the supplier, and retain Copy 3 in his own files.
(b) The supplier shall fill the order, if possible and if he desires
to do so, and record on Copies 1 and 2 the number of commercial or bulk
containers furnished on each item and the date on which such containers
are shipped to the purchaser. If an order cannot be filled in its
entirety, it may be filled in part and the balance supplied by
additional shipments within 60 days following the date of the order
form. No order form shall be valid more than 60 days after its execution
by the purchaser, except as specified in paragraph (f) of this section.
(c) The controlled substances shall only be shipped to the purchaser
and at the location printed by the Administration on the order form,
except as specified in paragraph (f) of this section.
(d) The supplier shall retain Copy 1 of the order form for his ovn
files and forward Copy 2 to the Special Agent in Charge of the Drug
Enforcement Administration in the area in which the supplier is located.
Copy 2 shall be forwarded at the close of the month during which the
order is filled; if an order is filled by partial shipments, Copy 2
shall be forwarded at the close of the month during which the final
shipment is made or during which the 60-day validity period expires.
(e) The purchaser shall record on Copy 3 of the order form the
number of commercial or bulk containers furnished on each item and the
dates on which such containers are received by the purchaser.
[[Page 67]]
(f) Order forms submitted by registered procurement officers of the
Defense Personnel Support Center of Defense Supply Agency for delivery
to armed services establishments within the United States may be shipped
to locations other than the location printed on the order form, and in
partial shipments at different times not to exceed six months from the
date of the order, as designated by the procurement officer when
submitting the order.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 47 FR 41735,
Sept. 22, 1982]
Sec. 1305.10 Procedure for endorsing order forms.
(a) An order form made out to any supplier who cannot fill all or a
part of the order within the time limitation set forth in Sec. 1305.09
may be endorsed to another supplier for filling. The endorsement hall be
made only by the supplier to whom the order form was first made, shall
state (in the spaces provided on the reverse sides of Copies 1 and 2 of
the order form) the name and address of the second supplier, and shall
be signed by a person authorized to obtain and execute order forms on
behalf of the first supplier. The first supplier may not fill any part
of an order on an endorsed form. The second supplier shall fill the
order, if possible and if he desires to do so, in accordance with
Sec. 1305.09 (b), (c), and (d), including shipping all substances
directly to the purchaser.
(b) Distributions made on endorsed order forms shall be reported by
the second supplier in the same manner as all other distributions except
that where the name of the supplier is requested on the reporting form,
the second supplier shall record the name, address and registration
number of the first supplier.
Sec. 1305.11 Unaccepted and defective order forms.
(a) No order form shall be filled if it:
(1) Is not complete, legible, or properly prepared, executed, or
endorsed; or
(2) Shows any alteration, erasure, or change of any description.
(b) If an order form cannot be filled for any reason under this
section, the supplier shall return Copies 1 and 2 to the purchaser with
a statement as to the reason (e.g., illegible or altered). A supplier
may for any reason refuse to accept any order and if a supplier refuses
to accept the order, a statement that the order is not accepted shall be
sufficient for purposes of this paragraph.
(c) When received by the purchaser, Copies 1 and 2 of the order form
and the statement shall be attached to Copy 3 and retained in the files
of the purchaser in accordance with Sec. 1305.13. A defective order form
may not be corrected; it must be replaced by a new order form in order
for the order to be filled.
Sec. 1305.12 Lost and stolen order forms.
(a) If a purchaser ascertains that an unfilled order form has been
lost, he shall execute another in triplicate and a statement containing
the serial number and date of the lost form, and stating that the goods
covered by the first order form were not received through loss of that
order form. Copy 3 of the second form and a copy of the statement shall
be retained with Copy 3 of the order form first executed. A copy of the
statement shall be attached to Copies 1 and 2 of the second order form
sent to the supplier. If the first order form is subsequently received
by the supplier to whom it was directed, the supplier shall mark upon
the face thereof ``Not accepted'' and return Copies 1 and 2 to the
purchaser, who shall attach it to Copy 3 and the statement.
(b) Whenever any used or unused order forms are stolen from or lost
(otherwise than in the course of transmission) by any purchaser or
supplier, he shall immediately upon discovery of such theft or loss,
report the same to the Registration Unit, Drug Enforcement
Administration, Department of Justice, Post Office Box 28083, Central
Station, Washington, DC 20005, stating the serial number of each form
stolen or lost. If the theft or loss includes any original order forms
received from purchasers and the supplier is unable to state the serial
numbers of such order forms, he shall report the date or approximate
date of receipt thereof and the names and addresses of the purchasers.
If an entire book of order
[[Page 68]]
forms is lost or stolen, and the purchaser is unable to state the serial
numbers of the order forms contained therein, he shall report, in lieu
of the numbers of the forms contained in such book, the date or
approximate date of issuance thereof. If any unused order form reported
stolen or lost is subsequently recovered or found, the Registration
Branch of the Administration shall immediately be notified.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 51 FR 5319,
Feb. 13, 1986]
Sec. 1305.13 Preservation of order forms.
(a) The purchaser shall retain Copy 3 of each order form which has
been filled. He shall also retain in his files all copies of each
unaccepted or defective order form and each statement attached thereto.
(b) The supplier shall retain Copy 1 of each order form which he has
filled.
(c) Order forms must be maintained separately from all other records
of the registrant. Order forms are required to be kept available for
inspection for a period of 2 years. If a purchaser has several
registered locations, he must retain Copy 3 of the executed order forms
and any attached statements or other related documents (not including
unexecuted order forms which may be kept elsewhere pursuant to
Sec. 1305.06(e)) at the registered location printed on the order form.
(d) The supplier of carfentanil etorphine hydrochloride and
diprenorphine shall maintain order forms for these substances separately
from all other order forms and records required to be maintained by the
registrant.
[36 FR 7796, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 39 FR 17839, May 21, 1974; 54 FR 33674, Aug. 16, 1989]
Sec. 1305.14 Return of unused order forms.
If the registration of any purchaser terminates (because the
purchaser dies, ceases legal existence, discontinues business or
professional practice, or changes his name or address as shown on his
registration) or is suspended or revoked pursuant to Secs. 1301.45 or
1301.46 of this chapter as to all controlled substances listed in
Schedules I and II for which he is registered, he shall return all
unused order forms for such substance to the nearest office of the
Administration.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1305.15 Cancellation and voiding of order forms.
(a) A purchaser may cancel part or all of an order on an order form
by notifying the supplier in writing of such cancellation. The supplier
shall indicate the cancellation on Copies 1 and 2 of the order form by
drawing a line through the canceled items and printing ``canceled'' in
the space provided for number of items shipped.
(b) A supplier may void part or all of an order on an order form by
notifying the purchaser in writing of such voiding. The supplier shall
indicate the voiding in the manner prescribed for cancellation in
paragraph (a) of this section.
(c) No cancellation or voiding permitted by this section shall
affect in any way contract rights of either the purchaser or the
supplier.
[36 FR 7796, Apr. 24, 1971, as amended at 36 FR 13386, July 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1305.16 Special procedure for filling certain order forms.
(a) The purchaser of carfentanil etorphine hydrochloride or
diprenorphine shall submit copy 1 and 2 of the order form to the
supplier and retain copy 3 in his own files.
(b) The supplier, if he determines that the purchaser is a
veterinarian engaged in zoo and exotic animal practice, wildlife
management programs and/or research and authorized by the Administrator
to handle these substances shall fill the order in accordance with the
procedures set forth in Sec. 1305.09 except that:
(1) Order forms for carfentanil etorphine hydrochloride and
diprenorphine shall only contain these substances in reasonable
quantities and (2) the substances shall only be shipped to the purchaser
at the location printed by the Administration
[[Page 69]]
upon the order form under secure conditions using substantial packaging
material with no markings on the outside which would indicate the
content.
[39 FR 17839, May 21, 1974, as amended at 54 FR 33674, Aug. 16, 1989]
PART 1306--PRESCRIPTIONS--Table of Contents
General Information
Sec.
1306.01 Scope of Part 1306.
1306.02 Definitions.
1306.03 Persons entitled to issue prescriptions.
1306.04 Purpose of issue of prescription.
1306.05 Manner of issuance of prescriptions.
1306.06 Persons entitled to fill prescriptions.
1306.07 Administering or dispensing of narcotic drugs.
Controlled Substances Listed in Schedule II
1306.11 Requirement of prescription.
1306.12 Refilling prescriptions.
1306.13 Partial filling of prescriptions.
1306.14 Labeling of substances.
1306.15 Filing of prescriptions.
Controlled Substances Listed in Schedules III and IV
1306.21 Requirement of prescription.
1306.22 Refilling of prescriptions.
1306.23 Partial filling of prescriptions.
1306.24 Labeling of substances.
1306.25 Filing prescriptions.
1306.26 Transfer between pharmacies of presription information for
Schedules III, IV, and V controlled substances for refill
purposes.
Controlled Substances Listed in Schedule V
1306.31 Requirement of prescription.
1306.32 Dispensing without prescription.
Authority: 21 U.S.C. 821, 829, 871(b), unless otherwise noted.
Source: 36 FR 7799, Apr. 24, 1971; 36 FR 13386, July 21, 1971,
unless otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973.
General Information
Sec. 1306.01 Scope of Part 1306.
Rules governing the issuance, filling and filing of prescriptions
pursuant to section 309 of the Act (21 U.S.C. 829) are set forth
generally in that section and specifically by the sections of this part.
Sec. 1306.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substances Act (84 Stat. 1242;
21 U.S.C. 801).
(b) The term individual practitioner means a physician, dentist,
veterinarian, or other individual licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which he
practices, to dispense a controlled substance in the course of
professional practice, but does not include a pharmacist, a pharmacy, or
an institutional practitioner.
(c) The term institutional practitioner means a hospital or other
person (other than an individual) licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which it
practices, to dispense a controlled substance in the course of
professional practice, but does not include a pharmacy.
(d) The term pharmacist means any pharmacist licensed by a State to
dispense controlled substances, and shall include any other person
(e.g., a pharmacist intern) authorized by a State to dispense controlled
substances under the supervision of a pharmacist licensed by such State.
(e) A Long Term Care Facility (LTCF) means a nursing home,
retirement care, mental care or other facility or institution which
provides extended health care to resident patients.
(f) The term prescription means an order for medication which is
dispensed to or for an ultimate user but does not include an order for
medication which is dispensed for immediate administration to the
ultimate used. (e.g., an order to dispense a drug to a bed patient for
immediate administration in a hospital is not a prescription.)
(g) The terms register and registered refer to registration required
and permitted by section 303 of the Act (21 U.S.C. 823).
(h) The term home infusion pharmacy means a pharmacy which compounds
solutions for direct administration to a patient in a private residence,
Long Term Care Facility or hospice setting by means of parenteral,
intravenous,
[[Page 70]]
intramuscular, subcutaneous or intraspinal infusion.
(i) Any term not defined in this section shall have the definition
set forth in section 102 of the Act (21 U.S.C. 802) or Sec. 1301.02 of
this chapter.
(21 U.S.C. 801, et seq.)
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and further amended at 45
FR 54330, July 15, 1980; 59 FR 26111, May 19, 1994]
Sec. 1306.03 Persons entitled to issue prescriptions.
(a) A prescription for a controlled substance may be issued only by
an individual practitioner who is:
(1) authorized to prescribe controlled substances by the
jurisdiction in which he is licensed to practice his profession and
(2) either registered or exempted from registration pursuant to
Secs. 1301.24(c) and 1301.25 of this chapter.
(b) A prescription issued by an individual practitioner may be
communicated to a pharmacist by an employee or agent of the individual
practitioner.
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1306.04 Purpose of issue of prescription.
(a) A prescription for a controlled substance to be effective must
be issued for a legitimate medical purpose by an individual practitioner
acting in the usual course of his professional practice. The
responsibility for the proper prescribing and dispensing of controlled
substances is upon the prescribing practitioner, but a corresponding
responsibility rests with the pharmacist who fills the prescription. An
order purporting to be a prescription issued not in the usual course of
professional treatment or in legitimate and authorized research is not a
prescription within the meaning and intent of section 309 of the Act (21
U.S.C. 829) and the person knowingly filling such a purported
prescription, as well as the person issuing it, shall be subject to the
penalties provided for violations of the provisions of law relating to
controlled substances.
(b) A prescription may not be issued in order for an individual
practitioner to obtain controlled substances for supplying the
individual practitioner for the purpose of general dispensing to
patients.
(c) A prescription may not be issued for the dispensing of narcotic
drugs listed in any schedule for ``detoxification treatment'' or
``maintenance treatment'' as defined in Section 102 of the Act (21
U.S.C. 802).
[36 FR 7799, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 39 FR 37986, Oct. 25, 1974]
Sec. 1306.05 Manner of issuance of prescriptions.
(a) All prescriptions for controlled substances shall be dated as
of, and signed on, the day when issued and shall bear the full name and
address of the patient, the drug name, strength, dosage form, quantity
prescribed, directions for use and the name, address and registration
number of the practitioner. A practitioner may sign a prescription in
the same manner as he would sign a check or legal document (e.g., J.H.
Smith or John H. Smith). Where an oral order is not permitted,
prescriptions shall be written with ink or indelible pencil or
typewriter and shall be manually signed by the practitioner. The
prescriptions may be prepared by the secretary or agent for the
signature of a practitioner, but the prescribing practitioner is
responsible in case the prescription does not conform in all essential
respects to the law and regulations. A corresponding liability rests
upon the pharmacist who fills a prescription not prepared in the form
prescribed by these regulations.
(b) An individual practitioner exempted from registration under
Sec. 1301.24(c) of this chapter shall include on all prescriptions
issued by him or her the registration number of the hospital or other
institution and the special internal code number assigned to him or her
by the hospital or other institution as provided in Sec. 1301.24(c) of
this chapter, in lieu of the registration number of the practitioner
required by this section. Each written prescription shall have the name
of the physician stamped, typed, or handprinted on it,
[[Page 71]]
as well as the signature of the physician.
(c) An official exempted from registration under Sec. 1301.25 shall
include on all prescriptions issued by him his branch of service or
agency (e.g., ``U.S. Army'' or ``Public Health Service'') and his
service identification number, in lieu of the registration number of the
practitioner required by this section. The service identification number
for a Public Health Service employee is his Social Security
identification number. Each prescription shall have the name of the
officer stamped, typed, or handprinted on it, as well as the signature
of the officer.
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 56 FR 25026,
June 3, 1991; 60 FR 36641, July 18, 1995]
Sec. 1306.06 Persons entitled to fill prescriptions.
A prescription for controlled substances may only be filled by a
pharmacist acting in the usual course of his professional practice and
either registered individually or employed in a registered pharmacy or
registered institutional practitioner.
Sec. 1306.07 Administering or dispensing of narcotic drugs.
(a) The administering or dispensing directly (but not prescribing)
of narcotic drugs listed in any schedule to a narcotic drug dependent
person for ``detoxification treatment'' or ``maintenance treatment'' as
defined in section 102 of the Act (21 U.S.C. 802) shall be deemed to be
within the meaning of the term ``in the course of his professional
practice or research'' in section 308(e) and section 102(20) of the Act
(21 U.S.C. 828 (e)): Provided, That the practitioner is separately
registered with the Attorney General as required by section 303(g) of
the Act (21 U.S.C. 823(g)) and then thereafter complies with the
regulatory standards imposed relative to treatment qualification,
security, records and unsupervised use of drugs pursuant to such Act.
(b) Nothing in this section shall prohibit a physician who is not
specifically registered to conduct a narcotic treatment program from
administering (but not prescribing) narcotic drugs to a person for the
purpose of relieving acute withdrawal symptoms when necessary while
arrangements are being made for referral for treatment. Not more than
one day's medication may be administered to the person or for the
person's use at one time. Such emergency treatment may be carried out
for not more than three days and may not be renewed or extended.
(c) This section is not intended to impose any limitations on a
physician or authorized hospital staff to administer or dispense
narcotic drugs in a hospital to maintain or detoxify a person as an
incidental adjunct to medical or surgical treatment of conditions other
than addiction, or to administer or dispense narcotic drugs to persons
with intractable pain in which no relief or cure is possible or none has
been found after reasonable efforts.
[39 FR 37986, Oct. 25, 1974]
Controlled Substances Listed in Schedule II
Sec. 1306.11 Requirement of prescription.
(a) A pharmacist may dispense directly a controlled substance in
Schedule II, which is a prescription drug as determined by the Federal
Food, Drug and Cosmetic Act, only pursuant to a written prescription
signed by the practitioner, except as provided in paragraph (d) of this
section. A prescription for a Schedule II controlled substance may be
transmitted by the practitioner or the practitioner's agency to a
pharmacy via facsimile equipment, provided the original written, signed
prescription is presented to the pharmacist for review prior to the
actual dispensing of the controlled substance, except as noted in
paragraph (e) or (f) of this section. The original prescription shall be
maintained in accordance with Sec. 1304.04(h).
(b) An individual practitioner may administer or dispense directly a
controlled substance listed in Schedule II in the course of his
professional practice without a prescription, subject to Sec. 1306.07.
(c) An institutional practitioner may administer or dispense
directly (but not prescribe) a controlled substance listed in Schedule
II only pursuant to a
[[Page 72]]
written prescription signed by the prescribing individual practitioner
or to an order for medication made by an individual practitioner which
is dispensed for immediate administration to the ultimate user.
(d) In the case of an emergency situation, as defined by the
Secretary in Sec. 290.10 of this title, a pharmacist may dispense a
controlled substance listed in Schedule II upon receiving oral
authorization of a prescribing individual practitioner, provided that:
(1) The quantity prescribed and dispensed is limited to the amount
adequate to treat the patient during the emergency period (dispensing
beyond the emergency period must be pursuant to a written prescription
signed by the prescribing individual practitioner);
(2) The prescription shall be immediately reduced to writing by the
pharmacist and shall contain all information required in Sec. 1306.05,
except for the signature of the prescribing individual practitioner;
(3) If the prescribing individual practitioner is not known to the
pharmacist, he must make a reasonable effort to determine that the oral
authorization came from a registered individual practitioner, which may
include a callback to the prescribing individual practitioner using his
phone number as listed in the telephone directory and/or other good
faith efforts to insure his identity; and
(4) Within 72 hours after authorizing an emergency oral
prescription, the prescribing individual practitioner shall cause a
written prescription for the emergency quantity prescribed to be
delivered to the dispensing pharmacist. In addition to conforming to the
requirements of Sec. 1306.05, the prescription shall have written on its
face ``Authorization for Emergency Dispensing,'' and the date of the
oral order. The written prescription may be delivered to the pharmacist
in person or by mail, but if delivered by mail it must be postmarked
within the 72-hour period. Upon receipt, the dispensing pharmacist shall
attach this prescription to the oral emergency prercription which had
earlier been reduced to writing. The pharmacist shall notify the nearest
office of the Administration if the prescribing individual practitioner
fails to deliver a written prescription to him; failure of the
pharmacist to do so shall void the authority conferred by this paragraph
to dispense without a written prescription of a prescribing individual
practitioner.
(e) A prescription prepared in accordance with Sec. 1306.05 written
for a Schedule II narcotic substance to be compounded for the direct
administration to a patient by parenteral, intravenous, intramuscular,
subcutaneous or intraspinal infusion may be transmitted by the
practitioner or the practitioner's agent to the home infusion pharmacy
by facsimile. The facsimile serves as the original written prescription
for purposes of this paragraph (e) and it shall be maintained in
accordance with Sec. 1304.04(h).
(f) A prescription prepared in accordance with Sec. 1306.05 written
for Schedule II substance for a resident of a Long Term Care Facility
may be transmitted by the practitioner or the practitioner's agent to
the dispensing pharmacy by facsimile. The facsimile serves as the
original written prescription for purposes of this paragraph (f) and it
shall be maintained in accordance with Sec. 1304.04(h).
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973 and amended at 53 FR 4964,
Feb. 19, 1988; 59 FR 26111, May 19, 1994; 59 FR 30832, June 15, 1994]
Sec. 1306.12 Refilling prescriptions.
The refilling of a prescription for a controlled substance listed in
Schedule II is prohibited.
Sec. 1306.13 Partial filling of prescriptions.
(a) The partial filling of a prescription for a controlled substance
listed in Schedule II is permissible, if the pharmacist is unable to
supply the full quantity called for in a written or emergency oral
prescription and he makes a notation of the quantity supplied on the
face of the written prescription (or written record of the emergency
oral prescription). The remaining portion of the prescription may be
filled within 72 hours of the first partial filling; however, if the
remaining portion is not or cannot be filled within the 72-hour period,
the
[[Page 73]]
pharmacist shall so notify the prescribing individual practitioner. No
further quantity may be supplied beyond 72 hours without a new
prescription.
(b) A prescription for a Schedule II controlled substance written
for a patient in a Long Term Care Facility (LTCF) or for a patient with
a medical diagnosis documenting a terminal illness may be filled in
partial quantities to include individual dosage units. If there is any
question whether a patient may be classified as having a terminal
illness, the pharmacist must contract the practitioner prior to
partially filling the prescription. Both the pharmacist and the
prescribing practitioner have a corresponding responsibility to assure
that the controlled substance is for a terminally ill patient. The
pharmacist must record on the prescription whether the patient is
``terminally ill'' or an ``LTCF patient.'' A prescription that is
partially filled and does not contain the notation ``terminally ill'' or
``LTCF patient'' shall be deemed to have been filled in violation of the
Act. For each partial filling, the dispensing pharmacist shall record on
the back of the prescription (or on another appropriate record,
uniformly maintained, and readily retrievable) the date of the partial
filling, quantity dispensed, remaining quantity authorized to be
dispensed, and the identification of the dispensing pharmacist. Prior to
any subsequent partial filling the pharmacist is to determine that the
additional partial filling is necessary. The total quantity of Schedule
II controlled substances dispensed in all partial fillings must not
exceed the total quantity prescribed. Schedule II prescriptions for
patients in a LTCF or patients with a medical diagnosis documenting a
terminal illness shall be valid for a period not to exceed 60 days from
the issue date unless sooner terminated by the discontinuance of
medication.
(c) Information pertaining to current Schedule II prescriptions for
patients in a LTCF or for patients with a medical diagnosis documenting
a terminal illness may be maintained in a computerized system if this
system has the capability to permit:
(1) Output (display or printout) of the original prescription
number, date of issue, identification of prescribing individual
practitioner, identification of patient, address of the LTCF or address
of the hospital or residence of the patient, identification of
medication authorized (to include dosage, form, strength and quantity),
listing of the partial fillings that have been dispensed under each
prescription and the information required in Sec. 1306.13(b).
(2) Immediate (real time) updating of the prescription record each
time a partial filling of the prescription is conducted.
(3) Retrieval of partially filled Schedule II prescription
information is the same as required by Sec. 1306.22(b) (4) and (5) for
Schedule III and IV prescription refill information.
(21 U.S.C. 801, et seq.)
[36 FR 7799, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 45 FR 54330, July 15, 1980; 56 FR 25027, June 3, 1991]
Sec. 1306.14 Labeling of substances.
(a) The pharmacist filling a written or emergency oral prescription
for a controlled substance listed in Schedule II shall affix to the
package a label showing date of filling, the pharmacy name and address,
the serial number of the prescription, the name of the patient, the name
of the prescribing practitioner, and directions for use and cautionary
statements, if any, contained in such prescription or required by law.
(b) The requirements of paragraph (a) of this section do not apply
when a controlled substance listed in Schedule II is prescribed for
administration to an ultimate user who is institutionalized: Provided,
That:
(1) Not more than 7-day supply of the controlled substance listed in
Schedule II is dispensed at one time;
(2) The controlled substance listed in Schedule II is not in the
possession of the ultimate user prior to the administration;
(3) The institution maintains appropriate safeguards and records
regarding the proper administration, control, dispensing, and storage of
the controlled substance listed in Schedule II; and
(4) The system employed by the pharmacist in filling a prescription
is adequate to identify the supplier, the
[[Page 74]]
product, and the patient, and to set forth the directions for use and
cautionary statements, if any, contained in the prescription or required
by law.
[36 FR 13368, July 21, 1971, as amended at 37 FR 15921, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1306.15 Filing of prescriptions.
All written prescriptions and written records of emergency oral
prescriptions shall be kept in accordance with requirements of
Sec. 1304.04(h) of this chapter.
[36 FR 7799, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 51 FR 5320, Feb. 13, 1986]
Controlled Substances Listed in Schedules III and IV
Sec. 1306.21 Requirement of prescription.
(a) A pharmacist may dispense directly a controlled substance listed
in Schedule III or IV, which is a prescription drug as determined under
the Federal Food, Drug and Cosmetic Act, only pursuant to either a
written prescription signed by a practitioner or a facsimile of a
written, signed prescription transmitted by the practitioner or the
practitioner's agent to the pharmacy or pursuant to an oral prescription
made by an individual practitioner and promptly reduced to writing by
the pharmacist containing all information required in Sec. 1306.05,
except for the signature of the practitioner.
(b) An individual practitioner may administer or dispense directly a
controlled substance listed in Schedule III or IV in the course of his
professional practice without a prescription, subject to Sec. 1306.07.
(c) An institutional practitioner may administer or dispense
directly (but not prescribe) a controlled substance listed in Schedules
III or IV only pursuant to written prescription signed by an individual
practitioner, or pursuant to a facsimile of a written prescription or
order for medication transmitted by the practitioner or the
practitioner's agent to the institutional practitioner-pharmacist, or
pursuant to an oral prescription made by an individual practitioner and
promptly reduced to writing by the pharmacist (containing all
information required in Sec. 1306.05 except for the signature of the
individual practitioner), or pursuant to an order for medication made by
an individual practitioner which is dispensed for immediate
administration to the ultimate user, subject to Sec. 1306.07.
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973; 59 FR 26112, May 19, 1994]
Sec. 1306.22 Refilling of prescriptions.
(a) No prescription for a controlled substance listed in Schedule
III or IV shall be filled or refilled more than six months after the
date on which such prescription was issued and no such prescription
authorized to be refilled may be refilled more than five times. Each
refilling of a prescription shall be entered on the back of the
prescription or on another appropriate document. If entered on another
document, such as a medication record, the document must be uniformly
maintained and readily retrievable. The following information must be
retrievable by the prescription number consisting of the name and dosage
form of the controlled substance, the date filled or refilled, the
quantity dispensed, initials of the dispensing pharmacist for each
refill, and the total number of refills for that prescription. If the
pharmacist merely initials and dates the back of the prescription it
shall be deemed that the full face amount of the prescription has been
dispensed. The prescribing practitioner may authorize additional refills
of Schedule III or IV controlled substances on the original prescription
through an oral refill authorization transmitted to the pharmacist
provided the following conditions are met:
(1) The total quantity authorized, including the amount of the
original prescription, does not exceed five refills nor extend beyond
six months from the date of issue of the original prescription.
(2) The pharmacist obtaining the oral authorization records on the
reverse of the original prescription the date, quantity of refill,
number of additional refills authorized, and initials the prescription
showing who received the authorization from the prescribing
[[Page 75]]
practioner who issued the original prescription.
(3) The quantity of each additional refill authorized is equal to or
less than the quantity authorized for the initial filling of the
original prescription.
(4) The prescribing practitioner must execute a new and separate
prescription for any additional quantities beyond the five refill, six-
month limitation.
(b) As an alternative to the procedures provided by subsection (a),
an automated data processing system may be used for the storage and
retrival of refill information for prescription orders for controlled
substances in Schedule III and IV, subject to the following conditions:
(1) Any such proposed computerized system must provide on-line
retrieval (via CRT display or hard-copy printout) of original
prescription order information for those prescription orders which are
currently authorized for refilling. This shall include, but is not
limited to, data such as the original prescription number, date of
issuance of the original prescription order by the practitioner, full
name and address of the patient, name, address, and DEA registration
number of the practitioner, and the name, strength, dosage form,
quantity of the controlled substance prescribed (and quantity dispensed
if different from the quantity prescribed), and the total number of
refills authorized by the prescribing practitioner.
(2) Any such proposed computerized system must also provide on-line
retrieval (via CRT display or hard-copy printout) of the current refill
history for Schedule III or IV controlled substance prescription orders
(those authorized for refill duing the past six months.) This refill
history shall include, but is not limited to, the name of the controlled
substance, the date of refill, the quantity dispensed, the
identification code, or name or initials of the dispensing pharmacist
for each refill and the total number of refills dispensed to date for
that prescription order.
(3) Documentation of the fact that the refill information entered
into the computer each time a pharmacist refills an original
prescription order for a Schedule III or IV controlled substance is
correct must be provided by the individual pharmacist who makes use of
such a system. If such a system provides a hard-copy printout of each
day's controlled substance prescription order refill data, that printout
shall be verified, dated, and signed by the individual pharmacist who
refilled such a prescription order. The individual pharmacist must
verify that the data indicated is correct and then sign this document in
the same manner as he would sign a check or legal document (e.g., J. H.
Smith, or John H. Smith). This document shall be maintained in a
separate file at that pharmacy for a period of two years from the
dispensing date. This printout of the day's controlled substance
prescription order refill data must be provided to each pharmacy using
such a computerized system within 72 hours of the date on which the
refill was dispensed. It must be verified and signed by each pharmacist
who is involved with such dispensing. In lieu of such a printout, the
pharmacy shall maintain a bound log book, or separate file, in which
each individual pharmacist involved in such dispensing shall sign a
statement (in the manner previously described) each day, attesting to
the fact that the refill information entered into the computer that day
has been reviewed by him and is correct as shown. Such a book or file
must be maintained at the pharmacy employing such a system for a period
of two years after the date of dispensing the appropriately authorized
refill.
(4) Any such computerized system shall have the capability of
producing a printout of any refill data which the user pharmacy is
responsible for maintaining under the Act and its implementing
regulations. For example, this would include a refill-by-refill audit
trail for any specified strength and dosage form of any controlled
substance (by either brand or generic name or both). Such a printout
must include name of the prescribing practitioner, name and address of
the patient, quantity dispensed on each refill, date of dispensing for
each refill, name or identification code of the dispensing pharmacist,
and the number of the original prescription order. In any computerized
system employed by a
[[Page 76]]
user pharmacy the central recordkeeping location must be capable of
sending the printout to the pharmacy within 48 hours, and if a DEA
Special Agent or Compliance Investigator requests a copy of such
printout from the user pharmacy, it must, if requested to do so by the
Agent or Investigator, verify the printout transmittal capability of its
system by documentation (e.g., postmark).
(5) In the event that a pharmacy which employs such a computerized
system experiences system down-time, the pharmacy must have an auxiliary
procedure which will be used for documentation of refills os Schedule
III and IV controlled substance prescription orders. This auxiliary
procedure must insure that refills are authorized by the original
prescription order, that the maximum number of refills has not been
exceeded, and that all of the appropriate data is retained for on-line
data entry as soon as the computer system is available for use again.
(c) When filing refill information for original prescription orders
for Schedule III or IV controlled substances, a pharmacy may use only
one of the two systems described in paragraphs (a) or (b) of this
section.
[36 FR 7799, Apr. 24, 1971; 36 FR 13386, July 21, 1971. Redesignated at
38 FR 26609, Sept. 24, 1973, and amended at 42 FR 28878, June 6, 1977;
45 FR 44266, July 1, 1980; 52 FR 3605, Feb. 5, 1987]
Sec. 1306.23 Partial filling of prescriptions.
The partial filling of a prescription for a controlled substance
listed in Schedule III or IV is permissible, provided that:
(a) Each partial filling is recorded in the same manner as a
refilling,
(b) The total quantity dispensed in all partial fillings does not
exceed the total quantity prescribed, and
(c) No dispensing occurs after 6 months after the date on which the
prescription was issued.
[36 FR 18733, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 51 FR 5320, Feb. 13, 1986]
Sec. 1306.24 Labeling of substances.
(a) The pharmacist filling a prescription for a controlled substance
listed in Schedule III or IV shall affix to the package a label showing
the pharmacy name and address, the serial number and date of initial
filling, the name of the patient, the name of the practitioner issuing
the prescription, and directions for use and cautionary statements, if
any, contained in such prescription as required by law.
(b) The requirements of paragraph (a) of this section do not apply
when a controlled substance listed in Schedule III or IV is prescribed
for administration to an ultimate user who is institutionalized:
Provided, That:
(1) Not more than a 34-day supply or 100 dosage units, whichever is
less, of the controlled substance listed in Schedule III or IV is
dispensed at one time;
(2) The controlled substance listed in Schedule III or IV is not in
the possession of the ultimate user prior to administration;
(3) The institution maintains appropriate safeguards and records the
proper administration, control, dispensing, and storage of the
controlled substance listed in Schedule III or IV; and
(4) The system employed by the pharmacist in filling a prescription
is adequate to identify the supplier, the product and the patient, and
to set forth the directions for use and cautionary statements, if any,
contained in the prescription or required by law.
[36 FR 7799, Apr. 24, 1971. Redesignated at 36 FR 18733, Sept. 21, 1971,
and amended at 37 FR 15921, Aug. 8, 1972]
Sec. 1306.25 Filing prescriptions.
All prescriptions for controlled substances listed in Schedules III
and IV shall be kept in accordance with Sec. 1304.04(h) of this chapter.
[36 FR 7799, Apr. 24, 1971. Redesignated at 36 FR 18733, Sept. 21, 1971,
and amended at 51 FR 5320, Feb. 13, 1986]
Sec. 1306.26 Transfer between pharmacies of prescription information for Schedules III, IV, and V controlled substances for refill purposes.
(a) The transfer of original prescription information for a
controlled substance listed in Schedules III, IV or V for the purpose of
refill dispensing is permissible between pharmacies on a
[[Page 77]]
one time basis subject to the following requirements:
(1) The transfer is communicated directly between two licensed
pharmacists and the transferring pharmacist records the following
information:
(i) Write the word ``VOID'' on the face of the invalidated
prescription.
(ii) Record on the reverse of the invalidated prescription the name,
address and DEA registration number of the pharmacy to which it was
transferred and the name of the pharmacist receiving the prescription
information.
(iii) Record the date of the transfer and the name of the pharmacist
transferring the information.
(b) The pharmacist receiving the transferred prescription
information shall reduce to writing the following:
(1) Write the word ``transfer'' on the face of the transferred
prescription.
(2) Provide all information required to be on a prescription
pursuant to 21 CFR 1306.05 and include:
(i) Date of issuance of original prescription;
(ii) Original number of refills authorized on original prescription;
(iii) Date of original dispensing;
(iv) Number of valid refills remaining and date of last refill;
(v) Pharmacy's name, address, DEA registration number and original
prescription number from which the prescription information was
transferred;
(vi) Name of transferor pharmacist.
(3) Both the original and transferred prescription must be
maintained for a period of two years from the date of last refill.
(c) Pharmacies electronically accessing the same prescription record
must satisfy all information requirements of a manual mode for
prescription transferral.
(d) The procedure allowing the transfer of prescription information
for refill purposes is permissible only if allowable under existing
state or other applicable law.
[46 FR 48919, Oct. 5, 1981]
Controlled Substances Listed in Schedule V
Sec. 1306.31 Requirement of prescription.
(a) A pharmacist may dispense directly a controlled substance listed
in Schedule V pursuant to a prescription as required for controlled
substances listed in Schedules III and IV in Sec. 1306.21. A
prescription for a controlled substance listed in Schedule V may be
refilled only as expressly authorized by the prescribing individual
practitioner on the prescription; if no such authorization is given, the
prescription may not be refilled. A pharmacist dispensing such substance
pursuant to a prescription shall label the substance in accordance with
Sec. 1306.24 and file the prescription in accordance with Sec. 1306.25.
(b) An individual practitioner may administer or dispense directly a
controlled substance listed in Schedule V in the course of his
professional practice without a prescription, subject to Sec. 1306.07.
(c) An institutional practitioner may administer or dispense
directly (but not prescribe) a controlled substance listed in Schedule V
only pursuant to a written prescription signed by an individual
practitioner, or pursuant to a facsimile of a written prescription
transmitted by the practitioner or the practitioner's agent to the
institutional practitioner--pharmacist, or pursuant to an oral
prescription made by an individual practitioner and promptly reduced to
writing by the pharmacist (containing all information required in
Sec. 1306.05 except for the signature of the individual practitioner),
or pursuant to an order for medication made by an individual
practitioner which is dispensed for immediate administration to the
ultimate user, subject to Sec. 1306.07.
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 51 FR 5320,
Feb. 13, 1986; 59 FR 26112, May 19, 1994; 59 FR 30832, June 15, 1994]
[[Page 78]]
Sec. 1306.32 Dispensing without prescription.
A controlled substance listed in Schedule V, and a controlled
substance listed in Schedule II, III, or IV which is not a prescription
drug as determined under the Federal Food, Drug, and Cosmetic Act, may
be dispensed by a pharmacist without a prescription to a purchaser at
retail, provided that:
(a) Such dispensing is made only by a pharmacist (as defined in
Sec. 1306.02(d)), and not by a nonpharmacist employee even if under the
supervision of a pharmacist (although after the pharmacist has fulfilled
his professional and legal responsibilities set forth in this section,
the actual cash, credit transaction, or delivery, may be completed by a
nonpharmacist);
(b) Not more than 240 cc. (8 ounces) of any such controlled
substance containing opium, nor more than 120 cc. (4 ounces) of any
other such controlled substance nor more than 48 dosage units of any
such controlled substance containing opium, nor more than 24 dosage
units of any other such controlled substance may be dispensed at retail
to the same purchaser in any given 48-hour period;
(c) The purchaser is at least 18 years of age;
(d) The pharmacist requires every purchaser of a controlled
substance under this section not known to him to furnish suitable
identification (including proof of age where appropriate);
(e) A bound record book for dispensing of controlled substances
under this section is maintained by the pharmacist, which book shall
contain the name and address of the purchaser, the name and quantity of
controlled substance purchased, the date of each purchase, and the name
or initials of the pharmacist who dispensed the substance to the
purchaser (the book shall be maintained in accordance with the
recordkeeping requirement of Sec. 1304.04 of this chapter); and
(f) A prescription is not required for distribution or dispensing of
the substance pursuant to any other Federal, State or local law.
[36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
PART 1307--MISCELLANEOUS--Table of Contents
General Information
Sec.
1307.01 Definitions.
1307.02 Application of State law and other Federal law.
1307.03 Exceptions to regulations.
Special Exceptions for Manufacture and Distribution of Controlled
Substances
1307.11 Distribution by dispenser to another practitioner.
1307.12 Manufacture and distribution of narcotic solutions and
compounds by a pharmacist.
1307.13 Distribution to supplier.
1307.14 Distribution upon discontinuance or transfer of business.
1307.15 Incidental manufacture of controlled substances.
Disposal of Controlled Substances
1307.21 Procedure for disposing of controlled substances.
1307.22 Disposal of controlled substances by the Administration.
Special Exempt Persons
1307.31 Native American Church.
Authority: 21 U.S.C. 821, 822(d), 871(b), unless otherwise noted.
Source: 36 FR 7801, Apr. 24, 1971, unless otherwise noted.
Redesignated at 38 FR 26609, Sept. 24, 1973.
General Information
Sec. 1307.01 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substances Act (84 Stat. 1242;
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act
(84 Stat. 1285; 21 U.S.C. 951).
(b) Any term not defined in this section shall have the definition
set forth in section 102 and 1001 of the Act (21 U.S.C. 802 and 951) and
in Sec. 1301.02 of this chapter.
Sec. 1307.02 Application of State law and other Federal law.
Nothing in parts 1301-1308, 1311, 1312, or 1316 of this chapter
shall be construed as authorizing or permitting any person to do any act
which such person is not authorized or permitted
[[Page 79]]
to do under other Federal laws or obligations under international
treaties, conventions or protocols, or under the law of the State in
which he desires to do such act nor shall compliance with such parts be
construed as compliance with other Federal or State laws unless
expressly provided in such other laws.
Sec. 1307.03 Exceptions to regulations.
Any person may apply for an exception to the application of any
provision of parts 1301-1313, or 1316 of this chapter by filing a
written request stating the reasons for such exception. Requests shall
be filed with the Administrator, Drug Enforcement Administration,
Department of Justice, Washington, D.C. 20537. The Administrator may
grant an exception in his discretion, but in no case shall he be
required to grant an exception to any person which is not otherwise
required by law or the regulations cited in this section.
[60 FR 32454, June 22, 1995]
Special Exceptions for Manufacture and Distribution of Controlled
Substances
Sec. 1307.11 Distribution by dispenser to another practitioner.
(a) A practitioner who is registered to dispense a controlled
substance may distribute (without being registered to distribute) a
quantity of such substance to another practitioner for the purpose of
general dispensing by the practitioner to his or its patients: Provided,
That:
(1) The practitioner to whom the controlled substance is to be
distributed is registered under the Act to dispense that controlled
substance;
(2) The distribution is recorded by the distributing practitioner in
accordance with Sec. 1304.24(e) of this chapter and by the receiving
practitioner in accordance with Sec. 1304.24(c) of this chapter;
(3) If the substance is listed in Schedule I or II, an order form is
used as required in part 1305 of this chapter;
(4) The total number of dosage units of all controlled substances
distributed by the practitioner pursuant to this section and
Sec. 1301.28 of this chapter during each calendar year in which the
practitioner is registered to dispense does not exceed 5 percent of the
total number of dosage units of all controlled substances distributed
and dispensed by the practitioner during the same calendar year.
(b) If, during any calendar year in which the practitioner is
registered to dispense, the practitioner has reason to believe that the
total number of dosage units of all controlled substances which will be
distributed by him pursuant to this section and Sec. 1301.28 of this
chapter will exceed 5 percent of the total number of dosage units of all
controlled substances distributed and dispensed by him during that
calendar year, the practitioner shall obtain a registration to
distribute controlled substances.
[36 FR 18733, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
1973, and amended at 50 FR 31590, Aug. 5, 1985]
Sec. 1307.12 Manufacture and distribution of narcotic solutions and compounds by a pharmacist.
As an incident to a distribution under Sec. 1307.11, a pharmacist
may manufacture (without being registered to manufacture) an aqueous or
oleaginous solution or solid dosage form containing a narcotic
controlled substance in a proportion not exceeding 20 percent of the
complete solution, compound, or mixture.
[36 FR 18733, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24,
1973]
Sec. 1307.13 Distribution to supplier.
Any person lawfully in possession of a controlled substance listed
in any schedule may distribute (without being registered to distribute)
that substance to the person from whom he obtained it or to the
manufacturer of the substance, provided that a written record is
maintained which indicates the date of the transaction, the name, form
and quantity of the substance, the name, address, and registration
number, if any, of the person making the distribution, and the name,
address, and registration number, if known, of the supplier or
manufacturer. In the case of returning a controlled substance listed in
Schedule I or II, an order form shall be used in the manner prescribed
in part 1305 of this chapter and be maintained as the written record of
the
[[Page 80]]
transaction. Any person not required to register pursuant to sections
302(c) or 1007(b)(1) of the Act (21 U.S.C. 823(c) or 957(b)(1)) shall be
exempt from maintaining the records required by this section.
[36 FR 7801, Apr. 24, 1971, as amended at 36 FR 18733, Sept. 21, 1971.
Redesignated at 38 FR 26609, Sept. 24, 1973]
Sec. 1307.14 Distribution upon discontinuance or transfer of business.
(a) Any registrant desiring to discontinue business activities
altogether or with respect to controlled substances (without
transferring such business activities to another person) shall return
for cancellation his certificate of registration, and any unexecuted
order forms in his possession, to the Registration Unit, Drug
Enforcement Administration, Department of Justice, Post Office Box
28083, Central Station, Washington, DC 20005. Any controlled substances
in his possession may be disposed of in accordance with Sec. 1307.21.
(b) Any registrant desiring to discontinue business activities
altogether or with respect to controlled substance (by transferring such
business activities to another person) shall submit in person or by
registered or certified mail, return receipt requested, to the Special
Agent in Charge in his area, at least 14 days in advance of the date of
the proposed transfer (unless the Special Agent in Charge waives this
time limitation in individual instances), the following information:
(1) The name, address, registration number, and authorized business
activity of the registrant discontinuing the business (registrant-
transferor);
(2) The name, address, registration number, and authorized business
activity of the person acquiring the business (registrant-transferee);
(3) Whether the business activities will be continued at the
location registered by the person discontinuing business, or moved to
another location (if the latter, the address of the new location should
be listed);
(4) Whether the registrant-transferor has a quota to manufacture or
procure any controlled substance listed in Schedule I or II (if so, the
basic class or class of the substance should be indicated); and
(5) The date on which the transfer of controlled substances will
occur.
(c) Unless the registrant-transferor is informed by the Regional
Administrator, before the date on which the transfer was stated to
occur, that the transfer may not occur, the registrant-transferor may
distribute (without being registered to distribute) controlled
substances in his possession to the registrant-transferee in accordance
with the following:
(1) On the date of transfer of the controlled substances, a complete
inventory of all controlled substances being transferred shall be taken
in accordance with Secs. 1304.11-1304.19 of this chapter. This inventory
shall serve as the final inventory of the registrant-transferor and the
initial inventory of the registrant-transferee, and a copy of the
inventory shall be included in the records of each person. It shall not
be necessary to file a copy of the inventory with the Administration
unless requested by the Regional Administrator. Transfers of any
substances listed in Schedule I or II shall require the use of order
forms in accordance with part 1305 of this chapter.
(2) On the date of transfer of the controlled substances, all
records required to be kept by the registrant-transferor with reference
to the controlled substances being transferred, under part 1304 of this
chapter, shall be transferred to the registrant-transferee.
Responsibility for the accuracy of records prior to the date of transfer
remains with the transferor, but responsibility for custody and
maintenance shall be upon the transferee.
(3) In the case of registrants required to make reports pursuant to
part 1304 of this chapter, a report marked ``Final'' will be prepared
and submitted by the registrant-transferor showing the disposition of
all the controlled substances for which a report is required; no
additional report will be required from him, if no further transactions
involving controlled substances are consummated by him. The initial
report of the registrant-transferee shall account for transactions
beginning with the day next succeeding the date of discontinuance or
transfer of
[[Page 81]]
business by the transferor-registrant and the substances transferred to
him shall be reported as receipts in his initial report.
[37 FR 15921, Aug. 8, 1972. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 47 FR 41735, Sept. 22, 1982; 51 FR 5319, Feb. 13, 1986]
Sec. 1307.15 Incidental manufacture of controlled substances.
Any registered manufacturer who, incidentally but necessarily,
manufactures a controlled substance as a result of the manufacture of a
controlled substance or basic class of controlled substance for which he
is registered and has been issued an individual manufacturing quota
pursuant to part 1303 of this chapter (if such substance or class is
listed in Schedule I or II) shall be exempt from the requirement of
registration pursuant to part 1301 of this chapter and, if such
incidentally manufactured substance is listed in Schedule I or II, shall
be exempt from the requirement of an individual manufacturing quota
pursuant to part 1303 of this chapter, if such substances are disposed
of in accordance with Sec. 1307.21.
Disposal of Controlled Substances
Sec. 1307.21 Procedure for disposing of controlled substances.
(a) Any person in possession of any controlled substance and
desiring or required to dispose of such substance may request the
Special Agent in Charge of the Administration in the area in which the
person is located for authority and instructions to dispose of such
substance. The request should be made as follows:
(1) If the person is a registrant required to make reports pursuant
to part 1304 of this chapter, he shall list the controlled substance or
substances which he desires to dispose of on the ``b'' subpart of the
report normally filed by him, and submit three copies of that subpart to
the Special Agent in Charge of the Administration in his area.
(2) If the person is a registrant not required to make reports
pursuant to part 1304 of this chapter, he shall list the controlled
substance or substances which he desires to dispose of on DEA Form 41,
and submit three copies of that form to the Special Agent in Charge in
his area; and
(3) If the person is not a registrant, he shall submit to the
Special Agent in Charge a letter stating:
(i) The name and address of the person;
(ii) The name and quantity of each controlled substance to be
disposed of;
(iii) How the applicant obtained the substance, if known; and
(iv) The name, address, and registration number, if known, of the
person who possessed the controlled substances prior to the applicant,
if known.
(b) The Special Agent in Charge shall authorize and instruct the
applicant to dispose of the controlled substance in one of the following
manners:
(1) By transfer to person registered under the Act and authorized to
possess the substance;
(2) By delivery to an agent of the Administration or to the nearest
office of the Administration;
(3) By destruction in the presence of an agent of the Administration
or other authorized person; or
(4) By such other means as the Special Agent in Charge may determine
to assure that the substance does not become available to unauthorized
persons.
(c) In the event that a registrant is required regularly to dispose
of controlled substances, the Special Agent in Charge may authorize the
registrant to dispose of such substances, in accordance with paragraph
(b) of this section, without prior approval of the Administration in
each instance, on the condition that the registrant keep records of such
disposals and file periodic reports with the Special Agent in Charge
summarizing the disposals made by the registrant. In granting such
authority, the Special Agent in Charge may place such conditions as he
deems proper on the disposal of controlled substances, including the
method of disposal and the frequency and detail of reports.
(d) This section shall not be construed as affecting or altering in
any way the disposal of controlled substances through procedures
provided in
[[Page 82]]
laws and regulations adopted by any State.
[36 FR 7801, Apr. 24, 1971, as amended at 37 FR 15922, Aug. 8, 1972.
Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 47 FR 41735,
Sept. 22, 1982]
Sec. 1307.22 Disposal of controlled substances by the Administration.
Any controlled substance delivered to the Administration under
Sec. 1307.21 or forfeited pursuant to section 511 of the Act (21 U.S.C.
881) may be delivered to any department, bureau, or other agency of the
United States or of any State upon proper application addressed to the
Administrator, Drug Enforcement Administration, Department of Justice,
Washington, DC 28083. The application shall show the name, address, and
official title of the person or agency to whom the controlled drugs are
to be delivered, including the name and quantity of the substances
desired and the purpose for which intended. The delivery of such
controlled drugs shall be ordered by the Administrator, if, in his
opinion, there exists a medical or scientific need therefor.
Special Exempt Persons
Sec. 1307.31 Native American Church.
The listing of peyote as a controlled substance in Schedule I does
not apply to the nondrug use of peyote in bona fide religiots ceremonies
of the Native American Church, and members of the Native American Church
so using peyote are exempt from registration. Any person who
manufactures peyote for or distributes peyote to the Native American
Church, however, is required to obtain registration annually and to
comply with all other requirements of law.
PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES--Table of Contents
General Information
Sec.
1308.01 Scope of Part 1308.
1308.02 Definitions.
1308.03 Administration Controlled Substances Code Number.
1308.04 Submission of information by manufacturers.
Schedules
1308.11 Schedule I.
1308.12 Schedule II.
1308.13 Schedule III.
1308.14 Schedule IV.
1308.15 Schedule V.
Excluded Nonnarcotic Substances
1308.21 Application for exclusion of a nonnarcotic substance.
1308.22 Excluded substances.
Exempt Chemical Preparations
1308.23 Exemption of certain chemical preparations; application.
1308.24 Exemption chemical preparations.
Excluded Veterinary Anabolic Steroid Implant Products
1308.25 Exclusion of a veterinary anabolic steroid implant product;
application.
1308.26 Excluded veterinary anabolic steroid implant products.
Exempted Prescription Products
1308.31 Application for exemption of a nonnarcotic prescription
product.
1308.32 Exempted prescription products.
Exempt Anabolic Steroid Products
1308.33 Exemption of certain anabolic steroid products; application.
1308.34 Exempt anabolic steroid products.
Hearings
1308.41 Hearings generally.
1308.42 Purpose of hearing.
1308.43 Waiver or modification of Rules.
1308.44 Initiation of proceedings for rule-making.
1308.45 Request for hearing or appearance; waiver.
1308.46 Burden of proof.
1308.47 Time and place of hearing.
1308.48 Final order.
1308.49 Control required under international treaty.
1308.50 Control of immediate precursors.
1308.51 Pending proceedings.
1308.52 Emergency sheduling.
Authority: 21 U.S.C. 811, 812, 871(b), unless otherwise noted.
Source: 38 FR 8254, Mar. 30, 1973, unless otherwise noted.
Redesignated at 38 FR 26609, Sept. 24, 1973.
General Information
Sec. 1308.01 Scope of Part 1308.
Schedules of controlled substances established by section 202 of the
Act (21
[[Page 83]]
U.S.C. 812), as they are changed, updated, and republished from time to
time, are set forth in this part.
Sec. 1308.02 Definitions.
As used in this part, the following terms shall have the meanings
specified:
(a) The term Act means the Controlled Substance Act (84 Stat. 1242;
21 U.S.C. 801) and/or the Controlled Substances Import and Export Act
(84 Stat. 1285; 21 U.S.C. 951).
(b) The term anabolic steroid means any drug or hormonal substance,
chemically and pharmacologically related to testosterone (other than
estrogens, progestins, and corticosteroids) that promotes muscle growth,
and includes:
(1) Boldenone;
(2) Chlorotestosterone (4-chlortestosterone);
(3) Clostebol;
(4) Dehydrochlormethyltestosterone;
(5) Dihydrotestosterone (4-dihydrotestosterone);
(6) Drostanolone;
(7) Ethylestrenol;
(8) Fluoxymesterone;
(9) Formebulone (formebolone);
(10) Mesterolone;
(11) Methandienone;
(12) Methandranone;
(13) Methandriol;
(14) Methandrostenolone;
(15) Methenolone;
(16) Methyltestosterone;
(17) Mibolerone;
(18) Nandrolone;
(19) Norethandrolone;
(20) Oxandrolone;
(21) Oxymesterone;
(22) Oxymetholone;
(23) Stanolone;
(24) Stanozolol;
(25) Testolactone;
(26) Testosterone;
(27) Trenbolone; and
(28) Any salt, ester, or isomer of a drug or substance described or
listed in this paragraph, if that salt, ester, or isomer promotes muscle
growth. Except such term does not include an anabolic steroid which is
expressly intended for administration through implants to cattle or
other nonhuman species and which has been approved by the Secretary of
Health and Human Services for such administration. If any person
prescribes, dispenses, or distributes such steroid for human use, such
person shall be considered to have prescribed, dispensed, or distributed
an anabolic steroid within the meaning of this paragraph.
(c) The term hearing means any hearing held pursuant to this part
for the issuance, amendment, or repeal of any rule issuable pursuant to
section 201 of the Act.
(d) The term isomer means the optical isomer, except as used in
Sec. 1308.11(d) and Sec. 1308.12(b)(4). As used in Sec. 1308.11(d), the
term isomer means the optical, positional, or geometric isomer. As used
in Sec. 1308.12(b)(4), the term isomer means the optical or geometric
isomer.
(e) The term interested person means any person adversely affected
or aggrieved by any rule or propored rule issuable pursuant to section
201 of the Act.
(f) The term narcotic drug means any of the following whether
produced directly or indirectly by extraction from substances of
vegetable origin or independently by means of chemical synthesis or by a
combination of extraction and chemical synthesis:
(1) Opium, opiates, derivatives of opium and opiates, including
their isomers, esters, ethers, salts, and salts of isomers, esters, and
ethers whenever the existence of such isomers, esters, ethers and salts
is possible within the specific chemical designation. Such term does not
include the isoquinoline alkaloids of opium.
(2) Poppy straw and concentrate of poppy straw.
(3) Coca leaves, except coco leaves and extracts of coca leaves from
which cocaine, ecgonine and derivatives of ecgonine or their salts have
been removed.
(4) Cocaine, its salts, optical and geometric isomers, and salts of
isomers.
(5) Ecgonine, its derivatives, their salts, isomers and salts of
isomers.
(6) Any compotnd, mixture, or preparation which contains any
quantity of any of the substances referred to in subparagraphs (1)
through (5).
[[Page 84]]
(g) The term proceeding means all actions taken for the issuance,
amendment, or repeal of any rule issued pursuant to section 201 of the
Act, commencing with the publication by the Administrator of the
proposed rule, amended rule, or repeal in the Federal Register.
(h) Any term not defined in this section shall have the definition
set forth in section 102 and 1001 of the Act (21 U.S.C. 802 and 951) and
Sec. 1301.02 of this chapter.
[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 51 FR 15317, Apr. 23, 1986; 56 FR 5754, Feb. 13, 1991]
Sec. 1308.03 Administration Controlled Substances Code Number.
(a) Each controlled substance, or basic class thereof, has been
assigned an ``Administration Controlled Substances Code Number'' for
purposes of identification of the substances or class on certain
Certificates of Registration issued by the Administration pursuant to
Secs. 1301.44 and 1311.43 of this chapter and on certain order forms
issued by the Administration pursuant to Sec. 1305.05(d) of this
chapter. Applicants for procurement and/or individual manufacturing
quotas must include the appropriate code number on the application as
required in Secs. 1303.12(b) and 1303.22(a) of this chapter. Applicants
for import and export permits must include the appropriate code number
on the application as required in Secs. 1312.12(a) and 1312.22(a) of
this chapter. Authorized registrants who desire to import or export a
controlled substance for which an import or export permit is not
required must include the appropriate Administration Controlled
Substances Code Number beneath or beside the name of each controlled
substance listed on the DEA Form 236 (Controlled Substance Import/Export
Declaration) which is executed for such importation or exportation as
required in Secs. 1312.18(c) and 1312.27(b) of this chapter.
(b) Except as stated in paragraph (a) of this section, no applicant
or registrant is required to use the Administration Controlled
Substances Code Number for any purpose.
[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973
and amended at 51 FR 15318, Apr. 23, 1986]
Sec. 1308.04 Submission of information by manufacturers.
(a) Each person who manufactures, packages, repackages, labels,
relabels, or distributes under his own label any product (including any
compound, mixture, or preparation, diagnostic, reagent, buffer, or
biological) containing any quantity of any controlled substance (whether
such product is itself controlled or is excepted, exempted, or excluded
from some or all controls pursuant to Sec. 1308.21-24 or Sec. 1308.31-
32) shall submit information required in paragraph (b) of this section
for each such product being manufactured or sold on July 1, 1972. The
information should be submitted by registered mail, return receipt
requested, to the Regulatory Support Section, Attention: Project Label,
Drug Enforcement Administration, Department of Justice, Washington, DC
20537, by August 31, 1972. In the case of new products manufactured
after July 1, 1972, or new dosage forms or other unit forms manufactured
after July 1, 1972, or changes in information submitted by August 31,
1972, the registrant shall submit the information regarding such item
within 30 days after the date on which the manufacture commences or
information change occurs. In the case of products, the manufacture of
which is discontinued after July 1, 1972, the registrant shall submit
notice of such discontinuance within 30 days after the date on which
manufacture ceases. In the case of products the manufacture of which was
discontinued before July 1, 1972, which are still being sold, the
registrant shall submit a notice of such discontinuance with his initial
submission.
(b) Two labels or other documents reflecting the following
information shall be submitted with reference to each dosage form or
other unit form of each item containing any quantity of any controlled
substance:
(1) The trade name, brand name, or other commercial name of the
product;
[[Page 85]]
(2) The generic or chemical name and quantity of each active
ingredient, including both controlled and noncontrolled substances (if
any of this information is a proprietary trade secret, please indicate
those portions);
(3) The National Drug Code Number assigned to the product, if any;
and
(4) The weight (in metric measure) of each dosage unit or the weight
(in metric measure) of the controlled substance per 100 grams of
finished product for all items containing any quantity of any narcotic
controlled substance in solid dosage forms.
(21 U.S.C. 821 and 871(b))
[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 46 FR 28841, May 29, 1981]
Schedules
Sec. 1308.11 Schedule I.
(a) Schedule I shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section. Each drug or substance has been
assigned the DEA Controlled Substances Code Number set forth opposite
it.
(b) Opiates. Unless specifically excepted or unless listed in
another schedule, any of the following opiates, including their isomers,
esters, ethers, salts, and salts of isomers, esters and ethers, whenever
the existence of such isomers, esters, ethers and salts is possible
within the specific chemical designation (for purposes of paragraph
(b)(34) only, the term isomer includes the optical and geometric
isomers):
(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
piperidinyl]-N-phenylacetamide)................................. 9815
(2) Acetylmethadol............................................... 9601
(3) Allylprodine................................................. 9602
(4) Alphacetylmethadol (except levo-alphacetylmethadol also known
as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM).... 9603
(5) Alphameprodine............................................... 9604
(6) Alphamethadol................................................ 9605
(7) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-
piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
propanilido) piperidine)........................................ 9814
(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide)............................... 9832
(9) Benzethidine................................................. 9606
(10) Betacetylmethadol........................................... 9607
(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
piperidinyl]-N-phenylpropanamide)............................... 9830
(12) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-
phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide.......... 9831
(13) Betameprodine............................................... 9608
(14) Betamethadol................................................ 9609
(15) Betaprodine................................................. 9611
(16) Clonitazene................................................. 9612
(17) Dextromoramide.............................................. 9613
(18) Diampromide................................................. 9615
(19) Diethylthiambutene.......................................... 9616
(20) Difenoxin................................................... 9168
(21) Dimenoxadol................................................. 9617
(22) Dimepheptanol............................................... 9618
(23) Dimethylthiambutene......................................... 9619
(24) Dioxaphetyl butyrate........................................ 9621
(25) Dipipanone.................................................. 9622
(26) Ethylmethylthiambutene...................................... 9623
(27) Etonitazene................................................. 9624
(28) Etoxeridine................................................. 9625
(29) Furethidine................................................. 9626
(30) Hydroxypethidine............................................ 9627
(31) Ketobemidone................................................ 9628
(32) Levomoramide................................................ 9629
(33) Levophenacylmorphan......................................... 9631
(34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-
N-phenylpropanamide)............................................ 9813
(35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
piperidinyl]-N-phenylpropanamide)............................... 9833
(36) Morpheridine................................................ 9632
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine)............. 9661
(38) Noracymethadol.............................................. 9633
(39) Norlevorphanol.............................................. 9634
(40) Normethadone................................................ 9635
(41) Norpipanone................................................. 9636
(42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
piperidinyl] propanamide........................................ 9812
(43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine........ 9663
(44) Phenadoxone................................................. 9637
(45) Phenampromide............................................... 9638
(46) Phenomorphan................................................ 9647
(47) Phenoperidine............................................... 9641
(48) Piritramide................................................. 9642
(49) Proheptazine................................................ 9643
(50) Properidine................................................. 9644
(51) Propiram.................................................... 9649
(52) Racemoramide................................................ 9645
(53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
propanamide..................................................... 9835
(54) Tilidine.................................................... 9750
(55) Trimeperidine............................................... 9646
(c) Opium derivatives. Unless specifically excepted or unless listed
in another schedule, any of the following opium derivatives, its salts,
isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
(1) Acetorphine.................................................. 9319
(2) Acetyldihydrocodeine......................................... 9051
(3) Benzylmorphine............................................... 9052
(4) Codeine methylbromide........................................ 9070
(5) Codeine-N-Oxide.............................................. 9053
(6) Cyprenorphine................................................ 9054
(7) Desomorphine................................................. 9055
(8) Dihydromorphine.............................................. 9145
(9) Drotebanol................................................... 9335
(10) Etorphine (except hydrochloride salt)....................... 9056
(11) Heroin...................................................... 9200
(12) Hydromorphinol.............................................. 9301
(13) Methyldesorphine............................................ 9302
(14) Methyldihydromorphine....................................... 9304
(15) Morphine methylbromide...................................... 9305
(16) Morphine methylsulfonate.................................... 9306
[[Page 86]]
(17) Morphine-N-Oxide............................................ 9307
(18) Myrophine................................................... 9308
(19) Nicocodeine................................................. 9309
(20) Nicomorphine................................................ 9312
(21) Normorphine................................................. 9313
(22) Pholcodine.................................................. 9314
(23) Thebacon.................................................... 9315
(d) Hallucinogenic substances. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation, which contains any quantity of the following hallucinogenic
substances, or which contains any of its salts, isomers, and salts of
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation (for
purposes of this paragraph only, the term ``isomer'' includes the
optical, position and geometric isomers):
(1) Alpha-ethyltryptamine........................................ 7249
Some trade or other names: etryptamine; Monase; -ethyl-
1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; -ET;
and AET.
(2) 4-bromo-2,5-dimethoxy-amphetamine............................ 7391
Some trade or other names: 4-bromo-2,5-dimethoxy--
methylphenethylamine; 4-bromo-2,5-DMA
(3) 4-Bromo-2,5-dimethoxyphenethylamine.......................... 7392
Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-
aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
(4) 2,5-dimethoxyamphetamine..................................... 7396
Some trade or other names: 2,5-dimethoxy--
methylphenethylamine; 2,5-DMA
(5) 2,5-dimethoxy-4-ethylamphet-amine............................ 7399
Some trade or other names: DOET
(6) 4-methoxyamphetamine......................................... 7411
Some trade or other names: 4-methoxy--
methylphenethylamine; paramethoxyamphetamine, PMA
(7) 5-methoxy-3,4-mdthylenedioxy-amphetamine..................... 7401
(8) 4-methyl-2,5-dimethoxy-amphetamine........................... 7395
Some trade and other names: 4-methyl-2,5-dimethoxy--
methylphenethylamine; ``DOM''; and ``STP''
(9) 3,4-methylenedioxy amphetamine............................... 7400
(10) 3,4-methylenedioxymethamphetamine (MDMA).................... 7405
(11) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-
alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA,
MDE, MDEA....................................................... 7404
(12) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-
hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-
hydroxy MDA..................................................... 7402
(13) 3,4,5-trimethoxy amphetamine................................ 7390
(14) Bufotenine.................................................. 7433
Some trade and other names: 3-(-Dimethylaminoethyl)-5-
hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-
dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine
(15) Diethyltryptamine........................................... 7434
Some trade and other names: N,N-Diethyltryptamine; DET
(16) Dimethyltryptamine.......................................... 7435
Some trade or other names: DMT
(17) Ibogaine.................................................... 7260
Some trade and other names: 7-Ethyl-6,6,7,8,9,10,12,13-
octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
[5,4-b] indole; Tabernanthe iboga
(18) Lysergic acid diethylamide.................................. 7315
(19) Marihuana................................................... 7360
(20) Mescaline................................................... 7381
(21) Parahexyl--7374; some trade or other names: 3-Hexyl-1-
hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
dibenzo[b,d]pyran; Synhexyl.
(22) Peyote...................................................... 7415
Meaning all parts of the plant presently classified botanically
as Lophophora williamsii Lemaire, whether growing or not, the
seeds thereof, any extract from any part of such plant, and
every compound, manufacture, salts, derivative, mixture, or
preparation of such plant, its seeds or extracts
(Interprets 21 USC 812(c), Schedule I(c) (12))
(23) N-ethyl-3-piperidyl benzilate............................... 7482
(24) N-methyl-3-piperidyl benzilate.............................. 7484
(25) Psilocybin.................................................. 7437
(26) Psilocyn.................................................... 7438
(27) Tetrahydrocannabinols....................................... 7370
Synthetic equivalents of the substances contained in the plant,
or in the resinous extractives of Cannabis, sp. and/or
synthetic substances, derivatives, and their isomers with
similar chemical structure and pharmacological activity such
as the following:
1 cis or trans tetrahydrocannabinol, and their optical
isomers
6 cis or trans tetrahydrocannabinol, and their optical
isomers
3,4 cis or trans tetrahydrocannabinol, and its optical
isomers
(Since nomenclature of these substances is not internationally
standardized, compounds of these structures, regardless of
numerical designation of atomic positions covered.)
(28) Ethylamine analog of phencyclidine.......................... 7455
Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-
phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine,
cyclohexamine, PCE
(29) Pyrrolidine analog of phencyclidine......................... 7458
Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine,
PCPy, PHP
(30) Thiophene analog of phencyclidine........................... 7470
Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-
piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP
(31) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine...................... 7473
Some other names: TCPy
(e) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation:
(1) Mecloqualone................................................. 2572
(2) Methaqualone................................................. 2565
(f) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound,
[[Page 87]]
mixture, or preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous system,
including its salts, isomers, and salts of isomers:
(1) Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-
oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine)............... 1585
(2) Cathinone.................................................... 1235
Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-
aminopropiophenone, 2-aminopropiophenone, and norephedrone
(3) Fenethylline................................................. 1503
(4) Methcathinone (Some other names: 2-(methylamino)-
propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-
1-phenylpropan-1-one; alpha-N-methylaminopropiophenone;
monomethylpropion; ephedrone; N-methylcathinone;
methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts,
optical isomers and salts of optical isomers.................... 1237
(5) ()cis-4-methylaminorex (()cis-4,5-
dihydro-4-methyl-5-phenyl-2-oxazolamine)........................ 1590
(6) N-ethylamphetamine........................................... 1475
(7) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-
benzeneethanamine; N,N-alpha-trimethylphenethylamine)........... 1480
(g) Temporary listing of substances subject to emergency scheduling.
Any material, compound, mixture or preparation which contains any
quantity of the following substances:
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
(benzylfentanyl), its optical isomers, salts and salts of
isomers......................................................... 9818
(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), its optical isolers, salts and salts of
isomers......................................................... 9834
[39 FR 22141, June 20, 1974]
Editorial Note: For Federal Register citations affecting
Sec. 1308.11, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
Sec. 1308.12 Schedule II.
(a) Schedule II shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section. Each drug or substance has been
assigned the Controlled Substances Code Number set forth opposite it.
(b) Substances, vegetable origin or chemical synthesis. Unless
specifically excepted or unless listed in another schedule, any of the
following substances whether produced directly or indirectly by
extraction from substances of vegetable origin, or independently by
means of chemical synthesis, or by a combination of extraction and
chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or
preparation of opium or opiate excluding apomorphine, thebaine-derived
butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and
naltrexone, and their respective salts, but including the following:
(1) Raw opium.................................................... 9600
(2) Opium extracts............................................... 9610
(3) Opium fluid.................................................. 9620
(4) Powdered opium............................................... 9639
(5) Granulated opium............................................. 9640
(6) Tincture of opium............................................ 9630
(7) Codeine...................................................... 9050
(8) Ethylmorphine................................................ 9190
(9) Etorphine hydrochloride...................................... 9059
(10) Hydrocodone................................................. 9193
(11) Hydromorphone............................................... 9150
(12) Metopon..................................................... 9260
(13) Morphine.................................................... 9300
(14) Oxycodone................................................... 9143
(15) Oxymorphone................................................. 9652
(16) Thebaine.................................................... 9333
(2) Any salt, compound, derivative, or preparation thereof which is
chemically equivalent or identical with any of the substances referred
to in paragraph (b) (1) of this section, except that these substances
shall not include the isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
(4) Coca leaves (9040) and any salt, compound, derivative or
preparation of coca leaves (including cocaine (9041) and ecgonine (9180)
and their salts, isomers, derivatives and salts of isomers and
derivatives), and any salt, compound, derivative, or preparation thereof
which is chemically equivalent or identical with any of these
substances, except that the substances shall not include decocainized
coca leaves or extraction of coca leaves, whhch extractions do not
contain cocaine or ecgonine.
(5) Concentrate of poppy straw (the crude extract of poppy straw in
either liquid, solid or powder form which contains the phenanthrene
alkaloids of the opium poppy), 9670.
(c) Opiates. Unless specifically excepted or unless in another
schedule any of the following opiates, including its isomers, esters,
ethers, salts and salts of isomers, esters and ethers
[[Page 88]]
whenever the existence of such isomers, esters, ethers, and salts is
possible within the specific chemical designation, dextrorphan and
levopropoxyphene excepted:
(1) Alfentanil................................................... 9737
(2) Alphaprodine................................................. 9010
(3) Anileridine.................................................. 9020
(4) Bezitramide.................................................. 9800
(5) Bulk dextropropoxyphene (non-dosage forms)................... 9273
(6) Carfentanil.................................................. 9743
(7) Dihydrocodeine............................................... 9120
(8) Diphenoxylate................................................ 9170
(9) Fentanyl..................................................... 9801
(10) Isomethadone................................................ 9226
(11) Levo-alphacetylmethadol..................................... 9648
[Some other names: levo-alpha-acetylmethadol, levomethadyl
acetate, LAAM]
(12) Levomethorphan.............................................. 9210
(13) Levorphanol................................................. 9220
(14) Metazocine.................................................. 9240
(15) Methadone................................................... 9250
(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl
butane.......................................................... 9254
(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-
diphenylpropane-carboxylic acid................................. 9802
(18) Pethidine (meperidine)...................................... 9230
(19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
phenylpiperidine................................................ 9232
(20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-
carboxylate..................................................... 9233
(21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-
carboxylic acid................................................. 9234
(22) Phenazocine................................................. 9715
(23) Piminodine.................................................. 9730
(24) Racemethorphan.............................................. 9732
(25) Racemorphan................................................. 9733
(26) Sufentanil.................................................. 9740
(d) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system:
(1) Amphetamine, its salts, optical isomers, and salts of its
optical isomers................................................. 1100
(2) Methamphetamine, its salts, isomers, and salts of its isomers 1105
(3) Phenmetrazine and its salts.................................. 1631
(4) Methylphenidate.............................................. 1724
(e) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system, including its salts, isomers, and
salts of isomers whenever the existence of such salts, isomers, and
salts of isomers is possible within the specific chemical designation:
(1) Amobarbital.................................................. 2125
(2) Glutethimide................................................. 2550
(3) Pentobarbital................................................ 2270
(4) Phencyclidine................................................ 7471
(5) Secobarbital................................................. 2315
(f) Hallucinogenic substances.
(1) Dronabinol (synthetic) in sesame oil and encapsulated in a
soft gelatin capsule in a U.S. Food and Drug Administration
approved drug product........................................... 7369
[Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-
tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol,
or (-)-delta-9-(trans)-tetrahydrocannabinol]
(2) Nabilone..................................................... 7379
[Another name for nabilone: ()-trans-3-(1,1-
dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-
dimethyl-9H-dibenzo[b,d]pyran-9-one]
(g) Immediate prectrsors. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances:
(1) Immediate precursor to amphetamine and methamphetamine:
(i) Phenylacetone................................................ 8501
Some trade or other names: phenyl-2-propanone; P2P; benzyl
methyl ketone; methyl benzyl ketone;
(2) Immediate precursors to phencyclidine (PCP):
(i) 1-phenylcyclohexylamine...................................... 7460
(ii) 1-piperidinocyclohexanecarbonitrile (PCC)................... 8603
[39 FR 22142, June 20, 1974]
Editorial Note: For Federal Register citations affecting
Sec. 1308.12, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
Sec. 1308.13 Schedule III.
(a) Schedule III shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section. Each drug or substance has been
assigned the DEA Controlled Substances Code Number set forth opposite
it.
(b) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous sxstem, including its salts, isomers
(whether optical, position, or geometric), and salts of such isomers
whenever the existence of such salts, isomers, and salts of isomers is
[[Page 89]]
possible within the specific chemical designation:
(1) Those compounds, mixtures, or preparations in dosage unit
form containing any stimulant substances lirted in schedule II
which compounds, mixtures, or preparations were listed on August
25, 1971, as excepted compounds under Sec. 308.32, and any
other drug of the quantitive composition shown in that list for
those drugs or which is the same except that it contains a
lesser quantity of controlled substances........................ 1405
(2) Benzphetamine................................................ 1228
(3) Chlorphentermine............................................. 1645
(4) Clortermine.................................................. 1647
(5) Phendimetrazine.............................................. 1615
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a depressant
effect on the central nervous system:
(1) Any compound, mixture or preparation containing:
(i) Amobarbital.............................................. 2126
(ii) Secobarbital............................................ 2316
(iii) Pentobarbital.......................................... 2271
or any salt thereof and one or more other active medicinal
ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing:
(i) Amobarbital.............................................. 2126
(ii) Secobarbital............................................ 2316
(iii) Pentobarbital.......................................... 2271
or any salt of any of these drugs and approved by the Food and
Drug Administration for marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative of
barbituric acid or any salt thereof............................. 2100
(4) Chlorhexadol................................................. 2510
(5) Lysergic acid................................................ 7300
(6) Lysergic acid amide.......................................... 7310
(7) Methyprylon.................................................. 2575
(8) Sulfondiethylmethane......................................... 2600
(9) Sulfonethylmethane........................................... 2605
(10) Sulfonmethane............................................... 2610
(11) Tiletamine and zolazepam or any salt thereof................ 7295
Some trade or other names for a tiletamine-zolazepam
combination product:
Telazol......................................................
Some trade or other names for tiletamine:
2-(ethylamino)-2-(2-thienyl)-cyclohexanone...................
Some trade or other names for zolazepam:
4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-
e] [1,4]-diazepin-7(1H)-one, flupyrazapon...................
(d) Nalorphine 9400.
(e) Narcotic Drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in limited quantities
as set forth below:
(1) Not more than 1.8 grams of codeine per 100 milliliters or not
more than 90 milligrams per dosage unit, with an equal or
greater quantity of an isoquinoline alkaloid of opium........... 9803
(2) Not more than 1.8 grams of codeine per 100 milliliters or not
more than 90 milligrams per dosage unit, with one or more
active, nonnarcotic ingredients in recognized therapeutic
amounts......................................................... 9804
(3) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone) per 100 milliliters or not more than 15 milligrams
per dosage unit, with a fourfold or greater quantity of an
isoquinoline alkaloid of opium.................................. 9805
(4) Not more than 300 milligrams of dihydrocodeinone
(hydrocodone) per 100 milliliters or not more than 15 milligrams
per dosage unit, with one or more active nonnarcotic ingredients
in recognized therapeutic amounts............................... 9806
(5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters
or not more than 90 milligrams per dosage unit, with one or more
active nonnarcotic ingredients in recognized therapeutic amounts 9807
(6) Not more than 300 milligrams of ethylmorphine per 100
milliliters or not more than 15 milligrams per dosage unit, with
one or more active, nonnarcotic ingredients in recognized
therapeutic amounts............................................. 9808
(7) Not more than 500 milligrams of opium per 100 milliliters or
per 100 grams or not more than 25 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in recognized
therapeutic amounts............................................. 9809
(8) Not more than 50 milligrams of morphine per 100 milliliters
or per 100 grams, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts................... 9810
(f) Anabolic steroids. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation
containing any quantity of the following substances, including its
salts, isomers, and salts of isomers whenever the existence of such
salts of isomers is possible within the specific chemical designation:
(1) Anabolic Steroids...............................................4000
[39 FR 22142, June 20, 1974, as amended at 41 FR 43401, Oct. 1, 1976; 43
FR 3359, Jan. 25, 1978; 44 FR 40888, July 13, l979; 46 FR 52334, Oct.
27, 1981; 51 FR 5320, Feb. 13, 1986; 52 FR 2222, Jan. 21, 1987; 52 FR
5952, Feb. 27, 1987; 56 FR 5754, Feb. 13, 1991; 56 FR 11932, Mar. 21,
1991]
Sec. 1308.14 Schedule IV.
(a) Schedule IV shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section. Each drug or substance has been
assigned the DEA Controlled Substances Code Number set forth opposite
it.
(b) Narcotic drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any
[[Page 90]]
of the following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin and not less than 25
micrograms of atropine sulfate per dosage unit.................. 9167
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-
methyl-2-propionoxybutane)...................................... 9278
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances, including its salts,
isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
(1) Alprazolam................................................. 2882
(2) Barbital................................................... 2145
(3) Bromazepam................................................. 2748
(4) Camazepam.................................................. 2749
(5) Chloral betaine............................................ 2460
(6) Chloral hydrate............................................ 2465
(7) Chlordiazepoxide........................................... 2744
(8) Clobazam................................................... 2751
(9) Clonazepam................................................. 2737
(10) Clorazepate................................................ 2768
(11) Clotiazepam................................................ 2752
(12) Cloxazolam................................................. 2753
(13) Delorazepam................................................ 2754
(14) Diazepam................................................... 2765
(15) Estazolam.................................................. 2756
(16) Ethchlorvynol.............................................. 2540
(17) Ethinamate................................................. 2545
(18) Ethyl loflazepate.......................................... 2758
(19) Fludiazepam................................................ 2759
(20) Flunitrazepam.............................................. 2763
(21) Flurazepam................................................. 2767
(22) Halazepam.................................................. 2762
(23) Haloxazolam................................................ 2771
(24) Ketazolam.................................................. 2772
(25) Loprazolam................................................. 2773
(26) Lorazepam.................................................. 2885
(27) Lormetazepam............................................... 2774
(28) Mebutamate................................................. 2800
(29) Medazepam.................................................. 2836
(30) Meprobamate................................................ 2820
(31) Methohexital............................................... 2264
(32) Methylphenobarbital (mephobarbital)........................ 2250
(33) Midazolam.................................................. 2884
(34) Nimetazepam................................................ 2837
(35) Nitrazepam................................................. 2834
(36) Nordiazepam................................................ 2838
(37) Oxazepam................................................... 2835
(38) Oxazolam................................................... 2839
(39) Paraldehyde................................................ 2585
(40) Petrichloral............................................... 2591
(41) Phenobarbital.............................................. 2285
(42) Pinazepam.................................................. 2883
(43) Prazepam................................................... 2764
(44) Quazepam................................................... 2881
(45) Temazepam.................................................. 2925
(46) Tetrazepam................................................. 2886
(47) Triazolam.................................................. 2887
(48) Zolpidem................................................... 2783
(d) Fenfluramine. Any material, compound, mixture, or preparation
which contains any quantity of the following substances, including its
salts, isomers (whether optical, position, or geometric), and salts of
such isomers, whenever the existence of such salts, isomers, and salts
of isomers is possible:
(1) Fenfluramine................................................. 1670
(e) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation which
contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers and
salts of isomers:
(1) Cathine ((+)-norpseudoephedrine)............................. 1230
(2) Diethylpropion............................................... 1610
(3) Fencamfamin.................................................. 1760
(4) Fenproporex.................................................. 1575
(5) Mazindol..................................................... 1605
(6) Mefenorex.................................................... 1580
(7) Pemoline (including organometallic complexes and chelates
thereof)........................................................ 1530
(8) Phentermine.................................................. 1640
(9) Pipradrol.................................................... 1750
(10) SPA ((-)-1-dimethylamino-1,2-diphenylethane)................ 1635
(f) Other substances. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture or preparation
which contains any quantity of the following substances, including its
salts:
(1) Pentazocine.................................................. 9709
[39 FR 22143, June 20, 1974]
Editorial Note: For Federal Register citations affecting
Sec. 1308.14, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
Sec. 1308.15 Schedule V.
(a) Schedule V shall consist of the drugs and other substances, by
whatever official name, common or usual name, chemical name, or brand
name designated, listed in this section.
(b) Narcotic drugs. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs and their salts, as set
forth below:
(1) Buprenorphine................................................ 9064
(c) Narcotic drugs containing non-narcotic active medicinal
ingredients. Any compound, mixture, or preparation containing any of the
following
[[Page 91]]
narcotic drugs, or their salts calculated as the free anhydrous base or
alkaloid, in limited quantities as set forth below, which shall include
one or more non-narcotic active medicinal ingredients in sufficient
proportion to confer upon the compound, mixture, or preparation valuable
medicinal qualities other than those possessed by narcotic drugs alone:
(1) Not more than 200 milligrams of codeine per 100 milliliters or
per 100 grams.
(2) Not more than 100 milligrams of dihydrocodeine per 100
milliliters or per 100 grams.
(3) Not more than 100 milligrams of ethylmorphine per 100
milliliters or per 100 grams.
(4) Not more than 2.5 milligrams of diphenoxylate and not less than
25 micrograms of atropine sulfate per dosage unit.
(5) Not more than 100 milligrams of opium per 100 milliliters or per
100 grams.
(6) Not more than 0.5 milligram of difenoxin and not less than 25
micrograms of atropine sulfate per dosage unit.
(d) Stimulants. Unless specifically exempted or excluded or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances
having a stimulant effect on the central nervous system, including its
salts, isomers and salts of isomers:
(1) Pyrovalerone...................................................1485.
(2) [Reserved]
[39 FR 22143, June 20, 1974, as amended at 43 FR 38383, Aug. 28, 1978;
44 FR 40888, July 13, 1979; 47 FR 49841, Nov. 3, 1982; 50 FR 8108, Feb.
28, 1985; 52 FR 5952, Feb. 27, 1987; 53 FR 10870, Apr. 4, 1988; 56 FR
61372, Dec. 3, 1991]
Excluded Nonnarcotic Substances
Sec. 1308.21 Application for exclusion of a nonnarcotic substance.
(a) Any person seeking to have any nonnarcotic substance which may,
under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301), be
lawfully sold over the counter without a prescription, excluded from any
schedule, pursuant to section 201(g) (1) of the Act (21 U.S.C. 811 (g)
(1)), may apply to the Administrator, Drug Enforcement Administration,
Department of Justice, Washington, DC 20537.
(b) An application for an exclusion under this section shall contain
the following information:
(1) The name and address of the applicant;
(2) The name of the substance for which exclusion is sought; and
(3) The complete quantitative composition of the substance.
(c) Within a reasonable period of time after the receipt of an
application for an exclusion under this section, the Administrator shall
notify the applicant of his acceptance or nonacceptance of his
application, and if not accepted, the reason therefore. The
Administrator need not accept an application for filing if any of the
requirements prescribed in paragraph (b) of this section is lacking or
is not set forth as to be readily understood. If the applicant desires,
he may amend the application to meet the requirements of paragraph (b)
of this section. If the application is accepted for filing, the
Administrator shall issue and publish in the Federal Register his order
on the application, which shall include a reference to the legal
authority under which the order is issued and the findings of fact and
conclusions of law upon which the order is based. This order shall
specify the date on which it shall take effect. The Administrator shall
permit any interested person to file written comments on or objections
to the order within 60 days of the date of publication of his order in
the Federal Register. If any such comments or objections raise
significant issues regarding any finding of fact or conclusion of law
upon which the order is based, the Administrator shall immediately
suspend the effectiveness of the order until he may reconsider the
application in light of the comments and objections filed. Thereafter,
the Administrator shall reinstate, revoke, or amend his original order
as he determines appropriate.
(d) The Administrator may at any time revoke any exclusion granted
pursuant to section 201(g) of the Act (21 U.S.C. 811(g)) by following
the procedures set forth in paragraph (c) of this section for handling
an application for
[[Page 92]]
an exclusion which has been accepted for filing.
Sec. 1308.22 Excluded substances.
The following nonnarcotic substances which may, under the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 301), be lawfully sold over the
counter without a prescription, are excluded from all schedules pursuant
to section 201(g) (1) of the Act (21 U.S.C. 811(g) (1)):
Excluded Nonarcotic Products
----------------------------------------------------------------------------------------------------------------
Controlled (mg or mg/
Company Trade name NDC code Form substance ml)
----------------------------------------------------------------------------------------------------------------
Bioline Laboratories........... Theophed.......... 00719-1945 TB Phenobarbital..... 8.00
Goldline Laboratories.......... Guiaphed Elixir... 00182-1377 EL Phenobarbital..... 4.00
Goldline Laboratories.......... Tedrigen Tablets.. 00182-0134 TB Phenobarbital..... 8.00
Hawthorne Products Inc......... Choate's Leg .............. LQ Chloral hydrate... 246.67
Freeze.
Parke-Davis & Co............... Tedral............ 00071-0230 TB Phenobarbital..... 8.00
Parke-Davis & Co............... Tedral Elixir..... 00071-0242 EX Phenobarbital..... 40.00
Parke-Davis & Co............... Tedral S.A........ 00071-0231 TB Phenobarbital..... 8.00
Parke-Davis & Co............... Tedral Suspension. 00071-0237 SU Phenobarbital..... 80.00
Parmed Pharmacy................ Asma-Ese.......... 00349-2018 TB Phenobarbital..... 8.10
Rondex Labs.................... Azma-Aids......... 00367-3153 TB Phenobarbital..... 8.00
Smith Kline Consumer........... Benzedrex......... 49692-0928 IN Propylhexedrine... 250.00
Sterling Drug, Inc............. Bronkolixir....... 00057-1004 EL Phenobarbital..... 0.80
Sterling Drug, Inc............. Bronkotabs........ 00057-1005 TB Phenobarbital..... 8.00
Vicks Chemical Co.............. Vicks Inhaler..... 23900-0010 IN I-Desoxyephedrine. 113.00
White Hall Labs................ Primatene (P- 00573-2940 TB Phenobarbital..... 8.00
tablets).
----------------------------------------------------------------------------------------------------------------
[38 FR 8255, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, l973,
and amended at 41 FR 16553, Apr. 20, 1976; 41 FR 53477, Dec. 7, 1976; 46
FR 51603, Oct. 21, 1981; 47 FR 45867, Oct. 14, 1982; 54 FR 2100, Jan.
19, 1989; 55 FR 12162, Mar. 30, 1990]
Exempt Chemical Preparations
Sec. 1308.23 Exemption of certain chemical preparations; application.
(a) The Administrator may, by regulation, exempt from the
application of all or any part of the Act any chemical preparation or
mixture containing one or more controlled substances listed in any
schedule, which preparation or mixture is intended for laboratory,
industrial, educational, or special research purposes and not for
general administration to a human being or other animal, if the
preparation or mixture either:
(1) Contains no narcotic controlled substance and is packaged in
such a form or concentration that the packaged quantity does not present
any significant potential for abuse (the type of packaging and the
history of abuse of the same or similar preparations may be considered
in determining the potential for abuse of the preparation or mixture);
or
(2) Contains either a narcotic or nonnarcotic controlled substance
and one or more adulterating or denaturing agents in such a manner,
combination, quantity, proportion, or concentration, that the
preparation or mixture does not present any potential for abuse. If the
preparation or mixture contains a narcotic controlled substance, the
preparation or mixture must be formulated in such a manner that it
incorporates methods of denaturing or other means so that the
preparation or mixture is not liable to be abused or have ill effects,
if abused, and so that the narcotic substance cannot in practice be
removed.
(b) Any person seeking to have any preparation or mixture containing
a controlled substance and one or more noncontrolled substances exempted
from the application of all or any part of the Act, pursuant to
paragraph (a) of this section, may apply to the Administrator, Drug
Enforcement Administration, Department of Justice, Washington, DC 20537.
(c) An application for an exemption under this section shall contain
the following information:
(1) The name, address, and registration number, if any, of the
applicant;
(2) The name, address, and registration number, if any, of the
manufacturer or importer of the preparation or mixture, if not the
applicant;
[[Page 93]]
(3) The exact trade name or other designation of the preparation or
mixture;
(4) The complete qualitative and quantitative composition of the
preparation or mixture (including all active and inactive ingredients
and all controlled and noncontrolled substances);
(5) The form of the immediate container in which the preparation or
mixture will be distributed with sufficient descriptive detail to
identify the preparation or mixture (e.g., bottle, packet, vial, soft
plastic pillow, agar gel plate, etc.);
(6) The dimensions or capacity of the immediate container of the
preparation or mixture;
(7) The label and labeling, as defined in Sec. 1302.01 of this
chapter, of the immediate container and the commercial containers, if
any, of the preparation or mixture;
(8) A brief statement of the facts which the applicant believes
justify the granting of an exemption under this paragraph, including
information on the use to which the preparation or mixture will be put;
(9) The date of the application; and
(10) Which of the information submitted on the application, if any,
is deemed by the applicant to be a trade secret or otherwise
confidential and entitled to protection under subsection 402(a)(8) of
the Act (21 U.S.C. 842(a) (8)) or any other law restricting public
disclosure of information.
(d) The Administrator may require the applicant to submit such
documents or written statements of fact relevant to the application as
he deems necessary to determine whether the application should be
granted.
(e) Within a reasonable period of time after the receipt of an
application for an exemption under this section, the Administrator shall
notify the applicant of his acceptance or nonacceptance of his
application, and if not accepted, the reason therefor. The Administrator
need not accept an application for filing if any of the requirements
prescribed in paragraph (c) or requested pursuant to paragraph (d) is
lacking or is not set forth as to be readily understood. If the
applicant desires, he may amend the application to meet the requirements
of paragraphs (c) and (d) of this section. If the application is
accepted for filing, the Administrator shall issue and publish in the
Federal Register his order on the application, which shall include a
reference to the legal authority under which the order is based. This
order shall specify the date on which it shall take effect. The
Administrator shall permit any interested person to file written
comments on or objections to the order within 60 days of the date of
publication of his order in the Federal Register. If any such comments
or objections raise significant issues regarding any finding of fact or
conclusion of law upon which the order is based, the Administrator shall
immediately suspend the effectiveness of the order until he may
reconsider the application in light of the comments and objections
filed. Thereafter, the Administrator shall reinstate, revoke, or amend
his original order as he determines appropriate.
(f) The Administrator may at any time revoje or modify any exemption
granted pursuant to this section by following the procedures set forth
in paragraph (e) of this section for handling an application for an
exemption which has been accepted for filing. The Administrator may also
modify or revoke the criteria by which exemptions are granted (and
thereby modify or revoke all preparations and mixtures granted under the
old criteria) and modify the scope of exemptions at any time.
[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973,
and amended at 46 FR 28841, May 29, 1981]
Sec. 1308.24 Exempt chemical preparations.
(a) The chemical preparations and mixtures set forth in paragraph
(i) of this section have been exempted by the Administrator from
application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003
and 1004 of the Act (21 U.S.C. 822-3, 825-9, 952-4) and Sec. 1301.74 of
this chapter, to the extent described in paragraphs (b) to (h) of this
section. Substances set forth in paragraph (j) shall be exempt from the
application of sections 305, 306, 307, 308, 309, 1002, 1003 and 1004 of
the Act (21 U.S.C. 825-9, 952-4) and Secs. 1301.71-1301.73 and
1301.74(a), (b),
[[Page 94]]
(d), (e) and (f) of this chapter to the extent as hereinafter may be
provided.
(b) Registration and security: Any person who manufactures an exempt
chemical preparation or mixture must be registered under the Act and
comply with all relevant security requirements regarding controlled
substances being used in the manufacturing process until the preparation
or mixture is in the form described in paragraph (i) of this section.
Any other person who handles an exempt chemical preparation after it is
in the form described in paragraph (i) of this section is not required
to be registered under the Act to handle that preparation, and the
preparation is not required to be stored in accordance with security
requirements regarding controlled substances.
(c) Labeling: In lieu of the requirements set forth in part 1302 of
this chapter, the label and the labeling of an exempt chemical
preparation must be prominently marked with its full trade name or other
description and the name of the manufacturer or supplier as set forth in
paragraph (i) of this section, in such a way that the product can be
readily identified as an exempt chemical preparation. The label and
labeling must also include in a prominent manner the statement ``For
industrial use only'' or ``For chemical use only'' or ``For in vitro use
only--not for human or animal use'' or ``Diagnostic reagent--for
professional use only'' or a comparable statement warning the person
reading it that human or animal use is not intended. The symbol
designating the schedule of the controlled substance is not required on
either the label or the labeling of the exempt chemical preparation, nor
is it necessary to list all ingredients of the preparation.
(d) Records and reports: Any person who manufactures an exempt
chemical preparation or mixture must keep complete and accurate records
and file all reports required under part 1304 of this chapter regarding
all controlled substances being used in the manufacturing process until
the preparation or mixture is in the form described in paragraph (i) of
this section. In lieu of records and reports required under part 1304 of
this chapter regarding exempt chemical preparations, the manufacturer
need only record the name, address, and registration number, if any, of
each person to whom the manufacturer distributes any exempt chemical
preparation. Each importer or exporter of an exempt narcotic chemical
preparation must submit a semiannual report of the total quantity of
each substance imported or exported in each calendar half-year within 30
days of the close of the period to the Drug Control Section, Drug
Enforcement Administration, Department of Justice, Washington, DC 20537.
Any other person who handles an exempt chemical preparation after it is
in the form described in paragraph (i) of this section is not required
to maintain records or file reports.
(e) Quotas, order forms, prescriptions, import, export, and
transshipment requirements: Once an exempt chemical preparation is in
the form described in paragraph (i) of this section, the requirements
regarding quotas, order forms, prescriptions, import permits and
declarations, export permit and declarations, and transshipment and
intransit permits and declarations do not apply. These requirements do
apply, however, to any controlled substances used in manufacturing the
exempt chemical preparation before it is in the form described in
paragraph (i) of this section.
(f) Criminal penalties: No exemption granted pursuant to
Sec. 1308.23 affects the criminal liability for illegal manufacture,
distribution, or possession of controlled substances contained in the
exempt chemical preparation. Distribution, possession, and use of an
exempt chemical preparation are lawful for registrants and
nonregistrants only as long as such distribution, possession, or use is
intended for laboratory, industrial, or educational purposes and not for
immediate or subsequent administration to a human being or other animal.
(g) Bulk materials: For materials exempted in bulk quantities, the
Administrator may prescribe requirements other than those set forth in
paragraphs (b) through (e) of this section on a case-by-case basis.
(h) Changes in chemical preparations: Any change in the quantitative
or
[[Page 95]]
qualitative composition of the preparation or mixture after the date of
application, or change in the trade name or other designation of the
preparation or mixture, set forth in paragraph (i) of this section,
requires a new application for exemption.
(i) The following preparations and mixtures, in the form and
quantity listed in the application submitted (indicated as the ``date of
application'') are designated as exempt chemical preparations for the
purposes set forth in this section:
Exempt Chemical Preparations
----------------------------------------------------------------------------------------------------------------
Supplier Product name Form Date
----------------------------------------------------------------------------------------------------------------
Aalto Scientific, LTD.................. Therapeutic Drug Monitoring Vial: 5ml................ 4/09/91
Control Level I, II, III
Freeze Dried.
Abbott Laboratories.................... 125I Cholylglycyltyrosine Plastic Bottle: 20ml..... 4/07/78
Reagent Solution, No. 7816.
Abbott Laboratories.................... ADx Benzoylecgonine Fluorescein Bottle: 3.2 ml........... 12/02/86
Tracer Solution.
Abbott Laboratories.................... ADx Cannabinoids Fluorescein Bottle: 3.2ml............ 12/02/86
Tracer Solution.
Abbott Laboratories.................... ADx Cannabinoids Reagent Pack Reagent Pack: 50 tests... 12/02/86
(No. 9671-55).
Abbott Laboratories.................... ADx Cocaine Metabolite Vial: 3.2ml, Kit: 100 4/18/89
Fluorescein Tracer Solution, vials.
No. 9670-T, No. 9670T0013.
Abbott Laboratories.................... ADx Cocaine Metabolite Reagent 50 Test Unit............. 4/18/89
Pack, No. 9670-55.
Abbott Laboratories.................... ADx Opiates Fluorescein Tracer Vial: 3.2ml, Kit: 100 4/18/89
Solution, No. 9673-T, No. vials.
9673T0013.
Abbott Laboratories.................... ADx Opiates Reagent Pack, No. 50 Test Unit............. 4/18/89
9673-55.
Abbott Laboratories.................... ADx Propoxyphene Fluorescein Box: 100 bottles or less. 11/30/90
Tracer Solutions Item No.
9675T0011.
Abbott Laboratories.................... ADx Propoxyphene Reagent Pack Kit: 50 test............. 11/30/90
Item No.9675-55.
Abbott Laboratories.................... Advisor (4 Track); Code 9A18-21 Kit: 40 Discs............ 3/25/94
Abbott Laboratories.................... Advisor Cannabinoids Bulk Flasks: 6L, 4L, 2L, 1L, 4/10/92
Tracer No.76224. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml, 5ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Advisor Card & Cover No.07A15.. Box: 2000 Cards.......... 4/10/92
Abbott Laboratories.................... Advisor Card & Tracer No.07A14. Box: 2000 Cards.......... 4/10/92
Abbott Laboratories.................... Advisor Card with Cover; Code # Box: 2000 Cards.......... 3/25/94
05B08.
Abbott Laboratories.................... Advisor Card with Tracer; Code Box: 2000 Cards.......... 3/25/94
# 05B07.
Abbott Laboratories.................... Advisor Cocaine Bulk Tracer (in- Flasks: 6L, 4L, 2L, 1L, 6/08/92
process) No.77458A. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml, 5ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Advisor Cocaine Bulk Tracer Flasks: 6L, 4L, 2L, 1L, 4/10/92
No.77458. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml, 5ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Advisor Controls, Code # 6A63- Kit: 2 Bottles........... 1/25/94
10.
Abbott Laboratories.................... Advisor Drug of Abuse Screening Kit: 10 Discs............ 4/10/92
System No.6A60-10.
Abbott Laboratories.................... Advisor Drug of Abuse Screening Kit: 40 Discs............ 4/10/92
System No.6A60-21.
Abbott Laboratories.................... Advisor Opiates Bulk Tracer (in- Flasks: 6L, 4L, 2L, 1L, 6/08/92
process) No.78692A. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml, 5ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Advisor Opiates Bulk Tracer Flasks: 6L, 4L, 2L, 1L, 4/10/92
No.78692. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml, 5ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Advisor Positive Control, Bulk, Carboy: 50, 45, 20, 10L; 1/25/94
Code # 82979. Flask: 6, 4, 2, 1L; 500,
250, 200, 125, 100,
50ml; Bottle: 8, 4, 2,
1L; 500, 250, 125, 50,
30, 10, 5ml.
Abbott Laboratories.................... Advisor Positive Control, Code Bottle: 5ml.............. 1/25/94
# 6A63P.
Abbott Laboratories.................... Advisor Positive Control, In- Box: 100 Bottles......... 1/25/94
Process, Code # 6A63P001.
[[Page 96]]
Abbott Laboratories.................... Advisor Reaction Disc No.6A60B. Disc: 1 Card............. 4/10/92
Abbott Laboratories.................... Advisor Reaction Discs (4 Inner Carton: 20 Discs... 3/25/94
Track); Code # 9A18.
Abbott Laboratories.................... Advisor Reaction Discs No.6A60. Carton: 20 Discs......... 4/10/92
Abbott Laboratories.................... Amphetamine Bulk Calibrators, B- Carboy: 10L Flask: 6L, 10/09/85
F. 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Amphetamine Bulk Controls, L Flask: 2 liter........... 12/09/85
and H.
Abbott Laboratories.................... Amphetamine Class Bulk 50L, 45L, 20L, 10L, 8L, 3/01/88
Calibrator B-F. 6L, 4L, 2L, 1L, 500ml,
250ml, 200ml, 125ml,
100ml, 50ml, 30ml, 20ml,
15ml, 10ml, 5ml, 2ml.
Abbott Laboratories.................... Amphetamine Class Bulk Control 50L, 45L, 20L, 10L, 8L, 3/01/88
L and H. 6L, 4L, 2L, 1L, 500ml,
250ml, 200ml, 125ml,
100ml, 50ml, 30ml, 20ml,
15ml, 5ml, .2ml.
Abbott Laboratories.................... Amphetamine Class Bulk Tracer: 50L, 45L, 20L, 10L, 8L, 3/01/88
No. 94699. 6L, 4L, 2L, 1L, 500ml,
250ml, 200ml, 125ml,
100ml, 50ml, 30ml, 20ml,
15ml, 10ml, 5ml, 2ml.
Abbott Laboratories.................... Amphetamine Class QC Primary B- Carboy: 10L Flask: 4L, 11/22/88
F, L, M, H No. 9667 (B-F, L, 2L, 1L, 500 ml, 250 ml,
M, H) QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Amphetamine Class Stock Tracer: Bottle: 30 ml............ 3/01/88
No. 94700.
Abbott Laboratories.................... Amphetamine Stock Standard No. Carboy: 20L, 10L Flask: 11/22/88
97072, 97072 A-B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Amphetamine Stock Standard, No. Bottle: 125ml............ 9/30/85
97072.
Abbott Laboratories.................... Amphetamine/ Methamphetamine II 5 ML Vial................ 8/26/88
Controls (L, M, H) No. 1A99-L,
M, H.
Abbott Laboratories.................... Amphetamine/ Methamphetamine II Kit: 3 Vials............. 8/26/88
Controls No. 1A99-10.
Abbott Laboratories.................... Amphetamine/ Methamphetamine QC Carboy: 10L Flask: 4L, 11/22/88
Primary B-F, L, M, H No. 9668 2L, 1L, 500 ml, 250 ml,
(B-F, L, M, H) QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Amphetamine/ Methamphetamine QC Bottle: 5 ml............. 11/10/87
Primary Standard Control M,
No. 9668-M.
Abbott Laboratories.................... Amphetamine/Metamphetamine QC Flasks: 1 liter, 250 ml, 11/10/87
Primary Bulk Control M, No. and 200 ml.
9668-M.
Abbott Laboratories.................... Amphetamine/Methamphetamine Carboy: 10L Flask: 4L, 11/22/88
(II) QC Primary B-F, L, M, H 2L, 1L, 500 ml, 250 ml,
No. 1A99 (B-F, L, M, H) QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboy: 20L, 10L, 6L, 2L, 7/14/89
Bulk Calibrator B, C, D, E, F; 1L, 250ml, 200ml.
No. 01A99-B, C, D, E, F.
Abbott Laboratories.................... Amphetamine/Methamphetamine II 50L, 45.5L, 20 L, 19L, 8/26/88
Bulk Calibrators B-F Code No. 13.25L, 13L, 10 L, 9.5L,
1A99 (B-F). 9L Carboy; 6 L, 4L, 2 L,
1 L, 250 ml, 200 ml
Flask.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboy: 20L, 10L, Flask: 7/14/89
Bulk Control L, M, H, ; No. 6L, 2L, 1L, 250ml, 200ml.
01A99-L, M, H.
Abbott Laboratories.................... Amphetamine/Methamphetamine II 50L, 45.5L, 20 L, 19L, 8/26/88
Bulk Controls (L, M, H) Code 13.25L, 13L, 10 L, 9.5L,
No. 1A99 (L, M, H). 9L Carboy; 6 L, 4L, 2 L,
1 L, 250 ml, 200 ml
Flask.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboy: 20L, 10L, Flask: 1/19/89
Bulk Controls, No. 1A99X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboys: 50, 45, 20, 10L; 6/12/95
Bulk Master Calibrator W, 3B27- Flasks: 6, 4, 2, 1L;
W. 500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Amphetamine/Methamphetamine II 5 ml Vial................ 8/26/88
Calibrators B-F No. 1A99 B-F.
[[Page 97]]
Abbott Laboratories.................... Amphetamine/Methamphetamine II Kit: 100 vials........... 1/19/89
Control X, Y, Z; No. 1A99-02,
03, 04.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Vial: 5ml................ 1/19/89
Control X, Y, Z; No. 1A99X, Y,
Z.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboy: 20, 10L; Flask: 2/20/91
QC Primary 2-6 QT, NG, CO, PS 6, 4, 2, 1L, 500, 250,
No. 1A99 2-6 QT-QC & NG/CO/PS- 200, 100ml; Bottle: 950,
QC. 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Amphetamine/Methamphetamine II Carboy: 20L, 10L; Flask: 10/25/91
QC Primary 8QT No. 1A998QT-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... AxSYM Amphetamine/ Bottle: 5ml.............. 6/12/95
Methamphetamine II Master
Calibrator 2.
Abbott Laboratories.................... AxSYM Amphetamine/ Kit: 2 Bottles, 5ml each. 6/12/95
Methamphetamine II Master
Calibrators, 3B27-30.
Abbott Laboratories.................... AxSYM Barbiturates II U Master Bottle: 5ml.............. 5/10/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Barbiturates II U Master Kit: 2 Bottles........... 5/10/95
Calibrators.
Abbott Laboratories.................... AxSYM Benzodiazepines Master Bottle: 5ml.............. 5/10/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Benzodiazepines Master Kit: 2 Bottles........... 5/10/95
Calibrators.
Abbott Laboratories.................... AxSYM Cannabinoids Fluorescin Bottles: 35, 20, 15ml; 6/02/94
Tracer; Code 3B28T0001. Box: 100 vials; Tray:
200vials.
Abbott Laboratories.................... AxSYM Cannabinoids Master Bottle: 5ml.............. 5/10/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Cannabinoids Master Kit: 2 Bottles........... 5/10/95
Calibrators.
Abbott Laboratories.................... AxSYM Cannabinoids Reagent Pack Kit: 100 Tests........... 7/27/94
Abbott Laboratories.................... AxSYM Cocaine Metabolite Kit: 100 Tests........... 7/27/94
Reagent Pack.
Abbott Laboratories.................... AxSYM Cocaine Metabolite Bottles: 35, 20, 15ml; 6/02/94
Fluorescin Tracer Solution; Box: 100 vials; Tray:
Code 3B24T0001. 200 vials.
Abbott Laboratories.................... AxSYM Cocaine Metabolite Master Bottle: 5ml.............. 5/10/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Cocaine Metabolite Master Kit: 2 Bottles........... 5/10/95
Calibrators.
Abbott Laboratories.................... AxSYM Methadone Master Bottle: 5ml.............. 6/12/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Methadone Master Kit: 2 Bottles, 5ml each. 6/12/95
Calibrators, 3B31-30.
Abbott Laboratories.................... AxSYM Opiates Fluorescin Tracer Bottles: 35, 20, 15ml; 6/02/94
Solution; Code 3B25T0001. Box: 100 vials; Tray:
200 vials.
Abbott Laboratories.................... AxSYM Opiates Master Calibrator Bottle: 5ml.............. 5/10/95
2.
Abbott Laboratories.................... AxSYM Opiates Master Kit: 2 Bottles........... 5/10/95
Calibrators.
Abbott Laboratories.................... AxSYM Opiates Reagent Pack..... Kit: 100 Tests........... 7/27/94
Abbott Laboratories.................... AxSYM Phencyclidine Master Bottle: 5ml.............. 6/12/95
Calibrator 2.
Abbott Laboratories.................... AxSYM Phencyclidine Master Kit: 2 Bottles, 5ml each. 6/12/95
Calibrators, 3B26-30.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrator Vial: 5ml................ 1/25/94
B, Code # 7A70-B.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrator Vial: 5ml................ 1/25/94
C, Code # 7A70-C.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrator Vial: 5ml................ 1/25/94
D, Code # 7A70-D.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrator Vial: 5ml................ 1/25/94
E, Code 7A70-E.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrator Vial: 5ml................ 1/25/94
F, Code 7A70-F.
Abbott Laboratories.................... AxSYM Phenobarbital Calibrators Kit: 6 Vials............. 1/25/94
(B-F), Code # 7A70-01.
Abbott Laboratories.................... AxSYM Phenobarbital Control H, Vial: 10ml............... 1/25/94
Code # 7A70-H.
Abbott Laboratories.................... AxSYM Phenobarbital Control M, Vial: 10ml............... 1/25/94
7A70-M.
Abbott Laboratories.................... AxSYM Phenobarbital Controls Kit: 3 Vials............. 1/25/94
(L, M, H), Code # 7A70-L.
Abbott Laboratories.................... Barbital Buffer, 0.06 M; Plastic Bottle: 2.5ml.... 4/07/78
Reagent Solution No. 7824.
Abbott Laboratories.................... Barbiturate II U Control L, M, Bottle: 5 ml............. 10/17/89
H; No. 9669 L, M, H-11.
Abbott Laboratories.................... Barbiturates Bulk Calibrator B- Carboy: 50L, 45.5L, 20L, 7/01/88
F; No. 9669 B-F. 19L, 13.25L, 13L, 10L,
9.5L, 9L, 6L, 4L, 2L,
1L, 250ml, 200ml.
Abbott Laboratories.................... Barbiturates Bulk Control L, H; Carboy: 50L, 45.5L, 20L, 7/01/88
No. 9669 L, H. 19L, 13.25L, 13L, 10L,
9.5, 9L, 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Barbiturates Bulk Controls, No. Carboy: 20L, 10L, Flask: 1/19/89
9669X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Barbiturates Control X, Y, Z; Vial: 5ml................ 1/19/89
No. 9669X, Y, Z.
[[Page 98]]
Abbott Laboratories.................... Barbiturates II QC Primary NG, Carboy: 20, 10L; Flask: 2/20/91
CO, PS; No. 9669 NG/CO/PS-11- 6, 4, 2, 1L, 500, 250,
QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Barbiturates II U Bulk Carboy: 50L, 45.5L, 20L, 10/17/89
Calibrators B-F; No. 9669 B-F- 19L, 13.25L, 13L, 10L,
05. 9.5L, 9L, 6L, 4L, 2L,
1L, Flask: 250ml, 200ml.
Abbott Laboratories.................... Barbiturates II U Bulk Controls Carboy: 50L, 45.5L, 20L, 10/17/89
L, M, H; No. 9669 L, M, H-11. 19L, 13.25L, 13L, 10L,
9.5L, 9L, 6L, 4L, 2L,
1L, Flask: 250ml, 200ml.
Abbott Laboratories.................... Barbiturates II U Bulk Master Carboys: 50, 45, 20, 10L; 5/10/95
Calibrator W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Barbiturates II U Calibrators B- Bottle: 5 ml............. 10/17/89
F; No. 9669 B-F-05.
Abbott Laboratories.................... Barbiturates II U Controls L, Kit: 3 vials............. 10/17/89
M, H; No. 9661-11.
Abbott Laboratories.................... Barbiturates II U QC Primary B- Carboy: 10L, Flask: 4L, 10/17/89
F; No. 9669 B-F-05 QC. 2L, 1L, 500ml, 250ml,
200ml, 100ml, Bottle:
950ml, 500ml, 100ml, 5ml.
Abbott Laboratories.................... Barbiturates II U QC Primary L, Carboy: 10L, Flask: 4L, 10/17/89
M, H; No. 9669 L, M, H-11 QC. 2L, 1L, 500ml, 250ml,
200ml, 100ml, Bottle:
950ml, 500ml, 100ml, 5ml.
Abbott Laboratories.................... Barbiturates QC Primary B-F, L, Carboy: 10L Flask: 4L, 11/22/88
M, H No. 9669 (B-F, L, M, H) 2L, 1L, 500 ml, 250 ml,
QC. 200 ml, 100 ml Bottle: 5
ml.
Abbott Laboratories.................... Barbiturates QC Primary Bulk Flasks: 1 liter, 250 ml, 11/10/87
Control M, No. 9669-M. and 200 ml.
Abbott Laboratories.................... Barbiturates QC Primary Bottle: 5 ml............. 11/10/87
Standard Control M, No. 9669-M.
Abbott Laboratories.................... Barbiturates QC Primary X, No. Carboy: 10L, Flask: 4L, 6/05/89
9669X-QC. 2L, 1L, 500ml, 250ml,
200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Barbiturates Serum Bulk Carboy, Flask, Bottle or 1/03/89
Calibrator B-F, No. 9679 B-F. Ampule: 50, 45, 20, 10,
8, 6, 4, 2, 1-(L); 500,
250, 200, 125, 100, 50,
30, 20, 15, 10, 5, 2-
(ml).
Abbott Laboratories.................... Barbiturates Serum Bulk Control Carboy: 20L, 10L, Flask: 1/03/89
L, M, H; No. 9676 L, M, H. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Barbiturates Serum Calibrators Kit: 6 vials............. 1/03/89
B-F, No. 9679-01.
Abbott Laboratories.................... Barbiturates Serum Calibrators Bottle: 5ml.............. 1/03/89
B/F, No. 9679 B/F.
Abbott Laboratories.................... Barbiturates Serum Controls L, Bottle: 5ml.............. 1/03/89
M, H; No. 9679 L, M, H.
Abbott Laboratories.................... Barbiturates Serum Controls L, Kit: 3 vials............. 1/03/89
M, H; No. 9679-10.
Abbott Laboratories.................... Barbiturates Serum QC Primary B- Carboy: 10L, Flask: 4L, 1/03/89
F, L, M, H; No. 9679 (B-F, L, 2L, 1L, 500ml, 250ml,
M, H)-QC. 200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Benzodiazepine Serum QC Primary Carboy: 10L Flask: 4L, 11/22/88
B-F, L, M, H No. 9682 (B-F, L, 2L, 1L, 500 ml, 250 ml,
M, H)-QC. 200 ml, 100 ml Bottle: 5
ml.
Abbott Laboratories.................... Benzodiazepines Bulk Calibrator Carboy: 50L, 45.5L, 20L, 7/18/88
No. 9674 B-F. l9.5L, 19L, 13.25L, 13L,
10L, 9L, 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Benzodiazepines Bulk Control L, Carboy: 50L, 45.5L, 20L, 7/18/88
H No. 9674 L, H. 19L, 13.25zl, 13L, 10L,
9.5, 9L, 6L, 4L, 2L, 1L,
250ml, 200ml,.
Abbott Laboratories.................... Benzodiazepines Bulk Master Carboys: 50, 45, 20, 10L; 5/10/95
Calibrator W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
[[Page 99]]
Abbott Laboratories.................... Benzodiazepines QC Primary Bulk Flasks: 1 liter, 250 ml, 11/10/87
Control M, No. 9674-M. and 200 ml.
Abbott Laboratories.................... Benzodiazepines QC Primary Bulk Flasks: 1 liter, 250 ml, 11/10/87
Control M, No. 9674-M. and 200 ml.
Abbott Laboratories.................... Benzodiazepines QC Primary NG, Carboy: 20, 10L; Flask: 2/20/91
CO, PS No. 9674NG/CO/PS-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Benzodiazepines QC Primary, B- Carboy: 10L Flask: 4L, 11/22/88
F, L, M, H No. 9674 (B-F, L, 2L, 1L, 500 ml, 250 ml,
M, H) QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Benzodiazepines Serum Bulk Carboy: 10 liter; Flask: 12/07/87
Calibrators B-F: Code No. 9682 6 liter, 2 liter.
B-F.
Abbott Laboratories.................... Benzodiazepines Serum Bulk Carboy: 20 liters, 10 5/02/88
Calibrators: No. 9682 B-F. liters; Flask: 6 liters,
2 liters, 1 liter.
Abbott Laboratories.................... Benzodiazepines Serum Bulk Carboy: 10 liter; Flask: 12/07/88
Controls L, M, & H: Code No. 6 liter, 2 liter.
9682 L, M, & H.
Abbott Laboratories.................... Benzodiazepines Serum Bulk Carboy: 20 liters, 10 5/02/88
Controls: No. 9682 L, M, H. liters; Flask: 6 liters,
2 liters, 1 liter, 250
ml, 200 ml.
Abbott Laboratories.................... Benzoylecgonine Stock Standard Carboy: 20L, 10L Flask: 11/23/88
No. 97182, 97182 A-B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml,
Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Benzoylecgonine Stock Standard, Bottle: 125ml............ 11/21/85
No. 97182.
Abbott Laboratories.................... CG RIA Diagnostic Kit No. 7815. Kit: 100 tests........... 4/07/78
Abbott Laboratories.................... Cannabinoids--GS Bulk Controls, Carboy: 20L, 10L, Flask: 1/19/89
No. 3897X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Cannabinoids--GS Control X, Y, Kit: 100 vials........... 1/19/89
Z; No. 3897-02, 03, 04.
Abbott Laboratories.................... Cannabinoids--GS Control X, Y, Vial: 5ml................ 1/19/89
Z; No. 3897X, Y, Z.
Abbott Laboratories.................... Cannabinoids Bulk Calibrators B- Carboy: 50L, 45.5L, 20L, 10/24/86
F, No. 9671 (B02-F02). 19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Cannabinoids Bulk Controls L, Carboy: 50L, 45.5L, 20L, 10/24/86
M, H; No. 9671 (L11, M11H11). 19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Cannabinoids Bulk Master Carboys: 50, 45, 20, 10L; 5/10/95
Calibrator W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Cannabinoids Bulk Tracer (No. Carboy: 50L, 45.5L, 20L, 10/27/86
94192). 19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Cannabinoids Bulk Tracer; Code Sizes: 50, 45, 20, 10, 8, 6/02/94
3B28T. 6, 4, 2, 1L; 500, 250,
200, 125, 100, 50, 35,
30, 20, 15, 10, 5ml;
Ampules: 50, 20, 15, 10,
5, 2ml.
Abbott Laboratories.................... Cannabinoids QC Primary 2-6 QT, Carboy: 20, 10L; Flask: 2/20/91
NG, CO, PS No. 9671-11 2-6 QT- 6, 4, 2, 1L, 500, 250,
QC & NG/CO/PS-QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Cannabinoids QC Primary 8QT No. Carboy: 20, 10L; Flask: 10/25/91
9671-11 8QT-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Cannabinoids QC Primary NBS, B- Carboy: 10L, Flask: 4L, 12/27/88
F, L, M, H; No. 9671-02[NBS, B- 2L, 500ml, 250ml, 100ml,
F]-QC; No. 9671-11[L, M, H]-QC. 200ml, Bottle: 5ml.
[[Page 100]]
Abbott Laboratories.................... Cannabinoids QC Primary NBS, B- Carboy: 10L, Flask: 4L, 12/27/88
F, L, M, H; No. 9671 (NBS, B- 2L, 1L, 500ml, 250ml,
F, L, M, H)-QC. 200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Cannabinoids Stock Standard Bottle: 125 ml........... 6/19/87
(94568).
Abbott Laboratories.................... Cannabinoids Stock Standard Bottle: 125 ml........... 10/24/86
(No. 94193).
Abbott Laboratories.................... Cannabinoids Stock Standard Carboy: 20L, 10L, Flask: 12/27/89
10mcg/ml-No. 94568, 5mcg/ml- 4L, 2L, 1L, 500ml,
NO. 94568A, 1mcg/ml-No. 94568B. 250ml, 200ml, 100ml,
bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Cannabinoids Stock Standard; Carboy: 20L, 10L, Flask: 12/27/88
10mcg/ml-No. 94193, 5mcg/ml- 4L, 2L, 1L, 500ml,
No. 94193A, 1mcg/ml-No. 94193B. 250ml, 200ml, 100ml,
bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Cannabinoids Stock Tracer (No. Flasks: 6L, 4L, 2L, 1L, 10/27/86
94194). 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml,
30ml, 5ml; Amp: 20, 10,
5, 2ml.
Abbott Laboratories.................... Cannabinoids--GS Bulk 20 L, 10 L Carboy; 6 L, 2 7/28/88
Calibrators B-F No. 3897 B-F. L, 1 L, 250 ml, 200 ml
Flask.
Abbott Laboratories.................... Cannabinoids--GS Bulk Controls 20 L, 10 L Carboy; 6 L, 2 7/28/88
(L, M, H) Code No. 3897 (L, M, L, 1 L, 250 ml, 200 ml
H). Flask.
Abbott Laboratories.................... Cannabinoids--GS Bulk Tracer 10 L Carboy; 6 L, 2 L 7/28/88
Code No. 95826. Flask.
Abbott Laboratories.................... Cannabinoids--GS Calibrators B- 5 ml Vial................ 7/28/88
F No. 3897 B-F.
Abbott Laboratories.................... Cannabinoids--GS Calibrators Kit: 6 Vials............. 7/28/88
No. 3897-01.
Abbott Laboratories.................... Cannabinoids--GS Controls (L, 5 ml Vial................ 7/28/88
M, H) No. 3897-L, M, H.
Abbott Laboratories.................... Cannabinoids--GS Controls No. Kit: 3 Vials............. 7/28/88
3897-10.
Abbott Laboratories.................... Cannabinoids--GS QC Primary Carboy: 10L, Flask: 4L, 12/27/88
NBS, B-F, L, M, H; No. 3897 2L, 1L, 500ml, 250ml,
(NBS, B-F, L, M, H)-QC. 200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Cannabinoids--GS Reagent Pack Kit: 100 Tests........... 7/28/88
100 Test No. 3897-20.
Abbott Laboratories.................... Cannabinoids--GS Reagent Pack Kit: 100 Tests........... 9/22/89
100 Test, No. 3897-19.
Abbott Laboratories.................... Cannabinoids--GS Tracer Code 5 ml Vial................ 7/28/88
No. 3897-T.
Abbott Laboratories.................... Cholylglycine Antiserum Plastic Bottle: 20ml..... 4/07/78
(Rabbit) Reagent Solution No.
7817.
Abbott Laboratories.................... Cocaine Metabolite Bulk Carboy: 9.5, 19 L........ 7/07/88
Calibrator B-F No. 9670 B-F.
Abbott Laboratories.................... Cocaine Metabolite Bulk Carboy: 20L, 10L; Flask: 10/28/85
Calibrator, B-F No. 9670. 6L, 4L, 2L, 1L, 250ml,
200ml.
Abbott Laboratories.................... Cocaine Metabolite Bulk Carboy: 9.5, 19 L........ 7/07/88
Controls L, H No. 9670-L, H.
Abbott Laboratories.................... Cocaine Metabolite Bulk Carboy: 20L, 10L, Flask: 10/28/85
Controls, L and H No. 9670. 6L, 4L, 2L, 1L, 250ml,
200ml.
Abbott Laboratories.................... Cocaine Metabolite Bulk Carboy: 20L, 10L, Flask: 1/19/89
Controls, No. 9670X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Cocaine Metabolite Bulk Master Carboys: 50, 45, 20, 10L; 5/10/95
Calibrator W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Cocaine Metabolite Bulk Tracer, Carboy: 50L, 45.5L, 20L, 10/30/85
No. 97075. 13.25L, 13L, 10L, 9L;
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Cocaine Metabolite Control X, Vial: 5ml................ 1/19/89
Y, Z; No. 9670X, Y, Z.
Abbott Laboratories.................... Cocaine Metabolite QC Primary 2- Carboy: 20, 10L; Flask: 2/20/91
6 QT, NG, CO, PS No. 9670 2-6 6, 4, 2, 1L, 500, 250,
QT-QC & NG/CO/PS-QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
[[Page 101]]
Abbott Laboratories.................... Cocaine Metabolite QC Primary 2- Carboy: 20, 10L; Flask: 10/28/91
6 QT-C, 8QT-C No. 9670 2-6 QTC- 6, 4, 2, 1L, 500, 250,
QC, 9670 8QTC-QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Cocaine Metabolite QC Primary Carboy: 20, 10L; Flask: 10/25/91
8QT No. 9670 8QT-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Cocaine Metabolite QC Primary B- Carboy: 10L; Flask: 4L, 11/23/88
F, L, M. H, No. 9670 (B-F, L, 2L, 1L, 500 ml, 250 ml,
M, H)-QC. 200 ml, 100 ml, Bottle:
5 ml.
Abbott Laboratories.................... Cocaine Metabolite QC Primary Flasks: 1 liter, 250 ml, 11/10/87
Bulk Control M, No. 9670-M. and 200 ml.
Abbott Laboratories.................... Cocaine Metabolite QC Primary Bottle: 5 ml............. 11/10/87
Standard Control M, No. 9670-M.
Abbott Laboratories.................... Cocaine Metabolite QC Primary Carboy: 10L; Flask: 4L, 6/05/89
X, No. 9670X-QC; Primary Z, 2L, 1L, 500ml, 250ml,
No. 9670Z-QC. 200ml, 100ml; Bottle:
5ml.
Abbott Laboratories.................... Cocaine Metabolite Stock Flasks: 6L, 4L, 2L, 1L, 10/30/85
Tracer, No. 97156. 500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml,
30ml, 5ml; Amp: 20, 10,
5, 2ml.
Abbott Laboratories.................... Codeine Metabolite Bulk Tracer; Sizes: 50, 45, 20, 10, 8, 6/02/94
Code 3B48T. 6, 4, 2, 1L; 500, 250,
200, 125, 100, 50, 35,
30, 20, 15, 10, 5ml;
Ampules: 50, 20, 15, 10,
5, 2ml.
Abbott Laboratories.................... High Multiconstituent (9) Stock Carboy: 50, 20, 10L; 7/02/91
Standard Cat. No. 92622. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Low Multiconstituent (9) Stock Carboy: 50, 20, 10L; 7/02/91
Standard Cat. No. 92620. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Low, Medium, High Carboy: 10, 20L; Flask: 10/06/89
Multiconstituent Stock 6, 4, 2, 1L, 500, 250,
Standards, No. 90967, 90968, 200, 100ml; Bottle: 950,
90969. 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Medium Multiconstituent (9) Carboy: 50, 20, 10L; 7/02/91
Stock Standard Cat. No. 92621. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Methadone Bulk Calibrators (B- 20 L, 10 L Carboy; 6 L, 2 9/02/88
F) Code No. 9676 (B-F). L, 1 L, 250 ml, 200 ml
Flask.
Abbott Laboratories.................... Methadone Bulk Calibrators (L, 20 L, 10 L Carboy; 6 L, 2 9/02/88
M, H) Code No. 9676 (L, M, H). L, 1 L, 250 ml, 200 ml
Flask.
Abbott Laboratories.................... Methadone Bulk Master Carboys: 50, 45, 20, 10L; 6/12/95
Calibrator W, 3B31-W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Methadone Bulk Stock Standard 10 L Carboy; 6 L, 2 L, 1 9/02/88
Code No. 95952. L Flask.
Abbott Laboratories.................... Methadone Calibrators B-F No. 5 ml Vial................ 9/02/88
9676 B-F.
Abbott Laboratories.................... Methadone Controls L, M, H No. 5 ml Vial................ 9/02/88
9676-L, M, H.
Abbott Laboratories.................... Methadone Controls No. 9676-10. Kit: 3 Vials............. 9/02/88
[[Page 102]]
Abbott Laboratories.................... Methadone QC Primary NG, CO, PS Carboy: 20, 10L; Flask: 2/20/91
No. 9676 NG/CO/PS-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Methadone Stock Standard Code 1 L, 500 ml, 100 ml 9/02/88
No. 95720. Bottle.
Abbott Laboratories.................... Morphine Stock Standard, No. Vial: 125ml.............. 10/16/85
97291.
Abbott Laboratories.................... Morphine Stock Standard, No. Carboy: 20L, 10L Flask: 11/22/88
97291 A-B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Multiconstituent (9) QC Control Carboy: 50, 20, 10L; 7/02/91
H Cat. No. 92625. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Multiconstituent (9) QC Control Carboy: 50, 20, 10L; 7/02/91
L Cat. No. 92623. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Multiconstituent (9) QC Control Carboy: 50, 20, 10L; 7/02/91
M Cat. No. 92624. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml; Bottle:
950, 500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Multiconstituent Bulk Controls Carboy: 20L, 10L, Flask: 9/03/87
L, M, H (No. 9687-L, M, H). 10L, 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Multiconstituent Control for Carboy: 20L, 10L, 19L, 10/06/89
Abused Drug Assays Bulk L, M, 9.5L, 6L, 4L, 1L, Flask:
H; No. 9687-L, M, H. 250ml, 200ml.
Abbott Laboratories.................... Multiconstituent Control for Vial: 5 ml............... 10/06/89
Abused Drug Assays L, M, H;
No. 9687-L, M, H.
Abbott Laboratories.................... Multiconstituent Control for Carboy: 10L, Flask: 4L, 10/06/89
Abused Drug Assays QC 2L, 1L, 500ml, 250ml,
Primaries L, M, H; No. 9687-L, 200ml, 100ml, Bottle:
H, H-QC. 950ml, 500ml, 100ml, 5ml.
Abbott Laboratories.................... Nordiazepam Serum Bulk Stock Carboy: 10 liters; Flask: 5/02/88
Standard No. 94941. 6 liters, 2 liters, 1
liter.
Abbott Laboratories.................... Nordiazepam Serum Bulk Stock Carboy: 10 liter; Flask: 12/07/87
Standard: Code No. 94941. 6 liter, 2 liter.
Abbott Laboratories.................... Nordiazepam Serum Stock Carboy: 20L, 10L Flask: 11/22/88
Standard No. 94941, 94941 A, B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950 ml, 500 ml,
100 ml, 5 ml.
Abbott Laboratories.................... Nordiazepam Serum Stock Bottle: 125 ml........... 12/07/87
Standard: Code No. 94941.
Abbott Laboratories.................... Nordiazepam Serum Stock Bottle: 125 ml........... 5/02/88
Standard: No. 94941.
Abbott Laboratories.................... Nordiazepam Stock Standard No. Carboy: 20L, 10L Flask: 11/22/88
97757, 97757 A, B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Nordiazepam Stock Standard, No. Bottle: 125ml............ 4/21/86
97757.
Abbott Laboratories.................... Opiate Bulk Calibrators, B-F, Carboy: 50L, 45.5L, 20L, 5/07/86
No. 9673 B-F. 19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Opiate Bulk Controls, L and H Carboy: 50L, 45.5L, 20L, 5/07/86
No. 9673 L and H. 19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Opiates Bulk Controls, No. Carboy: 20L, 10L, Flask: 1/19/89
9673X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
[[Page 103]]
Abbott Laboratories.................... Opiates Bulk Master Calibrator Carboys: 50, 45, 20, 10L; 5/10/95
W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Opiates Bulk Tracer, No. 97458. Carboy: 50L, 45.5L, 20L, 5/07/86
19L, 13.25L, 13L, 10L,
9.5L, 9L Flask: 6L, 4L,
2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Opiates Bulk Tracer; Code # Sizes: 50, 45, 20, 10, 8, 6/02/94
3B25T. 6, 4, 2, 1L; 500, 250,
200, 125, 100, 50, 35,
30, 20, 15, 10, 5ml;
Ampules: 50, 20, 15, 10,
5, 2ml.
Abbott Laboratories.................... Opiates Control X, Y, Z; No. Vial: 5ml................ 1/19/89
9673X, Y, Z.
Abbott Laboratories.................... Opiates QC Primary (B-F, L, M, Carboy: 10L Flask: 4L, 11/22/88
H) QC No. 9673 (B-F, L, M, H) 2L, 1L, 500 ml, 250 ml,
QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Opiates QC Primary 2-6 QT, NG, Carboy: 20, 10L; Flask: 2/20/91
CO, PS No. 9673 2-6 QT-QC & NG/ 6, 4, 2, 1L, 500, 250,
CO/PS-QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Opiates QC Primary 8QT No. 9673 Carboy: 20, 10L; Flask: 10/25/91
8QT-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Opiates QC Primary Bulk Control Flasks: 1 liter, 250 ml, 11/10/87
M, No. 9673-M. and 200 ml.
Abbott Laboratories.................... Opiates QC Primary Standard Bottle: 5 ml............. 11/10/87
Control M, No. 9673-M.
Abbott Laboratories.................... Opiates QC Primary X, No. 9673X- Carboy: 10L, Flask: 4L, 6/05/89
QC; Primary Y, No. 9673Y-QC; 2L, 1L, 500ml, 250ml,
PrimaryZ, No. 9673Z-QC. 200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Opiates Stock Tracer, No. 98718 Flasks: 6L, 4L, 2L, 1L, 5/07/86
500ml, 250ml, 200ml,
100ml; Bottles: 950ml,
500ml, 100ml, 50ml,
30ml, 5ml; Amp: 20, 10,
5, 2ml.
Abbott Laboratories.................... Phencyclidine Bulk Calibrator, Carboy: 50L, 45.5L, 20L, 3/21/86
B-F No. 9672 B-F. 13.25L, 13L, 10L, 9L
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Phencyclidine Bulk Control M, Carboy: 50L, 45.5L, 20L, 9/26/86
No. 9672 M. 13.25L, 13L, 10L, 9L
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Phencyclidine Bulk Controls, L Carboy: 50L, 45.5L, 20L, 3/21/86
and H No. 9672 L and H. 13.25L, 13L, 10L, 9L
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Phencyclidine Bulk Controls, Carboy: 20L, 10L, Flask: 1/19/89
No. 9672X, Y, Z. 6L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Phencyclidine Bulk Master Carboys: 50, 45, 20, 10L; 6/12/95
Calibrator W, 3B26-W. Flasks: 6, 4, 2, 1L;
500, 250, 200, 125, 100,
50ml.
Abbott Laboratories.................... Phencyclidine Control X, Y, Z; Vial: 5ml................ 1/19/89
No. 9672X, Y, Z.
Abbott Laboratories.................... Phencyclidine QC Primary (B-F, Carboy: 10L Flask: 4L, 11/22/88
L, M, H) QC No. 9672 (B-F, L, 2L, 1L, 500 ml, 250 ml,
M, H) QC. 200 ml, 100 ml Bottle:
5ml.
Abbott Laboratories.................... Phencyclidine QC Primary 2-6 QT Carboy: 20, 10L; Flask: 2/20/91
NG, CO, PS No. 9672 2-6 QT-QC 6, 4, 2, 1L, 500, 250,
& NG/CO/PS-QC. 200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
[[Page 104]]
Abbott Laboratories.................... Phencyclidine QC Primary 8QT Carboy: 20, 10L; Flask: 10/25/91
No. 9672 8QT-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... Phencyclidine QC Primary X, No. Carboy: 10L, Flask: 4L, 6/05/89
9672X-QC; Primary Z, No. 9672Z- 2L, 1L, 500ml, 250ml,
QC. 200ml, 100ml, Bottle:
5ml.
Abbott Laboratories.................... Phencyclidine Stock Standard Carboy: 20L, 10L Flask: 11/22/88
No. 97158, 97158 A-B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Phencyclidine Stock Standard, Flask: 100ml, 200ml, 4/18/89
No. 95356. 250ml, 500ml, 1L, 2L,
4L, Bottle: 5ml, 100ml,
500ml, 950 ml, Carboys:
10L, 20L.
Abbott Laboratories.................... Phencyclidine Stock Standard, Bottle: 125ml............ 11/21/85
No. 97158.
Abbott Laboratories.................... Phenobarbital Bulk Calibrators Carboy: 50L, 45.5L, 19L, 6/16/88
No. 9500 B-F. 13.25L, 13L, 9.5L, 9L;
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Phenobarbital Bulk Controls No. Carboy: 50L, 45.5L, 19L, 6/16/88
9500 L, M, H. 13.25L, 13L, 9.5L, 9L;
Flask: 6L, 4L, 2L, 1L,
250ml, 200ml.
Abbott Laboratories.................... Phenobarbital Control L, Code # Vial: 10ml............... 1/25/94
7A70-L.
Abbott Laboratories.................... Phenobarbital Enzyme Inhibitor Vial: 2ml................ 1/20/84
Stock.
Abbott Laboratories.................... Phenobarbital QC Primary B-F, Carboy: 20, 10L; Flask: 1/04/91
L, M, H Item No. 9500B-F, L, 6, 4, 2, 1L, 500, 250,
M, H. 200, 100ml; Bottles:
950, 500, 100, 50, 5ml;
Ampules: 20, 10, 5, 2ml.
Abbott Laboratories.................... Phenobarbital Stock Solution 1 Plastic Bottle: 125 ml... 3/23/87
mg/ml Code No. 94312.
Abbott Laboratories.................... Phenobarbital Stock Solution 10 Plastic Bottle: 125 ml... 3/23/87
mg/ml Code No. 94313.
Abbott Laboratories.................... Phenobarbital Stock Standard Carboy: 50, 20, 10L; 1/04/91
500 ug/ml Item No. 99259. Flask: 6, 4, 2, 1L, 500,
250, 200, 100ml;
Bottles: 950, 500, 100,
50, 5ml; Ampules: 20,
10, 5, 2ml.
Abbott Laboratories.................... Phenobarbital Stock Standard Bottle: 1 liter.......... 8/12/82
Solution.
Abbott Laboratories.................... Polyethylene Glycol 8000, 16% Plastic Bottle: 300 ml, 9/21/77
Solution in 0.09 M Barbital 150 ml.
Buffer, No. 7541.
Abbott Laboratories.................... Polyethylene Glycol 8000, 18% Stainless Steel Tank: 3/09/88
Solution in 0.09M Barbital 1000 liters.
Buffer: No. 07602.
Abbott Laboratories.................... Progesterone Buffer No. 2242J.. Bottle: 30ml............. 3/11/92
Abbott Laboratories.................... Progesterone Buffer No. Box: 100 Bottles/30ml.... 3/11/92
2242J0001.
Abbott Laboratories.................... Progesterone Bulk Buffer No. Carboy: 50L, 25L, 20L, 5/11/92
12918. 19L, 15L, 13L, 10L, 9L;
Bottle: 950ml, 500ml,
100ml, 50ml, 30ml, 20ml;
Amp: 20ml, 10ml, 5ml,
2ml.
Abbott Laboratories.................... Progesterone Reagent Pack No. Kit: 4 Bottles........... 3/11/92
2242-20.
Abbott Laboratories.................... Propoxyphene Bulk Calibrator B- Carboys or Flasks: 50L, 11/30/90
F No. 9675 B-F. 45.5L, 20L, 19L, 13.25L,
13L, 10L, 9.5L, 9L, 6L,
4L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Propoxyphene Bulk Control L, M, Carboys or Flasks: 50L, 11/30/90
H No. 9675 L, M, H. 45.5L, 20L, 19L, 13.25L,
13L, 10L, 9.5L, 9L, 6L,
4L, 2L, 1L, 250ml, 200ml.
[[Page 105]]
Abbott Laboratories.................... Propoxyphene Bulk Tracer Item Carboys or Flasks: 50L, 11/30/90
No. 92003. 45.5L, 20L, 19L, 13.25L,
13L, 10L, 9.5L, 9L, 6L,
4L, 2L, 1L, 250ml, 200ml.
Abbott Laboratories.................... Propoxyphene Calibrators Item Kit: 5 vials............. 11/30/90
No. 9675-01.
Abbott Laboratories.................... Propoxyphene Calibrators Item Vial: 5ml................ 11/30/90
No. 9675B-F.
Abbott Laboratories.................... Propoxyphene Controls Item No. Kit: 3 vials............. 11/30/90
9675-10.
Abbott Laboratories.................... Propoxyphene Controls Item No. Vial: 5ml................ 11/30/90
9675L, M, H.
Abbott Laboratories.................... Propoxyphene QC Primary B-F, L, Carboy: 20, 10L Flasks: 11/30/90
M, H, Z Item No. 9675(B-F, L, 6, 4, 2, 1L, 500, 250,
M, H, Z)-QC. 200, 100ml Bottles: 950,
500, 100, 50, 5ml
Ampules: 20, 10, 5, 2ml.
Abbott Laboratories.................... Propoxyphene QC Primary NG, CO, Carboy: 20, 10L; Flask: 2/20/91
PS No. 9675 NG/CO/PS-QC. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle:
950ml, 500, 100, 50,
5ml; Ampule: 20, 10, 5,
2ml.
Abbott Laboratories.................... Propoxyphene Stock Standard, Carboys: 20, 10L Flasks: 11/30/90
100 mcg/ml Item No. 92005. 6, 4, 2, 1L, 500, 250,
200, 100ml Bottles: 950,
500, 100, 50, 5ml
Ampules: 20, 10, 5, 2ml.
Abbott Laboratories.................... Propoxyphene Stock Tracer Item Bottle: 12ml............. 11/30/90
No. 92001.
Abbott Laboratories.................... Propoxyphene Tracer Item No. Bottles: 3.2ml, 5ml...... 11/30/90
9675-T.
Abbott Laboratories.................... Secobarbital Bulk Calibrator, B- Carboy: 20L, 10L, Flask: 3/21/86
F No. 9669. 6L, 4L, 2L, 1L, 250ml,
200ml.
Abbott Laboratories.................... Secobarbital Bulk Controls, L Carboy: 20L, 10L, Flask: 3/21/86
and H No. 9669. 6L, 4L, 2L, 1L, 250ml,
200ml.
Abbott Laboratories.................... Secobarbital Stock Standard Carboy: 20L, 10L, Flask: 1/03/89
1000mcg/ml-No. 90107, 500mcg/ 4L, 2L, 1L, 500ml,
ml-No. 90107A, 200mcg/ml-No. 250ml, 200ml, 100ml,
90107B. Bottle: 950ml, 500ml,
100ml, 5ml.
Abbott Laboratories.................... Secobarbital Stock Standard No. Carboy: 20L, 10L Flask: 11/22/88
97171, 97171 A, B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950 ml, 500 ml,
100 ml, 5 ml.
Abbott Laboratories.................... Secobarbital Stock Standard, Bottle: 125ml............ 11/21/85
No. 97171.
Abbott Laboratories.................... Spectrum Phenobarbital Bottle: 4ml.............. 10/03/85
Calibrator II-VI, Nos. 9755,
9757, 9759, 9761, 9763.
Abbott Laboratories.................... Spectrum Phenobarbital Control, Bottle: 4ml.............. 10/03/85
Nos. 9876, 9878, 9880. (L, M,
H).
Abbott Laboratories.................... TDx Amphetamine Class Kit containing 6 vials... 3/01/88
Calibrators 9667-01.
Abbott Laboratories.................... TDx Amphetamine Class Bottle: 5 ml............. 3/01/88
Calibrators B-F.
Abbott Laboratories.................... TDx Amphetamine Class Control L Bottle: 5 ml............. 3/01/88
and H.
Abbott Laboratories.................... TDx Amphetamine Class Controls Kit containing 2 vials... 3/01/88
9667-10.
Abbott Laboratories.................... TDx Amphetamine Class Reagent Kit containing 1 vial.... 3/01/88
Pack, No. 9667-60.
Abbott Laboratories.................... TDx Amphetamine Class Tracer Bottle: 5 ml............. 3/01/88
Solution, No. 9667T.
Abbott Laboratories.................... TDx Amphetamine/Methamphetamine Bottles: 4ml............. 8/23/85
Calibrator, No. 9668-01.
Abbott Laboratories.................... TDx Amphetamine/Methamphetamine Bottles: 4ml............. 8/23/85
Controls, No. 9668-10.
Abbott Laboratories.................... TDx Barbiturates Calibrators 5 ml Vial................ 7/01/88
No. 9669 B-F.
Abbott Laboratories.................... TDx Barbiturates Calibrators Kit: 5 Vials, 5 ml each.. 7/01/88
No. 9669-01.
Abbott Laboratories.................... TDx Barbiturates Calibrators, B- Bottle: 4 ml............. 10/08/85
F No. 9669.
Abbott Laboratories.................... TDx Barbiturates Control L, H 5 ml Vial................ 7/01/88
No. 9669 L, H.
Abbott Laboratories.................... TDx Barbiturates Control, L and Bottle: 4ml.............. 10/08/85
H No. 9669.
Abbott Laboratories.................... TDx Barbiturates Controls No. Kit: 2 Vials, 5 ml each.. 7/01/88
9669-10.
Abbott Laboratories.................... TDx Benzodiazepines Calibrator 5 ml Vial................ 7/18/88
No. 9674 B-F.
Abbott Laboratories.................... TDx Benzodiazepines Bottles: 4ml............. 4/21/86
Calibrators, No. 9674-01.
Abbott Laboratories.................... TDx Benzodiazepines Controls L, 5 ml Vial................ 7/18/88
H No. 9674 L, H.
Abbott Laboratories.................... TDx Benzodiazepines Controls L, Kit: 2 Vials, 5 ml each.. 7/18/88
H No. 9674-10.
Abbott Laboratories.................... TDx Benzodiazepines Controls, Bottles: 4ml............. 4/21/86
No. 9674-10.
Abbott Laboratories.................... TDx Benzodiazepines Serum Bottle: 4 ml............. 5/02/88
Calibrator No. 9682 B-F.
Abbott Laboratories.................... TDx Benzodiazepines Serum Bottle: 4ml, 5ml......... 12/07/88
Calibrators B-F: Code No. 9682
B-F.
[[Page 106]]
Abbott Laboratories.................... TDx Benzodiazepines Serum Kit...................... 12/07/88
Calibrators: Code No. 9682-01.
Abbott Laboratories.................... TDx Benzodiazepines Serum Kit containing 6 vials... 5/02/88
Calibrators: No. 9682-01.
Abbott Laboratories.................... TDx Benzodiazepines Serum Bottle: 4 ml............. 12/07/87
Controls L, M, & H: No. 9682
L, M, H.
Abbott Laboratories.................... TDx Benzodiazepines Serum Bottle: 4 ml............. 5/02/88
Controls L, M, H: No. 9682 L,
M, H.
Abbott Laboratories.................... TDx Benzodiazepines Serum Kit...................... 12/07/88
Controls: Code No. 9682-10.
Abbott Laboratories.................... TDx Benzodiazepines Serum Kit containing 3 vials... 5/02/88
Controls: No. 9682-10.
Abbott Laboratories.................... TDx Cannabinoids Calibrators B- Bottles: 5 ml............ 10/24/86
F (No. 9671-01).
Abbott Laboratories.................... TDx Cannabinoids Controls L, M, Bottle: 5 ml............. 6/19/87
and H (9671-11).
Abbott Laboratories.................... TDx Cannabinoids Controls L, M, Bottles: 5 ml............ 10/24/86
H (No. 9671-10).
Abbott Laboratories.................... TDx Cannabinoids Fluorescein Bottle: 5 ml............. 10/27/86
Tracer Solution (No. 9671-T).
Abbott Laboratories.................... TDx Cannabinoids Reagent Pack 100 tests................ 10/27/86
(No. 9671-20).
Abbott Laboratories.................... TDx Cocaine Metabolite 5 ml Vial................ 7/07/88
Calibrator B-F No. 9670 B-F.
Abbott Laboratories.................... TDx Cocaine Metabolite Bottle: 4ml.............. 10/02/85
Calibrator, B-F No. 9670.
Abbott Laboratories.................... TDx Cocaine Metabolite Control 5 ml Vial................ 7/07/88
L, H No. 9670 L, H.
Abbott Laboratories.................... TDx Cocaine Metabolite Control, Bottle: 4ml.............. 10/02/85
L and H No. 9669.
Abbott Laboratories.................... TDx Cocaine Metabolite Controls Kit: 2 Vials, 5 ml each.. 7/07/88
No. 9670-10.
Abbott Laboratories.................... TDx Cocaine Metabolite Kit: 100 Vials, 5 ml Each 7/07/88
Fluorescein Tracer Solution
No. 9670 T0001.
Abbott Laboratories.................... TDx Cocaine Metabolite Box: 5 ml Vial........... 7/07/88
Fluorescein Tracer Solution
No. 9670-T.
Abbott Laboratories.................... TDx Cocaine Metabolite Reagent Reagent well: 5ml........ 10/02/85
Pack.
Abbott Laboratories.................... TDx Cocaine Metabolite Reagent Kit: 100 Tests........... 7/07/88
Pack No. 9670-20.
Abbott Laboratories.................... TDx Multiconstituent Controls Bottle: 5 ml............. 9/03/87
L, M, H (No. 9687-L, M, H).
Abbott Laboratories.................... TDx Opiates Calibrators B-F: Kit: 6 Vials............. 2/29/88
No. 9673-01.
Abbott Laboratories.................... TDx Opiates Calibrators, B-F 5 ml Vial................ 5/07/86
No. 9673.
Abbott Laboratories.................... TDx Opiates Controls L and H, Kit: 2 Vials............. 2/29/88
No. 9673-10.
Abbott Laboratories.................... TDx Opiates Controls L and H: Vial: 5 ml............... 2/29/88
No. 9673 L, H.
Abbott Laboratories.................... TDx Opiates Controls, L and H Vials: 5ml............... 5/07/86
No. 9673.
Abbott Laboratories.................... TDx Opiates Fluorescein Tracer Box: 10 Vials, 5 ml each. 7/08/88
Solution No. 9673 T0001.
Abbott Laboratories.................... TDx Opiates Fluorescein Tracer Vial: 5 ml............... 2/29/88
Solution: No. 9673-T.
Abbott Laboratories.................... TDx Opiates Reagent Pack No. Kit: 100 tests........... 5/07/86
9673-20, 100 tests.
Abbott Laboratories.................... TDx Phencyclidine Bulk 5 ml Vial................ 7/18/88
Calibrator B-F No. 9672 B-F.
Abbott Laboratories.................... TDx Phencyclidine Bulk Carboy: 9.5, 19 L........ 7/18/88
Calibrator B-F No. 9672 B-F.
Abbott Laboratories.................... TDx Phencyclidine Bulk Control Carboy: 9.5, 19 L........ 7/18/88
L, M, H No. 9672 L, M, H.
Abbott Laboratories.................... TDx Phencyclidine Calibrators, Bottle: 4ml.............. 10/09/85
B-F No. 9672.
Abbott Laboratories.................... TDx Phencyclidine Control M No. Bottle: 4ml.............. 9/26/86
9672.
Abbott Laboratories.................... TDx Phencyclidine Controls L, 5 ml Vial................ 7/18/88
M, H No. 9672 L, M, H.
Abbott Laboratories.................... TDx Phencyclidine Controls No. Kit: 3 Vials, 5 ml each.. 7/18/88
9672-10.
Abbott Laboratories.................... TDx Phencyclidine Controls, L Bottle: 4ml.............. 10/09/85
and H No. 9672.
Abbott Laboratories.................... TDx Phenobarbital Calibrator- Kit ctg: 6 vials......... 8/31/81
0.0, 5.0, 10.0, 20.0, 40.0,
and 80.0 mcg/ml.
Abbott Laboratories.................... TDx Phenobarbital Calibrators B- 5 ml Vial................ 6/16/88
F No. 9500 B-F.
Abbott Laboratories.................... TDx Phenobarbital Calibrators Kit: 6 Vials, 5 ml each.. 6/16/88
No. 9500-01 (9500 B-F).
Abbott Laboratories.................... TDx Phenobarbital Controls No. 5 ml Vial................ 6/16/88
9500 L, M, H.
Abbott Laboratories.................... TDx Phenobarbital Controls No. Kit: 3 Vials, 5 ml each.. 6/16/88
9500-10 (9500 L, M, H).
Abbott Laboratories.................... TDx Phenobarbital Controls- Kit ctg: 3 vials......... 8/31/81
15.0, 30.0, 50.0 mcg/ml.
Abbott Laboratories.................... TDx Propoxyphene Reagent Pack Kit: 100 tests........... 11/30/90
Item No. 9675-20.
Abbott Laboratories.................... TDx Systems Multiconstituent Kit: 6 Bottles........... 9/03/87
Controls for Abused Drug (No.
9687-10).
Abbott Laboratories.................... TDx or TDx/TDxFLx Propoxyphene Box: 100 bottles or less. 11/30/90
Fluorescein Tracer Solution
Item No. 9675T0001.
Abbott Laboratories.................... TDx, ADx Amphetamine Class Kit: 100 tests........... 3/01/88
Reagent Pack, No. 9667-20, No.
9667-55.
Abbott Laboratories.................... TDx/TDxFLx Propoxyphene Reagent Kit: 100 tests........... 11/30/90
Pack Item No. 9675-60.
Abbott Laboratories.................... Thyroxine Binding Globulin, Glass Bottle: 13ml. 4/22/76
Thyroxine I 125. Plastic Bottle: 250ml.
Abbott Laboratories.................... TrakPak Five Drug Control 2-6 Carboy: 20, 10L Flask: 6, 10/19/90
QT Nos. 92212-92216. 4, 2, 1L, 500, 250, 200,
100ml Bottle: 950, 500,
100, 50, 5ml Ampule: 20,
10, 5, 2ml.
[[Page 107]]
Abbott Laboratories.................... TrakPak Five Drug Control 8QT Carboy: 20, 10L; FlaskL: 10/25/91
No. 93349. 6, 4, 2, 1L, 500, 250,
200, 100ml; Bottle: 950,
500, 100, 50, 5ml;
Ampule: 20, 10, 5, 2ml.
Abbott Laboratories.................... TrakPak Five Drug Control Stock Carboy: 20, 10L Flask: 6, 10/19/90
No. 92210. 4, 2, 1L, 500, 250, 200,
100ml Bottle: 950, 500,
100, 50, 5ml Ampule: 20,
10, 5, 2ml.
Abbott Laboratories.................... Trakpak Card w/Cover Code Box: 2000 cards w/cover.. 3/08/91
#01249.
Abbott Laboratories.................... Trakpak Card w/Tracers Code Box: 2000 cards.......... 3/08/91
#01248.
Abbott Laboratories.................... Trakpak Cocaine Tracer Code Flasks: 6, 4, 2, 1L, 500, 3/08/91
#92199. 250, 200, 100ml;
Bottles: 950, 500, 100,
50, 5ml; Ampules: 20,
10, 5, 2ml.
Abbott Laboratories.................... Trakpak Drug of Abuse Screening Kit: 40 cartridges....... 3/08/91
System (40 test kit) Code
#04A74.
Abbott Laboratories.................... Trakpak Negative Control Code Vial: 5ml................ 3/08/91
#04A74C.
Abbott Laboratories.................... Trakpak Opiates Tracer Code Flasks: 6, 4, 2, 1L, 500, 3/08/91
#92198. 250, 200, 100ml;
Bottles: 950, 5, 00,
100, 50, 5ml; Ampules:
20, 10, 5, 2ml.
Abbott Laboratories.................... Trakpak Reaction Cartridge Code Cartridge: 1 card........ 3/08/91
#04A74B.
Abbott Laboratories.................... Trakpak THC Tracer Code #92200. Flasks: 6, 4, 2, 1L, 500, 3/08/91
250, 200, 100ml;
Bottles: 950, 500, 100,
50, 5ml; Ampules: 20,
10, 5, 2ml.
Abbott Laboratories.................... X Systems Amphetamine/ Vial: 5 ml............... 7/14/89
Methamphetamine II Calibrator
B, C, D, E, F; No. 01A99-B, C,
D, E, F.
Abbott Laboratories.................... X Systems Amphetamine/ Kit: 6 vials............. 7/14/89
Methamphetamine II
Calibrators, No. 01A99-01.
Abbott Laboratories.................... X Systems Amphetamine/ Vial: 5 ml............... 7/14/89
Methamphetamine II Control L,
M, H; No. 01A99-L, M, H.
Abbott Laboratories.................... X Systems Amphetamine/ Kit: 3 vials............. 7/14/89
Methamphetamine II Controls,
No. 01A99-10.
Abbott Laboratories.................... X Systems Methadone Calibrators Bottle: 5ml.............. 5/15/92
B-F.
Abbott Laboratories.................... X Systems Methadone Calibrators Kit: 6 Bottles........... 5/12/92
B-F.
Abbott Laboratories.................... X Systems Methadone Controls L, Kit: 3 Bottles........... 5/15/92
M, H, No. 9676-10.
Abbott Laboratories.................... X Systems Methadone Controls L, Bottle: 5ml.............. 5/15/92
M, H; No. 9676 L, M, H.
Abbott Laboratories.................... XSYSTEMS Amphetamine/ Kit: 6 Vials............. 8/26/88
Methamphetamine II Calibrators
No. 1A99-06.
Abbott Laboratories.................... XSYSTEMS Barbiturates II U Kit: 6 vials............. 10/17/89
Calibrators , No. 9669-07.
Abbott Laboratories.................... XSYSTEMS Benzodiazepines Kit: 5 Vials, 5 ml each.. 7/18/88
Calibrators, No. 9674-02.
Abbott Laboratories.................... XSYSTEMS Cannabinoids Bottle: 5 ml............. 6/19/87
Calibrators, No. 9671-04.
Abbott Laboratories.................... XSYSTEMS Cocaine Metabolite Kit: 5 Vials, 5 ml each.. 7/07/88
Calibrators No. 9670-06.
Abbott Laboratories.................... XSYSTEMS Methadone Calibrators Kit: 6 Vials............. 9/02/88
No. 9676-02.
Abbott Laboratories.................... XSYSTEMS Multiconstituent Kit: 6 vials............. 10/06/89
Controls, No. 9687-12.
Abbott Laboratories.................... XSYSTEMS Opiates Calibrators, Vial: 5 ml............... 2/29/88
No. 9673-06.
Abbott Laboratories.................... XSYSTEMS Phencyclidine Kit: 5 Vials, 5 ml each.. 7/18/88
Calibrators, No. 9672-06.
Abbott Laboratories.................... d-Amphetamine (II) Bulk Stock 10 L Carboy; 6 L, 2 L, 1 8/26/88
Standard Code No. 95947. L Flask.
Abbott Laboratories.................... d-Amphetamine (II) Stock 1 L, 500 ml, 100 ml 8/26/88
Standard Code No. 95934. Bottle.
Abbott Laboratories.................... d-Amphetamine (II) Stock Carboy: 20L, 10L Flask: 11/22/88
Standard No. 95934, 95934 A-B. 4L, 2L, 1L, 500 ml, 250
ml, 200 ml, 100 ml
Bottle: 950ml, 500ml,
100ml, 5ml.
Adri/Technam........................... 3-Ortho-Carboxymethylmorphine.. Screw Cap Vial........... 5/03/73
Adri/Technam........................... 5-Ethyl-5-(1-Carboxy-n-propyl) Screw Cap Vial........... 5/03/73
Barbituric Acid.
Adri/Technam........................... 5-Ethyl-5-(1-Carboxy-n-propyl) Vaccine Vial: 10ml....... 5/03/73
Barbituric Acid-Bovine Serum
Albumin.
Adri/Technam........................... 5-Ethyl-5-(1-Carboxy-n-propyl) Vaccine Vial: 10ml....... 5/03/73
Barbituric Acid-Rabbit Serum
Albumin.
Adri/Technam........................... Barbiturate Standard........... Screw-cap vial: 10ml..... 7/17/76
[[Page 108]]
Adri/Technam........................... Barbituric Acid Sensitized Red Vaccine Vial: 50ml....... 5/03/73
Blood Cells.
Adri/Technam........................... Benzoyl Ecgonine............... Screw-cap vial: 10ml..... 4/18/74
Adri/Technam........................... Benzoyl Ecgonine Sensitized Red Vaccine Vial: 50ml....... 5/03/73
Blood Cells.
Adri/Technam........................... Benzoyl Ecgonine Standard...... Screw-cap vial: 10ml..... 7/17/76
Adri/Technam........................... Benzoyl Ecgonine-BSA........... Vaccine Vial............. 7/21/75
Adri/Technam........................... Benzoyl Ecgonine-RSA........... Vaccine Vial............. 7/21/75
Adri/Technam........................... CMM-BSA and CMM-RSA Vaccine Vial: 10ml....... 5/03/73
(Carboxymethylmorphine Bovine
Serum Albumin or
Carboxymethylmorphine Rabbit
Serum Albumin).
Adri/Technam........................... Cannabuse Cannabidiol Standard. Disks: 25/package........ 5/03/85
Adri/Technam........................... Cannabuse Delta 8 THC Disks: 25/package........ 9/19/84
Carboxylic Acid Standard.
Adri/Technam........................... Cannabuse Delta 8 THC Vial: 6 ml............... 9/19/84
Carboxylic Acid Standard.
Adri/Technam........................... Cannabuse Delta 9 THC Vial: 6 ml............... 9/19/84
Carboxylic Acid Standard.
Adri/Technam........................... Cannabuse Delta 9 THC Disks: 25/package........ 9/19/84
Carboxylic Acid Standard.
Adri/Technam........................... Cannabuse Delta 9 THC Standard. Disks: 25/package........ 9/19/84
Adri/Technam........................... Cannabuse Delta 9 THC Standard. Vial: 6 ml............... 9/19/84
Adri/Technam........................... Drug Standards, Acid/Neutral Disks: 25/package........ 11/15/85
Mixture A and B.
Adri/Technam........................... Drug Standards, Basic Mixture A Disks: 25/package........ 11/15/85
and B.
Adri/Technam........................... Methadone Standard............. Screw-cap vial: 10ml..... 7/17/76
Adri/Technam........................... Morphine Sensitized Red Blood Vaccine Vial: 50ml....... 5/03/73
Cells.
Adri/Technam........................... Morphine Standard (in distilled Screw-cap vial: 10ml..... 7/17/77
water).
Adri/Technam........................... Tropinecarboxylic Acid Screw-cap Bottle: 10ml... 5/03/73
(ecgonine).
Alltech-Applied Science Laboratories... (D)-Norpseudoephedrine HCL..... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... 4-Chlorotestosterone........... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... 4-Methylaminorex............... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... 6-Acetylcodeine................ Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... 6-Monoacetylmorphine HCl....... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Allylisobutylbarbituric Acid... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Alphaprodine HCL............... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Alphenal....................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Alprazolam..................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Amobarbital.................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Amphetamine HCL................ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Antidepressants Mix............ Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Aprobarbital................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Barbital....................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Barbiturates, Mixture 4........ Vial: 10ml............... 10/04/72
Alltech-Applied Science Laboratories... Benzoylecgonine Tetrahydrate... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Benzoylecgonine Tetrahydrate Amber Ampoule: 1ml....... 2/16/90
7.5ug, 50ug, 250ug.
Alltech-Applied Science Laboratories... Benzphetamine HCL.............. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Boldenone...................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Bromazepam..................... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Butabarbital................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Butethal....................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Cannabidiol.................... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Cannabinol..................... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Chloral Hydrate................ Vial: 1ml................ 4/16/85
[[Page 109]]
Alltech-Applied Science Laboratories... Chlordiazepoxide HCL........... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Clonazepam..................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Clorazepate Dipotassium........ Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Clostebol...................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Cocaethylene................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Cocaine........................ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Codeine........................ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Cyclopentobarbital............. Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Delta-8-Tetrahydro-cannabinol.. Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Delta-9-Tetrahydrocannabinol... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Depressants, Mixture 3......... Vial: 10ml............... 10/04/72
Alltech-Applied Science Laboratories... Dextropropoxyphene HCL......... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Diacetylmorphine HCL........... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Diallybarbituric acid.......... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Diazepam....................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Diethylpropion HCL............. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Dihydrocodeine................. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Dimethyltryptamine............. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Drostanolone................... Ampule: 2ml.............. 9/26/05
Alltech-Applied Science Laboratories... Drug Mix Four.................. Ampoule: 1 ml............ 11/03/86
Alltech-Applied Science Laboratories... Drug Mix One................... Ampoule: 1 ml............ 10/21/86
Alltech-Applied Science Laboratories... Drug Mix Three................. Ampoule: 1 ml............ 11/03/86
Alltech-Applied Science Laboratories... Drug Mix Two................... Ampoule: 1 ml............ 10/21/86
Alltech-Applied Science Laboratories... Ecgonine HCL................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Ecgonine Methyl Ester HCl...... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Ethchlorvynol.................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Ethinamate..................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Ethylmorphine HCL.............. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Fenfluramine HCL............... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Fentanyl....................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Flunitrazepam.................. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Fluoxymesterone................ Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Flurazepam HCL................. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... GC/MS Benzoylecgonine Kit: 3 vials............. 2/16/90
Calibration Standards Kit.
Alltech-Applied Science Laboratories... Glutethimide................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Halazepam...................... Vial: 1ml................ 4/16/85
[[Page 110]]
Alltech-Applied Science Laboratories... Hexobarbital................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Hydrocodone Bitartrate......... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Hydromorphone HCL.............. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... L-Amphetamine HCl.............. Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... L-Methamphetamine HCl.......... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Levorphanol Tartrate........... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Lorazepam...................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Lysergic Acid.................. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Lysergic Acid Diethylamide..... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Lysergic Acid N-(methylpropyl) Vial: 1ml................ 4/16/85
amide.
Alltech-Applied Science Laboratories... MDA HCl........................ Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... MDE HCl........................ Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... MDMA HCl....................... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Medazepam...................... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Meperidine HCL................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Mephobarbital.................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Meprobamate.................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Mescaline...................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Mesterolone.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methadone HCL.................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Methamphetamine HCL............ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Methandriol.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methandrostenolone............. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methaqualone HCL............... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Metharbital.................... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Methcathinone.................. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methenolone.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methohexital................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Methylphenidate................ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Methyltestosterone............. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Methyprylon.................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Mixture 1-Opiates.............. Vial: 1ml................ 10/04/72
Alltech-Applied Science Laboratories... Mixture 2-Stimulants........... Vial: 1ml................ 10/04/72
Alltech-Applied Science Laboratories... Mixture 3-Depressants.......... Vial: 1ml................ 10/04/72
Alltech-Applied Science Laboratories... Mixture 4-Barbiturates......... Vial: 1ml................ 10/04/72
Alltech-Applied Science Laboratories... Mixture 5-Kit of Vial: 1ml................ 10/04/72
Representatives.
[[Page 111]]
Alltech-Applied Science Laboratories... Morphine....................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... N-Ethylamphetamine............. Amber Ampoule: 1ml....... 2/16/90
Alltech-Applied Science Laboratories... N-Hydroxy-MDA.................. Amber Ampoule: 1ml....... 2/16/90
Alltech-Applied Science Laboratories... Nalorphine..................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Nandrolone..................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Nitrazepam..................... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Norcocaine..................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Norcodeine HCL................. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Nordiazepam.................... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Norethandrolone................ Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Normeperidine HCL.............. Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Normorphine.................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Opiates Mix #2................. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Opiates, Mixture 1............. Vial: 10ml............... 10/04/72
Alltech-Applied Science Laboratories... Oxandrolone.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Oxazepam....................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Oxycodone HCL.................. Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Oxymesterone................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Oxymetholone................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Oxymorphone.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Oxymorphone HCL................ Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Paraldehyde.................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Pemoline....................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Pentazocine.................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Pentazocine HBr................ Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Pentobarbital.................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Phencyclidine HCL.............. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Phendimetrazine Bitartrate..... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Phenmetrazine HCl.............. Amber Ampoule: 1ml....... 2/16/90
Alltech-Applied Science Laboratories... Phenobarbital.................. Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Phentermine.................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Prazepam....................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Propylbenzoyl-ecgonine......... Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Psilocybin..................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Psilocyn....................... Vial: 1 ml............... 11/06/87
Alltech-Applied Science Laboratories... Secobarbital................... Vial: 1ml................ 1/24/73
[[Page 112]]
Alltech-Applied Science Laboratories... Spot Chek Test Mix 1-A-PPS..... Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 1A-M........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 1B-1........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 1B-2........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 1B-3........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 2A-A........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 2A-N........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 2B-B........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Spot Chek Test Mix 2C-C........ Ampule: 2ml.............. 12/19/95
Alltech-Applied Science Laboratories... Stanolone...................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Stanolone Valerate............. Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Stanolzolol.................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Stimulants, Mixture 2.......... Vial: 10ml............... 10/04/72
Alltech-Applied Science Laboratories... Talbutal....................... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Temazepam...................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... Testosterone................... Ampule: 2ml.............. 9/26/95
Alltech-Applied Science Laboratories... Thebaine....................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Thiamylal...................... Vial: 1ml................ 1/24/73
Alltech-Applied Science Laboratories... Thiopental..................... Vial: 1 ml............... 6/16/89
Alltech-Applied Science Laboratories... Toxi Clean Test Mix............ Vial: 1 ml............... 3/30/88
Alltech-Applied Science Laboratories... Triazolam...................... Vial: 1ml................ 4/16/85
Alltech-Applied Science Laboratories... d3-Benzoylecgonine Tetrahydrate Amber Ampoule: 5ml....... 2/16/90
American Biological Technologies, Inc.. Dade Urine Chemistry Control, Glass Vial: 15ml......... 4/08/91
Level I & II.
American Monitor Corporation........... Qualify I...................... Glass Vial: 10ml......... 10/09/75
American Monitor Corporation........... Qualify II..................... Glass Vial: 10ml......... 10/09/75
Amerscham Corporation.................. [N-Methyl-3H]Lysergic Acid Vial: 5-7ml.............. 10/11/95
Diethylamide.
Amersham Corporation................... 5 Alpha-Dihydro[1, 2, 4, 5, 6, Vial: 6ml................ 4/02/91
7-3H]Testosterone Cat. No.
TRK.443.
Amersham Corporation................... 5 alpha-Dihydro[1 alpha, 2 Vial: 6ml................ 4/02/91
alpha(n)-3H] Testosterone Cat.
No. TRK.395.
Amersham Corporation................... 5 alpha-dihydro[1, 2, 4, 5, 6, Vial: 1ml................ 4/11/91
7-3H] Testosterone Reagent 4 T/
DHT RIA Kit.
Amersham Corporation................... Amerlex T-3 RIA Kit, IM 2000, Kit: 50 tests, 100 tests, 2/18/80
IM 2001, IM 2004. 400 tests.
Amersham Corporation................... Amerlex T-4 RIA Kit, IM 2010, Kit: 50 tests, 100 tests, 2/06/80
IM 2011, IM 2014. 400 tests.
Amersham Corporation................... Amerlex-M B-hCG Kit: 100 tests, 400 tests 6/19/85
Radioimmunoassay Kit IM 3091,
IM 3094.
Amersham Corporation................... Amerlex-M T3 RIA Kit, 1M.3001, Kit: 100 Tests 400 Tests. 8/27/86
1M.3004.
Amersham Corporation................... Amerlex-M T4 RIA Kit, 1M.3011, Kit: 100 Tests 400 Tests. 8/27/86
1M.3014.
Amersham Corporation................... Amerlite FSH Assay, Cat. Code Glass vial: 5.8ml, 5/30/89
LAN.0077, Cat. Code LAN.2077. 38.1ml, 240 tests, 144
tests.
Amersham Corporation................... Amerlite Rubella Antibody Glass vial: 5.8ml, 5/30/89
Assay, Cat. Code LAN.0200, 38.1ml, 240 tests, 144
Cat. Code LAN.2200. tests.
Amersham Corporation................... Amerlite TSH Assay, Cat. Code Glass vial: 5.8ml, 240 5/30/89
LAN.0001, Cat. Code LAN.2001. tests, 144 tests.
[[Page 113]]
Amersham Corporation................... Amerlite TT3 Assay: Catalog Kit: 144 tests, 240 11/24/87
Code Lan. 0003, Lan. 1003, and tests, 480 tests.
Lan.2003.
Amersham Corporation................... Amerlite TT4 Assay: Catalog Kit: 144 tests, 240 11/24/87
Code Lan. 0002, Lan. 1002, tests, 480 tests.
Lan. 2002.
Amersham Corporation................... Codeine (N-methyl-C14) Custom Preparation....... 3/27/72
Hydrochloride.
Amersham Corporation................... Dihydrotestosterone Standard Vial: 5.5ml.............. 4/11/91
Reagnet 3 T/DHT RIA Kit.
Amersham Corporation................... Morphine (N-methyl-C14) Vial: 0.32 to 1.89mg..... 3/27/72
Hydrocloride No. CFA-363.
Amersham Corporation................... Pheno [2-14C] barbital Catalog Vial: 0.39 to 5.85mg..... 11/05/74
No. CFA 537.
Amersham Corporation................... Prolactin RIA Kit, IM 1060, Kit: 50 tests, 100 tests. 3/28/80
1061.
Amersham Corporation................... T-3 Uptake (MAA) Kit-IM 1020, Kit: 50 tests, 100 tests, 2/05/79
IM 1021, IM 1024. 400 tests.
Amersham Corporation................... Testosterone Standard Reagent 2 Vial: 5.5ml.............. 4/11/91
T/DHT RIA Kit.
Amersham Corporation................... Testosterone-3-(0- Vial: 1.2ml.............. 4/02/91
carboxymethyl)oximino-(2-
[125I] iodohistamine)10uCi,
25uCi Cat. No. IM.128.
Amersham Corporation................... Testosterone/ Kit: 200 assays.......... 4/11/91
dihydrotestosterone [3H] assay
system Cat. No. TRK-600.
Amersham Corporation................... [1(N)-3H] Hydromorphone TRQ Vial: 47.5-95 micrograms. 7/31/87
4729.
Amersham Corporation................... [1(n)-3H] Codeine, No. TRK 448. Ampule: 0.002mg to 2/26/74
0.015mg.
Amersham Corporation................... [1(n)-3H] Morphine, No. TRK-447 Vial: 0.002 mg to 0.015 2/26/74
mg.
Amersham Corporation................... [1, 2, 6, 7-3H] Testosterone Vial: 6ml................ 4/02/91
Cat. No. TRK.402.
Amersham Corporation................... [1, 7, 8(n)-3H]Dihydromorphine, Vial: 0.0008 mg to 0.008 2/26/74
No. TRK-450. mg.
Amersham Corporation................... [15, 16(n)-3H] Etorphine, Vial: 3.45 to 6.9 11/19/74
Catalog No. TRK 476. micrograms.
Amersham Corporation................... [15, 16(n)-3H] Etorphine Vial: 13.8 to 27.6 2/17/75
Catalog No. TRK 476. micrograms.
Amersham Corporation................... [17 alpha-methyl-3H] Mibolerone Vial: 6ml................ 4/02/91
Cat. No. TRK.764.
Amersham Corporation................... [2(n)-3H] Lysergic Acid Vial: 0.003mg to 0.04mg.. 5/22/74
Diethylamide, No. TRK. 461.
Amersham Corporation................... [2-14C] Diazepam Catalog No. Multidose Glass Vial: 9/28/77
CFA.591. 56mm x 25mm.
Amersham Corporation................... [3H]11-Ketotestosterone Cat. Vial: 5.7ml.............. 6/13/91
No. TRQ.5919.
Amersham Corporation................... [4-14C] Testosterone 50uCi, Vial: 6ml................ 4/02/91
250uCi Cat. No. CFA.129.
Amersham Corporation................... [N-methyl-3H] Diazepam Catalog Multidose Glass Vial: 9/28/77
Code: TRK.572. 56mm x 25mm.
Amersham Life Science.................. [125I] Iodo-Lysergic Acid Vial: 1.2ml.............. 11/22/95
Diethylamide.
Analytical Control Systems, Inc........ Benchmark I TDM Control 1L, 2M, Plastic Vial: 5ml per 10/02/91
3H. Vial; 1-120 Vials per
Bag.
Armed Forces Institute of Pathology.... 11-nor-9-carboxy-delta 8-THC in Glass Ampule: 1mg/ml, 1/25/82
Ethanol Ampules. 1ml, 5ml, 10ml.
Astral Medical Systems................. Barbital Buffer................ Plastic bag: 12.2g/bag... 5/01/85
Astral Medical Systems................. Barbital Lactate Buffer........ Plastic bag: 18g/bag..... 5/01/85
Astral Medical Systems................. Isoenzyme Buffer............... Plastic bag: 14g/bag..... 5/01/85
Astral Medical Systems................. Tris-Barbital Sodium Barbital Plastic bag: 18g/bag..... 5/01/85
Buffer.
Atochem North America, Inc............. M&T NiproTeq SB Additive....... Polypropylene Containers: 3/10/88
5 gallons, 55 gallons.
BHP Diagnostix, Inc.................... Kallestad TDM Multi-Calibrator- Kit: 7-3 ml Vials; 3 ml 8/18/88
Pilot Lot B-G. Vial.
BHP Diagnostix, Inc.................... Kallestad TDM Multi-Calibrator- 3ml, 6ml, 10ml, 30ml, 8/18/88
Pilot-Lot Phenobarbital. 50ml Vial.
BHP Diagnostix, Inc.................... Kodak Ektachem-DT Calibrator... Bottle: 6ml.............. 1/05/85
Baxter Diagnostics Inc................. Dade Moni-Trol Gold, Level 1X Kit: 55 Vials............ 8/31/94
Chemistry Control and
Carbonate Diluent 1.
Baxter Diagnostics Inc................. Dade Moni-Trol Gold, Level 1X Bottle: 18ml............. 8/31/94
and Level 2X Chemistry
Controls.
Baxter Diagnostics Inc................. Dade Moni-Trol Gold, Level 2X Kit: 55 Vials............ 8/31/94
Chemistry Control and
Carbonate Diluent 2.
Baxter Diagnostics Inc................. EXCEL-QC Level 1 Serum Bottle: 18ml............. 8/4/93
Chemistry Control.
Baxter Diagnostics Inc................. EXCEL-QC Level 1 and Level 2 Kit: 12 Bottles.......... 8/4/93
Serum Chemistry Control and
Carbonate Diluent 1 and 2.
Baxter Diagnostics Inc................. EXCEL-QC Level 2 Serum Bottle: 18ml............. 8/4/93
Chemistry Control.
Baxter Diagnostics Inc................. Paramax Phenobarbital Kit: 6 Glass Bottles; 6ml 7/7/93
Calibrator I, II, III, Cat. # each.
B-6109-11.
Baxter Diagnostics Inc................. Paramax Phenobarbital Glass Bottle: 6ml........ 7/7/93
Calibrator Level II.
Baxter Diagnostics Inc................. Paramax Phenobarbital Glass Bottle: 6ml........ 7/07/93
Calibrator Level III.
Bayer Corporation...................... Estradiol Antibody Conjugate R1 Bulk..................... 8/16/95
Bayer Corporation...................... Technicon Immuno 1 Estradiol Kit: 1 Cassette.......... 8/16/95
Reagents Kit No. T01-3595-51.
Beckman Instruments, Inc............... ARRAY 360 System: Drug Bottle: 3ml.............. 3/13/95
Calibrator.
Beckman Instruments, Inc............... ARRAY 360 System: Drug Control Bottle: 1ml.............. 3/13/95
Kit.
[[Page 114]]
Beckman Instruments, Inc............... Beckman Buffer B-2............. Packet: 18.16 g.......... 4/24/71
Beckman Instruments, Inc............... Beckman ICS Drug Calibrators A, Vials: 5ml............... 10/29/80
B, C, D, and E.
Beckman Instruments, Inc............... Beckman ICS Drug Control Sera.. Kit containing: 6-1ml 11/11/80
bottles.
Beckman Instruments, Inc............... Beckman ICS Phenobarbital Vial: 5ml................ 10/29/80
Conjugate.
Beckman Instruments, Inc............... Beckman LD Buffer.............. Bottle: 14.3 grams....... 7/31/86
Beckman Instruments, Inc............... Beckman LD Buffer.............. Bottle: 14.3 grams....... 7/31/86
Beckman Instruments, Inc............... IFE Gel........................ Foil Packet: 1 Gel; Box: 1/22/96
10 Gels.
Beckman Instruments, Inc............... LD Gel......................... Foil Pack: 1 Gel; Box: 10 1/22/96
Gels.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml, Box: 5/19/89
Alkaline Phosphatase Isoenzyme 10 trays, Kit: 10 trays.
Electrophoresis (Isopal) Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml, Box: 5/19/89
High Resolution 10 trays, Kit: 10 trays.
Electrophoresis (HRE) Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml, Box: 5/19/89
Immunoelectrophoresis (IEP) 10 trays, Kit: 10 trays.
Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml...... 7/31/86
Immunofixation Electrophoresis
(IFE) Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml...... 7/31/86
Lactate Dehydrogenase
Isoenzyme Electrophoresis (LD)
Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5 ml, 5/19/89
Lipoprotein Electrophoresis Box: 10 trays, Kit: 10
(LIPO) Kit. trays.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml...... 7/31/86
Protein Electrophoresis (SPE-
II) Kit.
Beckman Instruments, Inc............... Paragon Electrophoresis System: Plastic Tray: 3.5ml, Box: 5/19/89
Serum Protein Electrophoresis 10 trays, Kit: 10 trays.
(SPE) Kit.
Beckman Instruments, Inc............... SPE Gel........................ Foil Pack: 1 Gel; Box: 10 1/22/96
Gels.
Beckman Instruments, Inc............... Synchron CX Systems: CX Cartridge: 150 Tests..... 3/13/95
Amphetamines Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: CX Cartridge: 150 Tests..... 3/13/95
Barbiturates Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: CX Cartridge: 150 Tests..... 3/13/95
Benzodiazepine Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: CX Cartridge: 150 Tests..... 3/13/95
Cannabinoid 50ng and
Cannabinoid 100ng Reagent Kits.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Bottle: 5ml.............. 3/13/95
High Urine Calibrator I.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Bottle: 5ml.............. 3/13/95
High Urine Calibrator II.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Bottle: 5ml.............. 3/13/95
High Urine Control I.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Bottle: 5ml.............. 3/13/95
High Urine Control II.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Low Bottle: 5ml.............. 3/13/95
Urine Calibrator I.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Low Bottle: 5ml.............. 3/13/95
Urine Calibrator II.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Low Bottle: 5ml.............. 3/13/95
Urine Control I.
Beckman Instruments, Inc............... Synchron CX Systems: CX DAT Low Bottle: 5ml.............. 3/13/95
Urine Control II.
Beckman Instruments, Inc............... Synchron CX Systems: CX Opiate Cartridge: 150 Tests..... 3/13/95
Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: CX Cartridge: 150 Tests..... 3/13/95
Phencyclidine Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: CX THC Bottle: 5ml.............. 3/13/95
Urine 20ng/ml, 75ng/ml, 125ng/
ml Controls.
Beckman Instruments, Inc............... Synchron CX Systems: CX THC Bottle: 5ml.............. 3/13/95
Urine 50ng/ml, 100ng/ml, 200ng/
ml Calibrators.
Beckman Instruments, Inc............... Synchron CX Systems: Cocaine Cartridge: 150 Tests..... 3/13/95
Metabolite Reagent Kit.
Beckman Instruments, Inc............... Synchron CX Systems: Methadone Cartridge: 150 Tests..... 3/13/95
Reagent Kit.
Beckman Instruments, Inc............... Synchron Control: Multilevel Plastic Bottle: 20ml; 5/13/91
Comprehensive Chemistry Kit: 6 bottles.
Control Serum Levels I, II,
III.
Beckman Instruments, Inc............... Triad LINK Comprehensive Custom Plastic Bottle: 20ml; 5/13/91
Unassayed Chemistry Control Box: 20 Bottles.
Serum Levels I, II, III.
Beckman Instruments, Inc............... Triad NYSPATH Comprehensive Plastic Bottle: 20ml; Box 5/13/91
Custom Unassayed Chemistry 20 Bottles.
Control Serum Levels I, II,
III.
Beckman Instruments, Inc............... Vigil PRx Multilevel Protein/ Plastic Bottle: 10ml; 5/13/91
Drug Control Serum Levels I, Kit: 6 Bottles.
II, III.
Becton Dickinson & Company............. IQ Immunochemistry System, Kit: 25 tests............ 6/30/87
Thyroid Stimulating Hormone
Catalog No. 3010.
Becton Dickinson & Company............. Neonatal T4 Tracer, Catalog Bottle: 125ml............ 1/15/92
#264015.
Becton Dickinson & Company............. T3 Tracer Solution Catalog No. Bottle: 125ml............ 9/27/78
237728.
[[Page 115]]
Becton Dickinson & Company............. TSH [125I] Tracer, Catalog No. Clear vial: 10ml......... 9/04/86
259624.
Behring Diagnostics.................... IEP Buffer, 793001 pH 8.2...... Foil Pouch: 6.5 g........ 9/17/79
Behring Diagnostics.................... Immuno-tec II Agarose Plate, Foil Pouch: ``5.35'' x 9/17/79
839013, 850013. ``5.25''.
Behring Diagnostics Inc................ Emit 5B3 THC; Calibrators; 0, Vial: 10ml............... 12/14/95
50, 100, 200ng/ml.
Behring Diagnostics Inc................ Emit II 5B3 THC Assay.......... Kit: 2 Vials, 500ml each. 12/14/94
Bio-Metric Systems, Incorporated....... Cocaine-Enzyme Conjugate....... Vial: 250ml, 100ml, 50ml. 7/07/92
Bio-Metric Systems, Incorporated....... Cocaine-ImmunoPrime Modified Vial: 50ml, 10ml......... 7/07/92
Carrier.
Bio-Metric Systems, Incorporated....... Morphine-Enzyme Conjugate...... Vial: 250ml, 100ml, 50ml. 7/07/92
Bio-Metric Systems, Incorporated....... Morphine-ImmunoPrime Modified Vial: 50ml, 10ml......... 7/07/92
Carrier.
Bio-Metric Systems, Incorporated....... Phencyclidine-Enzyme Conjugate. Vial: 250ml, 100ml, 50ml. 7/07/92
Bio-Metric Systems, Incorporated....... Phencyclidine-ImmunoPrime Vial: 50ml, 10ml......... 7/07/92
Modified Carrier.
Bio-Metric Systems, Incorporated....... Tetrahydrocannabinol-Enzyme Vial: 250ml, 100ml, 50ml. 7/07/92
Conjugate.
Bio-Metric Systems, Incorporated....... Tetrahydrocannabinol- Vial: 50ml, 10ml......... 7/07/92
ImmunoPrime Carrier.
Bio-Rad Laboratories................... Benzodiazepines/Tricyclic Kit: 100 tests........... 2/08/90
Antidepressants by HPLC.
Bio-Rad Laboratories................... CoTube Estradiol Tracer........ Glass Bottle: 125ml...... 7/28/93
Bio-Rad Laboratories................... Dade Urine Chemistry Control Vial: 20 ml, 50 ml....... 1/05/88
Levels I AND II.
Bio-Rad Laboratories................... Dade Urine Toxiology Control... Vial: 50 ml.............. 1/05/88
Bio-Rad Laboratories................... Internal Standard.............. Amber vial: 30ml Flask: 2/08/90
200ml-2000ml.
Bio-Rad Laboratories................... Methadone/Methadone Metabolite 400 tests................ 9/17/90
Reagent Kit.
Bio-Rad Laboratories................... Quantaphase Thyroxine RIA-125I Plastic bottle: 60ml, 5/06/81
Tracer/Dissociating Reagent. 260ml.
Bio-Rad Laboratories................... Quantaphase Thyroxine RIA- Plastic bottle: 60ml, 5/06/81
Thyroxine Immunobeads. 260ml.
Bio-Rad Laboratories................... Quantimune Barbital Buffer..... Plastic Bottle: 1000ml, 5/31/78
250ml, 200ml.
Bio-Rad Laboratories................... Quantimune Radioimmunoassay T-4 Vial: 10 ml.............. 7/21/76
Tracer, Iodine-125.
Bio-Rad Laboratories................... Quantimune T-3 RIA Barbital Bottle: 220ml............ 9/24/82
Buffer.
Bio-Rad Laboratories................... Quantimune T-3 RIA Test Kit.... Kit: 500 tests, 100 tests 5/31/78
Bio-Rad Laboratories................... Quantimune T-4 RIA Kit......... Kit: 500 tests........... 7/01/77
Bio-Rad Laboratories................... Quantimune T-4 RIA Test Kit.... Kit: 5000 tests, 100 5/31/78
tests.
Bio-Rad Laboratories................... Quantimune Thyroxine Plastic Bottle with Screw 7/01/77
Radioimmunoassay Barbital cap: 1 liter.
Buffer.
Bio-Rad Laboratories................... Quantimune Thyroxine Glass Serum Vial: 10 ml.. 7/01/77
Radioimmunoassay T-4 125I
Tracer/Dissociating Agent.
Bio-Rad Laboratories................... REMEDI DPS Check Mix........... Vial: 20ml, Flask: 1L-10L 9/17/90
Bio-Rad Laboratories................... REMEDI DPS Internal Standard Vial: 20ml, Flask: 250ml- 9/17/90
Combination. 6000ml.
Bio-Rad Laboratories................... REMEDI DPS Internal Standard Vial: 20ml, Flask: 250ml- 9/17/90
One. 2500ml.
Bio-Rad Laboratories................... REMEDI DPS Internal Standard Vial: 20ml, Flask: 250ml- 9/17/90
Two. 5000ml.
Bio-Rad Laboratories................... REMEDI DPS Urine Calibrator.... Vial: 20ml, Flask: 1L-10L 9/17/90
Bio-Rad Laboratories................... Serum Calibrator 1............. Amber vial: 20ml 2/08/90
Polypropylene container:
20L.
Bio-Rad Laboratories................... Serum Calibrator 2............. Amber vial: 20ml 2/08/90
Polypropylene container:
20L.
Bio-Rad Laboratories................... Serum Calibrator for Box: 2 vials............. 2/08/90
Benzodiazepines/Tricyclics,
Contains 2.
Bio-Rad Laboratories................... T-4 Competitive Binding Bottle: 385 ml........... 7/21/76
Reagent, Iodine-125.
Bio-Rad Laboratories, (Chemical Barbital Buffer................ Vial: 10ml............... 7/21/76
Division).
Bio-Rad Laboratories, (Chemical Barbital Buffer Powder......... Plastic bottle: 250 ml... 9/09/77
Division).
Bio-Rad Laboratories, (Chemical Barbital Buffer Powder......... Plastic bottle: 250ml.... 7/21/76
Division).
Bio-Rad Laboratories, (Chemical Barbital Buffer-Dry Pack....... Packages: 9.11 g., 18.21 5/09/74
Division). g., 12.14 g.
Bio-Rad Laboratories, (Chemical Bio-Rad Electrophoresis Buffer. Bottle: 500ml............ 12/14/72
Division).
Bio-Rad Laboratories, (Chemical Electrophoresis Buffer, Dry- Package: 6.15 g.......... 12/14/72
Division). Pack.
[[Page 116]]
Bio-Rad Laboratories, (Chemical Immunoelectrophoresis Barbital Dry-pack: 25.6 g......... 8/06/75
Division). Buffer I, pH 8.6.
Bio-Rad Laboratories, (Chemical Immunoelectrophoresis Barbital Dry-pack: 15.61 g........ 8/06/75
Division). Buffer II, pH 8.6.
Bio-Rad Laboratories, (Chemical Immunoelectrophoresis Barbital Dry-pack: 6.82 g......... 1/22/76
Division). Buffer III, pH 8.6.
Bio-Rad Laboratories, (Chemical Immunoelectrophoresis Barbital Dry-pack: 15.07 g........ 8/06/75
Division). Buffer III-a, pH 8.8.
Bio-Rad Laboratories, (Chemical Reagent No. 3.................. Bottle: 165 ml........... 12/14/72
Division).
Bio-Rad Laboratories, (Clinical Benzodiazepines/Tricyclics/ Polypropylene Container: 3/28/91
Division). Plasma Catecholamines (BZ/TCA/ 15L - 100L.
pCats) Serum Calibrators Bulk
Preparations.
Bio-Rad Laboratories, (Clinical Plasma Catecholamines by HPLC, Kit: 100 Test............ 3/28/91
Division). 100 Test.
Bio-Rad Laboratories, (Clinical Plasma Catecholamines by HPLC, Vial: 20 ml; Set: 6 vials 3/28/91
Division). Serum Calibrator Set, 1x6
vials.
Bio-Rad Laboratories, (ECS Division)... Benzo/TCA Control Levels I & II Vial: 10ml Box: 6 vials.. 3/20/91
Bio-Rad Laboratories, (ECS Division)... Blind Performance Specimen Set Kit: 5 bottles........... 9/14/90
Cat. #610.
Bio-Rad Laboratories, (ECS Division)... LYPHOCHEK Assayed Chemistry Vials: 10 ml each........ 4/13/88
Control Serum (Human) Levels I
and II.
Bio-Rad Laboratories, (ECS Division)... LYPHOCHEK Immunoassay Plus Vial: 10ml; Kit: 12 vials 9/14/90
Control Serum Levels 1-3.
Bio-Rad Laboratories, (ECS Division)... LYPHOCHEK Urine Toxicology Box: 10 vials; Vial: 50ml 9/14/91
Control-Confirm.
Bio-Rad Laboratories, (ECS Division)... LYPHOCHEK Urine Toxicology Vials: 20 ml each........ 4/13/88
Control-Law.
Bio-Rad Laboratories, (ECS Division)... LYPHOCHEK Urine Toxicology Box: 10 vials; Vial: 20ml 9/14/90
Control-Screen.
Bio-Rad Laboratories, (ECS Division)... Liquichek Therapeutic Drug Vial: 10ml............... 6/01/94
Monitoring Control (TDM),
Levels 1, 2, 3.
Bio-Rad Laboratories, (ECS Division)... Liquichek Unassayed Chemistry Vial: 20ml............... 6/01/94
Control (Human) Levels 1, 2.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Immunoassay Control Vial: 10 ml.............. 9/24/87
Levels I, II, III.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Quantitative Urine Vial: 20 ml, 50 ml....... 9/24/87
Control Levels I and II.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Therapeutic Drug Vial: 10ml............... 8/20/84
Monitoring Control (TDM),
Levels I, II, III.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Unassayed Chemistry Vial: 20 ml.............. 9/24/87
Control (Bovine) Levels I, II.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Unassayed Chemistry Vial: 20ml............... 9/24/87
Control (Human) Levels I, II.
Bio-Rad Laboratories, (ECS Division)... Lyphochek Urine Toxicology Vial: 20ml............... 6/01/94
Screen-Low Control.
Bio-Rad Laboratories, (ECS Division)... Lypochek Fertility Control Vial: 10ml............... 6/01/94
Serum (Human) Levels 1, 2, 3.
Bio-Rad Laboratories, (ECS Division)... Positive for Amphetamines...... Bottle: 90ml............. 9/14/90
Bio-Rad Laboratories, (ECS Division)... Positive for Cocaine........... Bottle: 90ml............. 9/14/90
Bio-Rad Laboratories, (ECS Division)... Positive for Marihuana......... Bottle: 90ml............. 9/14/90
Bio-Rad Laboratories, (ECS Division)... Positive for Opiates........... Bottle: 90ml............. 9/14/90
Bio-Rad Laboratories, (ECS Division)... Positive for Phencyclidine..... Bottle: 90ml............. 9/14/90
Bio-Rad Laboratories, (ECS Division)... Urine Toxicology Control No. C- Amber Vial: 50ml......... 9/19/79
470-25.
Biochemical Diagnostics, Inc........... (DL) Methadone................. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... (DL)-9-Carboxy-11-nor-Delta-9- Vial: 1ml; 200ml (In- 12/22/95
THC. house).
Biochemical Diagnostics, Inc........... Alprazolam..................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Amobarbital.................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Benzoylecgonine................ Vial: 1ml; 200ml (In- 12/22/95
house).
[[Page 117]]
Biochemical Diagnostics, Inc........... Butalbital..................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Chlordiazepoxide............... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Codeine........................ Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... D-Amphetamine.................. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... D-Methamphetamine.............. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... D-Propoxyphene................. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Detectabuse GC/MS Liquid Bottle: 50ml............. 10/31/95
Control Urine.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bottle: 20ml............. 10/31/95
Control Urine, Series I.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bulk: Up to 100L......... 1/02/96
Control Urine, Series I, II,
II, IV, V.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bottle: 20ml............. 10/31/95
Control Urine, Series II.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bottle: 20ml............. 10/31/95
Control Urine, Series III.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bottle: 20ml............. 10/31/95
Control Urine, Series IV.
Biochemical Diagnostics, Inc........... Detectabuse Immunoassay Liquid Bottle: 20ml............. 10/31/95
Control Urine, Series V.
Biochemical Diagnostics, Inc........... Diazepam....................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Hydrocodone Bitartrate......... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... LSD 25ug/ml.................... Vial: 1ml................ 12/22/95
Biochemical Diagnostics, Inc........... Meperidine..................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Methaqualone................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Morphine....................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Morphine-6-Glucuronide......... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Nordiazepam.................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Oxazepam....................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Oxycodone...................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Oxymorphone.................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Pentobarbital.................. Vial: 1ml; 200 ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Phencyclidine.................. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Phenobarbital.................. Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Phentermine.................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Secobarbital................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biochemical Diagnostics, Inc........... Triazolam...................... Vial: 1ml; 200ml (In- 12/22/95
house).
Biodiagnostic International............ Liqui-Ura Toxic Control........ Vial: 5ml................ 3/11/85
Biopool International.................. Drugs of Abuse Controls GC/MS L- Kit: 6 Vials............. 1/04/94
2, L-3 and L-4.
Biopool International.................. Drugs of Abuse Controls GC/MS L- Vial: 12ml............... 1/04/94
2, L-3 and L-4.
Biopool International.................. Drugs of Abuse Controls L-2, L- Kit: 6 Vials............. 1/04/94
3 and L-4.
Biopool International.................. Drugs of Abuse Controls L-2, L- Vial: 12ml............... 1/04/94
3 and L-4.
Bioscientific Corp..................... ECA Buffer, Catalog No. ECA Plastic Packet: 18.0 g., 7/14/77
05805. 10 packets per box.
Bioscientific Corp/ECA................. Agarose Barbital Buffer CSB Vial: 7 drams............ 11/15/90
470182.
Bioscientific Corp/ECA................. Agarose Barbital Buffer ECA Vial: 12 drams; Box: 3 11/15/90
470182. vials.
Bioscientific Corp/ECA................. Agarose Barbital-EDTA Buffer Vial: 12 drams, Box: 3 11/15/90
ECA 470180. vials.
[[Page 118]]
Bioscientific Corp/ECA................. ECA Buffer ECA 0320024......... Vial: 12 drams, Box: 12 11/15/90
vials.
Bioscientific Corp/ECA................. General Procedure Agarose Film Plastic Tray 4.5''x5'', 9/10/90
#ECA 470100. Kit: 10 trays.
Bioscientific Corp/ECA................. LD Agarose Gel #CSB 102........ Plastic Tray: 3''x5'', 9/10/90
Kit: 10 trays.
Bioscientific Corp/ECA................. Protein Agarose Gel #PSB 103... Plastic Tray 3''x5'', 9/10/90
Kit: 10 trays.
Biosite Diagnostics.................... Alprazolam Stock Solution, Vial: 2ml................ 5/26/92
31366.
Biosite Diagnostics.................... Alprazolam Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6; 31446-31450.
Biosite Diagnostics.................... Amphetamine Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31111, Bulk Formulation.
Biosite Diagnostics.................... Amphetamine QC Control......... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Amphetamine QC Control (Bulk).. Bottle: 0.5L-10L......... 10/29/91
Biosite Diagnostics.................... Barbiturate Conjugate.......... Plastic Bottles: 2ml-60 11/30/90
ml.
Biosite Diagnostics.................... Barbiturate Conjugate Control.. Vial: 0.5, 1, 2, 5, 15, 3/28/94
50ml.
Biosite Diagnostics.................... Barbiturate Derivative......... Vial: 8, 16, 32 ml....... 11/30/90
Biosite Diagnostics.................... Barbiturate Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31110, Bulk Formulation.
Biosite Diagnostics.................... Barbiturate QC Control......... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Barbiturate QC Control (Bulk).. Bottle: 5L-10L........... 10/29/91
Biosite Diagnostics.................... Barbiturate Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6; 31356-31360.
Biosite Diagnostics.................... Benzodiazepine Controls, 1-6 Vial: 50ml, 1.5ml........ 10/24/91
31088-31093, 7-11 31098-31102,
Bulk Formulation.
Biosite Diagnostics.................... Benzodiazepine QC Control 3.... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Benzodiazepines QC Control 1... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Benzodiazepines QC Control 1 Bottle: 0.5L-10L......... 10/29/91
(Bulk).
Biosite Diagnostics.................... Benzodiazepines QC Control 2... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Benzodiazepines QC Control 2 Bottle: 0.5L-10L......... 10/29/91
(Bulk).
Biosite Diagnostics.................... Benzodiazepines QC Control 3 Bottle: 0.5L-10L......... 10/29/91
(Bulk).
Biosite Diagnostics.................... Benzoylecgonine Conjugate...... Plastic Bottles: 2ml-60 11/30/90
ml.
Biosite Diagnostics.................... Benzoylecgonine Conjugate II, Vial: 1.5ml.............. 3/14/91
III, IV, & V.
Biosite Diagnostics.................... Benzoylecgonine Conjugate II, Bottle: 5, 15, 30 & 60 ml 3/14/91
III, IV, & V Bulk.
Biosite Diagnostics.................... Benzoylecgonine Controls, 1-5 Vial: 50ml, 1.5ml........ 10/24/90
31041-31045, Bulk Formulation.
Biosite Diagnostics.................... Benzoylecgonine Enzyme Vial: 100ml, 1.5ml....... 10/24/90
Conjugate 31105, Bulk
Formulation.
Biosite Diagnostics.................... Benzoylecgonine Enzyme Vial: 1.5ml.............. 3/14/91
Conjugate II.
Biosite Diagnostics.................... Benzoylecgonine Standards, 1-6 Vial: 50ml, 1.5ml........ 10/24/90
31035-31040, Bulk Formulation.
Biosite Diagnostics.................... Benzoylecgonine Stock Solution. Vial: 3ml................ 6/01/95
Biosite Diagnostics.................... Benzoylecgonine Stock Solution, Vial: 2ml................ 5/26/92
31322.
Biosite Diagnostics.................... Benzoylecgonine Stock Solution, Bottle: 15-100ml......... 6/01/95
Bulk.
Biosite Diagnostics.................... Benzoylecgonine Threshold Flask: 250ml............. 5/26/92
Control Calibrators 2-6; 31341-
31345.
Biosite Diagnostics.................... Cocaine QC Control............. Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Cocaine QC Control (Bulk)...... Bottle: 0.5L-10L......... 10/29/91
Biosite Diagnostics.................... Conjugate (Intermediate)....... Vial: 2, 5, 15, 50, 60, 3/28/94
100, 250, 500, 1000,
2000ml.
Biosite Diagnostics.................... Conjugate Bead, Intervention... Bottle: 15, 50, 100, 250, 11/09/93
500, 1000, 2000ml.
Biosite Diagnostics.................... Conjugate Bead, TCA............ Bottle: 15, 50, 100, 250, 11/09/93
500, 1000, 2000ml.
Biosite Diagnostics.................... Conjugate Beads (Bulk)......... Bottles: 15, 50, 100, 11/30/90
250, 500, 1000, 2000ml.
Biosite Diagnostics.................... Conjugate Beads Triage MTD..... Vial: 15, 50, 100, 250, 3/28/94
500, 1000, 2000ml.
Biosite Diagnostics.................... Conjugate Beads Triage and MTD. Vial: 15, 50, 100, 250, 3/28/94
500, 1000, 2000ml.
Biosite Diagnostics.................... D-Amphetamine Stock Solution, Vial: 2ml................ 5/26/92
31323.
Biosite Diagnostics.................... D-Amphetamine Threshold Control Flask: 250ml............. 5/26/92
Calibrator, 31376.
Biosite Diagnostics.................... D-Methamphetamine Stock Vial: 2ml................ 5/26/92
Solution, 31324.
Biosite Diagnostics.................... D-Methamphetamine Threshold Flask: 250 ml............ 5/26/92
Control Calibrator, 31381.
Biosite Diagnostics.................... Drugs of Abuse Controls-Level Pack: 6 Vials; 5ml/vial.. 12/14/94
2, Positive.
Biosite Diagnostics.................... Drugs of Abuse Controls-Level Pack: 6 Vials; 5ml/vial.. 12/14/94
3, Hi-Positive.
Biosite Diagnostics.................... Estazolam TTC Stock Solution... Vial: 1ml................ 11/09/93
Biosite Diagnostics.................... Estazolam Threshold Control Vial: .25-1ml............ 11/09/93
Calibrators 2-6.
Biosite Diagnostics.................... Estazolam Threshold Control Vial: 5-20ml............. 11/09/93
Calibrators 2-6 Bulk
Formulation.
[[Page 119]]
Biosite Diagnostics.................... Flurazepam Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31109, Bulk Formulation.
Biosite Diagnostics.................... Flurazepam Standards, 1-7 31081- Vial: 50ml, 1.5ml........ 10/24/90
31087, Bulk Formulation.
Biosite Diagnostics.................... Intervention Bead Solution..... Vial: 2, 5, 15, 50, 100, 3/28/94
250, 500ml.
Biosite Diagnostics.................... Intervention Conjugate (Bulk).. Bottled/Flask: .1L-4L.... 11/09/93
Biosite Diagnostics.................... Labeled Benzoylecgonine Plastic Bottles: 0.5, 1, 11/30/90
Conjugate. 2 & 5 L.
Biosite Diagnostics.................... Labeled Conjugate Mixture 13... Vial: 2, 5, 15, 50, 100, 3/28/94
250, 500ml.
Biosite Diagnostics.................... Labeled Conjugate Mixture 2.... Plastic Bottles: 10ml-1L. 11/30/90
Biosite Diagnostics.................... Labeled Conjugate Mixture 5.... Bottles: 2, 5, 15, 50, 10/29/91
100, 250, 500ml.
Biosite Diagnostics.................... Labeled Conjugate Mixture 7.... Bottle: 20L, 10L, 5L, 1L. 12/22/92
Biosite Diagnostics.................... Labeled Conjugate Mixture 9.... Plastic Bottles: 0.5, 1, 11/30/90
2 & 5 L.
Biosite Diagnostics.................... Labeled Morphine Conjugate..... Plastic Bottles: 0.5, 1, 11/30/90
2 & 5 L.
Biosite Diagnostics.................... Labeled TCA Conjugate.......... Bottled/Flask: 2, 5, 15, 11/09/93
50, 60, 100, 250, 260,
500, 1000, 2000ml.
Biosite Diagnostics.................... Labeled THC Conjugate.......... Plastic Bottles: 10ml-1L. 11/30/90
Biosite Diagnostics.................... Labeled THC Conjugate (Mixture Flask: 500, 250, 100, 50, 3/28/94
13). 15, 5, 2ml.
Biosite Diagnostics.................... Labeled THC Conjugate Mixture 4 Bottles: 2, 5, 15, 50, 10/29/91
100, 250, 500ml.
Biosite Diagnostics.................... Labeled Triage MTD Conjugate Vial: 2, 5, 15, 50, 60, 3/28/94
(Bulk). 100, 250, 260, 500ml.
Biosite Diagnostics.................... Lorazepam Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31108, Bulk Formulation.
Biosite Diagnostics.................... Lorazepam Standards, 1-4 31094- Vial: 50ml, 1.5ml........ 10/24/90
31097, Bulk Formulation.
Biosite Diagnostics.................... Lormetazepam Stock Solution.... Vial: 1ml................ 11/09/93
Biosite Diagnostics.................... Methadone Control.............. Vial: 2ml................ 12/22/92
Biosite Diagnostics.................... Methadone Standards 1-6........ Vial: 2ml, 50ml.......... 12/22/92
Biosite Diagnostics.................... Methadone Stock Solution....... Vial: 2ml, 50ml.......... 12/22/92
Biosite Diagnostics.................... Methamphetamine Enzyme Vial: 100ml, 1.5ml....... 10/24/90
Conjugate 31104, Bulk
Formulation.
Biosite Diagnostics.................... Methamphetamine QC Control..... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Methamphetamine QC Control Bottle: 5L-10L........... 10/29/91
(Bulk).
Biosite Diagnostics.................... Morphine Conjugate............. Plastic Bottles: 2ml-60 11/30/90
ml.
Biosite Diagnostics.................... Morphine Control 3............. Vial: 2ml, 50ml.......... 12/22/92
Biosite Diagnostics.................... Morphine Controls, 1-5 31076- Vial: 50ml, 1.5ml........ 10/24/90
31080, Bulk Formulation.
Biosite Diagnostics.................... Morphine Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31107, Bulk Formulation.
Biosite Diagnostics.................... Morphine Standard 6, 31220 Bulk Vial: 1.5ml, 5-20ml; 3/14/91
Formulation. Flask: 20-50ml.
Biosite Diagnostics.................... Morphine Standards, 1-5 31071- Vial: 50ml, 1.5ml........ 10/24/90
31075, Bulk Formulation.
Biosite Diagnostics.................... Morphine Stock Solution, 31325. Vial: 2ml................ 5/26/92
Biosite Diagnostics.................... Opiate QC Control.............. Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Opiate QC Control (Bulk)....... Bottle: 05.L-10L......... 10/29/91
Biosite Diagnostics.................... Opiate Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6; 31346-31350.
Biosite Diagnostics.................... PCP QC Control................. Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... PCP QC Control (Bulk).......... Bottle: 0.5L-10L......... 10/29/91
Biosite Diagnostics.................... Phencyclidine Control 7 Bulk Vial: 5-20ml............. 11/09/93
Formulation.
Biosite Diagnostics.................... Phencyclidine Controls 5-6, Vial: 1.5ml, 5-20ml; 3/14/91
31255-31256 Bulk Formulation. Flask: 20-50ml.
Biosite Diagnostics.................... Phencyclidine Controls, 1-4 Vial: 50ml, 1.5ml........ 10/24/90
31010-31013, Bulk Formulation.
Biosite Diagnostics.................... Phencyclidine Enzyme Conjugate Vial: 100ml, 1.5ml....... 10/24/90
31103, Bulk Formulation.
Biosite Diagnostics.................... Phencyclidine Standard 7....... Vial: .25-1ml............ 11/09/93
Biosite Diagnostics.................... Phencyclidine Standards 1-4 Vial: 50ml, 1.5ml........ 10/24/90
31006-31009, Bulk Formulation.
Biosite Diagnostics.................... Phencyclidine Standards 5-6, Vial: 1.5ml, 5-20 ml; 3/14/91
31253-31254 Bulk Formulation. Flask: 20-50ml.
Biosite Diagnostics.................... Phencyclidine Stock Solution, Vial: 2ml................ 5/26/92
31321.
Biosite Diagnostics.................... Phencyclidine Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6; 31366-31370.
[[Page 120]]
Biosite Diagnostics.................... Phenobarbital Controls, 1-8 Vial: 50ml, 1.5ml........ 10/24/90
31063-31070, Bulk Formulation.
Biosite Diagnostics.................... Phenobarbital Standards, 1-8 Vial: 50ml, 1.5ml........ 10/24/90
31055-31062, Bulk Formulation.
Biosite Diagnostics.................... RT-5 Drugs of Abuse, Positive.. Pack: 6 Vials; 5ml/vial.. 12/14/94
Biosite Diagnostics.................... Secobarbital Stock Solution, Vial: 2ml................ 5/26/92
31326.
Biosite Diagnostics.................... THC Conjugate.................. Plastic Bottles: 2ml-60 11/30/90
ml.
Biosite Diagnostics.................... THC Conjugate Control.......... Vial: 0.5, 1, 2, 5, 15, 3/28/94
50ml.
Biosite Diagnostics.................... THC Controls, 1-3 31052-31054, Vial: 50ml, 1.5ml........ 10/24/90
Bulk Formulation.
Biosite Diagnostics.................... THC Enzyme Conjugate 31106, Vial: 100ml, 1.5ml....... 10/24/90
Bulk Formulation.
Biosite Diagnostics.................... THC QC Control................. Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... THC QC Control (Bulk).......... Bottle: 0.5L-10L......... 10/29/91
Biosite Diagnostics.................... THC Standards, 1-6 31046-31051, Vial: 50ml, 1.5ml........ 10/24/90
Bulk Formulation.
Biosite Diagnostics.................... THC Standards, 7-9............. Vial: .25-1ml............ 11/09/93
Biosite Diagnostics.................... THC Standards, 7-9 Bulk Vial: 5-20ml............. 11/09/93
Formulation.
Biosite Diagnostics.................... THC Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6 31371-31375.
Biosite Diagnostics.................... Temazepam Stock Solution, 31337 Vial: 2ml................ 5/26/92
Biosite Diagnostics.................... Temazepam Threshold Control Flask: 250ml............. 5/26/92
Calibrators 2-6 31451-31455.
Biosite Diagnostics.................... Threshold Control A & B........ Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Threshold Control A & B (Bulk). Bottle: 1L-20L........... 10/29/91
Biosite Diagnostics.................... Threshold Control F-1.......... Vial: 3.5-5ml............ 6/01/96
Biosite Diagnostics.................... Threshold Control F-1, Bulk Bottle: .05-5L........... 6/01/95
Solution.
Biosite Diagnostics.................... Threshold Controls C, D, E, F, Vial: 3.5-5ml............ 11/09/93
G, H.
Biosite Diagnostics.................... Thresholds C, D, E, F, G, H Bottle: 1-5ml............ 11/09/93
Bulk Solution.
Biosite Diagnostics.................... Triage 6 Panel for Drugs of Box: 10, 25 cassettes.... 10/05/92
Abuse.
Biosite Diagnostics.................... Triage 7 Conjugate............. Vial: 2, 5, 15, 50, 60, 3/28/94
100, 250, 260, 500ml.
Biosite Diagnostics.................... Triage 8 Panel for Drugs of Box: 3, 10, 25 Cassettes. 3/23/94
Abuse.
Biosite Diagnostics.................... Triage 8 Panel for Drugs of Box: 3, 10, 25 Cassettes. 3/28/94
Abuse.
Biosite Diagnostics.................... Triage 8 Panel for Drugs of Pouch: 1 Cassette........ 3/28/94
Abuse.
Biosite Diagnostics.................... Triage DOA Demo Control........ Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Triage DOA Demo Control (Bulk). Bottle: 0.5L-10L......... 10/29/91
Biosite Diagnostics.................... Triage Drug Screen Control..... Vial: 5ml................ 10/29/91
Biosite Diagnostics.................... Triage Drug Screen Control Bottle: 0.5-20L.......... 10/29/91
(Bulk).
Biosite Diagnostics.................... Triage Intervention Panel for Box: 10, 25 Pouches...... 11/09/93
Drugs of Abuse.
Biosite Diagnostics.................... Triage Intervention Test Device Pouch: 1 each............ 11/09/93
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Box: 10, 25 cassettes.... 11/30/90
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Box: 10, 25 Pouches...... 11/09/93
Plus Tricyclic Antidepressants.
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Box; 3, 10, 25 Cassettes. 3/23/94
Plus Methadone.
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Box: 3, 10, 25 Cassettes. 3/28/94
Plus Methadone.
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Pouch: 1 Cassette........ 3/28/94
Plus Methadone Test Device.
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Kit: 25 Tests............ 11/01/93
Plus Tricyclic
Antidepressants, Cat #92000.
Biosite Diagnostics.................... Triage Panel for Drugs of Abuse Kit: 10 Tests............ 11/01/93
plus Tricyclic
Antidepressants, Cat #92010.
Biosite Diagnostics.................... Triage Plus TCA Test Device.... Pouch: 1 each............ 11/09/93
Biosite Diagnostics.................... Triage Test Device............. Metallic Pouch: 1 each... 11/30/90
Biosite Diagnostics.................... Triage and MTD Conjugate (Bulk) Vial: 2, 5, 15, 50, 60, 3/28/94
100, 250, 260, 500ml.
Biosite Diagnostics.................... Triage-7 Conjugate Beads....... Bottle: 15, 50, 100, 250, 12/22/92
500, 1000, 2000ml.
Biosite Diagnostics.................... Triage-7 Device................ Pouch: 1 cassette........ 12/22/92
Biosite Diagnostics.................... Triage-7 Panel for Drugs....... Box: 10, 25 cassettes.... 12/22/92
Biosite Diagnostics.................... d-Amphetamine Controls, 1-5 Vial: 50ml, 1.5ml........ 10/24/90
31030-31034, Bulk Formulation.
Biosite Diagnostics.................... d-Amphetamine Standards, 1-6 Vial: 50ml, 1.5ml........ 10/24/90
31024-31029, Bulk Formulation.
Biosite Diagnostics.................... d-Methamphetamine Controls 5-6, Vial: 1.5ml, 20-50ml; 3/14/91
31020, 31257 Bulk Formulation. Flask: 20-50ml.
Biosite Diagnostics.................... d-Methamphetamine Controls, 1-4 Vial: 50ml, 1.5ml........ 10/24/90
31020-31023, Bulk Formulation.
Biosite Diagnostics.................... d-Methamphetamine Standards, 1- Vial: 50ml, 1.5ml........ 10/24/90
6 31014-31019, Bulk
Formulation.
Boehringer Mannheim.................... 2a Amph ED Reagent for 500ml; Vial: 500ml.............. 4/13/94
Cat # 1300796.
Boehringer Mannheim.................... 2a Amphetamines ED Reagent for Vial: 100ml.............. 4/13/94
85 ml; Cat # 1404234.
Boehringer Mannheim.................... Amphetamine System Pack for Kit: 4 Bottles........... 4/13/94
85ml; Cat # 81-3300.
Boehringer Mannheim.................... Amphetamines Systems Pack for Kit: 4 Bottles........... 4/13/94
500ml; Cat # 81-3400.
[[Page 121]]
Boehringer Mannheim.................... Bulk Reference Methadone Carboy: 5L............... 8/18/95
Manufacturing Calibrators E,
F, G, H, I, J, K, Open.
Boehringer Mannheim.................... CEDIA DAU 4-Drug Cutoff Bottle: 10, 15ml......... 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU 4-Drug High Bottle: 10, 15ml......... 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU 4-Drug Intermediate Bottle: 10, 15ml......... 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU 5-Drug Cutoff Bottle: 5, 15ml.......... 6/30/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU Amphetamine Assay- Kit: 4 Bottles; 18ml each 7/19/94
Cat # 83-3300 and 85-3300.
Boehringer Mannheim.................... CEDIA DAU Barb/Benz 200........ Bottle: 10, 15ml......... 4/01/94
Boehringer Mannheim.................... CEDIA DAU Barb/Benz 300 Bottle: 10, 15ml......... 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU Barb/Benz High Bottle: 10, 15ml......... 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU Barb/Benz Bottle: 10, 15ml......... 4/01/94
Intermediate Calibrator.
Boehringer Mannheim.................... CEDIA DAU Cocaine Assay; Cat # Kit: 4 Bottles; 18ml each 7/19/94
83-2300 and 85-2300.
Boehringer Mannheim.................... CEDIA DAU Cocaine Assay; Cat # Kit: 4 Bottles, 85ml..... 1/24/94
81-2300.
Boehringer Mannheim.................... CEDIA DAU Cocaine Assay; Cat # Kit: 4 Bottles, 500ml.... 1/24/94
81-2400.
Boehringer Mannheim.................... CEDIA DAU LSD Assay............ Kit: 15, 70ml............ 12/01/95
Boehringer Mannheim.................... CEDIA DAU LSD Cutoff Calibrator Bottle: 10ml............. 12/01/95
Boehringer Mannheim.................... CEDIA DAU LSD High Calibrator.. Vial: 10ml............... 12/01/95
Boehringer Mannheim.................... CEDIA DAU LSD Intermediate Vial: 10ml............... 12/01/95
Calibrator.
Boehringer Mannheim.................... CEDIA DAU LSD Reagent.......... Vial: 7, 100ml........... 12/01/95
Boehringer Mannheim.................... CEDIA DAU Methadone Assay...... Kit: 18, 85, 500ml....... 8/18/95
Boehringer Mannheim.................... CEDIA DAU Methadone ED Reagent. Vial: 7, 100, 190ml...... 8/18/95
Boehringer Mannheim.................... CEDIA DAU Multi-Level THC Kit: 4 Bottles, 85ml..... 1/24/94
Assay; Cat # 81-2700.
Boehringer Mannheim.................... CEDIA DAU Multi-Level THC Kit: 4 Bottles, 500ml.... 1/24/94
Assay; Cat # 81-2800.
Boehringer Mannheim.................... CEDIA DAU Opiate Assay- Cat # Kit: 4 Bottles; 18ml each 7/19/94
83-2900 and 85-2900.
Boehringer Mannheim.................... CEDIA DAU Opiate Assay; Cat # Kit: 4 Bottles, 85ml..... 1/24/94
81-2900.
Boehringer Mannheim.................... CEDIA DAU Opiate Assay; Cat # Kit: 4 Bottles, 500ml.... 1/24/94
81-3000.
Boehringer Mannheim.................... CEDIA DAU Propoxyphene Assays; Kit: 4 Bottles........... 11/30/94
18ml, 85ml, 500ml.
Boehringer Mannheim.................... CEDIA DAU Propoxyphene Cutoff Vial: 10ml............... 11/30/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU Propoxyphene High Vial: 10ml............... 11/30/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU Propoxyphene Vial: 10ml............... 11/30/94
Intermediate Calibrator.
Boehringer Mannheim.................... CEDIA DAU THC 100ng/ml Bottle: 15ml............. 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU THC 150ng/ml Bottle: 15ml............. 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU THC 25ng/ml Bottle: 15ml............. 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU THC 50ng/ml Bottle: 15ml............. 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA DAU THC 75 ng/ml Bottle: 15ml............. 4/01/94
Calibrator.
Boehringer Mannheim.................... CEDIA Multi-Level THC Assay-Cat Kit: 4 Bottles; 18ml each 7/19/94
# 83-2700 and 85-2700.
Boehringer Mannheim.................... LSD Conjugate.................. Bottle: 50-200ml......... 12/01/95
Boehringer Mannheim.................... LSD Cutoff Calibrator Bulk..... Carboy: 4L............... 12/01/95
Boehringer Mannheim.................... LSD ED Bulk Reagent............ Carboy: 25L.............. 12/01/95
Boehringer Mannheim.................... LSD High Calibrator Bulk....... Carboy: 4L............... 12/01/95
Boehringer Mannheim.................... LSD Intermediate Calibrator Carboy: 4L............... 12/01/95
Bulk.
Boehringer Mannheim.................... LSD Spiking Solution........... Vial: 2L................. 12/01/95
Boehringer Mannheim.................... Methadone Conjugate............ Vial: 25ml............... 8/18/95
Boehringer Mannheim.................... Methadone ED Bulk Reagent...... Carboy: 50L.............. 8/18/95
Boehringer Mannheim.................... Methadone Reference Carboy: 10L.............. 8/18/95
Manufacturing Calibrator
Spiking Solution.
Boehringer Mannheim.................... Multi-Drug Control Set, #946380 2 Vials; 15ml/vial....... 5/10/94
Boehringer Mannheim.................... Multi-Drug Set, #946379........ 2 Vials; 5ml/vial........ 5/10/94
Boehringer Mannheim.................... Propoxyphene Conjugate......... Vial: 25ml............... 11/30/94
Boehringer Mannheim.................... Propoxyphene Cutoff Bulk Carboy: 4L............... 11/30/94
Calibrator.
Boehringer Mannheim.................... Propoxyphene ED Bulk Reagent... Carboy: 25L.............. 11/30/94
Boehringer Mannheim.................... Propoxyphene ED Reagent........ Vial: 7, 100, 190ml...... 11/30/94
Boehringer Mannheim.................... Propoxyphene High Bulk Carboy: 4L............... 11/30/94
Calibrator.
Boehringer Mannheim.................... Propoxyphene Intermediate Bulk Carboy: 4L............... 11/30/94
Calibrator.
Boehringer Mannheim.................... Propoxyphene Spiking Solution.. Vial: 2L................. 11/30/94
Boehringer Mannheim.................... Reference LSD Manufacturing Vial: 3 or 5ml........... 12/01/95
Calibrator A, B, C, D, E, F,
G, Open.
Boehringer Mannheim.................... Reference LSD Manufacturing Carboy: 5L............... 12/01/95
Calibrator Bulk A, B, C, D, E,
F, G, Open.
Boehringer Mannheim.................... Reference Methadone Vial: 3, 5ml............. 8/18/95
Manufacturing Calibrators E,
F, G, H, I, J, K, Open.
Boehringer Mannheim.................... Reference Propoxyphene Bulk Carboy: 5L............... 11/30/94
Manufacturing Calibrators E,
F, G, H, I, J, K and Open.
Boehringer Mannheim.................... Reference Propoxyphene Vial: 3, 5ml............. 11/30/94
Manufacturing Calibrators E,
F, G, H, I, J, K and Open.
Boehringer Mannheim.................... Specialty Control Set 1, 2 Vials; 15ml/vial....... 5/10/94
#946381.
Boehringer Mannheim.................... Specialty Control Set 2, 2 Vials: 15ml/vial....... 5/10/94
#946383.
[[Page 122]]
Boehringer Mannheim.................... THC 100 Control Set............ Box: 2 Bottles; 15ml each 6/30/94
Boehringer Mannheim.................... THC 100 Controls (High & Low).. Bottle: 15ml............. 6/30/94
Boehringer Mannheim.................... THC 100 Controls (High & Low) Carboy: 150L............. 6/30/94
Bulk.
Boehringer Mannheim.................... THC 25 Control Set............. Box: 2 Bottles; 15ml each 6/30/94
Boehringer Mannheim.................... THC 25 Controls (High & Low)... Bottle: 15ml............. 6/30/94
Boehringer Mannheim.................... THC 25 Controls (High & Low) Carboy: 150L............. 6/30/94
Bulk.
Boehringer Mannheim.................... THC 50 Control Set............. Box: 2 Bottles; 15ml each 6/30/94
Boehringer Mannheim.................... THC 50 Controls (High & Low)... Bottle: 15ml............. 6/30/94
Boehringer Mannheim Diagnostics........ Amphetamine Spiking............ Carboy: 5-10L............ 9/26/95
Boehringer Mannheim Diagnostics........ Barbiturate Spiking Solution... Carboy: 5-10L............ 9/26/95
Boehringer Mannheim Diagnostics........ Benzodiazepine Spiking Solution Carboy: 5-10L............ 9/26/95
Boehringer Mannheim Diagnostics........ Benzodiazepine Spiking Solution Bottle: 2L............... 9/26/95
''A''.
Boehringer Mannheim Diagnostics........ CEDIA DAU Multi-Drug Vial: 10, 15ml........... 9/26/95
Calibrator, Primary Cutoffs.
Boehringer Mannheim Diagnostics........ CEDIA DAU Multi-Drug Vial: 10, 15ml........... 9/26/95
Calibrator, Secondary Cutoffs.
Boehringer Mannheim Diagnostics........ CEDIA DAU Multi-Drug High Vial: 10, 15ml........... 9/26/95
Calibrator.
Boehringer Mannheim Diagnostics........ CEDIA DAU Multi-Drug Vial: 10, 15ml........... 9/26/95
Intermediate Calibrator.
Boehringer Mannheim Diagnostics........ Cocaine Spiking Solution....... Carboy: 5-10L............ 9/26/95
Boehringer Mannheim Diagnostics........ Multi-Drug Cutoff, Bulk Bottle: 20L.............. 9/26/95
Calibrator.
Boehringer Mannheim Diagnostics........ Multi-Drug High Bulk Calibrator Bottle: 20L.............. 9/26/95
Boehringer Mannheim Diagnostics........ Multi-Drug Intermediate Bulk Bottle: 20L.............. 9/26/95
Calibrator.
Boehringer Mannheim Diagnostics........ Multi-Drug Secondary Cutoffs, Bottle: 20L.............. 9/26/95
Bulk Calibrator.
Boehringer Mannheim Diagnostics........ Opiate Spiking Solution........ Carboy: 5-10L............ 9/26/95
Boehringer Mannheim Diagnostics........ PCP Spiking Solution........... Carboy: 5-10L............ 9/26/95
Boehringere Mannheim Diagnostics....... Methamphetamine Spiking Carboy: 5-10L............ 9/26/95
Solution.
California Bionuclear Corporation...... Amobarbital-2-C-14, Catalog No. Screw Cap Vial: 50 1/08/75
72077. microcuries, 0.1, 0.5,
and 1.0 millicuries.
California Bionuclear Corporation...... Cocaine (methoxy-C-14) Catalog Screw Cap Vial: 50 1/08/75
No. 72182. microcuries, 0.1, 0.5,
and 1.0 millicuries.
California Bionuclear Corporation...... D-Amphetamine (propyl-1-C-14) Screw Cap Vial: 50 1/08/75
Sulfate, Catalog No. 72078. microcuries, 0.1, 0.5,
and 1.0 millicuries.
California Bionuclear Corporation...... DL-Amphetamine (propyl-1-C-14) Screw Cap Vial: 50 1/08/75
Sulfate, Catalog No. 72079. microcuries, 0.1, 0.5,
and 1.0 millicuries.
California Bionuclear Corporation...... Meperidine (N-methyl-C-14) Screw Cap Vial: 50 1/08/75
Hydrochloride, Catalog No. microcuries, 0.1, 0.5,
72508. 1.0 millicuries.
California Bionuclear Corporation...... Mescaline (aminomethylene-C-14) Screw Cap Vial: 50 1/08/75
Hydrochloride, Catalog No. microcuries, 0.1, 0.5,
72512. 1.0 millicuries.
California Bionuclear Corporation...... Methadone (heptanone-2-C-14) Screw Cap Vial: 50 1/08/75
Hydrochloride, Catalog No. microcuries, 0.1, 0.5,
72516. 1.0 millicuries.
California Bionuclear Corporation...... Methamphetamine (propyl-1-C-14) Screw Cap Vial: 50 1/08/75
Sulfate, Catalog No. 72517. microcuries, 0.1, 0.5,
1.0 millicuries.
California Bionuclear Corporation...... Methylphenidate (carbonyl-C-14) Screw Cap Vial: 50 1/08/75
Hydrochloride, Catalog No. microcuries, 0.1, 0.5,
72550. 1.0 millicuries.
California Bionuclear Corporation...... Morphine (n-methyl-C-14) Screw Cap Vial: 50 1/08/75
Hydrochloride, Catalog No. microcuries, 0.1, 0.5,
72560. 1.0 millicuries.
[[Page 123]]
California Bionuclear Corporation...... Pentobarbital-2-C-14, Catalog Screw Cap Vial: 50 1/08/75
No. 72618. microcuries, 0.1, 0.5,
1.0 millicuries.
California Bionuclear Corporation...... Secobarbital-2-C-14, Catalog Ampule: 50 microcuries, 1/08/75
No. 72675. 0.1, 0.5, and 1.0
millicuries.
Cambridge Medical Diagnostics, 125I Human Parathyroid Hormone Vial: 5ml................ 3/29/85
Incorporated. 44-68.
Cambridge Medical Diagnostics, 125I-Tetraiodothyronine........ Vial: 11ml............... 3/29/85
Incorporated.
Cambridge Medical Diagnostics, 125I-Triiodothyronine.......... Vial: 11ml............... 3/29/85
Incorporated.
Cambridge Medical Diagnostics, Donkey Anti Goat Gamma Globulin Vial: 5ml................ 3/29/85
Incorporated.
Cambridge Medical Diagnostics, Parathyroid Hormone (Human 1- 6 Vials: 5ml each........ 3/29/85
Incorporated. 84) Standard.
Cambridge Medical Diagnostics, Parathyroid Hormone Assay Vial: 10ml............... 3/29/85
Incorporated. Buffer.
Cambridge Medical Diagnostics, T3 AntiSerum (Rabbit).......... Vial: 11ml............... 3/29/85
Incorporated.
Cambridge Medical Diagnostics, T3 Standard.................... Vial: 1ml................ 3/29/85
Incorporated.
Cambridge Medical Diagnostics, T4 Antiserum (Rabbit).......... Vial: 11ml............... 3/29/85
Incorporated.
Cambridge Medical Diagnostics, T4 Standard.................... Vial: 1ml................ 3/29/85
Incorporated.
Casco Standards........................ 1-(1- Cryo-vial: 1.1ml Box: 25, 3/21/90
Phenylcyclohexyl)pyrrolidine 50, 75 vials Plastic
Cross-Reactant. Cup: 125ml.
Casco Standards........................ 1-Phenylcyclohexylamine Cross- Cryo-vial: 1.1ml Box: 25, 3/23/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ 1-[1-(2-thienyl)-cyclohexyl]- Cryo-vial: 1.1ml Box: 25, 3/23/90
piperdine Cross-Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ 1-[1-2(2-thienyl)-cyclohexyl]- Cryo-vial: 1.1ml Box: 25, 3/23/90
pyrrolidine Cross-Reactant. 50, 75 Plastic Cup:
125ml.
Casco Standards........................ 11-OH-delta-8-THC Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ 11-OH-delta-9-THC Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
cup: 125ml.
Casco Standards........................ 11-nor-delta-8-THC-9-carboxilic Cryo-vial: 1.1ml Box: 25, 3/21/90
c acid Cross-Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ 11-nor-delta-9-THC-9-carboxilic Cryo-vial: 1.1ml Box: 25, 3/21/90
acid Cross-Reactant. 50, 75 vials.
Casco Standards........................ 8-B-11-diOH-delta-9-THC Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ 8-B-OH-delta-9-THC Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Allobarbital Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Alphenal Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50 75 vials Plastic cup:
125ml.
Casco Standards........................ Alprazolam Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Amobarbital Cross-Reactant..... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Aprobarbital Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
[[Page 124]]
Casco Standards........................ Barbital Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Benzoylecgonine Cross-Reactant. Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Benzphetamine Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Bromazepam Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Butabarbital Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Butalbital Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Butethal Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Cannabidiol Cross-Reactant..... Cryo-Vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Cannabinol Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
cup: 125ml.
Casco Standards........................ Chlordiazepoxide Cross-Reactant Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Clonazepam Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Cocaine Cross-Reactant......... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Cyclopentobarbital Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Diazepam Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Ecgonine HCl Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Ecgonine-methyl ester HCl Cryo-vial: 1.1ml Box: 25, 3/21/90
hydrate Cross-Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Fenfluramine Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Flunitrazepam Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Flurazepam Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Halazepam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Hexobarbital Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Lorazepam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ MDA Cross-Reactant............. Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ MDE Cross-Reactant............. Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
[[Page 125]]
Casco Standards........................ MDMA Cross-Reactant............ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Medazepam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Midazolam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Nitrazepam Cross-Reactant...... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 03/21/90.
Casco Standards........................ Nordiazepam Cross-Reactant..... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Oxazepam Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Pentobarbital Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Phencyclidine Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/23/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Phenmetrazine Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Phenobarbital Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Phentermine Cross-Reactant..... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Pinazepam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Prazepam Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Propylhexedrine Cross-Reactant. Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Secobarbital Cross-Reactant.... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Talbutal Cross-Reactant........ Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Temazepam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ Triazolam Cross-Reactant....... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ d-Amphetamine Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ d-Methamphetamine Cross- Cryo-vial: 1.1ml Box: 25, 3/21/90
Reactant. 50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ l-Amphetamine Cross-Reactant... Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Casco Standards........................ p-OH-Amphetamine Cross-Reactant Cryo-vial: 1.1ml Box: 25, 3/21/90
50, 75 vials Plastic
Cup: 125ml.
Cayman Chemical Company................ Testosterone................... Vial: 3ml................ 4/07/93
Ciba Corning Diagnostics Corp.......... Magic Lite HCG Solid Phase..... Plastic vial: 50ml, Kit: 12/09/88
100 tests.
Ciba Corning Diagnostics Corp.......... AACC Tox....................... Glass Vial: 30ml......... 1/20/86
[[Page 126]]
Ciba Corning Diagnostics Corp.......... ACS Estradiol Component Sets... Kits: 3 Vials; 18 vials.. 1/31/94
Ciba Corning Diagnostics Corp.......... ACS Estradiol Component Sets Bottle: 30ml............. 1/31/94
Releasing Reagent.
Ciba Corning Diagnostics Corp.......... ACS Estradiol-6 Antibody Bottle: 3ml.............. 11/20/95
Reagent.
Ciba Corning Diagnostics Corp.......... ACS FT4........................ Kit: 50 Test, 300 Test... 3/26/91
Ciba Corning Diagnostics Corp.......... ACS FT4 Lite Reagent........... Vial: 7ml................ 3/26/91
Ciba Corning Diagnostics Corp.......... ACS FT4 Lite Reagent........... Vial: 7ml................ 3/26/91
Ciba Corning Diagnostics Corp.......... ACS FT4 Solid Phase............ Vial: 26ml............... 3/26/91
Ciba Corning Diagnostics Corp.......... ACS Ferritin Lite Reagent...... Vial: 7ml; Kit: 50, 300, 4/15/91
3000 Tests.
Ciba Corning Diagnostics Corp.......... ACS Ferritin Solid Phase....... Vial: 26ml; Kit: 50 4/15/91
Tests, 300 Tests.
Ciba Corning Diagnostics Corp.......... ACS HCG Solid Phase............ Vial: 26ml; Kit: 50 4/18/91
Tests, 300 Tests.
Ciba Corning Diagnostics Corp.......... ACS Magnetic Check............. Plastic Vial: 26ml....... 6/18/91
Ciba Corning Diagnostics Corp.......... ACS Magnetic Check II.......... Plastic Vial: 26ml....... 6/18/91
Ciba Corning Diagnostics Corp.......... ACS Multical E Pack (Low & High Kits: 4 Vials; 2 vials... 1/31/94
Calibrator).
Ciba Corning Diagnostics Corp.......... ACS Multical High Calibrator... Vial: 10ml............... 1/31/94
Ciba Corning Diagnostics Corp.......... ACS Multical Low Calibrator.... Vial: 10ml............... 1/31/94
Ciba Corning Diagnostics Corp.......... ACS Performance Verification Kit: 6 Vials............. 6/18/91
Test Kit.
Ciba Corning Diagnostics Corp.......... ACS Phenobarbital High Bottle: 5ml.............. 5/08/95
Calibrator.
Ciba Corning Diagnostics Corp.......... ACS Phenobarbital Lite Reagent. Bottle: 10ml............. 5/08/95
Ciba Corning Diagnostics Corp.......... ACS Phenobarbital Low Bottle: 5ml.............. 5/08/95
Calibrator.
Ciba Corning Diagnostics Corp.......... ACS Phenobarbital Master Curve Bottle: 5ml.............. 5/08/95
Material.
Ciba Corning Diagnostics Corp.......... ACS Phenobarbital Master Curve Set: 6 Bottles........... 5/08/95
Material Set.
Ciba Corning Diagnostics Corp.......... ACS T3 Kit..................... Kit: 50, 300, 3000 Tests. 7/22/91
Ciba Corning Diagnostics Corp.......... ACS T3 Lite Reagent............ Plastic Vial: 7ml........ 7/22/91
Ciba Corning Diagnostics Corp.......... ACS T3 Solid Phase............. Plastic Vial: 26ml....... 7/22/91
Ciba Corning Diagnostics Corp.......... ACS T4......................... Kit: 50 Test, 300 Test... 3/26/91
Ciba Corning Diagnostics Corp.......... ACS T4 Lite Reagent............ Vial: 7ml................ 3/26/91
Ciba Corning Diagnostics Corp.......... ACS T4 Solid Phase............. Vial: 26ml............... 3/26/91
Ciba Corning Diagnostics Corp.......... ACS Testosterone Component Sets Set: 2 Bottles........... 3/28/94
(50 Tests).
Ciba Corning Diagnostics Corp.......... ACS Testosterone Component Sets Set: 12 Bottles.......... 3/28/94
(500 Tests).
Ciba Corning Diagnostics Corp.......... ACS Testosterone Lite Reagent.. Bottle: 10ml............. 3/28/94
Ciba Corning Diagnostics Corp.......... ACS Testosterone Releasing Bottle: 30ml............. 7/20/94
Agent.
Ciba Corning Diagnostics Corp.......... ACS Wash Check Solid Phase..... Plastic Vial: 26ml....... 6/18/91
Ciba Corning Diagnostics Corp.......... ALP Buffer Concentrate Cat. No. Plastic Bottle: 175ml.... 10/28/91
470244.
Ciba Corning Diagnostics Corp.......... ALP Gel/12 Cat. No. 470246..... 2 Plates: 24 Tests....... 10/28/91
Ciba Corning Diagnostics Corp.......... ALP Gel/8 Cat. No. 470243...... 2 Plates: 16 Tests....... 10/28/91
Ciba Corning Diagnostics Corp.......... ALP Gel/8 and Buffer Cat. No. Kit: 10 Plates; Plastic 10/28/91
470240. Bottle: 175ml.
[[Page 127]]
Ciba Corning Diagnostics Corp.......... Alkaline Hemoglobin Buffer Cat. Plastic Vial: 25 Drams... 10/28/91
No. 470580.
Ciba Corning Diagnostics Corp.......... Alkaline Hemoglobin Kit/8 Cat. Kit: 10 Plates; Plastic 10/28/91
No. 470678. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... CVM Chemistry (Calibration Kit: 16 Vials; 5ml/vial.. 6/14/94
Verification Material for
Chemistry), Levels 1 thru 8.
Ciba Corning Diagnostics Corp.......... Ciba Corning ANTICONV/ASTH I, Kit Contains: 10ml vial, 10/22/85
II. 5 Vials each level.
Ciba Corning Diagnostics Corp.......... Ciba Corning Liquid 3.......... Glass Vials: 15; 5ml each 1/31/95
Ciba Corning Diagnostics Corp.......... Ciba Corning Liquid TDM 1...... Glass Vials: 15; 5ml each 1/31/95
Ciba Corning Diagnostics Corp.......... Ciba Corning Liquid TDM 1, 2, 3 Kit: 15 Vials............ 1/31/95
Ciba Corning Diagnostics Corp.......... Ciba Corning Liquid TDM 2...... Glass Vials: 15; 5ml each 1/31/95
Ciba Corning Diagnostics Corp.......... Ciba Corning TDM I............. Vial: 5ml, 10 vials...... 10/22/85
Ciba Corning Diagnostics Corp.......... Ciba Corning TDM I, II & III... Kit Contains: 5 Vials 10/22/85
each level.
Ciba Corning Diagnostics Corp.......... Ciba Corning TDM II............ Vial: 5ml, 10 vials...... 10/22/85
Ciba Corning Diagnostics Corp.......... Ciba Corning TDM III........... Vial: 5ml, 10 vials...... 10/22/85
Ciba Corning Diagnostics Corp.......... Ciba Corning TOX I, II......... Kit: Contains: 10ml vial, 12/16/85
5 Vials each level.
Ciba Corning Diagnostics Corp.......... Ciba Corning Urine II.......... Vial: 30ml............... 5/22/85
Ciba Corning Diagnostics Corp.......... DAU I, No. 9076................ Glass vial: 25ml, Box: 10 5/23/89
vials.
Ciba Corning Diagnostics Corp.......... DAU II No. 9077................ Glass Vial: 25ml, Box: 10 5/23/89
vials.
Ciba Corning Diagnostics Corp.......... DAU III, No. 9078.............. Glass vial: 25ml, Box: 10 5/23/89
Vials.
Ciba Corning Diagnostics Corp.......... DAU IV, No. 9079............... Glass Vial: 25ml, Box: 10 5/23/89
Vials.
Ciba Corning Diagnostics Corp.......... DAU V, No. 9085................ Glass Vial: 25ml; Box: 10 5/10/91
vials.
Ciba Corning Diagnostics Corp.......... Double Four-Track Gel Cat. No. Plate: 8 Tests; Kit: 12 10/28/91
470179. Plates.
Ciba Corning Diagnostics Corp.......... HDL Cholesterol Gel/8 and Kit: 10 Plates; Plastic 10/28/91
Buffer Cat. No. 470618. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... High Resolution Protein Gel/8 Kit: 12 Plates; 2 Plates: 10/28/91
Cat. NO. 470201. 16 Tests.
Ciba Corning Diagnostics Corp.......... High Resolution Protein Kit/8 Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470682. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Immophase Ferritin Controls.... Glass Vial: 3 ml......... 1/19/87
Ciba Corning Diagnostics Corp.......... Immophase Ferritin Standards... Glass Vial: 5 ml......... 9/16/86
Ciba Corning Diagnostics Corp.......... Immunoelectrophoresis Gel/10 Kit: 12 Plates; 2 Plates: 10/28/91
Cat. No. 470090. 20 Tests.
Ciba Corning Diagnostics Corp.......... Immunoelectrophoresis Kit/8 Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470684. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... L-TDM I........................ Glass Vial: 5 ml, Box: 15 5/23/89
Vials.
Ciba Corning Diagnostics Corp.......... L-TDM I, II, III Kit........... Kit: 15 Vials............ 5/23/89
Ciba Corning Diagnostics Corp.......... L-TDM II....................... Glass Vial: 5ml, Box: 15 5/23/89
Vials.
Ciba Corning Diagnostics Corp.......... L-TDM III...................... Glass Vial: 5ml, Box: 15 5/23/89
Vials.
Ciba Corning Diagnostics Corp.......... LD Isoenzyme Gel/8 and Buffer Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470620. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... LVM HI-CHEM DIL................ Vial: 10ml............... 6/21/90
Ciba Corning Diagnostics Corp.......... LVM, Product Code--9774........ Carton: 12 vials......... 6/21/90
Ciba Corning Diagnostics Corp.......... Ligand Plus 1, 2, 3............ Kit: 15 Bottles, 5ml/ 6/17/94
bottle.
Ciba Corning Diagnostics Corp.......... Linearity Reference Material Vial: 10ml; Kit: 2 vials. 2/12/91
LNM-A, LNM-B, LNM-C.
[[Page 128]]
Ciba Corning Diagnostics Corp.......... Linearity Survey LN3-A, LN3-B, Vial: 10ml; Kit: 2 vials. 2/12/91
LN3-C.
Ciba Corning Diagnostics Corp.......... Linearity Survey LN4-A, LN4-B, Vial: 25ml; Kit: 2 vials. 2/12/91
LN4-C.
Ciba Corning Diagnostics Corp.......... Lipoprotein Kit/8 Cat. No. Kit: 10 Plates; Plastic 10/28/91
470694. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... MULTIQUAL ABN UNASY............ Vial: 3ml, 10ml, Carton: 4/09/89
15 vials, 10 vials.
Ciba Corning Diagnostics Corp.......... MULTIQUAL I Assay, Product Code Kit: 15 vials; 3ml/vial.. 8/05/92
9816.
Ciba Corning Diagnostics Corp.......... MULTIQUAL II Assay, Product Kit: 15 vials; 3ml/vial.. 8/05/92
Code 9817.
Ciba Corning Diagnostics Corp.......... MULTIQUAL III Assay, Product Kit: 15 vials; 3ml/vial.. 8/05/92
Code 9818.
Ciba Corning Diagnostics Corp.......... MULTIQUAL NOR UNASY............ Vial: 3ml, 10ml, Carton: 4/09/89
15 vials, 10 vials.
Ciba Corning Diagnostics Corp.......... Magic Ferritin 2000 Standard... Plastic Vial: 1 ml....... 1/19/87
Ciba Corning Diagnostics Corp.......... Magic Ferritin Controls........ Plastic Vial: 5 ml....... 1/19/87
Ciba Corning Diagnostics Corp.......... Magic Ferritin Standards....... Polypropylene Vial: 3 ml. 9/16/86
Ciba Corning Diagnostics Corp.......... Magic Ferritin Zero Standard... Plastic Vial: 50 ml...... 1/19/87
Ciba Corning Diagnostics Corp.......... Magic Lite FT4 Component Set... Set: 100, 400 Tests...... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite FT4 Kit............. Kit: 100 Tests........... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite FT4 Lite Reagent.... Bottle: 10ml, 40ml....... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite FT4 Solid Phase..... Bottle: 50ml, 200ml...... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite Ferritin Bulk Lite Plastic Vial: 50 ml...... 2/16/88
Reageant.
Ciba Corning Diagnostics Corp.......... Magic Lite Ferritin Bulk Solid Plastic Vial: 200 ml..... 2/16/88
Phase.
Ciba Corning Diagnostics Corp.......... Magic Lite Ferritin Solid Phase Plastic Vial: 50 ml...... 2/16/88
Ciba Corning Diagnostics Corp.......... Magic Lite T3 Bulk Solid Phase. Plastic Vial: 200 ml..... 2/16/88
Ciba Corning Diagnostics Corp.......... Magic Lite T3 Kit.............. Kit: 100 Tests........... 6/27/91
Ciba Corning Diagnostics Corp.......... Magic Lite T3 Lite Reagent..... Plastic Vial: 30ml....... 6/27/91
Ciba Corning Diagnostics Corp.......... Magic Lite T3 Solid Phase...... Plastic Vial: 75ml....... 6/27/91
Ciba Corning Diagnostics Corp.......... Magic Lite T4 Component Set.... Set: 100, 400, 1200 Tests 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite T4 Kit.............. Kit: 100 Tests........... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic Lite T4 Solid Phase...... Bottle: 25ml, 100ml...... 7/06/94
Ciba Corning Diagnostics Corp.......... Magic T4 Antibody.............. Plastic Vial: 50 ml and 2/16/88
200 ml.
Ciba Corning Diagnostics Corp.......... Magic T4 Antibody.............. Vial: 50ml, 200ml........ 11/01/90
Ciba Corning Diagnostics Corp.......... Multi-LD Gel Cat. No. 470221... Kit: 12 Plates; 2 Plates: 10/28/91
32 Tests.
Ciba Corning Diagnostics Corp.......... Multi-SPE Gel Cat. No. 470252.. Kit: 12 Plates; 2 Plates: 10/28/91
32 Tests.
Ciba Corning Diagnostics Corp.......... Multitrac ALP Gel/12 and Buffer Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470240. Bottle: 175ml.
Ciba Corning Diagnostics Corp.......... Multitrac Immunofixation Kit/12 Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470685. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Multitrac LD Isoenzyme Gel/12 Kit: 10 Plates; Plastic 10/28/91
and Buffer Cat. No. 470622. vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Multitrac LD Isoenzyme Gel/16 Kit: 10 Plates; Plastic 10/28/91
and Buffer Cat. No. 470625. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Multitrac Lipoprotein Kit/12 Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470695. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Multitrac Serum Protein Kit/12 Kit: 10 Plates; Plastic 10/28/91
Cat. No. 470697. vial: 25 Drams.
[[Page 129]]
Ciba Corning Diagnostics Corp.......... QCS ABN ASY.................... Vial: 5ml, Kit: 5 vials.. 1/21/89
Ciba Corning Diagnostics Corp.......... QCS ABN ASY No. 9705/9705A..... Box: 10 vials, Vial: 5 ml 12/15/89
Ciba Corning Diagnostics Corp.......... QCS ABN ASY No. 9707/9707A..... Box: 10 vials, Vial: 5 ml 12/15/89
Ciba Corning Diagnostics Corp.......... QCS ABN UNASY No. 9691/9691A... Box: 40 vials, Vial: 25 12/15/89
ml.
Ciba Corning Diagnostics Corp.......... QCS ABN UNASY No. 9717/9717A... Box: 10 vials, Vial: 10 12/15/89
ml.
Ciba Corning Diagnostics Corp.......... QCS NOR ASY.................... Vial: 5 ml, Kit: 5 vials. 1/21/89
Ciba Corning Diagnostics Corp.......... QCS NOR ASY No. 9702/9702A..... Box: 10 vials, Vial: 5 ml 12/15/89
Ciba Corning Diagnostics Corp.......... QCS NOR ASY No. 9704/9704A..... Box: 10 vials, Vial: 5 ml 12/15/89
Ciba Corning Diagnostics Corp.......... QCS Nor UNASY No. 9681/9681A... Box: 40 vials, Vial: 25 12/15/89
ml.
Ciba Corning Diagnostics Corp.......... QCS Nor UNASY No. 9716/9716A... Box: 10 vials, Vial 10 ml 12/15/89
Ciba Corning Diagnostics Corp.......... Reagent A- Alt 14.............. Vial: 15 ml.............. 3/24/79
Ciba Corning Diagnostics Corp.......... Reagent A- Alt 7............... Vial: 15 ml.............. 3/24/79
Ciba Corning Diagnostics Corp.......... Reagent A-Ammonia 10........... Vial: 10 ml.............. 3/24/79
Ciba Corning Diagnostics Corp.......... Serum Protein Kit/8 Cat. No. Kit: 10 Plates; Plastic 10/28/91
470696. Vial: 25 Drams.
Ciba Corning Diagnostics Corp.......... Special Barbital Buffer Set, Vial: 3 per kit.......... 4/17/79
Catalog No. 470182.
Ciba Corning Diagnostics Corp.......... Universal Buffer Cat. No. Plastic Vial: 25 Drams... 10/28/91
470586.
Ciba Corning Diagnostics Corp.......... Universal Electrophoresis Film Plates: 12 per kit....... 4/17/79
Agarose, Catalog No. 470100.
Ciba Corning Diagnostics Corp.......... Universal Gel/12 Cat. No. Kit: 12 Plates; 2 Plates: 10/28/91
470554. 24 Tests.
Ciba Corning Diagnostics Corp.......... Universal Gel/16 or Multi-SPE Kit: 12 Plates; 2 Plates: 10/28/91
Gel Cat. No. 470066. 32 Tests.
Ciba Corning Diagnostics Corp.......... Universal IEP Gel Cat. No. Kit: 12 Plates; 2 Plates: 10/28/91
470222. 16 Tests.
Ciba Corning Diagnostics Corp.......... Universal II Gel/12 Cat. No. Kit: 12 Plates; 2 Plates: 10/28/91
470262. 24 Tests.
Ciba Corning Diagnostics Corp.......... Universal II Gel/12 Cat. No. Kit: 12 Plates........... 9/22/92
470362.
Ciba Corning Diagnostics Corp.......... Universal II Gel/16 Cat. No. Kit: 12 Plates; 2 Plates: 10/28/91
470268. 32 Tests.
Ciba Corning Diagnostics Corp.......... Universal II Gel/8 Cat. No. Kit: 12 Plates; 2 Plates: 10/28/91
470261. 16 Tests.
Ciba Corning Diagnostics Corp.......... Universal II Gel/8 Cat. No. Kit: 12 Plates........... 9/22/92
470361.
Ciba Corning Diagnostics Corp.......... Universal PHAB Buffer Set Kit: 3 vials per kit..... 9/26/79
Catalog No. 470180.
Clinical Diagnostic Systems, Inc....... Gemini TT4 Reagent Assembly.... Kit: 100 Tests........... 1/11/95
Cone Biotech, Inc...................... American Association of Vial: 20ml Kit: 2 vials.. 5/30/90
Bioanalysts, Urine Toxicology
Survey.
Cone Biotech, Inc...................... CAP/Cocaine Reference Material Vial: 20 ml.............. 3/07/88
Levels II, III, and IV.
Cone Biotech, Inc...................... College of American Vial: 15ml Kit: 4 vials.. 5/30/90
Pathologists (CAP) Reference
Material for Cocaine in Urine.
Cone Biotech, Inc...................... College of American Vial: 100ml.............. 5/30/90
Pathologists Forensic Urine
Drug Testing Survey Material
(AACC/CAP).
Cone Biotech, Inc...................... College of American Vial: 50ml............... 5/30/90
Pathologists Toxicology Survey
(CAP).
Cone Biotech, Inc...................... College of American Vial: 50ml............... 5/30/90
Pathologists Urine Toxicology
Survey (CAP).
Cone Biotech, Inc...................... QCM-UTI........................ Vial: 20ml............... 3/07/85
Cone Biotech, Inc...................... RIATRAC-Three Level Ligand Vials: 8ml............... 2/27/84
Assay Controls.
Cone Biotech, Inc...................... UDM-CAP/AACC Forensic Urine Bottle: 60 ml............ 8/31/87
Drug Testing Survey (Initial
Phase).
Cone Biotech, Inc...................... UDS and UDC CAP/AACC Forensic Vial: 30 ml.............. 1/06/88
Urine Drug Testing.
[[Page 130]]
Consolidated Technologies, Inc......... AAB Urine Drug Screening Survey Vial: 20ml............... 7/14/94
Consolidated Technologies, Inc......... AAB Urine Drug Screening Survey Vial: 20ml............... 9/29/95
Material.
Consolidated Technologies, Inc......... AACC/CAP Athletic Drug Testing Bottle; 125ml............ 7/14/94
Survey.
Consolidated Technologies, Inc......... AACC/CAP Forensic Urine Drug Vial: 50ml............... 7/14/94
Testing Confirmatory Survey.
Consolidated Technologies, Inc......... AACC/CAP Forensic Urine Drug Vial: 15ml............... 7/14/94
Testing Screening Survey.
Consolidated Technologies, Inc......... ACA Toxicology Urine Survey.... Bottle: 15-60ml.......... 9/29/95
Consolidated Technologies, Inc......... ADT-1 thru ADT-40.............. Vial: 125ml.............. 6/10/92
Consolidated Technologies, Inc......... CAP Athletic Drug Testing Bottle: 125ml............ 9/29/95
Survey Material.
Consolidated Technologies, Inc......... CAP Forensic Pathology Survey.. Vial: 5, 15, 50ml........ 7/14/94
Consolidated Technologies, Inc......... CAP Forensic Pathology Survey Vial: 5, 15, 50ml........ 9/29/95
Material.
Consolidated Technologies, Inc......... CAP Forensic Urine Drug Testing Vial: 50ml............... 9/29/95
Confirmatory Survey Material.
Consolidated Technologies, Inc......... CAP Toxicology Survey.......... Vial: 30, 50ml........... 7/14/94
Consolidated Technologies, Inc......... CAP Toxicology Survey Material. Vial: Vial: 50ml......... 9/29/95
Consolidated Technologies, Inc......... CAP Urine Toxicology Survey.... Vial: 50ml............... 7/14/94
Consolidated Technologies, Inc......... CAP Urine Toxicology Survey Vial: 50ml............... 9/29/95
Material.
Consolidated Technologies, Inc......... HIST Multi-Drug Reference Vial: 15ml............... 10/22/92
Material.
Consolidated Technologies, Inc......... Morphine Glucuronide Kit: 4 Vials............. 9/08/92
Calibration Set.
Consolidated Technologies, Inc......... Morphine Glucuronide Reference Vial: 20ml............... 9/08/92
Levels 1, 2, 3.
DIagnostics Systems Laboratories Inc... DHEA Controls I and II, DSL Vial: 3.5ml.............. 10/08/93
8951 & 8952.
Dade International Inc................. Absorbed Plasma and Serum Glass Vial: 5ml 8/16/71
Reagents Kit B4233-2. (Lyophilized Material).
Dade International Inc................. Beckman B-1 Buffer............. Plastic Vial: 15 g....... 5/22/79
Dade International Inc................. Bovine Chemistry Control I.X Bottle: 18ml (Lyophilized 1/29/86
Special Order Request B5107- Material).
55XX.
Dade International Inc................. Bovine Chemistry Control II.X Bottle: 18 ml 1/29/86
Special Order Request B5107- (Lyophilized Material).
65XX.
Dade International Inc................. Buffered Thrombin (Bovine) Bottle: 5ml (Lyophilized 1/24/86
Catalog No. B4233-40. Material).
Dade International Inc................. Dade CA System Buffer, Cat # Plastic Bottle: 500ml.... 7/20/95
B4265-32.
Dade International Inc................. Dade CA System Buffer, Cat # Pack: 4 Bottles, 500ml 7/20/95
B4265-34. each.
Dade International Inc................. Dade IAC.X Comprehensive Immuno- Kit: 6 bottles........... 8/27/91
Assay Control, Tri-Level
Unassayed.
Dade International Inc................. Dade Immunoassay Control, Level Bottle: 9ml (Lyophilized 4/25/86
I-Low. Material).
Dade International Inc................. Dade Immunoassay Control, Level Bottle: 9ml (Lyophilized 4/25/86
II-Intermediate. Material).
Dade International Inc................. Dade Immunoassay Control, Level Bottle: 9ml (Lyophilized 4/25/86
III-High. Material).
Dade International Inc................. Dade Immunoassay Controls, Bottles: 18; 9ml each.... 3/28/95
Level 1 Cat # B5700-06.
Dade International Inc................. Dade Immunoassay Controls, Bottles: 18; 9ml each.... 3/28/95
Level 2 Cat # 5700-07.
Dade International Inc................. Dade Immunoassay Controls, Tri- Kit: 3 bottles........... 4/25/86
Level.
Dade International Inc................. Dade Immunoassay Controls, Tri- Bottles: 18; 9ml each.... 3/28/95
Level Cat # B5700-05.
Dade International Inc................. Dade International Inc......... Bottles: 18; 9ml each.... 3/28/95
Dade International Inc................. Dade Moni-Trol Level 1 Bottle: 9ml.............. 8/07/95
Chemistry Control.
Dade International Inc................. Dade Moni-Trol Level 2 Bottle: 9ml.............. 8/07/95
Chemistry Control.
Dade International Inc................. Dade TDM Control Level I-Low Glass Vial: 9ml 1/21/82
B5700-2. (Lyophilized Material).
Dade International Inc................. Dade TDM Control Level II- Glass Vial: 9ml 1/21/82
Intermediate B5700-3. (Lyophilized Material).
[[Page 131]]
Dade International Inc................. Dade TDM Control Level III-High Glass Vial: 9ml 1/21/82
B5700-4. (Lyophilized Material).
Dade International Inc................. Dade Therapeutic Drug Kit: 9 Vials............. 3/10/87
Monitoring (TDM) Controls
(Catalog No. B5700-1).
Dade International Inc................. Dade Urine Chemistry Control Kit: 10 Bottles; Bottle: 8/02/91
Level I, II. 18ml.
Dade International Inc................. Data-Fi Fibrin Monomer Control Glass Vial: 5ml 1/24/86
Catalog Nos. B4233-30 & B4233- (Lyophilized Material).
38.
Dade International Inc................. Data-Fi Fibrinogen Kit: 50 tests............ 9/09/86
Determination Reagents Cat.
No. B4233-15.
Dade International Inc................. Data-Fi Protamine Sulfate Kit: 10 Vials............ 3/10/87
Reagents Kit (Catalog No.
B4233-30).
Dade International Inc................. Immunoassay Control Level I-III Bottle: 9ml.............. 8/27/91
Unassayed.
Dade International Inc................. Moni-Trol Level I Chemistry Bottle: 9ml (Lyophilzed 1/20/84
Control, Assayed, Special Material).
Order Request. B5103-XXX.
Dade International Inc................. Moni-Trol Level I.X Special Bottle: 18ml (Lyophilized 6/30/83
Order Request B5106-5X. Material).
Dade International Inc................. Moni-Trol Level II Chemistry Bottle: 9ml (Lyophilized 1/20/84
Control, Assayed, Special Material).
Order Request. B5103-XXX,
B5113-XXX.
Dade International Inc................. Moni-Trol Level II.X Special Bottle: 18ml (Lyophilized 6/30/83
Order Request B5106-6X. Material).
Dade International Inc................. Moni-Trol. ES Level II Bottles: 9ml, 6.7ml 7/15/83
Chemistry Control, Assayed. (Lyophilized Material).
Dade International Inc................. Moni-Trol. ES Level II.X Bottle: 18ml, 9ml 6/27/86
Special Order Request Catalog (Lyophilized Material).
No. B5106-85AAA Catalog No.
B5106-2XAAA.
Dade International Inc................. Owren's Veronal Buffer......... Bottle: 18ml............. 8/16/71
Dade International Inc................. Stratus Phenobarbital Glass Vial: 3ml.......... 6/27/83
Calibrators B, C, D, E, & F.
Dade International Inc................. Stratus Phenobarbital Conjugate Glass Vial: 6ml.......... 1/25/82
Dade International Inc................. Stratus Phenobarbital Kit: 120 tests........... 3/10/87
Fluorometric Enzyme
Immunoassay Kit (Catalog No.
B5700-22).
Diagnostic Products Corporation...... 125-I Barbiturate Isotope: Cat. Vial: 110 ml, 550 ml..... 3/01/88
No. TBA2, TBAY2.
Diagnostic Products Corporation...... 125-I Benzolyecgonine Isotope: Vial: 100 ml, 550 ml..... 3/01/88
Cat. No. TCN2, TCNY2.
Diagnostic Products Corporation...... 125-I Benzoylecgonine Isotope Vial: 10 ml, 100 ml, 675 3/01/88
(DA): Cat. No. CND2, YCND2. ml.
Diagnostic Products Corporation...... 125-I Fentanyl Isotope: Cat. Vial: 500 ml............. 3/01/88
No. TFN2.
Diagnostic Products Corporation...... 125-I Methadone Isotope: Cat. Vial: 100 ml............. 3/01/88
No. TMD2.
Diagnostic Products Corporation...... 125-I Methaqualone Isotope: Vial: 100 ml............. 3/01/88
Cat. No. TMQ2.
Diagnostic Products Corporation...... 125-I Morphine Isotope: Cat. Vial: 110 ml, 550 ml..... 3/01/88
No. TMP2, TMPY2.
Diagnostic Products Corporation...... 125-I PCP Isotope: Cat. No. Vial: 110 ml, 550 ml..... 3/01/88
TPC2, TPCY2.
Diagnostic Products Corporation...... 125-I Serum Morphine Isotope: Vial: 110 ml............. 3/01/88
Cat. No. TSM2.
Diagnostic Products Corporation...... 125-I THC Isotope: Cat. No. Vial: 20 ml, 110 ml, 550 3/01/88
THD2, YTHD2. ml.
Diagnostic Products Corporation...... Amphetamine Calibrators B-F: Vial: 3.5 ml............. 3/01/88
Cat. No. APD4-8.
Diagnostic Products Corporation...... Amphetamine Calibrators Cat. Vial: 5ml................ 7/05/90
No. MAP 4-8.
Diagnostic Products Corporation...... Amphetamine Controls, Cat. No. Vial: 5 ml............... 3/20/89
ACO1, ACO2.
Diagnostic Products Corporation...... Amphetamine Controls: Cat. No. Vial: 100 ml............. 3/01/88
5AC01, 5ACO2.
Diagnostic Products Corporation...... Amphetamine Isotope: Cat. No. Vial: 20 ml, 100 ml, 550 3/01/88
APD2, 5APD2, YAPD2. ml.
Diagnostic Products Corporation...... Amphetamine Reference Vial: 120 ml............. 3/01/88
Preparation: Cat. No. 5YAP7.
Diagnostic Products Corporation...... Amphetamine Reference Vial: 5 ml............... 3/20/89
Preparations, Cat. No. APD5,
APD9.
Diagnostic Products Corporation...... Barbiturate Calibrators B-G: Vial: 3.5 ml............. 3/01/88
Cat. No. BAC4-9.
Diagnostic Products Corporation...... Barbiturate Reference Vial: 120 ml............. 3/01/88
Preparations: Cat. No. 5YBA5.
Diagnostic Products Corporation...... Benzoylecgonine Calibrators Vial: 3.5 ml............. 3/01/88
(CAC) B-F: Cat. No. COC4-8.
Diagnostic Products Corporation...... Benzoylecgonine Calibrators Vial: 3.5 ml............. 3/01/88
(DA) B-F: Cat. No. CND4-8.
[[Page 132]]
Diagnostic Products Corporation...... Benzoylecgonine Calibrators Vial: 3.5 ml............. 3/01/88
(DA): Cat. No. CNC4-8.
Diagnostic Products Corporation...... Benzoylecgonine Reference Vial: 120 ml............. 3/01/88
Preparation (DA): Cat. No.
5YCN5.
Diagnostic Products Corporation...... Benzoylecgonine Reference Vial: 120 ml............. 3/01/88
Preparation: Cat. No. 5YCN5.
Diagnostic Products Corporation...... C-Terminal PTH Antiserum: Cat. Vial: 10 ml.............. 3/01/88
No. PCD1.
Diagnostic Products Corporation...... CON6 Immunoassay Tri-level Kit: 6 vials............. 3/25/91
Control Cat. No. CON6.
Diagnostic Products Corporation...... Canine T3 Isotope: Cat. No. Vial: 120 ml............. 3/01/88
TC32.
Diagnostic Products Corporation...... Coat-A-Count Barbiturates In Kit: 100 tests, 500 tests 3/01/88
Urine: Cat. No. TKBA1, TKBA5.
Diagnostic Products Corporation...... Coat-A-Count Barbiturates Kit: 2500 tests.......... 3/01/88
Qualitative Determination In
Urine: Cat. No. TKBAY.
Diagnostic Products Corporation...... Coat-A-Count Canine T3: Cat. Kit: 100 tests, 500 tests 3/01/88
No. TKC31, TKC35.
Diagnostic Products Corporation...... Coat-A-Count Cocaine Kit: 100 tests, 500 tests 3/01/88
Metabolite: Cat. No. TKCN1,
TKCN5.
Diagnostic Products Corporation...... Coat-A-Count Fentanyl: Cat. No. Kit: 100 tests........... 3/01/88
TKFN1.
Diagnostic Products Corporation...... Coat-A-Count Free Testosterone Kit: 100, 200 Tests...... 3/25/91
Cat. No. TKTF 1, 2.
Diagnostic Products Corporation...... Coat-A-Count LSD 100, 500, Cat. Kit: 8 vials, 19 vials... 3/20/89
No. TKLS1, TKLS5.
Diagnostic Products Corporation...... Coat-A-Count LSD Qualitative Kit: 8 vials............. 3/20/89
Determination in Urine, Cat.
No. TKLSY.
Diagnostic Products Corporation...... Coat-A-Count Metabolite Kit: 2500 tests.......... 3/01/88
Qualitative Determinants In
Urine: Cat. No. TKCNY.
Diagnostic Products Corporation...... Coat-A-Count Methadone: Cat. Kit: 100 tests........... 3/01/88
No. TKMD1.
Diagnostic Products Corporation...... Coat-A-Count Methaqualone: Cat. Kit: 100 tests........... 3/01/88
No. TKMQ1.
Diagnostic Products Corporation...... Coat-A-Count Morphine Kit: 2500 tests.......... 3/01/88
Qualitative Determinations In
Urine: Cat. No. TKMPY.
Diagnostic Products Corporation...... Coat-A-Count Morphine: Cat. No. Kit: 100 tests, 500 3/01/88
TKMP1, TKMP5, TKMPX. tests, 1000 tests.
Diagnostic Products Corporation...... Coat-A-Count Opiates Screen Kit: 2500 tests.......... 3/1/88
Qualitative Determinations In
Urine: Cat. No. TKOSY.
Diagnostic Products Corporation...... Coat-A-Count Opiates Screen: Kit: 100 tests, 500 tests 3/1/88
Cat. No. TK0S1, TKOS5.
Diagnostic Products Corporation...... Coat-A-Count PCP Kit: 100 tests........... 3/1/88
(Phencyclidine) In Urine: Cat.
No. TKCY1.
Diagnostic Products Corporation...... Coat-A-Count PCP Kit: 2500 tests.......... 3/1/88
(Phencyclidine) Qualitative
Determinations In Urine: Cat.
No. TKPCY.
Diagnostic Products Corporation...... Coat-A-Count Serum Morphine: Kit: 100 tests........... 3/1/88
Cat. No. TKSM1.
Diagnostic Products Corporation...... Coat-A-Count Total Testosterone Kit: 100, 200, 500 Tests. 3/25/91
Cat. No. TKTT 1, 2, 5.
Diagnostic Products Corporation...... Donkey Anti-Goat Gamma Globulin Vial: 10 ml.............. 3/1/88
(PTH-Ultra): Cat. No. PTDG.
Diagnostic Products Corporation...... Double Antibody Amphetamine, Kit: 6 vials............. 3/20/89
Cat. No. KAPD1, KAPD5.
Diagnostic Products Corporation...... Double Antibody Amphetamine, Kit: 2500 tests.......... 3/1/88
Qualitative Determinations In
Urine: Cat. No. KAPDY.
Diagnostic Products Corporation...... Double Antibody Amphetamine: Kit: 100 tests, 500 tests 3/1/88
Cat. No. KAPD1, KAPD5.
Diagnostic Products Corporation...... Double Antibody Cannabinoids Kit: 100 tests, 500 tests 3/1/88
(THC) In Urine: Cat. No.
KTHD1, KTHD5.
Diagnostic Products Corporation...... Double Antibody Cannabinoids Kit: 2500 tests.......... 3/1/88
(THC) Quantitative
Determinations In Urine: Cat.
No. KTHDY.
Diagnostic Products Corporation...... Double Antibody Cocaine Kit: 2500 tests.......... 3/1/88
Metabolite Qualitive
Determination In Urine: Cat.
No. KCNDY.
Diagnostic Products Corporation...... Double Antibody Cocaine Kit: 100 tests, 500 tests 3/1/88
Metabolite: Cat. No. KCND1,
KCND5.
Diagnostic Products Corporation...... Double Antibody PTH-C: KPCD1, Kit: 70 tests, 140 tests. 3/1/88
KPCD2.
Diagnostic Products Corporation...... Double Antibody PTH-M: Cat. No. Kit: 70 tests............ 3/1/88
KPMD1.
Diagnostic Products Corporation...... Double Antibody Testosterone Kit: 100, 200 Tests...... 3/25/91
Cat. No. KTTD1, 2.
[[Page 133]]
Diagnostic Products Corporation...... Double Antibody Ultra-PTH: Cat. Kit: 70 tests, 140 tests. 3/1/88
No. KPTD1, KPTD2.
Diagnostic Products Corporation...... Enzyme-Labeled Amphetamine Cat. Vial: 20ml, 60ml......... 7/5/90
No. MEAP2, 5MEAP2.
Diagnostic Products Corporation...... Enzyme-Labeled Cocaine Glass Vial: 11ml, 60ml... 1/25/91
Metabolite Cat. No. MECC2,
5MECC2.
Diagnostic Products Corporation...... Enzyme-Labeled Methamphetamine Vial: 11ml, 60ml......... 9/28/90
Cat. No. MEMA2, 5MEMA2.
Diagnostic Products Corporation...... Enzyme-Labeled Opiates Cat. No. Vial: 20ml, 60ml......... 7/5/90
MEOP2, 5MEOP2.
Diagnostic Products Corporation...... Enzyme-Labeled PCP Cat. No. Vial: 20ml, 60ml......... 7/5/90
MEPC2, 5MEPC2.
Diagnostic Products Corporation...... Enzyme-Labeled THC Cat. No. Vial: 20ml, 60ml......... 7/5/90
METH 2, 5METH2.
Diagnostic Products Corporation...... EquiCON-DOA Drugs of Abuse Kit: 2 Vials............. 3/25/91
Equine Urine Controls Cat. No.
EDAC.
Diagnostic Products Corporation...... EquiCon-DOA Level 2, 3 Cat. No. Vial: 30ml............... 3/25/91
EDAC 2, 3.
Diagnostic Products Corporation...... Fentanyl Calibrators: Cat. No. Vial: 3.5 ml............. 3/1/88
FNC4-9.
Diagnostic Products Corporation...... Free Testosterone Calibrators Vial: 3.5ml.............. 3/25/91
Cat. No. TFC4-8.
Diagnostic Products Corporation...... Goat Anti-Rabbit Gamma Globulin/ Vial: 110 ml, 320 ml..... 3/1/88
4% PEG Saline: Cat. No. 5N6.
Diagnostic Products Corporation...... LSD Calibrators B-F, Cat. No. Vial: 5 ml............... 3/20/89
LSCH-8.
Diagnostic Products Corporation...... LSD Controls, Cat. No. 5LCO1, Vial: 120ml, 5ml......... 3/20/89
5LCO2, LSCO1, LSCO2.
Diagnostic Products Corporation...... LSD Isotope, Cat. No. TLSY2, Vial: 105 ml, 550 ml..... 3/20/89
TLS2.
Diagnostic Products Corporation...... LSD Reference Preparation, Cat. Vial: 120ml.............. 3/20/89
No. 5YLS6.
Diagnostic Products Corporation...... Low and High Barbiturate Vial: 100 ml............. 3/1/88
Urinary Controls: Cat. No.
5BCO1, 5BCO2.
Diagnostic Products Corporation...... Low and High Benzoylecgonine Vial: 3.5 ml, 100 ml..... 3/1/88
Urinary Controls (DA): Cat.
No. 5COO1, 5COO2, CNC02, CNCO3.
Diagnostic Products Corporation...... Low and High Cannabinoid Vial: 100 ml............. 3/1/88
Urinary Controls: Cat. No.
5TCO1, 5TCO2.
Diagnostic Products Corporation...... Low and High Morphine Urinary Vial: 100 ml............. 3/1/88
Controls: Cat. No. 5MCO1,
5MCO2.
Diagnostic Products Corporation...... Low and High Opiate Urinary Vial: 100 ml............. 3/1/88
Controls: Cat. No. 5OCO1,
5OCO2.
Diagnostic Products Corporation...... Low and High PCP Urinary Vial: 100 ml............. 3/1/88
Controls: Cat. No. 5PCO1,
5PCO2.
Diagnostic Products Corporation...... Methadone Calibrators: Cat. No. Vial: 3.5 ml............. 3/1/88
MDC4-8.
Diagnostic Products Corporation...... Methamphetamine Calibrators Vial: 5ml................ 9/28/90
Cat. No. MMA-8.
Diagnostic Products Corporation...... Methamphetamine Cartridges Cat. Cartridge: 5ml........... 1/25/91
No. VMADC.
Diagnostic Products Corporation...... Methamphetamine Positive Vial: 3ml................ 1/25/91
Reference Cat. No. VMAPC.
Diagnostic Products Corporation...... Methaqualone Calibrators: Cat. Vial: 3.5 ml............. 3/1/88
No. MQC4-8.
Diagnostic Products Corporation...... Mid-Molecule PTH Antiserum: Vial: 10 ml.............. 3/1/88
Cat. No. PMD1.
Diagnostic Products Corporation...... Milenia Amphetamine Cat. No. Kit: 7 vials, 96 tests, 7/5/90
MKAP1, MKAP5. 480 tests.
Diagnostic Products Corporation...... Milenia Cannabinoids Cat. No. Kit: 6 vials, 96 Tests, 7/5/90
MK TH1, MKTH5. 480 Tests.
Diagnostic Products Corporation...... Milenia Cocaine Metabolite Cat. Kit: 96 Tests, 480 Tests. 1/25/91
No. MKCC1, MKCC5.
Diagnostic Products Corporation...... Milenia Cocaine References and Glass Vial: 5ml.......... 1/25/91
Controls Cat. No. MC3, 6;
MCCC1, 2.
Diagnostic Products Corporation...... Milenia Methamphetamine Cat. Kit: 96 wells, 480 wells. 9/28/90
No. MKMA1, MKMA5.
Diagnostic Products Corporation...... Milenia Opiates Cat. No. MKOP1, Kit: 6 vials, 96 Tests, 7/5/90
MKOP5. 480 Tests.
Diagnostic Products Corporation...... Milenia PCP Cat. No. MKPC1, Kit: 6 vials, 96 tests, 7/5/90
MKPC5. 480 tests.
Diagnostic Products Corporation...... Morphine Calibrators: Cat. No. Vial: 3.5 ml, 10 ml...... 3/1/88
MPC4-8.
[[Page 134]]
Diagnostic Products Corporation...... Morphine Reference Preparation: Vial: 120 ml............. 3/1/88
Cat. No. 5YMPY7.
Diagnostic Products Corporation...... Opiate Calibrators: Cat. No. Vial: 3.5 ml............. 3/1/88
OSC4-8.
Diagnostic Products Corporation...... Opiate Cartridges Cat. No. Cartridge: 5ml........... 7/5/90
VOSDC.
Diagnostic Products Corporation...... Opiates Calibrators Cat. No. Vial: 5ml................ 7/5/90
MOP 4-7.
Diagnostic Products Corporation...... Opiates Positive Reference Cat. Vial: 1ml................ 7/5/90
No. VOSPC.
Diagnostic Products Corporation...... Opiates Reference Preparation: Vial: 120 ml............. 3/1/88
Cat. No. 5YOS7.
Diagnostic Products Corporation...... PCP Calibrators Cat. No. MPC 3- Vial: 5ml................ 7/5/90
7.
Diagnostic Products Corporation...... PCP Calibrators: Cat. No. PCC4- Vial: 3.5 ml............. 3/1/88
8.
Diagnostic Products Corporation...... PCP Reference Preparation: Cat. Vial: 120 ml............. 3/1/88
No. 5YPC6.
Diagnostic Products Corporation...... PTH (C-Terminal) Isotope: Cat. Vial: 10 ml.............. 3/1/88
No. PCD2.
Diagnostic Products Corporation...... PTH (Ultra) Antiserum: Cat. No. Vial: 5 ml............... 3/1/88
PTD1.
Diagnostic Products Corporation...... PTH (Ultra) Isotope: Cat. No. Vial 5 ml................ 3/1/88
PTD2.
Diagnostic Products Corporation...... PTH-M Isotope: Cat. No. PMD2... Vial: 10 ml.............. 3/1/88
Diagnostic Products Corporation...... RIA Controls Level 4, 5, 6 Cat. Vial: 10ml............... 3/25/91
No. CON4, CON5, CON6.
Diagnostic Products Corporation...... Serum Morphine Calibrators: Vial: 3.5 ml............. 3/1/88
Cat. No. SMC4-8.
Diagnostic Products Corporation...... Serum Morphine Controls: Cat. Vail: 3.5 ml............. 3/1/88
No. SMCO2, SMCO3.
Diagnostic Products Corporation...... THC Calibrators B-F: Cat. No. Vial: 3.5 ml............. 3/1/88
THD4-8.
Diagnostic Products Corporation...... THC Calibrators Cat. No. MTH 4- Vial: 5ml................ 7/5/90
7.
Diagnostic Products Corporation...... THC Reference Preparation: Cat. Vial: 120 ml............. 3/1/88
No. 5YTH7.
Diagnostic Products Corporation...... Ten One Methamphetamine Cat. Kit: 12 Tests, 48 Tests.. 1/25/91
No. VKMA1, VKMA4.
Diagnostic Products Corporation...... Ten One Opiates Cat. No. VKSO1, Kit: 1 vial, 12 & 48 5ml 7/5/90
VKSO4. cartridges.
Diagnostic Products Corporation...... Testosterone Calibrators Cat. Vial: 3.5ml.............. 3/25/91
No. TTD3-8.
Diagnostic Products Corporation...... Total Testosterone Calibrators Vial: 3.5ml.............. 3/25/91
Cat. No. TTC4-8.
Diagnostic Products Corporation...... Triiodothyronine (T3) Isotope: Vial: 120 ml............. 3/1/88
Cat. No. TT32.
Diagnostic Products Corporation...... [125I] Free Testosterone Cat. Vial: 105ml.............. 3/25/91
No. TTF2.
Diagnostic Products Corporation...... [125I] Testosterone Cat. No. Vial: 10ml............... 3/25/91
TTD2.
Diagnostic Products Corporation...... [125I] Total Testosterone Cat. Vial: 105ml.............. 3/25/91
No. TTT 2.
Diagnostic Systems Laboratories, Inc... Active DHT DSL 9600............ Kit: 100 Tests........... 1/25/96
Diagnostics Reagents, Inc.............. Amphetamines Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Amphetamines Enzyme Immunoassay Kit: 2 Bottles; 100ml 10/20/93
Kit # 0017. each.
Diagnostics Reagents, Inc.............. Amphetemine Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0018. each.
Diagnostics Reagents, Inc.............. Barbiturate Enzyme Congugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Barbiturate Enzyme Immunoassay Kit: 2 Bottles; 100 ml 10/20/93
Kit # 0225. each.
Diagnostics Reagents, Inc.............. Barbiturate Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0226. each.
Diagnostics Reagents, Inc.............. Benzodiazepine Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Benzodiazepine Enzyme Kit: 2 Bottles; 100ml 10/20/93
Immunoassay Kit # 0039. each.
Diagnostics Reagents, Inc.............. Benzodiazepine Enzyme Kit: 2 Bottles; 500ml 10/20/93
Immunoassay Kit # 0040. each.
Diagnostics Reagents, Inc.............. Caanbinoid Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0186. each.
Diagnostics Reagents, Inc.............. Cannabinoid Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Cannabinoid Enzyme Immunoassay Kit: 2 Bottles; 100ml 10/20/93
Kit # 0185. each.
Diagnostics Reagents, Inc.............. Cocaine Metabolite Enzyme Carboy: 20, 10, 5, 1 L... 10/20/93
Conjugate Reagent, Bulk.
Diagnostics Reagents, Inc.............. Cocaine Metabolite Enzyme Kit: 2 Bottles; 100ml 10/20/93
Immunoassay Kit # 0055. each.
Diagnostics Reagents, Inc.............. Cocaine Metabolite Enzyme Kit: 2 Bottles; 500ml 10/20/93
Immunoassay Kit # 0056. each.
Diagnostics Reagents, Inc.............. Drugs of Abuse High Calibrator Bottle: 5L, 1L, 500ml.... 10/20/93
A, Bulk.
[[Page 135]]
Diagnostics Reagents, Inc.............. Drugs of Abuse High Calibrator Bottle: 5ml.............. 10/20/93
A, Cat # 0324.
Diagnostics Reagents, Inc.............. Drugs of Abuse High Calibrator, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse High Calibrator, Bottle: 5ml.............. 10/20/93
Cat # 0036.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level 2 Control, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level 2 Control, Bottle: 5ml.............. 10/20/93
Cat # 0208.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level 2A Bottle: 5L, 1L, 500ml.... 10/20/93
Control, Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level 2A Bottle: 5ml.............. 10/20/93
Control, Cat # 0331.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level I Control, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level I Control, Bottle: 5ml.............. 10/20/93
Cat # 0210.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level IA Bottle: 5L, 1L, 500ml.... 10/20/93
Control, Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Level IA Bottle: 5ml.............. 10/20/93
Control, Cat # 0329.
Diagnostics Reagents, Inc.............. Drugs of Abuse Low Calibrator Bottle: 5ml.............. 10/20/93
A, Cat # 0322.
Diagnostics Reagents, Inc.............. Drugs of Abuse Low Calibrator, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Low Calibrator, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. Drugs of Abuse Low Calibrator, Bottle: 5ml.............. 10/20/93
Cat # 0034.
Diagnostics Reagents, Inc.............. Methadone Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Methadone Enzyme Immunoassay Kit: 2 Bottles; 100ml 10/20/93
Kit # 0596. each.
Diagnostics Reagents, Inc.............. Methadone Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0597. each.
Diagnostics Reagents, Inc.............. Methadone Metabolite Enzyme Carboy: 20, 10, 5, 1 L... 10/20/93
Conjugate Reagent, Bulk.
Diagnostics Reagents, Inc.............. Methadone Metabolite Enzyme Kit: 2 Bottles; 100ml 10/20/93
Immunoassay Kit # 0200. each.
Diagnostics Reagents, Inc.............. Methadone Metabolite Enzyme Kit: 2 Bottles; 500ml 10/20/93
Immunoassay Kit # 0201. each.
Diagnostics Reagents, Inc.............. Methaqualone Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Methaqualone Enzyme Immunoassay Kit: 2 Bottles; 100ml 10/20/93
Kit # 0514. each.
Diagnostics Reagents, Inc.............. Methaqualone Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0515. each.
Diagnostics Reagents, Inc.............. Opiate Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Opiate Enzyme Immunoassay Kit # Kit: 2 Bottles; 100ml 10/20/93
0135. each.
Diagnostics Reagents, Inc.............. Opiate Enzyme Immunoassay Kit # Kit: 2 Bottles; 500ml 10/20/93
0136. each.
Diagnostics Reagents, Inc.............. Phencyclidine Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Phencyclidine Enzyme Kit: 2 Bottles; 100ml 10/20/93
Immunoassay Kit # 0160. each.
Diagnostics Reagents, Inc.............. Phencyclidine Enzyme Kit: 2 Bottles; 500ml 10/20/93
Immunoassay Kit # 0161. each.
Diagnostics Reagents, Inc.............. Propoxyphene Enzyme Conjugate Carboy: 20, 10, 5, 1 L... 10/20/93
Reagent, Bulk.
Diagnostics Reagents, Inc.............. Propoxyphene Enzyme Immunoassay Kit: 2 Bottles; 100 ml 10/20/93
Kit # 0432. each.
Diagnostics Reagents, Inc.............. Propoxyphene Enzyme Immunoassay Kit: 2 Bottles; 500ml 10/20/93
Kit # 0433. each.
Diagnostics Reagents, Inc.............. THC Urine Calibrator 100ng/ml, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. THC Urine Calibrator 100ng/ml, Bottle: 5ml.............. 10/20/93
Cat # 0044.
Diagnostics Reagents, Inc.............. THC Urine Calibrator 200ng/ml Bottle: 5ml.............. 10/20/93
Cat # 0206.
Diagnostics Reagents, Inc.............. THC Urine Calibrator 200ng/ml, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. THC Urine Calibrator 50ng/ml... Bottle: 5ml.............. 10/20/93
Diagnostics Reagents, Inc.............. THC Urine Calibrator 50ng/ml, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. THC Urine Calibrator, 20ng/ml, Bottle: 5ml.............. 10/20/93
Cat # 0235.
Diagnostics Reagents, Inc.............. THC Urine Control 125ng/ml, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Reagents, Inc.............. THC Urine Control 40ng/ml, Bulk Bottle: 5L, 1L, 500ml.... 10/20/93
Diagnostics Reagents, Inc.............. THC Urine Control 60ng/ml, Bulk Bottle: 5L, 1L, 500ml.... 10/20/93
Diagnostics Reagents, Inc.............. THC Urine Control 75ng/ml, Bulk Bottle: 5L, 1L, 500ml.... 10/20/93
Diagnostics Reagents, Inc.............. THC Urine Control, 125ng/ml, Bottle: 5ml.............. 10/20/93
Cat # 0212.
Diagnostics Reagents, Inc.............. THC Urine Control, 40ng/ml, Cat Bottle: 5ml.............. 10/20/93
# 0170.
Diagnostics Reagents, Inc.............. THC Urine Control, 60ng/ml, Cat Bottle: 5ml.............. 10/20/93
# 0168.
Diagnostics Reagents, Inc.............. THC Urine Control, 75ng/ml, Cat Bottle: 5ml.............. 10/20/93
# 0214.
Diagnostics Reagents, Inc.............. THC urine Calibrator 20ng/ml, Bottle: 5L, 1L, 500ml.... 10/20/93
Bulk.
Diagnostics Systems Laboratories Inc... DHEA Standards, A-F, DSL 8901- Vial: 3.5ml.............. 10/08/93
8906.
Diagnostics Systems Laboratories Inc... Radioimmunoassay Kit for the Kit: 100 Tests........... 10/08/93
Measurement of
Dehydroepiandrosterone (DHEA),
DSL 8900.
Diagnostics Systems Laboratories Inc... Radioimmunoassay Kit for the Kit; 100 Tests........... 10/08/93
Measurement of
Dehydroepiandrosterone (DHEA),
DSL 9000.
Diagnostics Systems Laboratories Inc... Radioimmunoassay Kit for the Kit: 100 Tests........... 10/08/93
Quantitative Measurement of
Testosterone, DSL 4000.
Diagnostics Systems Laboratories Inc... Radioimmunoassay Kit for the Kit: 100 Tests........... 10/08/93
Quantitative Measurement of
Testosterone, DSL 4100.
Diagnostics Systems Laboratories Inc... Testosterone Controls I and II, Vial: 3.5ml.............. 10/08/93
DSL 4051 & 4052.
Diagnostics Systems Laboratories Inc... Testosterone Standards A-F, DSL Vial: 3.5ml.............. 10/08/93
4001-4006.
Diamedix Corporation................... Barbital-Acetate Buffer, Powder Package: 20 envelopes- 7/27/72
709-317. 10.65 g. per envelope.
Diamedix Corporation................... CEP Plate-Amebiasis Testing 40 Plate: 40mm x 80mm x 8/9/73
Test No. 730-274. 2.5mm.
Diamedix Corporation................... CEP VI No. 709-339............. Plate: 40mm x 80mm x 8/9/73
2.5mm.
[[Page 136]]
Diamedix Corporation................... Counterelectrophoresis (CEP) Plastic plates: 40mm x 6/16/75
Plates for Trichinosis Testing. 80mm x 2.5mm.
Diamedix Corporation................... EDTA (0.014M)-GVB Buffer, 753- Bottle: 5ml.............. 8/9/73
034.
Diamedix Corporation................... EDTA (0.01M)-GVB Buffer, 753- Bottle: 5ml.............. 8/9/73
031.
Diamedix Corporation................... GVB(3+) Buffer 753-037......... Bottle: 50ml............. 8/9/73
Diamedix Corporation................... Glucose-GVB 1 Buffer, 753-036.. Bottle: 50ml............. 8/9/73
DuPont Medical Products................ DuPont aca Urine Drugs of Abuse Carton: 10 Vials; 6ml/ 5/25/95
Control (Negative/Positive). vial.
Duo Research, Inc...................... Drug Testing Assessment Program Kit: 25 bottles.......... 12/26/86
Quality Control Samples.
Duo Research, Inc...................... Drug Testing Assessment Program- Bottle: 65ml............. 2/27/86
Quality Control Sample.
Duo Research, Inc...................... Drug Testing Assessment Program- Kit: 5-65ml bottles...... 2/27/86
Quality Control Sample Kit.
DynaGen, Inc........................... Benzoylecgonine and delta-8 THC- Plastic Bottle: 100ml.... 7/27/93
Carboxylic Acid Cat # 700-111.
DynaGen, Inc........................... D-Amphetamine and DL- Plastic Bottle: 100ml.... 7/27/93
Methamphetamine Cat # 700-107.
DynaGen, Inc........................... D-Amphetamine, D- Plastic Bottle: 100ml.... 7/27/93
Methamphetamine and delta-9
THC-Carboxylic Acid Cat # 700-
112.
DynaGen, Inc........................... D-Amphetamine, Pseudoephedrine, Plastic Bottle: 100ml.... 7/27/93
DL-Methamphetamine and
Phenylpropanolamine Cat # 700-
116.
DynaGen, Inc........................... DL-Methamphetamine Cat # 700- Plastic Bottle: 100ml.... 7/27/93
110.
DynaGen, Inc........................... Hydrocodone Cat # 700-106...... Plastic bottle: 100ml.... 7/27/93
DynaGen, Inc........................... Hydromorphone Cat # 700-108.... Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... Methadone Cat # 700-118........ Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... Methaqualone Cat # 700-119..... Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... Morphine, Codeine and 6- Plastic Bottle: 100ml.... 7/27/93
Monoacetylmorphine Cat # 700-
114.
DynaGen, Inc........................... Oxazepam Cat # 700-120......... Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... PeoCheck Blind Performance Kit: 25 Bottles; 100ml 7/27/93
Specimens Cat # 500-100. plastic.
DynaGen, Inc........................... Phencyclidine and Hydrocodone Plastic Bottle: 100ml.... 7/27/93
Cat # 700-115.
DynaGen, Inc........................... ProCheck Blind Performance Kit: 5 bottles; 100ml 7/27/93
Specimens Cat # 500-200. plastic.
DynaGen, Inc........................... Propoxyphene Cat # 700-121..... Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... Secobarbital Cat # 700-117..... Plastic Bottle: 100ml.... 7/27/93
DynaGen, Inc........................... delta 9 THC-Carboxylic Acid and Plastic Bottle: 100ml.... 7/27/93
Phentermine Cat # 700-113.
E.I. duPont de Nemours & Co., Inc...... (1) PREP Sample Preparation and Kit containing following: 9/25/78
Analysis Kit.
E.I. duPont de Nemours & Co., Inc...... (2) PREP Buffer/Internal Box containing following: 9/25/78
Standard and Liquid
Chromatography Verifier.
E.I. duPont de Nemours & Co., Inc...... (2a) PREP Liquid Chromatography Vial: 10ml (1 vial/box).. 9/25/78
Verifier.
E.I. duPont de Nemours & Co., Inc...... (2b) PREP Buffer/Internal Vial: 100ml (3 vials/box) 9/25/78
Standard.
E.I. duPont de Nemours & Co., Inc...... (3) PREP Calibrators........... Box containing following: 9/25/78
E.I. duPont de Nemours & Co., Inc...... (3a) PREP Calibrator-Level 1... Vial: 10ml (1 vial/box).. 9/25/78
E.I. duPont de Nemours & Co., Inc...... (3b) PREP Calibrator-Level 2... Vial: 10ml (1 vial/box).. 9/25/78
E.I. duPont de Nemours & Co., Inc...... (3c) PREP Calibrator-Level 3... Vial: 10ml ( 1 vial/box). 9/25/78
E.I. duPont de Nemours & Co., Inc...... (3d) PREP Calibrator-Level 4... Vial: 10ml (1 vial/box).. 9/25/78
E.I. duPont de Nemours & Co., Inc...... (4) PREP Controls.............. Box containing following: 9/25/78
E.I. duPont de Nemours & Co., Inc...... (4a) PREP Control-Low Level.... Vial: 10ml (2 vials/box). 9/25/78
E.I. duPont de Nemours & Co., Inc...... (4b) PREP Control-High Level... Vial: 10ml (2 vials/box). 9/25/78
E.I. duPont de Nemours & Co., Inc...... Cocaine [N-Methyl-3H].......... Vial: 1 or 5ml........... 10/4/95
E.I. duPont de Nemours & Co., Inc...... DM/TU Saturating Reagent....... Plastic Bottle: 1L, 10L, 2/22/89
20L.
E.I. duPont de Nemours & Co., Inc...... DuPont Drug Calibrator-A Vial: 6ml, Box: 10 vials. 9/28/90
(levels 1-5).
E.I. duPont de Nemours & Co., Inc...... DuPont Drug Calibrators- Levels Vial: 6ml (1 vial and 2 4/4/86
1 through 5. vials/box).
[[Page 137]]
E.I. duPont de Nemours & Co., Inc...... DuPont Phenobarbital Assay..... Vial: 6 ml............... 10/13/86
E.I. duPont de Nemours & Co., Inc...... DuPont U Amp Enzyme Pack Bottle: 1 liter.......... 10/19/87
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont U Barb Enzyme Pack Bottle: 1 liter.......... 10/19/87
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont U Benz Enzyme Pack Bottle: 1 liter.......... 10/19/87
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont U COC Enzyme Pack Bottle: 1 liter.......... 10/19/87
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont U OPI Enzyme Pack Bottle: 1 liter.......... 8/28/87
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont U THC Enzyme Pack Bottle: 1 Liter.......... 1/4/88
Reagent.
E.I. duPont de Nemours & Co., Inc...... DuPont Urine Drugs-of-Abuse Box: 6 Vials, 6ml Vial... 7/27/87
Calibrator (Levels 0, 1, 2).
E.I. duPont de Nemours & Co., Inc...... DuPont Urine Drugs-of-Abuse Vial: 6ml................ 8/3/87
Control.
E.I. duPont de Nemours & Co., Inc...... DuPont aca Barbiturate Screen Plastic Packs: 25 tests.. 12/23/84
Analytical Test Pack.
E.I. duPont de Nemours & Co., Inc...... DuPont aca Barbiturate Screen/ 6 Vials: 3ml............. 2/23/84
Benzodiazepine Screen
Calibrator.
E.I. duPont de Nemours & Co., Inc...... DuPont aca Benzodiazepine Plastic Packs: 25 tests.. 2/23/84
Screen Analytical Test Pack.
E.I. duPont de Nemours & Co., Inc...... Phenobarbital Calibrator-Level Vial: 6ml (1 vial/box)... 4/2/86
1.
E.I. duPont de Nemours & Co., Inc...... Phenobarbital Calibrator-Level Vial: 6ml (1 vial/box)... 4/2/86
2.
E.I. duPont de Nemours & Co., Inc...... Phenobarbital Calibrator-Level Vial: 6ml (1 vial/box)... 4/2/86
3.
E.I. duPont de Nemours & Co., Inc...... Phenobarbital Calibrator-Level Vial: 6ml (1 vial/box)... 4/2/86
4.
E.I. duPont de Nemours & Co., Inc...... Phenobarbital Calibrator-Level Vial: 6ml (1 vial/box)... 4/2/86
5.
E.I. duPont de Nemours & Co., Inc...... Theophylline Calibrator Levels Vial: 6ml. Box contains 2 9/21/88
1, 2 and 3. vials each level.
E.I. duPont de Nemours & Co., Inc...... Thyroid Rotor.................. Foil Pouch: 1 Rotor Shelf 10/25/88
Carton: 10 Rotors Box: 5
Shelf Cartons (50
Rotors).
E.I. duPont de Nemours & Co., Inc...... Thyronine (TU) Uptake Flex..... 32 Test Cartridge, 3/29/89
Carton: 7 cartridges.
E.I. duPont de Nemours & Co., Inc...... Thyronine (TU) Uptake Flex(tm) Plastic container: 2.3ml 4/28/86
Reagent Cartridge. (20 tests).
E.I. duPont de Nemours & Co., Inc...... Urine Amphetamine (U Amp) Test Carton: 50 tests......... 8/27/87
Pack.
E.I. duPont de Nemours & Co., Inc...... Urine Barbiturate (U Barb) Test Carton: 50 tests......... 8/27/87
Pack.
E.I. duPont de Nemours & Co., Inc...... Urine Benzodiazepine (U Benz) Carton: 50 tests......... 8/27/87
Test Pack.
E.I. duPont de Nemours & Co., Inc...... Urine Cannabinoid (U THC) Test Carton: 50 tests......... 11/9/87
Pack.
E.I. duPont de Nemours & Co., Inc...... Urine Cocaine (U COC) Test Pack Carton: 50 tests......... 8/27/87
E.I. duPont de Nemours & Co., Inc...... Urine Opiate (U OPI) Test Pack. Carton: 50 tests......... 7/8/87
E.I. duPont de Nemours & Co., Inc...... aca PHNO Analytical Test Pack.. Carton: 40 tests packs... 8/25/77
E.I. duPont de Nemours & Co., Inc...... aca Thryonine Uptake Analytical Plastic Pack: 1 test..... 8/25/83
Test Pack.
E.I. duPont de Nemours & Co., Inc...... aca Urine Methadone Calibrator Vial: 10ml............... 9/17/93
(Level 1 & 2).
E.I. duPont de Nemours & Co., Inc...... aca Urine Methadone Control Vial: 6ml................ 9/17/93
(Negative/Positive).
E.I. duPont de Nemours & Co., Inc., 5-Cyclohexenyl-3,5,-Dimethyl Combi-Vial: 250 1/4/77
Medical Products. barbituric Acid (3H(G)), microcuries, 1
Catalog No. NET-426. millicurie, and 5
millicuries.
E.I. duPont de Nemours & Co., Inc., Acetaldehyde (1, 2-14C) as Pyrex Glass Breakseal 1/4/77
Medical Products. Paraldehyde, Catalog No. NEC- Tube: 250 microcuries, 1
158. millicurie.
[[Page 138]]
E.I. duPont de Nemours & Co., Inc., Cocaine, Levo-[Benzoyl] [3.4- Combi-Vial: 100 1/4/77
Medical Products. 3H(N)] Catalog No. NET-510. microcuries, 250
microcuries.
E.I. duPont de Nemours & Co., Inc., Diazepam [Methyl-3H] Catalog Combi-Vial: 0.250 9/6/79
Medical Products. No. NET-564. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Dihydromorphine [7, 8-3H(N)]... Combi-Vial: 250 1/4/77
Medical Products. microcuries, 1
millicurie.
E.I. duPont de Nemours & Co., Inc., Dihydromorphine [N-Methyl-3H] Combi-Vial: 0.250 2/29/80
Medical Products. NET-658. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Dihydrotestosterone, [1, 2, 4, NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 5, 6, 7, 16, 17-3H(N)]. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Dihydrotestosterone, [1, 2, 4, NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 5, 6, 7-3H(N)]-. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Dihydrotestosterone, [1, 2- NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 3H(N)]. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Dihydrotestosterone, [4-14C]-.. NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Drug Discovery Kit, No. NED- Kit: 100 tests, 500 tests 8/8/89
Medical Products. 002, NED-002A.
E.I. duPont de Nemours & Co., Inc., Drugs of Abuse Controls........ Bottle: 5ml.............. 1/11/95
Medical Products.
E.I. duPont de Nemours & Co., Inc., Flunitrazepam (Methyl-3H)...... Combi-Vial: 5 8/8/89
Medical Products. microcuries, 14
microcuries.
E.I. duPont de Nemours & Co., Inc., Flunitrazepam 2.5 Micro M...... Combi-Vial: 2.0 ml....... 8/8/89
Medical Products.
E.I. duPont de Nemours & Co., Inc., Flunitrazepam [Methyl-3H] NET Combi-Vial: 0.250 4/29/87
Medical Products. 567. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., LSD [N-Methyl-3H] NET-638...... Combi-Vial: 0.250 11/6/79
Medical Products. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Mazindol (4'-3H) Catalog No.NET- Combi-Vial: 0.250 5/17/84
Medical Products. 816. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Methylenedioxymethamphetamine, Combi-Vial: 0.0250 8/25/75
Medical Products. (+)3,4-[N-methyl-3H] NET 957. millicuries, 0.25
millicuries, 1.0
millicuries.
E.I. duPont de Nemours & Co., Inc., Methylphenidate, +/- Combi-Vial: 0.250 6/11/84
Medical Products. threo[methyl-3H]NET-857. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Mibolerone..................... Glass Vial: 5ml.......... 11/1/91
Medical Products.
E.I. duPont de Nemours & Co., Inc., Mibolerone, [17Alpha-methyl-3H]- NENSURE Vial: 0.8ml, 11/1/91
Medical Products. . 6.2ml.
E.I. duPont de Nemours & Co., Inc., Morphine [N-methyl-3H] NET-653. Combi-Vial: 0.250 2/29/80
Medical Products. millicuries, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., N-[1-(2-Thienyl) Cyclohexyl]-3, Combi-Vial: 0.250 6/11/84
Medical Products. 4-Piperidine (Piperidyl-3,4- millicuries, 1.0
3H)NET-886. millicurie.
E.I. duPont de Nemours & Co., Inc., Phencyclidine [Piperidyl-3,4- Combi-Vial: 0.250 9/6/79
Medical Products. 3H(N)], Catalog No.NET-630. millicurie, 1.0
millicurie.
E.I. duPont de Nemours & Co., Inc., Phenobarbital (PHNO) Flex Cartridge: Plastic....... 5/26/94
Medical Products. Reagent Cartridge.
E.I. duPont de Nemours & Co., Inc., Testosterone, [1,2,6,7,16,17- NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 3H(N)]. 6.2ml.
[[Page 139]]
E.I. duPont de Nemours & Co., Inc., Testosterone, [1,2,6,7-3H(N)]-. NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Testosterone, [1Alpha, 2Alpha, - NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 3H(N)]-. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Testosterone, [1Beta, 2Beta,- NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 3H(N)]-. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Testosterone, [4-14C]-......... NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 6.2ml; Glass Vial: 10ml.
E.I. duPont de Nemours & Co., Inc., Testosterone, [7-3H(N)]-....... NENSURE Vial: 0.8ml, 11/1/91
Medical Products. 6.2ml.
E.I. duPont de Nemours & Co., Inc., Urine Cannabinoids Screen Cartridge: Plastic....... 4/19/94
Medical Products. (UTHC) Flex Reagent Cartridge.
E.I. duPont de Nemours & Co., Inc., Urine Cocaine Metabolites Cartridge: Plastic....... 4/19/94
Medical Products. Screen (UCOC) Flex Reagent
Cartridge.
E.I. duPont de Nemours & Co., Inc., Urine Opiates Screen (UOPI) Cartridge: Plastic....... 4/19/94
Medical Products. Flex Reagent Cartridge.
E.I. duPont de Nemours & Co., Inc., d-Amphetamine Sulfate (3H(G)), Combi-Vial: 250 1/4/77
Medical Products. Catalog No. NET-140. microcuries, 1
millicurie, and 5
millicuries.
EDITEK Inc............................. EZ-SCREEN Amphetamines Bulk Bottle: 250ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN Amphetamines Bulk Bottle: 4L............... 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN Amphetamines Positive Flask: 100ml............. 8/17/94
Control Stock.
EDITEK Inc............................. EZ-SCREEN Amphetamines QC Tube: 50ml............... 8/17/94
Standard.
EDITEK Inc............................. EZ-SCREEN Barbiturates Bulk Tube: 50ml............... 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN Barbiturates Bulk Bottle: 8L............... 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN Barbiturates Positive Flask: 100ml............. 8/17/94
Control Stock.
EDITEK Inc............................. EZ-SCREEN Barbiturates QC Tube: 50ml............... 8/17/94
Standard.
EDITEK Inc............................. EZ-SCREEN CANNABINOID/COCAINE Tube: 2.2ml.............. 8/17/94
0.5ml Positive Control.
[[Page 140]]
EDITEK Inc............................. EZ-SCREEN CANNABINOID/COCAINE Bottle: 15ml............. 8/17/94
5.0ml Positive Control.
EDITEK Inc............................. EZ-SCREEN CANNABINOID/COCAINE/ Bottle: 20L.............. 8/17/94
OPIATES Bulk Positive Control.
EDITEK Inc............................. EZ-SCREEN COCAINE Bulk Bottle: 250ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN COCAINE Bulk Positive Bottle: 8L............... 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN COCAINE Positive Flask: 100ml............. 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN COCAINE QC Standard.. Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN OPIATES Bulk Tube: 50ml............... 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN OPIATES Bulk Positive Bottle: 4L............... 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN OPIATES Positive Flask: 100ml............. 8/17/94
Control Stock.
EDITEK Inc............................. EZ-SCREEN OPIATES QC Standard.. Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN PCP Bulk Conjugate... Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN PCP Bulk Positive Bottle: 2L............... 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN PCP Positive Control Flask: 100ml............. 8/17/94
Stock.
EDITEK Inc............................. EZ-SCREEN PCP QC Standard...... Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN THC Bulk Conjugate... Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN THC Bulk Positive Bottle: 8L............... 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN THC Positive Control Flask: 10ml.............. 8/17/94
Stock.
EDITEK Inc............................. EZ-SCREEN THC QC Standard...... Tube: 50ml............... 8/17/94
EDITEK Inc............................. EZ-SCREEN: Amphetamines 0.5ml Tube: 2.2ml.............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: Amphetamines 20-Test Kit: 20 Tests............ 8/17/94
Bulk Kit.
EDITEK Inc............................. EZ-SCREEN: Amphetamines 20-Test Kit: 20 Tests............ 8/17/94
Pack.
EDITEK Inc............................. EZ-SCREEN: Amphetamines 5.0ml Bottle: 15ml............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: Amphetamines Enzyme Ampule: 0.8ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN: Amphetamines Test Kit: 1 Test.............. 8/17/94
Kit.
EDITEK Inc............................. EZ-SCREEN: Barbiturates 0.5ml Tube: 2.2ml.............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: Barbiturates 20-Test Kit: 20 Tests............ 8/17/94
Bulk Kit.
EDITEK Inc............................. EZ-SCREEN: Barbiturates 20-Test Kit: 20 Tests............ 8/17/94
Pack.
EDITEK Inc............................. EZ-SCREEN: Barbiturates 5.0ml Bottle: 15ml............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: Barbiturates Enzyme Ampule: 0.8ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN: Barbiturates Test Kit: 1 Test.............. 8/17/94
Kit.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID 0.5 ml Tube: 2.2ml.............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID 20-Test Kit: 20 Tests............ 8/17/94
Bulk Kit.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID 20-Test Kit: 20 Tests............ 8/17/94
Pack.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID 5.0ml Bottle: 15ml............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID Enzyme Ampule: 0.8ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID Test Kit Kit: 1 Test.............. 8/17/94
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE Kit: 20 Tests............ 8/17/94
20-Test Bulk Kit.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE Kit: 20 Tests............ 8/17/94
20-Test Pack.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE Ampule: 0.8ml............ 8/17/94
Enzyme Conjugate.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE Kit: 1 Test.............. 8/17/94
Test Kit.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Tube: 2.2ml.............. 8/17/94
OPIATES 0.5ml Positive Control.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Kit: 10 Tests............ 8/17/94
OPIATES 10-Test Bulk Kit.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Kit: 20 Tests............ 8/17/94
OPIATES 20-Test Kit Pack.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Bottle: 15ml............. 8/17/94
OPIATES 5.0ml Positive Control.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Ampule: 0.8ml............ 8/17/94
OPIATES Enzyme Conjugate.
EDITEK Inc............................. EZ-SCREEN: CANNABINOID/COCAINE/ Kit: 1 Test.............. 8/17/94
OPIATES Test Kit.
EDITEK Inc............................. EZ-SCREEN: COCAINE 0.5ml Tube: 2.2ml.............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: COCAINE 20 Test Bulk Kit: 20 Tests............ 8/17/94
Kit.
EDITEK Inc............................. EZ-SCREEN: COCAINE 20-Test Pack Kit: 20 Tests............ 8/17/94
EDITEK Inc............................. EZ-SCREEN: COCAINE 5.0ml Bottle: 15ml............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: COCAINE Enzyme Ampule: 0.8ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN: COCAINE Test Kit.... Kit: 1 Test.............. 8/17/94
EDITEK Inc............................. EZ-SCREEN: OPIATES 0.5ml Tube: 2.2ml.............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: OPIATES 20 Test Pack Kit: 20 Tests............ 8/17/94
EDITEK Inc............................. EZ-SCREEN: OPIATES 20-Test Bulk Kit: 20 Tests............ 8/17/94
Kit.
EDITEK Inc............................. EZ-SCREEN: OPIATES 5.0ml Bottle: 15ml............. 8/17/94
Positive Control.
EDITEK Inc............................. EZ-SCREEN: OPIATES Enzyme Ampule: 0.8ml............ 8/17/94
Conjugate.
EDITEK Inc............................. EZ-SCREEN: OPIATES Test Kit.... Kit: 1 Test.............. 8/17/94
EDITEK Inc............................. EZ-SCREEN: PCP 0.5ml Positive Ampule: 0.8ml............ 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN: PCP 20-Test Bulk Kit Kit: 20 Tests............ 8/17/94
EDITEK Inc............................. EZ-SCREEN: PCP 20-Test Kit..... Kit: 20 Tests............ 8/17/94
EDITEK Inc............................. EZ-SCREEN: PCP 5.0ml Positive Bottle: 15ml............. 8/17/94
Control.
EDITEK Inc............................. EZ-SCREEN: PCP Enzyme Conjugate Ampule: 0.8ml............ 8/17/94
EDITEK Inc............................. EZ-SCREEN: PCP Test Kit........ Kit: 1 Test.............. 8/17/94
EDITEK Inc............................. VERDICT COCAINE One-Step Drug Pouch: 1 each; Box: 50 8/2/94
Test; Product # 600230. Pouches.
EDITEK Inc............................. VERDICT Cocaine Bulk Conjugate. Vial: 2ml................ 8/14/94
EDITEK Inc............................. VERDICT Cocaine Bulk Conjugate. Vial: 2ml................ 8/14/94
EDITEK Inc............................. VERDICT Cocaine QC Standard.... Tube: 50ml............... 8/14/94
EDITEK Inc............................. VERDICT OPIATES One-Step Drug Pouch: 1 each; Box: 50 8/2/94
Test; Product # 600233. Pouches.
EDITEK Inc............................. VERDICT Opiates Bulk Conjugate. Vial: 2ml................ 8/14/94
EDITEK Inc............................. VERDICT Opiates Bulk Conjugate. Vial: 5ml................ 8/14/94
EDITEK Inc............................. VERDICT Opiates QC Standard.... Tube: 15ml............... 8/14/94
EDITEK Inc............................. VERDICT PCP 50-Test Kit, Cat # Kit: 50 Tests............ 1/11/96
600226.
EDITEK Inc............................. VERDICT PCP Bulk Conjugate Vial: 2ml................ 1/11/96
0.5ml, 2.0ml.
EDITEK Inc............................. VERDICT PCP QC Standard........ Tube: 50ml............... 1/11/96
EDITEK Inc............................. VERDICT THC Bulk Conjugate..... Vial: 2ml................ 8/14/94
EDITEK Inc............................. VERDICT THC Bulk Conjugate..... Vial: 5ml................ 8/14/94
EDITEK Inc............................. VERDICT THC One-Step Drug Test; Pouch: 1 each; Box: 50 8/2/94
Product # 600212. Pouches.
EDITEK Inc............................. VERDICT THC QC Standard........ Tube: 50ml............... 8/14/94
EDITEK Inc............................. VERDICT THC/COCAINE One-Step Pouch: 2 Kits............ 8/14/94
Drug Test.
EM Diagnostic Systems, Inc............. EMDS Antiepileptic Drug Box: 3 Vials, 5 ml each.. 6/11/86
Calibrator Item No. 67630/95.
EM Diagnostic Systems, Inc............. EMDS Test Packs, Phenobarbital Carton: 48 Test Packs.... 9/9/86
(PHENO) Item No. 67677/95.
EM Diagnostic Systems, Inc............. Easytest Phenobarbital Assay Cuvette: 1.8ml (40 6/11/86
Item No. 67534/93. cuvettes /carton).
Eastman Kodak Company.................. KODATROL Control I Control and 1 Set: 2 amber glass 7/21/88
Diluent Set. vials ea. 6 ml 1 Box: 12
sets.
Eastman Kodak Company.................. KODATROL Control II Control and 1 Set: 2 amber glass 7/21/88
Diluent Set. vials ea. 6 ml 1 Box: 12
sets.
Eastman Kodak Company.................. Kodak EKTACHEM Specialty Vial: 3ml................ 9/13/85
Calibrator.
Eastman Kodak Company.................. Kodak EKTACHEM Specialty Vial: 3ml................ 9/13/85
Control I.
Eastman Kodak Company.................. Kodak Ektachem Specialty Glass Vial: 6 ml......... 11/10/87
Control II.
[[Page 141]]
Electro-Nucleonics Laboratories, VIRGO IPA Immuno-Precipitation Kit...................... 11/30/82
Incorporated. Assay for Phenobarbital.
Eli Lilly and Company.................. Propoxyphene Industrial Hygiene Cassette: Plastic........ 7/13/94
Air Monitoring Sample Cassette.
Elsohly Laboratories, Inc.............. (-)-11 Nor-delta-9-THC-COOH Vial: 1ml................ 3/26/95
100ug/ml.
Elsohly Laboratories, Inc.............. 11-Hydroxy-delta-9-THC, 100ug/ Vial: 1ml................ 3/26/95
ml.
Elsohly Laboratories, Inc.............. 8-Beta, 11-dihydroxy-delta-9- Vial: 1ml................ 3/26/95
THC, 100ug/ml.
Elsohly Laboratories, Inc.............. 8-Beta-hydroxy-delta-9-THC, Vial: 1ml................ 3/26/95
100ug/ml.
Elsohly Laboratories, Inc.............. Difluorobenzoylecgonine, 100ug/ Vial: 1ml................ 3/26/95
ml.
Elsohly Laboratories, Inc.............. Difluorococaine, 100ug/ml...... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. Difluorophencyclidine, 100ug/ml Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. Urine Controls................. Bottles: 15ml-40L........ 3/26/95
Elsohly Laboratories, Inc.............. d2-Dihydrocodeine, 100ug/ml.... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d2-Dihydromorphine, 100ug/ml... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d3-Codeine, 100ug/ml........... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d3-Hydrocodone, 100ug/ml....... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d3-Hydromorphone, 100ug/ml..... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d3-Morphine, 100ug/ml.......... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d3-Oxycodone, 100ug/ml......... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d6-11-Nor-delta-8-THC-9-COOH, Vial: 1ml................ 3/26/95
100ug/ml.
Elsohly Laboratories, Inc.............. d6-11-Nor-delta-9-THC-9-COOH, Vial: 1ml................ 3/26/95
100ug/ml.
Elsohly Laboratories, Inc.............. d6-Amphetamine, 100ug/ml....... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d6-Delta-8-THC, 100ug/ml....... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d9-Delta-9-THC, 100ug/ml....... Vial: 1ml................ 3/26/95
Elsohly Laboratories, Inc.............. d9-Methamphetamine, 100ug/ml... Vial: 1ml................ 3/26/95
Endocrine Metabolic Center............. 0.1% Lysozyme-Barbital Buffer, Glass Bottle: 2 liter.... 5/28/87
0.05M.
Endocrine Metabolic Center............. 1% Lysozyme-Barbital Buffer, Glass Bottle: 2 liter.... 5/28/87
0.05M.
Endocrine Metabolic Center............. Barbital Buffer, 0.05M......... Plastic Bottle: 3000 ml.. 5/28/87
Endocrine Metabolic Center............. Barbital Buffer, 0.1M.......... Plastic Bottle: 3000 ml.. 5/28/87
Endocrine Metabolic Center............. Tracer Diluent................. Glass Bottle: 1 or 2 5/28/87
liter.
Environmental Diagnostics, Inc......... EZ-Screen: Cannabinoid Enzyme Ampule: 1 ml............. 2/3/87
Conjugate.
Environmental Diagnostics, Inc......... EZ-Screen: Cannabinoid Kit Kit: 1 test.............. 2/3/87
Catalog No. 216-2BP.
Environmental Diagnostics, Inc......... EZ-Screen: Cannabinoid Positive Ampule: 1 ml............. 2/3/87
Control.
Environmental Diagnostics, Inc......... EZ-Screen: Cannabinoid/Cocaine- Polyethylene Tube: 12/20/88
Enzyme Conjugate. containing ampule with 1
tablet, Kit: 1 test.
Environmental Diagnostics, Inc......... EZ-Screen: Cannabinoid/Cocaine- Polyethylene Tube: 2.2ml, 12/20/89
Positive Control. Kit: 1 test.
Fisher Diagnostics..................... TheraChem Anticonvulsants/ Kit: 9 vials, vial: 5ml.. 3/3/81
Theophylline, Level I, II.
Fisher Scientific...................... Electrophoretic Buffer No. 1 pH Packet: 12.14 g.......... 10/27/72
8.60, Ionic Strength 0.05,
Catalog No. E-1.
Fisher Scientific...................... Electrophoretic Buffer No. 2, Packet: 18.16 g.......... 10/27/72
pH 8.60, Ionic Strength 0.075,
Catalog No. E-2.
Fisher Scientific...................... IL-Test Phenobarbital.......... Kit: contains 2 plastic 3/15/88
containers of reagent 2.
Fisher Scientific...................... IL-Test Phenobarbital Plastic Container: 16 ml. 3/15/88
Conjugate, Reagent 2.
Fisher Scientific...................... Owren's Veronal Buffer, CS1094- Vial: 10 ml.............. 8/18/86
34.
Fisher Scientific...................... Owren's Veronal Buffer, CS1094- Vial: 25 ml.............. 8/18/86
38.
Fisher Scientific...................... SeraChem Abnormal Clinical Vial: 5ml, 10ml.......... 4/16/82
Chemistry Control Serum
(Human) Unassayed No. 2906.
Fisher Scientific...................... SeraChem Abnormal Clinical Vial: 5ml................ 4/16/82
Chemistry Control Serum
(Human), Assayed No. 2905.
Fisher Scientific...................... SeraChem Normal Clinical Vial: 5ml................ 4/16/82
Chemistry Control Serum
(Human), Assayed No. 2907.
Fisher Scientific...................... SeraChem Plus Clinical Vial: 10ml, Box: 50 7/25/89
Chemistry Control Sera vials, Carton: 4 boxes.
Unassayed (Bovine) Level I.
Fisher Scientific...................... SeraChem Plus Clinical Vial: 10 ml, Box: 50 7/25/89
Chemistry Control Sera vials, Carton: 4 boxes.
Unassayed (Bovine) Level II.
Fisher Scientific...................... SeraChem Normal Clinical Vial: 5ml, 10ml.......... 4/16/82
Chemistry Control Serum
(Human), Unassayed No. 2908.
Fisher Scientific...................... TDM Cal........................ Kit: 7 Vials............. 11/26/86
Fisher Scientific...................... TDM Cal (B-F).................. Vials: 5 ml.............. 11/26/86
Fisher Scientific...................... Thera Chem TDC Therapeutic Drug Kit: 6 vials............. 1/12/84
Controls, Low and High Levels,
2840-58.
Fisher Scientific...................... TheraChem-Plus TDC Therapeutic Kit: 9 vials............. 3/19/86
Drug Controls, Tri-Level, No.
2845-94.
Fisher Scientific...................... Therapeutic Drug Control, High Vial: 5ml................ 3/19/86
Level III, No. 2848-31.
Fisher Scientific...................... Therapeutic Drug Control, High Vial: 5ml................ 1/12/84
Level, 2842-31.
Fisher Scientific...................... Therapeutic Drug Control, Low Vial: 5ml................ 3/19/86
Level I, No. 2846-31.
[[Page 142]]
Fisher Scientific...................... Therapeutic Drug Control, Low Vial: 5ml................ 1/12/84
Level, 2841-31.
Fisher Scientific...................... Therapeutic Drug Control, Mid- Vial: 5ml................ 3/19/86
Range Level II, No. 2847-31.
Fisher Scientific...................... Urine Chemistry Control (Human) Vial: 25ml............... 4/6/78
Level II, No. 2935-80.
Fisher Scientific...................... Urine Toxicology Control No. Vial: 25ml............... 4/6/78
2950-61.
Flow Laboratories...................... DGV No. 28-010................. Bottle: 125 ml........... 4/16/73
Flow Laboratories...................... Human ``O'' DGV (Dextrose Glass Vial: 100 ml....... 10/14/76
Gelatin Veronal Buffer) No. 28-
080.
GIBCO Laboratories..................... Complement Fixation Buffer Bottle: 1 liter.......... 1/28/74
Solution, pH 7.3-7.4, NDC
0118115-0247-1.
GIBCO Laboratories..................... Complement Fixation Buffer Bottle: 500 ml........... 4/5/77
Solution, pH 7.3-7.4, NDC
011815-0247-2.
GIBCO Laboratories..................... Dextrose-Gelatin-Veronal Buffer Bottle: 100 and 500 ml... 7/5/73
Solution NDC No. 815-0566-1
and No. 815-0566-2.
GIBCO Laboratories..................... Electrophoresis Buffer Bottle: 1 liter.......... 1/28/74
Solution, pH 8.6, NDC 011815-
0245-1.
GIBCO Laboratories..................... I.E.P. Buffer Solution pH 8.2 Bottle: 1 liter.......... 1/28/74
NDC 011815-0246-1.
Gelman Sciences, Inc................... Drug Control Set No. 51911..... Set: 3 vials of 50 ml 4/6/72
each.
Gelman Sciences, Inc................... Drug Standard Set, No. 51910... Set: 3 vials of 2 ml each 4/6/72
Gelman Sciences, Inc................... Hi-Phore Buffer................ Glass Vial: 15 g......... 2/11/82
Gelman Sciences, Inc................... High Resolution Buffer-Tris Vial: 10 dr.............. 12/22/71
Barbital Buffer No. 51104.
Gumm Chem. Co.......................... Niflow Initial Additive........ Drums: 5 Gallons......... 9/30/85
Gumm Chem. Co.......................... Niflow Maintenace Additive..... Drums: 5 Gallons......... 9/30/85
Hach Chemical Co....................... pH 8.3 Buffer Powder Pillows. Pillow: 1 g. each........ 11/30/71
No. 898-98.
Helena Laboratories.................... Cardio REP CK Isoenzymes Gel... Plate: 4.6'' x 2.4''..... 9/24/93
Helena Laboratories.................... CK-LD Buffer Catalog No. 5808.. Packet: 18.332 g. , 10 3/26/86
packets/box.
Helena Laboratories.................... Cardio REP CK Isoenzymes Kit, Kit: 10 Plates........... 9/24/93
Cat. # 3310.
Helena Laboratories.................... Cardio REP CK Isoforms Gel..... Plate: 4.6'' x 2.4''..... 9/24/93
Helena Laboratories.................... Cardio REP CK Isoforms Kit, Kit: 10 Plates........... 9/24/93
Cat. # 3305.
Helena Laboratories.................... Electra B1 Buffer, Catalog No. Packet: 13.1g. 10 packets/ 12/28/73
5016. box.
Helena Laboratories.................... Electra B2 Buffer, Catalog No. Packet: 18.2 g. 10 12/28/73
5017. packets/ box.
Helena Laboratories.................... Electra HR Buffer, Catalog No. Packet: 18.1 g. 10 12/28/73
5805. packets/ box.
Helena Laboratories.................... HDL Electrophoresis Buffer..... Packet: 36 g............. 12/18/85
Helena Laboratories.................... Isoamylase Cathode Buffer...... Packet: 9.7 g............ 12/18/85
Helena Laboratories.................... Isoamylase Kit Catalog No. 5925 Kit: 2 Packets Cathode 1/24/86
Buffer.
Helena Laboratories.................... Owren's Veronal Buffer Cat. No. Plastic Bottle: 125 ml... 9/15/88
5375.
Helena Laboratories.................... REP ALP-15 Gel................. Plate: 5.8'' x 5.5''..... 8/26/93
Helena Laboratories.................... REP Alkaline Phosphatase Cat. # Kit: 10 Plates........... 8/26/93
3152.
Helena Laboratories.................... REP CK Isoforms-15............. Plate: 5.8'' x 5.5''..... 3/9/88
Helena Laboratories.................... REP CK Isoforms-15 Kit: Cat. Kit: 10 plates........... 3/9/88
No. 3081.
Helena Laboratories.................... REP CK Isoforms-4 Cat. # 3083.. Kit: 10 Plates........... 8/26/93
Helena Laboratories.................... REP CK Isoforms-4 Gel.......... PLate: 5.8'' x 1.25''.... 8/26/93
Helena Laboratories.................... REP CK Isoforms-8 Cat. # 3082.. Kit: 10 Plates........... 8/26/93
Helena Laboratories.................... REP CK Isoforms-8 Gel.......... Plate: 5.8'' x 2.18''.... 8/26/93
Helena Laboratories.................... REP CK-12...................... Plate: 5.8'' x 2.18''.... 3/9/88
Helena Laboratories.................... REP CK-12 Isoenzyme Kit: Cat. Kit: 10 plates........... 3/9/88
No. 3071.
Helena Laboratories.................... REP CK-2 STAT Kit, Cat. No. Kit: 10 plates (5.8'' x 3/30/89
3074. 0.6'').
Helena Laboratories.................... REP CK-30...................... Plate: 5.8'' x 5.5''..... 3/9/88
Helena Laboratories.................... REP CK-30 Isoenzyme Kit........ Kit: 10 plates........... 3/9/88
Helena Laboratories.................... REP CK-6....................... Plate: 5.8'' x 1.25''.... 3/9/88
Helena Laboratories.................... REP CK-6 Isoenzyme Kit: Cat. Kit: 10 plates........... 3/9/88
No. 3072.
Helena Laboratories.................... REP ImmunoFix Kit # 3150....... Kit: 10 plates........... 3/9/93
Helena Laboratories.................... REP LD......................... Plates: 5.8'' x 5.5'', 3/9/88
5.8'' x 2.18'', 5.8'' x
1.25''.
Helena Laboratories.................... REP SPE Hi Res-15 Kit, Cat. No. Kit: 10 plates (5.8'' x 3/30/89
3176. 5.5'').
Helena Laboratories.................... REP SPE-16 Template (Acid Blue) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3171.
Helena Laboratories.................... REP SPE-16 Template (Ponceau S) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3161.
Helena Laboratories.................... REP SPE-16 Template Gel........ Plate: 5.8'' 2.18''...... 9/14/93
Helena Laboratories.................... REP SPE-30 Template (Acid Blue) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3170.
Helena Laboratories.................... REP SPE-30 Template (Ponceau S) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3160.
Helena Laboratories.................... REP SPE-30 Template Gel........ Plate: 5.8'' x 5.5''..... 9/14/93
Helena Laboratories.................... REP SPE-8 Template (Acid Blue) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3172.
Helena Laboratories.................... REP SPE-8 Template (Ponceau S) Kit: 10 Plates........... 9/14/93
Kit, Cat. # 3162.
Helena Laboratories.................... REP SPE-8 Template Gel......... Plate: 5.8'' x 1.25''.... 9/14/93
Helena Laboratories.................... REP Ultra-30 HDL, VLDL/LDL Gel. Plate: 5.8'' x 5.5''..... 9/24/93
Helena Laboratories.................... REP Ultra-30 HDL, VLDL/LDL Kit, Kit: 10 Plates........... 9/24/93
Cat. # 3183.
[[Page 143]]
Helena Laboratories.................... REP Ultra-8 HDL, VLDL/LDL Gel.. Plate: 5.8'' x 1.25''.... 9/24/93
Helena Laboratories.................... REP Ultra-8 HDL, VLDL/LDL Kit, Kit: 10 Plates........... 9/24/93
Cat. # 3185.
Helena Laboratories.................... REP-HDL-12 Isoenzyme Kit Cat. Kit: 10 Plates (5.8'' x 9/15/88
No. 3187. 2.18'').
Helena Laboratories.................... REP-HDL-30 Isoenzyme Kit Cat. Kit: 10 Plates (5.8'' x 9/15/88
No. 3186. 5.5'').
Helena Laboratories.................... REP-HDL-6 Isoenzyme Kit Cat. Kit: 10 Plates (5.8'' x 9/15/88
No. 3188. 1.25'').
Helena Laboratories.................... REP-Lipo-12 Kit Cat. No. 3181.. Kit: 10 Plates (5.8'' x 9/15/88
2.18'').
Helena Laboratories.................... REP-Lipo-30 Kit Cat. No. 3180.. Kit: 10 Plates (5.8'' x 9/15/88
5.5'').
Helena Laboratories.................... REP-Lipo-6 Kit Cat. No. 3182... Kit: 10 Plates (5.8'' x 9/15/88
1.25'').
Helena Laboratories.................... REP-SP-12 Isoenzyme Kit Cat. Kit: 10 Plates (5.8'' x 9/15/88
No. 3171. 2.18'').
Helena Laboratories.................... REP-SP-30 Isoenzyme Kit Cat. Kit: 10 Plates (5.8'' x 9/15/88
No. 3170. 5.5'').
Helena Laboratories.................... REP-SP-6 Isoenzyme Kit Cat. No. Kit: 10 Plates (5.8'' x 9/15/88
3172. 1.25'').
Helena Laboratories.................... Super Z-12XHDL Cholesterol Kit: 3 Packages buffer 36 1/24/86
Supply Kit Catalog No. 5470). g.
Helena Laboratories.................... TITAN GEL Alkaline Phosphatase Kit: 10 Plates........... 8/26/93
(HR) Cat. No. 3058.
Helena Laboratories.................... TITAN GEL Alkaline Phosphatase Kit: 1 bag............... 6/19/89
(HR) Kit, Cat. No. 3058.
Helena Laboratories.................... TITAN GEL Alkaline Phosphatase Plastic Bag: 13.1g....... 6/19/89
Buffer.
Helena Laboratories.................... TITAN GEL Alkaline Phosphatase Plate: 3.5'' x 2.9''..... 8/26/93
Gel.
Helena Laboratories.................... Titan Gel High Resolution Packet: 25.9 g........... 4/12/83
Protein Buffer.
Helena Laboratories.................... Titan Gel High Resolution Kit: 10 Plates (90mm x 3/3/86
Protein Kit Catalog No. 3040. 75mm), 2 Packages Buffer.
Helena Laboratories.................... Titan Gel High Resolution Plate: (90mm x 75mm)..... 3/3/86
Protein Plate.
Helena Laboratories.................... Titan Gel IFE Buffer........... Packet: 25.9 g........... 12/18/85
Helena Laboratories.................... Titan Gel IFE Plate............ Plate: (90mm x 75mm)..... 3/5/86
Helena Laboratories.................... Titan Gel Immuno Fix Kit Kit: 10 Plates (90mm x 1/24/86
Catalog No. 3046. 75mm), 2 Packets IFE
Buffer.
Helena Laboratories.................... Titan Gel ImmunoFix Plus Kit # Kit: 10 plates, 1 pkg IFE 3/9/93
3067. buffer.
Helena Laboratories.................... Titan Gel ImmunoFix-9 Kit # Kit: 10 plates, 1 pkg IFE 3/9/93
3051. buffer.
Helena Laboratories.................... Titan Gel Iso Dot LDH Buffer... Packet: 19.6 g........... 1/7/86
Helena Laboratories.................... Titan Gel Iso Dot LDH Isoenzyme Plate: (90mm x 75mm)..... 12/18/85
Plate.
Helena Laboratories.................... Titan Gel Iso Dot LDH Kit Kit: 10 Plates (90mm x 1/24/86
Catalog No. 3062. 75mm), 1 Packet Iso Dot
LDH Buffer.
Helena Laboratories.................... Titan Gel LD Buffer............ Packet: 21.5 g........... 11/26/86
Helena Laboratories.................... Titan Gel LD Isoenzyme Diluent. Bottle: 10 ml............ 11/26/86
Helena Laboratories.................... Titan Gel LDH Isoenzyme Buffer. Packet: 22.7 g........... 3/7/83
Helena Laboratories.................... Titan Gel LDH Isoenzyme Plate.. Plate: (90mm x 75mm)..... 12/18/85
Helena Laboratories.................... Titan Gel LDH Isoenzyme Reagent Vial: 2ml, 10 vials/box.. 1/7/86
Helena Laboratories.................... Titan Gel Lipoprotein Buffer... Packet: 17.3 g........... 12/18/85
Helena Laboratories.................... Titan Gel Lipoprotein Kit Kit: 1 Packet Buffer..... 1/24/86
Catalog No. 3045.
Helena Laboratories.................... Titan Gel Lipoprotein Plate.... Plate: (90 x 75 mm)...... 1/9/87
Helena Laboratories.................... Titan Gel Multi-Slot Lipo-17 Kit: 10 plates (81 x 143 1/9/87
Kit Catalog No. 3095. mm) 1 packet buffer
(21.6 g).
Helena Laboratories.................... Titan Gel Multi-Slot Lipo-17 Plate: (81 x 143 mm)..... 1/9/87
Plate.
Helena Laboratories.................... Titan Gel Multi-Slot SP-17 Kit Kit: 10 plates (81 x 143 1/9/87
Catalog No. 3091. mm) 1 packet buffer
(29.1 g).
Helena Laboratories.................... Titan Gel Multi-Slot SP-17 Plate: 81 x 143 mm....... 1/9/87
Plate.
Helena Laboratories.................... Titan Gel Serum Protein Buffer. Packet: 29.1 g........... 4/12/83
Helena Laboratories.................... Titan Gel Serum Protein Kit Kit: 10 Plates (90mm x 1/24/86
Catalog No. 3041. 75mm), 1 Packet Buffer.
Helena Laboratories.................... Titan Gel Serum Protein Plate.. Plate: (90mm x 75mm)..... 12/18/85
Helena Laboratories.................... Titan Gel Silver Stain Buffer.. Packet: 25.9g............ 12/18/85
Helena Laboratories.................... Titan Gel Silver Stain Kit Kit: 10 Plates (90mm x 1/24/86
Catalog No. 3035. 75mm), 2 Packets Buffer.
Helena Laboratories.................... Titan Gel Silver Stain Plate... Plate: (90mm x 75mm)..... 3/3/86
Helena Laboratories.................... Titan Gel-PC LDH Isoenzyme Kit Kit: 10 Plates (90mm x 1/24/86
Catalog No. 3053. 75mm), 1 Packet LDH
Buffer, 1 Box LDH
Reagent.
Helena Laboratories.................... Titan Gel-PC LDH Isoenzyme Plate: (90mm x 75mm)..... 12/18/85
Plate.
Helena Laboratories.................... Titan III Agar Catalog No. 5023 Packet: 5 g. (5 Packets/ 12/28/73
box).
Helena Laboratories.................... Titan IV IE Plate (large)...... Package: plates, 3 by 4 12/28/73
in.
Helena Laboratories.................... Titan IV IE Plate (small)...... Package: plates, 1 by 3 12/28/73
in.
[[Page 144]]
Helena Laboratories.................... Titan IV IE Plate Kit.......... Kit: 12 small (1 by 3 12/28/73
in.) IE plates, 1 box B1
Buffer.
Helena Laboratories.................... Titan IV IE Plate Kit.......... Kit: 10 large (3 by 4 12/28/73
in.) IE Plates, 1 box B1
Buffer.
High Standard Products................. (DL) Methamphetamine 1.0mg/ml.. Ampule: 2ml.............. 5/11/93
High Standard Products................. (DL) Methamphetamine-d10 Ampule: 2ml.............. 5/11/93
100g/ml.
High Standard Products................. (DL) Methamphetamine-d5 Ampule: 2ml.............. 5/11/93
100g/ml.
High Standard Products................. 11-Nor-Delta-8-Carboxy- Ampule: 2ml.............. 5/11/93
Tetrahydrocannabinol 100g/ml.
High Standard Products................. 11-Nor-Delta-9-Carboxy- Ampule: 2ml.............. 5/11/93
Tetrahydrocannabinol 100ug/ml.
High Standard Products................. 11-Nor-Delta-9-Carboxy- Ampule: 2ml.............. 5/11/93
Tetrahydrocannabinol-d10 100ug/
ml.
High Standard Products................. 11-Nor-Delta-9-Carboxy- Ampule: 2ml.............. 5/11/93
Tetrahydrocannabinol-d3 100ug/
ml.
High Standard Products................. 11-Nor-Delta8 carboxy THC; Ampule: 2ml.............. 4/15/94
1.0mg/ml.
High Standard Products................. 11-Nor-Delta9 carboxy THC Ampules: 10; 5 of 2ml, 5 4/15/94
Screening/Confirmation of 20ml.
Calibrators; 10, 25, 50, 100,
250, ng/ml.
High Standard Products................. 11-Nor-Delta9 carboxy THC-d10; Ampule: 2ml.............. 4/15/94
0.1mg/ml.
High Standard Products................. 11-Nor-Delta9 carboxy THC; Ampule: 2ml.............. 4/15/94
1.0mg/ml.
High Standard Products................. 11-nor-Delta9 carboxy THC Ampules: 6; 3 of 2ml, 3 4/15/94
Controls; 10, 20, 100 ng/ml. of 20ml.
High Standard Products................. 3, 4- Ampule: 2ml.............. 5/11/93
Methylenedioxymethamphetamine
(MDMA) 100ug/ml.
High Standard Products................. 3, 4- Ampule: 2ml.............. 5/11/93
Methylenedioxymethamphetamine-
d5 (MDMA) 100ug/ml.
High Standard Products................. 3-Methylfentanyl 100ug/ml...... Ampule: 2ml.............. 5/11/93
High Standard Products................. 3-Methylfentanyl-d3 100ug/ml... Ampule: 2ml.............. 5/11/93
High Standard Products................. 4-Hydroxyamphetamine; 1.0mg/ml. Ampule: 2ml.............. 4/15/94
High Standard Products................. 4-Hydroxymethamphetamine; 1.0mg/ Ampule: 2ml.............. 4/15/94
ml.
High Standard Products................. 4-Methoxyamphetamine 1.0mg/ml.. Ampule: 2ml.............. 5/11/93
High Standard Products................. 4-Methoxyamphetamine-d5 100ug/ Ampule: 2ml.............. 5/11/93
ml.
High Standard Products................. 6-Acetylmorphine 100ug/ml...... Ampule: 2ml.............. 5/11/93
High Standard Products................. 6-Acetylmorphine-d3 100ug/ml... Ampule: 2ml.............. 5/11/93
High Standard Products................. 6-Acetylmorphine; 0.1mg/ml, Ampule: 2ml.............. 4/15/94
1.0mg/ml.
High Standard Products................. Amphetamine Cut-Off Controls; Ampules: 3; 20ml each.... 4/15/94
375, 625, 1500 ng/ml.
High Standard Products................. Amphetamine Screening Ampules: 4; 20ml each.... 4/15/94
Confirmation Calibrators; 500,
1000, 1500, 2000 ng/ml.
High Standard Products................. Benzoylecgonine 1.0mg/ml....... Ampule: 2ml.............. 5/11/93
High Standard Products................. Benzoylecgonine Cut-Off Ampules: 3; 20ml each.... 4/15/94
Controls; 100, 200, 300, ng/ml.
High Standard Products................. Benzoylecgonine Propyl Ester Ampule: 2ml.............. 5/11/93
1.0mg/ml.
High Standard Products................. Benzoylecgonine Screening Ampules: 4; 20ml each.... 4/15/94
Confirmation Calibrators; 150,
300, 450, 600 ng/ml.
High Standard Products................. Benzoylecgonine-d3 100ug/ml.... Ampule: 2ml.............. 5/11/93
High Standard Products................. Benzoylecgonine-d3; 0.1mg/ml... Ampule: 2ml.............. 4/15/94
High Standard Products................. Benzoylecgonine-d8 100ug/ml.... Ampule: 2ml.............. 5/11/93
High Standard Products................. Benzoylecgonine-d8; 0.1mg/ml... Ampule; 2ml.............. 4/15/94
High Standard Products................. Cocaethylene 1.0mg/ml.......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Cocaethylene-d3 100ug/ml....... Ampule: 2ml.............. 5/11/93
High Standard Products................. Cocaethylene-d3; 0.1mg/ml...... Ampule: 2ml.............. 4/15/94
High Standard Products................. Cocaethylene-d8 100ug/ml....... Ampule: 2ml.............. 5/11/93
High Standard Products................. Cocaethylene-d8; 0.1mg/ml...... Ampule: 2ml.............. 4/15/94
High Standard Products................. Cocaine 1.0mg/ml............... Ampule: 2ml.............. 5/11/93
High Standard Products................. Cocaine-d3 100ug/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Cocaine-d8 1.0mg/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Codeine 100ug/ml............... Ampule: 2ml.............. 5/11/93
High Standard Products................. Codeine Cut-Off Controls; 225, Ampules: 3; 20ml each.... 4/15/94
375, 900 ng/ml.
High Standard Products................. Codeine Screening Confirmation Ampules: 4; 20ml each.... 4/15/94
Calibrators; 300, 600, 900,
1200 ng/ml.
High Standard Products................. Codeine-d3 100ug/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Codeine-d3; 0.1mg/ml........... Ampule: 2ml.............. 4/15/94
High Standard Products................. Codeine-d6 100ug/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Codeine-d6; 0.1mg/ml........... Ampule: 2ml.............. 4/15/94
High Standard Products................. D-Amphetamine; 1.0mg/ml........ Ampule: 2ml.............. 4/15/94
High Standard Products................. DL Amphetamine 1.0mg/ml........ Ampule: 2ml.............. 5/11/93
High Standard Products................. DL Amphetamine-d10 100ug/ml.... Ampule: 2ml.............. 5/11/93
High Standard Products................. DL Amphetamine-d5 100ug/ml..... Ampule: 2ml.............. 5/11/93
High Standard Products................. DL-Amphetamine-d11; 0.1mg/ml... Ampule: 2ml, 20ml........ 4/15/94
High Standard Products................. DL-Amphetamine-d5; 0.1mg/ml.... Ampule; 2ml.............. 4/15/94
High Standard Products................. DL-Amphetamine-d6; 0.1mg/ml.... Ampule: 2ml, 20ml........ 4/15/94
High Standard Products................. Delta-8-Tetrahydrocannabinol Ampule: 2ml.............. 5/11/93
100ug/ml.
[[Page 145]]
High Standard Products................. Delta-9-Tetrahydrocannabinol Ampule: 2ml.............. 5/11/93
100ug/ml.
High Standard Products................. Delta-9-Tetrahydrocannabinol Ampule: 2ml.............. 5/11/93
100ug/ml.
High Standard Products................. Delta-9-Tetrahydrocannabinol- Ampule: 2ml.............. 5/11/93
d10 100ug/ml.
High Standard Products................. Delta-9-Tetrahydrocannabinol-d6 Ampule: 2ml.............. 5/11/93
100ug/ml.
High Standard Products................. Delta-9-THC; 1.0mg/ml.......... Ampule: 2ml.............. 4/15/94
High Standard Products................. Diazepam 1.0mg/ml.............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Diazepam-d5 100ug/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Diphenoxylate 1.0 mg/ml........ Ampule: 2ml.............. 5/11/93
High Standard Products................. Ecgonine 1.0mg/ml.............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Ecgonine Methyl Ester 1.0mg/ml. Ampule: 2ml.............. 5/11/93
High Standard Products................. Ecgonine Methyl Ester-d3 100ug/ Ampule: 2ml.............. 5/11/93
ml.
High Standard Products................. Ecgonine-d3 100ug/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Fentanyl 1.0mg/ml.............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Fentanyl-d5 100ug/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Fentanyl-d5; 0.1mg/ml.......... Ampule: 2ml.............. 4/15/94
High Standard Products................. Heroin, 1.0mg/ml............... Ampule: 2ml.............. 3/21/95
High Standard Products................. Heroin-D9, 0.1mg/ml............ Ampule: 2ml.............. 3/21/95
High Standard Products................. Hydrocodone 1.0mg/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Hydrocodone-d3 100ug/ml........ Ampule: 2ml.............. 5/11/93
High Standard Products................. Hydromorphone 1.0mg/ml......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Hydromorphone-d3 100ug/ml...... Ampule: 2ml.............. 5/11/93
High Standard Products................. Lysergic Acid Diethylamide 25 Ampule: 2ml.............. 5/11/93
ug/ml.
High Standard Products................. Lysergic Acid Diethylamide-d3 Ampule: 2ml.............. 5/11/93
25 ug/ml.
High Standard Products................. Lysergic Acid Diethylamide-dl Ampule: 2ml.............. 5/11/93
25ug/ml.
High Standard Products................. Lysergic Acid N-Methyl- Ampule: 2ml.............. 5/11/93
Propylamide (LAMPA) 25ug/ml.
High Standard Products................. Lysergic acid diethylamide-d7; Ampule: 2ml.............. 4/15/94
0.025mg/ml.
High Standard Products................. Methadone 1.0mg/ml............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Methadone-D6, 0.1mg/ml......... Ampule: 2ml.............. 3/21/95
High Standard Products................. Methadone-d3 100ug/ml.......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Methamphetamine Cut-Off Ampules: 3; 20ml each.... 4/15/94
Controls; 225, 375, 900 ng/ml.
High Standard Products................. Methamphetamine Screening Ampules: 4; 20ml each.... 4/15/94
Confirmation Calibrators; 500,
1000, 1500, 2000 ng/ml.
High Standard Products................. Methamphetamine-d14; 0.1mg/ml.. Ampule: 2ml, 20ml........ 4/15/94
High Standard Products................. Methamphetamine-d5; 0.1mg/ml... Ampule: 2ml.............. 4/15/94
High Standard Products................. Methamphetamine-d9; 0.1mg/ml... Ampule: 2ml, 20ml........ 4/15/94
High Standard Products................. Methaqualone 1.0 mg/ml......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Methaqualone-d3 100ug/ml....... Ampule: 2ml.............. 5/11/93
High Standard Products................. Methylenedioxyamphetamine (MDA) Ampule: 2ml.............. 5/11/93
1.0mg/ml.
High Standard Products................. Methylenedioxyamphetamine (MDA) Ampule: 2ml.............. 5/11/93
d-5 100ug/ml.
High Standard Products................. Methylenedioxyethylamphetamine, Ampule: 2ml.............. 3/21/95
1.0mg/ml.
High Standard Products................. Methylenedioxyethylamphetamine- Ampule: 2ml.............. 3/21/95
D7, 0.1mg/ml.
High Standard Products................. Morphine 1.0mg/ml.............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Morphine Cut-Off Controls; 225, Ampules: 3; 20ml each.... 4/15/94
375, 900 ng/ml.
High Standard Products................. Morphine Screening Confirmation Ampule: 4; 20ml each..... 4/15/94
Calibrators; 300, 600, 900,
1200 ng/ml.
High Standard Products................. Morphine-d3 100ug/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Morphine-d3; 0.1mg/ml.......... Ampule: 2ml.............. 4/15/94
High Standard Products................. Morphine-d4; 0.1mg/ml.......... Ampule: 2ml, 20ml........ 4/15/94
High Standard Products................. NIDA Cut-Off Controls; Levels Ampules: 6; 3 of 2ml, 3 4/15/94
1, 2, 3. of 20ml.
High Standard Products................. Norcocaine 1.0mg/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Norcodeine 1.0mg/ml............ Ampule: 2ml.............. 5/11/93
High Standard Products................. Nordiazepam 1.0mg/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Nordiazepam-d5 100ug/ml........ Ampule: 2ml.............. 5/11/93
High Standard Products................. Normorphine 1.0mg/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Oxazepam 1.0mg/ml.............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Oxazepam-d5 100ug/ml........... Ampule: 2ml.............. 5/11/93
High Standard Products................. Phencyclidine 1.0mg/ml......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Phencyclidine Cut-Off Controls; Ampules: 3; 20ml each.... 4/15/94
18, 32, 75 ng/ml.
High Standard Products................. Phencyclidine Screening Ampule: 4; 20ml each..... 4/15/94
Confirmation Calibrators; 25,
50, 75, 100 ng/ml.
High Standard Products................. Phencyclidine-d10 100ug/ml..... Ampule: 2ml.............. 5/11/93
High Standard Products................. Phencyclidine-d10; 0.1mg/ml.... Ampule: 2ml.............. 4/15/94
High Standard Products................. Phencyclidine-d5 100ug/ml...... Ampule: 2ml.............. 5/11/93
High Standard Products................. Phencyclidine-d5; 0.1mg/ml..... Ampule: 2ml.............. 4/15/94
High Standard Products................. Phenobarbital, 1.0mg/ml........ Ampule: 2ml.............. 3/21/95
High Standard Products................. Phenobarbital-D5............... Ampule: 2ml.............. 3/21/95
High Standard Products................. Propoxyphene, 1.0mg/ml......... Ampule: 2ml.............. 3/21/95
High Standard Products................. Propoxyphene-D5, 0.1mg/ml...... Ampule: 2ml.............. 3/21/95
High Standard Products................. Secobarbital, 1.0mg/ml......... Ampule: 2ml.............. 3/21/95
[[Page 146]]
High Standard Products................. Secobarbital-D5, 0.1mg/ml...... Ampule: 2ml.............. 3/21/95
High Standard Products................. Temazepam 1.0mg/ml............. Ampule: 2ml.............. 5/11/93
High Standard Products................. Temazepam-d5 100ug/ml.......... Ampule: 2ml.............. 5/11/93
High Standard Products................. Urine Confirm (+25%)........... Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Confirm (-25%)........... Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Confirm (-40%) Retest.... Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Confirm 3X Cutoff........ Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Confirm Cutoff........... Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Screen (+25%)............ Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Screen (-25%)............ Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Screen 3X Cutoff......... Ampule: 20ml............. 3/20/95
High Standard Products................. Urine Screen Cutoff............ Ampule: 20ml............. 3/20/95
HyClone Laboratories, Inc.............. HyQ-CCM1....................... Bottle: 50-1000ml; Lined 2/9/95
container: 10-1000L.
HyClone Laboratories, Inc.............. HyQ-CCM1 w/o Phenol Red........ Bottle: 50-1000ml; Lined 2/9/95
Container: 10-1000L.
HyClone Laboratories, Inc.............. Medium 925 w/o L-Glutamine, w/o Bottle: 50-1000ml; Lined 2/9/95
Phenol Red. Container: 10-1000L.
HyClone Laboratories, Inc.............. Medium 925 with IGF, w/o Phenol Bottle: 50-1000ml; Lined 2/9/95
Red. Container: 10-1000L.
HyClone Laboratories, Inc.............. Medium 925 with L-Glutamine, w/ Bottle: 50-1000ml; Lined 2/9/95
o Phenol Red. Container: 10-1000L.
HyClone Laboratories, Inc.............. Medium TLF with L-Glutamine.... Bottle: 50-1000ml; Lined 2/9/95
Container: 10-1000L.
Hycor Biomedical, Inc.................. Hycor AccuPINCH Cocaine Test... Bottle: 3ml Kit: 50 tests 8/21/90
Hycor Biomedical, Inc.................. Hycor AccuPINCH Morphine Test.. Bottle: 3ml Kit: 50 tests 8/21/90
Hycor Biomedical, Inc.................. Hycor AccuPINCH Phencyclidine Bottle: 3ml Kit: 50 tests 8/21/90
Test.
Hycor Biomedical, Inc.................. Hycor AccuPinch Methamphetamine Bottle: 3ml; Kit: 50 10/29/91
Test. Tests.
Hycor Biomedical, Inc.................. Hycor AccuPinch THC Test....... Bottle: 3ml; Kit: 50 10/29/91
Tests.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Bottle: 10ml Kit: 4 8/24/90
Calibrator BARBITURATES Urine bottles, 12 bottles.
Calibrator- 4 levels.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Bottle: 10ml Kit: 4 8/24/90
Calibrator DELTA-9-THC Urine bottles, 12 bottles.
Calibrator - 4 levels.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Bottle: 10ml Kit: 4 8/24/90
Calibrator NORDIAZEPAM Urine bottles, 12 bottles.
Calibrator - 3 levels.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Bottle: 10ml Kit: 4 8/24/90
Calibrator OPIATES Urine bottles, 12 bottles.
Calibrator - 4 levels.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Bottle: 10ml Kit: 4 8/24/90
Calibrator PHENCYCLIDINE Urine bottles, 12 bottles.
Calibrator - 4 levels.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Vial: 10ml, Kit: 12 3/29/89
Calibrator, Amphetamine Urine vials, Kit: 4 vials.
Calibrator - 4 level.
Hycor Biomedical, Inc.................. Sentry Drugs of Abuse Urine Vial: 10ml, Kit: 12 3/29/89
Calibrator, Benzoylecgonine vials, Kit: 4 vials.
Urine Calibrator - 4 level.
Hycor Biomedical, Inc.................. Sentry Ligand/Combo Control Vial: 10ml Box: 15 vials. 3/1/90
High Level.
Hycor Biomedical, Inc.................. Sentry Ligand/Combo Control Low Vial: 10ml Box: 15 vials. 3/1/90
Level.
Hycor Biomedical, Inc.................. Sentry Ligand/Combo Control Mid Vial: 10ml Box: 15 vials. 3/1/90
Level.
Hycor Biomedical, Inc.................. Sentry Ligand/Combo Control Kit: 15 vials............ 3/1/90
Multi-Pack.
Hycor/ICL Scientific................... Drugs of Abuse Comprehensive Bottle: 30ml............. 2/24/89
Urine Control, HIGH POSITIVE.
Hycor/ICL Scientific................... Drugs of Abuse Comprehensive Bottle: 30ml............. 2/24/89
Urine Control, LOWER THRESHOLD.
Hycor/ICL Scientific................... Drugs of Abuse Comprehensive Bottle: 30ml............. 2/24/89
Urine Control, UPPER THRESHOLD.
Hycor/ICL Scientific................... Drugs of Abuse Urine Control, Box: 4-100 ml Bottles.... 10/21/88
CONFIRMATION.
Hycor/ICL Scientific................... Drugs of Abuse Urine Control, Box: 4-30 ml Bottles..... 10/21/88
SCREEN.
ICL Scientific......................... Therapeutic Drug Control I , Glass Vial: 10ml......... 8/14/85
TDC I (High Level).
ICL Scientific......................... Therapeutic Drug Control I, II, Glass Vials (12): 10ml... 8/14/85
III, Tri-Level TDC Multipack.
ICL Scientific......................... Therapeutic Drug Control II, Glass Vial: 10ml......... 8/14/85
TDC II (Mid-Level).
ICL Scientific......................... Therapeutic Drug Control III, Glass Vial: 10ml......... 8/14/85
TDC III (Low Level).
ICN Micromedic Systems, Inc............ Immunogen: BZ-A................ Plastic Vial: 1.5 ml..... 2/29/88
ICN Micromedic Systems, Inc............ Immunogen: BZ-B................ Plastic Vial: 1.5 ml..... 2/29/88
ICN Micromedic Systems, Inc............ Immunogen: CD-A................ Plastic Vial: 1.5 ml..... 2/29/88
ICN Micromedic Systems, Inc............ Immunogen: M-A................. Plastic Vial: 1.5 ml..... 2/29/88
ICN Micromedic Systems, Inc............ Immunogen: M-B................. Plastic Vial: 1.5 ml..... 2/29/88
ICN Micromedic Systems, Inc............ Immunogen: TF-A................ Plastic Vial: 1.5 ml..... 2/29/88
[[Page 147]]
ICN Micromedic Systems, Inc............ Micromedic Combostat THC/ Amber Glass Vial: 2 ml 2/24/88
Cocaine STANDARDS-2, 3, and 4. Plastic Bottle: 100 ml.
ICN Micromedic Systems, Inc............ Micromedic CrackPot 57Co/125I Plastic Bottle: 25 ml, 2/24/88
Tracer Solution. 1000 ml.
ICN Micromedic Systems, Inc............ Micromedic Morphine 125I Tracer Bottle: 50 ml, 1000 ml... 2/29/88
Solution.
ICN Micromedic Systems, Inc............ Micromedic Morphine Standards Bottle: 5 ml, 100 ml..... 2/29/88
2, 3 and 4.
INCSTAR Corporation.................... (125I) Human TSH Tracer Cat. Vial: 15ml............... 3/08/91
No. CA-2623.
INCSTAR Corporation.................... Anticonvulsant Drug Controls Vial: 3.5ml.............. 3/08/91
Levels I and II Cat. Nos. CA-
2419, CA-2420.
INCSTAR Corporation.................... Assay Buffer Cat. No. CA-2742.. Bottle: 150ml............ 3/08/91
INCSTAR Corporation.................... Clinical Assays Gamma Coat Kit: 50, 500 assays...... 3/08/91
(125I) Phenobarbital
Radioimmunoassay Kits Cat.
Nos. CA-2545, CA-2565.
INCSTAR Corporation.................... Clinical Assays Gamma Coat Kit: 50, 500 assays...... 3/08/91
(125I) Phenytoin
Radioimmunoassay Kits Cat.
Nos. CA-2537, CA-2557.
INCSTAR Corporation.................... Clinical Assays Gamma Coat Kit: 100, 500 assays..... 3/08/91
(125I) T3 Uptake
Radioimmunoassay Kit Catalog
Nos. CA-2539, CA-2539J, CA-
2559, CA-2559J.
INCSTAR Corporation.................... Clinical Assays Gamma Dab Kit: 125 assays; Vial: 3/08/91
(125I) hTSH Radioimmunoassay 15ml.
Kit Cat. No. CA-1591.
INCSTAR Corporation.................... HTSH Non-Specific Binding Vial: 3.5ml.............. 3/08/91
Reagent Cat. No. CA-2752.
INCSTAR Corporation.................... Human TSH Controls Levels I & Vial: 3.5ml.............. 3/08/91
II Cat. Nos. CA-2452, CA-2453.
INCSTAR Corporation.................... Human hTSH Blank Cat. No. CA- Vial: 15ml............... 3/08/91
2885.
INCSTAR Corporation.................... Phenobarbital Standards: 1, 3, Bottle: 3.5ml............ 3/08/91
10, 30, 100 ug/ml Cat. Nos. CA-
2380-2384.
INCSTAR Corporation.................... Rabbit Anti-Human TSH Serum Vial: 15ml............... 3/08/91
Cat. No. CA-2145.
INCSTAR Corporation.................... htsH Standards: 2, 5, 10, 20, Bottle: 3.5ml............ 3/08/91
50 uIU/ml Cat. Nos. CA-2886-
2890.
ISOTEC, Inc............................ (-) 11 Nor-9-Carboxy-Delta-9- Ampule: 2ml.............. 6/19/95
THC-D3, 100ug/ml.
ISOTEC, Inc............................ (-) 11-Nor-9-Carboxy-Delta-9- Ampule: 2ml.............. 6/19/95
THC, 100ug/ml.
ISOTEC, Inc............................ 6-Acetylmorphine, 1 mg/ml...... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ 6-Acetylmorphine-D3, 100ug/ml, Ampule: 2ml.............. 6/19/95
1mg/ml.
ISOTEC, Inc............................ 6-Acetylmorphine-D6, 100ug/ml, Ampule; 2ml.............. 6/19/95
1mg/ml.
ISOTEC, Inc............................ Benzoylecgonine, 1mg/ml........ Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Benzoylecgonine-D3, 100ug/ml, Ampule: 2ml.............. 6/19/95
1mg/ml.
ISOTEC, Inc............................ Cocaethylene, 1mg/ml........... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Cocaethylene-D3, 100ug/ml, 1mg/ Ampule: 2ml.............. 6/19/95
ml.
ISOTEC, Inc............................ Cocaine, 1mg/ml................ Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Cocaine-D3, 100ug/ml, 1mg/ml... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Codeine, 1mg/ml................ Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Codeine-D3, 100ug/ml, 1mg/ml... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ DL-3, 4- Ampule: 2ml.............. 9/18/95
Methylenedioxyamphetamine, 1mg/
ml.
ISOTEC, Inc............................ DL-3, 4- Ampule: 2ml.............. 9/18/95
Methylenedioxyamphetamine-D5,
100ug/ml, 1mg/ml.
ISOTEC, Inc............................ DL-3, 4- Ampule: 2ml.............. 9/18/95
Methylenedioxymethamphetamine,
1mg/ml.
ISOTEC, Inc............................ DL-3, 4- Ampule: 2ml.............. 9/18/95
Methylenedioxymethamphetamine-
D8, 100ug/ml, 1mg/ml.
ISOTEC, Inc............................ DL-Amphetamine-D6, 100ug/ml, Ampule: 2ml.............. 6/19/95
1mg/ml.
ISOTEC, Inc............................ DL-Amphetamine, 1mg/ml......... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ DL-Methamphetamine, 1mg/ml..... Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ DL-Methamphetamine-D9, 100ug/ Ampule: 2ml.............. 9/18/95
ml, 1mg/ml.
ISOTEC, Inc............................ DL-Methylphenidate, 1mg/ml..... Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Delta-9-THC, 1mg/ml............ Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Delta-9-THC-D3, 100ug/ml....... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Ecgonine Methyl Ester, 1mg/ml.. Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Ecgonine Methyl Ester-D3, 100ug/ Ampule: 2ml.............. 6/19/95
ml, 1mg/ml.
ISOTEC, Inc............................ Ecgonine, 1mg/ml............... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Fentanyl, 100ug/ml, 1mg/ml..... Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Fentanyl-D5, 100ug/ml, 1mg/ml.. Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Hydrocodone, 1mg/ml............ Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Hydrocodone-D3, 100ug/ml, 1mg/ Ampule: 2ml.............. 6/19/95
ml.
ISOTEC, Inc............................ Hydromorphone, 1mg/ml.......... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Hydromorphone-D3, 100ug/ml, 1mg/ Ampule: 2ml.............. 6/19/95
ml.
ISOTEC, Inc............................ Lysergic Acid Diethylamide, Ampule: 2ml.............. 6/19/95
25ug/ml.
ISOTEC, Inc............................ Lysergic Acid Diethylamide-D3, Ampule: 2ml.............. 6/19/95
25ug/ml.
ISOTEC, Inc............................ Lysergic Acid N-Methyl Ampule: 2ml.............. 6/19/95
Propylamide, 25ug/ml.
ISOTEC, Inc............................ Methadone, 1mg/ml.............. Ampule: 2ml.............. 9/18/95
[[Page 148]]
ISOTEC, Inc............................ Methadone-D3, 100ug/ml, 1mg/ml. Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Morphine, 1mg/ml............... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Morphine-3-beta-D-Glucuronide, Ampule: 2ml.............. 9/18/95
100ug/ml, 1mg/ml.
ISOTEC, Inc............................ Morphine-D3, 100ug/ml, 1mg/ml.. Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Norcocaine, 1mg/ml............. Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Pentobarbital, 1mg/ml.......... Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Pentobarbital-D5, 100ug/ml, 1mg/ Ampule: 2ml.............. 9/18/95
ml.
ISOTEC, Inc............................ Phencyclidine, 1mg/ml.......... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Phencyclidine-D5, 100ug/ml..... Ampule: 2ml.............. 6/19/95
ISOTEC, Inc............................ Secobarbital, 1mg/ml........... Ampule: 2ml.............. 9/18/95
ISOTEC, Inc............................ Secobarbital-D5, 100ug/ml, 1mg/ Ampule: 2ml.............. 9/18/95
ml.
Immunotech Corp........................ Amphetamine Enzyme Conjugate... Bottle: 10.5ml........... 9/28/89
Immunotech Corp........................ Amphetamine Positive Urine Bottle: 1ml.............. 9/28/89
Calibrator.
Immunotech Corp........................ Amphetamine-ALK Phos Cat. No. Bottle: 10ml............. 3/12/90
612; 50 units, 300 units.
Immunotech Corp........................ Amphetamine-HRP Cat. No. 613; Bottle: 10ml............. 3/12/90
50 units.
Immunotech Corp........................ Benzoylecgonine-Alk Phos Cat. # Bottle: 10ml............. 3/12/90
602; 50 units, 300 units.
Immunotech Corp........................ Benzoylecgonine-HRP Cat. No. Bottle: 10ml............. 3/12/90
604; 50 units, 300 units.
Immunotech Corp........................ Cocaine Conjugate No. 0364-SIG. Bottle: 75ml............. 6/13/91
Immunotech Corp........................ Cocaine Metabolite Enzyme Vial: 10.5ml............. 9/28/89
Conjugate.
Immunotech Corp........................ Cocaine Metabolite Positive Vial: 2ml................ 9/28/90
Urine Calibrator.
Immunotech Corp........................ Delta-8-tetrahydrocannabinol- Bottle: 10 ml............ 3/12/90
ALK Phos Cat. No. 616; 50
units, 300 units.
Immunotech Corp........................ Delta-8-tetrahydrocannabinol- Bottle: 10ml............. 3/12/90
HRP Cat. No. 618; 50 units.
Immunotech Corp........................ ENDAB Phenobarbital Kit, Cat. Kit: 100 tests, 4 9/28/89
No. 119. Bottles: 1 ml ea.
Immunotech Corp........................ Methamphetamine-ALK Phos Cat. Bottle: 10ml............. 3/12/90
No. 614; 50 units.
Immunotech Corp........................ Methamphetamine-HRP Cat. No. Bottle: 10 ml............ 3/12/90
615; 50 units.
Immunotech Corp........................ Micro Dau Amphetamine Enzyme Kit: 96 tests, Bottle: 9/28/89
Immunoassay Test Kit. 10.5 ml, 2 ml.
Immunotech Corp........................ Micro Dau Benzodiazepine Enzyme Kit: 96 tests, Bottle: 9/28/89
Immunoassay Test Kit. 10.5 ml, 2 ml.
Immunotech Corp........................ Micro Dau Cocaine Metabolite Kit: 96 tests, Bottle: 9/28/89
Enzyme Immunoassay Test Kit. 10.5 ml, 2 ml.
Immunotech Corp........................ Micro Dau Opiates Enzyme Kit: 96 tests............ 12/19/89
Immunoassay Test Kit.
Immunotech Corp........................ Micro Dau PCP Enzyme Kit: 96 tests............ 7/11/90
Immunoassay Kit Cat. No. 175.
Immunotech Corp........................ Micro Dau THC Enzyme Kit: 96 tests............ 7/11/90
Immunoassay Test Kit Cat. No.
173.
Immunotech Corp........................ Morphine Positive Urine Vial: 3.5 ml............. 12/19/89
Calibrator.
Immunotech Corp........................ Morphine-ALK Phos Cat. No. 610; Bottle: 10ml............. 3/12/90
50 units, 300 units.
Immunotech Corp........................ Morphine-HRP Cat. No. 611; 50 Bottle: 10ml............. 3/12/90
units, 300 units.
Immunotech Corp........................ Opiates Enzyme Conjugate....... Vial: 10 ml.............. 12/19/89
Immunotech Corp........................ Oxazepam Enzyme Conjugate...... Bottle: 10.5ml........... 9/28/89
Immunotech Corp........................ Oxazepam Positive Urine Bottle: 2ml.............. 9/28/89
Calibrator.
Immunotech Corp........................ Oxazepam-ALK Phos Cat. No. 606; Bottle: 10ml............. 3/12/90
50 units.
Immunotech Corp........................ Oxazepam-HRP Cat No. 608; 50 Bottle: 10ml............. 3/12/90
units.
Immunotech Corp........................ PCP Enzyme Conjugate Cat. No. Vial: 20ml............... 7/11/90
375.
Immunotech Corp........................ PCP Positive Urine Calibrator Vial: 3ml................ 7/11/90
Cat. No. 418.
Immunotech Corp........................ Phenobarbital Enzyme Conjugate. Bottle: 10.0ml........... 9/28/89
Immunotech Corp........................ Phenobarbital Serum Standard: 4 Bottles: 1ml each...... 9/28/89
3ug/ml, 10ug/ml, 30ug/ml, 80ug/
ml.
Immunotech Corp........................ THC Enzyme Conjugate Cat. No. Vial: 20ml............... 7/11/90
373.
Immunotech Corp........................ THC Positive Urine Calibrator Vial: 3ml................ 7/11/90
Cat No. 416 50ng/ml, 417 100ng/
ml.
Industrial Analytical Laboratory, Inc.. 11-Nor-Carboxy-Delta-9- Ampule: 1ml.............. 9/04/85
Tetrahydrocannabinol.
Industrial Analytical Laboratory, Inc.. 11-hydroxy-delta-9- Ampule: 1 ml............. 2/18/87
tetrahydrocannabinol.
Industrial Optical..................... Opti-Kleen..................... Bottle: 5 gallon......... 6/24/81
International BioClinical, Inc......... Innofluor Phenobarbital Bottle: 3 ml............. 7/9/87
Calibrators 0.0, 3.0, 8.0,
20.0, 40.0, and 80.0 mcg/ml.
International BioClinical, Inc......... Phenobarbital Stock Tracer..... Vial: 5 ml............... 9/23/87
International Technidyne Corp.......... Hemochron Control Plasma Kit: 18 Tests; Test tube: 3/11/91
Quality Control Test Kit. 9ml; Vial: 5ml.
JRH Biosciences........................ HH4 Cell Culture Media......... Bulk Plastic Bag: 20, 10, 5/11/95
1L.
Janssen Pharmaceutica, Inc............. 3H Alfentanil.................. Vial: 0.5 ml............. 2/1/87
[[Page 149]]
Janssen Pharmaceutica, Inc............. 3H Fentanyl.................... Vial: 0.5 ml............. 2/1/87
Janssen Pharmaceutica, Inc............. 3H Sufentanil.................. Vial: 0.5 ml............. 2/1/87
Janssen Pharmaceutica, Inc............. Alfentanil Radioimmunoassay Kit Kit: 200 tests........... 5/13/85
Janssen Pharmaceutica, Inc............. Fentanyl Radioimmunoassay Kit.. Kit: 200 tests........... 5/13/85
Janssen Pharmaceutica, Inc............. Sufentanil Radioimmunoassay Kit Kit: 500 tests........... 5/13/85
Kallestad Diagnostics.................. Barbital Buffer 901............ Vial..................... 5/19/81
Kallestad Diagnostics.................. IEP Buffer No. 900............. Vial: 7 Dram............. 12/26/78
Kallestad Diagnostics.................. Immunoelectrofilm Catalog No. 1 Film Sealed in 3/11/80
910. Cardboard Container.
Kallestad Diagnostics.................. Immunoelectrofilms, Catalog No. Styrofoam Container: 25 6/22/87
1013. film.
Kallestad Diagnostics.................. Immunoelectrophoresis Reagent Kit: 3 Vials............. 6/22/87
Kit, Catalog No. 1012.
Kallestad Diagnostics.................. Quanticoat 125I-T3 Uptake Kit Kit: 400 Determinations.. 12/16/85
Catalog No. 823.
Kallestad Diagnostics.................. Quanticoat 125I-T3 Uptake Kit, Kit: 100 tests........... 6/24/81
Catalog No. 833.
Kallestad Diagnostics.................. Quanticoat 125I-T3 Uptake Bottle: 500ml............ 12/16/85
Reagent Catalog No. 785.
Kallestad Diagnostics.................. Quanticoat 125I-T3 Uptake 2 Glass Bottles: 110ml... 6/24/81
Reagent No. 834.
LIfe Technologies, Inc................. AmnioMax-C100 Second Dilution.. Bottle: 1L............... 2/17/94
LKB Instruments, Inc................... Tris-barbiturate Buffer pH 8.6. Packet: each 6.788 g. 20 5/15/78
packets/box.
Lemmon Company......................... Etorphine Standard Solution.... Plastic Carboy: 1 Liter.. 10/31/83
Life Technologies, Inc................. AmnioMax-C100 First Dilution... Bottle: 1L............... 2/17/94
Life Technologies, Inc................. AmnioMax-C100 Stock Solution... Bottle: 1L............... 2/17/94
Life Technologies, Inc................. AmnioMax-C100 Supplement....... Bottle: 15ml, 60ml, 75ml, 2/17/94
100ml.
Life Technologies, Inc................. Testosterone Stock Solution.... Bottle: 1L............... 10/4/94
MCI Biomedical......................... IEP Buffer, pH 8.2, 0.04 Ionic Package: 6.510 grams..... 8/28/72
Strength.
Mallinckrodt Chemical, Inc............. Naloxone/6-Beta Naltrexol...... Bottle: 60ml............. 10/6/94
Mallinckrodt Chemical, Inc............. Naltrexone/6-beta Naltrexol Bottle: 60ml............. 10/4/94
Standard Solution.
Materials & Technology Systems......... 5-Ethyl-5-(1 -Carboxy-N-Propyl) Screw Cap Vial: 8ml...... 5/3/73
Barbituric Acid.
Materials & Technology Systems......... 5-Ethyl-5-(1-Carboxy-N- Vaccine Vial: 8ml........ 5/3/73
Propyl)Barbituric Acid Bovine
Serum Albumin or Rabbit Serum
Albumin.
Materials & Technology Systems......... 5-Ethyl-5-(1-Carboxy-N- Vaccine Vial: 8ml........ 5/3/73
Propyl)Barbituric Acid
Sensitized RBC.
Materials & Technology Systems......... Barbiturate Standard........... Screwcap Vial: 10ml...... 9/17/76
Materials & Technology Systems......... Benzoylecgonine................ Screw Cap Vial: 25mg and 4/18/74
100 mg.
Materials & Technology Systems......... Benzoylecgonine Standard....... Screwcap Vial: 10ml...... 9/17/76
Materials & Technology Systems......... Carboxymethylmorphine.......... Screw Cap Vial: 8ml...... 5/3/73
Materials & Technology Systems......... Carboxymethylmorphine Bovine Vaccine Vial: 8ml........ 5/3/73
Serum Albumin or Rabbit Serum
Albumin.
Materials & Technology Systems......... Carboxymethylmorphine Vaccine Vial: 50ml....... 5/3/73
Sensitized RBC.
Materials & Technology Systems......... Ecgonine Bovine Serum Albumin Vaccine Vial: 8ml........ 5/3/73
or Rabbit Serum Albumin.
Materials & Technology Systems......... Ecgonine Sensitized RBC........ Vaccine Vial: 50ml....... 5/3/73
Materials & Technology Systems......... Methadone Standard............. Screwcap Vial: 10ml...... 9/17/76
Materials & Technology Systems......... Morphine Standard.............. Screw Cap Vial: 10ml..... 7/17/73
Materials & Technology Systems......... Tropinecarboxylic Acid......... Screw Cap Vial: 8ml, 10ml 5/3/73
McGean-Rocho, Inc...................... Chloral Solution Denatured..... Plastic container; 1, 5, 1/11/91
55 Gallons.
McGean-Rocho, Inc...................... Reflexion Semi-Bright B........ Plastic container; 1, 5, 1/11/91
55 Gallons.
McGean-Rocho, Inc...................... Reflexion Semi-Bright S........ Plastic container; 1, 5, 1/11/91
55 Gallons.
Medi-Chem, Inc......................... Barbiturate Test Set (Sodium Bottle: 120ml............ 2/22/74
Secobarbital Standard 10mg % w/
v) Catalog No.250.
Medical Analysis Systems, Inc.......... ACE II Calibrator for the Glass Vial: 2238mm, 5ml.. 8/7/86
DuPont aca Level 1.
[[Page 150]]
Medical Analysis Systems, Inc.......... ACE II Calibrator for the Glass Vial: 2238mm, 5ml.. 8/7/86
DuPont aca Level 2.
Medical Analysis Systems, Inc.......... ACE II Calibrator for the Glass Vial: 2238mm, 5ml.. 8/7/86
DuPont aca Level 3.
Medical Analysis Systems, Inc.......... Amobarbital, #117 Intermediate Bottle: 10-100ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Benzoylecgonine, #432 Bottle: 10-250ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Benzoylecgonine, #483 Bottle: 10-100ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Benzoylecgonine, #719 Bottle: 10-1800ml........ 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Butalbital, #429 Intermediate Bottle: 10-100ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... CHALLENGE Liquid Therapeutic Kit: 10 Bottles.......... 1/24/91
Drug Linearity Controls.
Medical Analysis Systems, Inc.......... CHALLENGE Liquid Therapeutic Glass Bottles: 5ml; 1 1/24/91
Drug Linearity Controls TD1 A- Set: 5 Bottles.
E; TD2 A-E.
Medical Analysis Systems, Inc.......... Chemistry Control Assayed, Vial: 15ml............... 4/30/85
Level 1, 2, & 3.
Medical Analysis Systems, Inc.......... Chemistry Control, Level 1, 2, Vial: 15ml............... 4/30/85
& 3.
Medical Analysis Systems, Inc.......... Clonazepam, #473 Intermediate Bottle: 50-500ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Codeine, #435 Intermediate Bottle: 10-100ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... D-Amphetamine, #423 Bottle: 10-250ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... D-Methamphetamine, #422 Bottle: 10-250ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 1, #1921 Bulk Bottle: 10-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 2, #1922 Bulk Bottle: 10-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 2, #C38979 Bulk Bottle: 10-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 3, #C38978 Bulk Bottle: 10-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 4, #C38980 Bulk Bottle: 10-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Calibrator 4, #C38980P Bottle: 20-300L.......... 10/22/93
Pilot Solution.
Medical Analysis Systems, Inc.......... DOA Control 2, #1912 Bulk Bottle: 20-200L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 3, #1943 Bulk Bottle: 20-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 3, #1913 Bulk Bottle: 20-300L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 4, #1914 Bulk Bottle: 20-300L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 4, #1914P Pilot Bottle: .1-1L............ 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 4, #1944 Bulk Bottle: 20-100L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control 4, #1944P Pilot Bottle: .1-1L............ 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control G2, #1915 Bulk Bottle: 20-200L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control G3, #1916 Bulk Bottle: 20-300L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control G4, #1917 Bulk Bottle: 20-300L.......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Control G4, #1917P Pilot Bottle: .1-1L............ 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Cutoff Control, #1946 Bulk Bottle: 1-10L............ 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Cutoff Control, #1946P Bottle: .1-1L............ 10/22/93
Pilot Solution.
Medical Analysis Systems, Inc.......... DOA High Control, #1945 Bulk Bottle: 1-10L............ 10/22/93
Solution.
[[Page 151]]
Medical Analysis Systems, Inc.......... DOA Liquid Drugs of Abuse Vial: 5ml, 18ml; Box: 6- 10/12/90
Controls Level 2, 3, 4. 8ml vials; Box: 8-5ml
vials.
Medical Analysis Systems, Inc.......... DOA Low Cointrol, #1947 Bulk Bottle: 1-10L............ 10/22/93
Solution.
Medical Analysis Systems, Inc.......... DOA Positive Control, #1924 Bottle: 10-100L.......... 10/22/93
Bulk Solution.
Medical Analysis Systems, Inc.......... DOA Positive Control, #1924P Bottle: .1-1L............ 10/22/93
Pilot Solution.
Medical Analysis Systems, Inc.......... DOA Positive Control, #C38981 Bottle: 10-100L.......... 10/22/93
Bulk Solution.
Medical Analysis Systems, Inc.......... Diazepam, #430 Intermediate Bottle: 10-100ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Liquid Urine Control Level 1... Vial: 5 ml............... 4/03/87
Medical Analysis Systems, Inc.......... Liquimmune Immunoassay Control Bottle: 40-100L.......... 10/22/93
1, #2300 Bulk Solution.
Medical Analysis Systems, Inc.......... Liquimmune Immunoassay Control Bottle: .1-1L............ 10/22/93
1, #2300P Pilot Solution.
Medical Analysis Systems, Inc.......... Liquimmune Immunoassay Control Bottle: 20-300L.......... 10/22/93
2, #2301 Bulk Solution.
Medical Analysis Systems, Inc.......... Liquimmune Immunoassay Control Bottle: 20-300L.......... 10/22/93
3, #2302 Bulk Solution.
Medical Analysis Systems, Inc.......... Liquimmune Immunoassay Control Bottle: .1-1L............ 10/22/93
3, #2302P Pilot Solution.
Medical Analysis Systems, Inc.......... Methadone, #438 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Methaqualone, #439 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Morphine Glucuronide, #433 Bottle: 10-100ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Morphine, #434 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Nordiazepam, #431 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Pentobarbital, #426 Bottle: 10-100ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Phencyclidine, #437 Bottle: 10-100ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Phenobarbital, #418 Bottle: 50-700ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Phenobarbital, #425 Bottle: 10-100ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Phenobarbital, #745 Bottle: 50-200ml......... 10/22/93
Intermediate Solution.
Medical Analysis Systems, Inc.......... Propoxyphene, #440 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Secobarbital, #427 Intermediate Bottle: 10-250ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... TDM Plus.XL Level I, II or III Bottle: 5ml, Box: 6 9/5/90
Unassayed Enhanced Liquid Drug bottles.
Control.
Medical Analysis Systems, Inc.......... Testosterone, #748 Intermediate Bottle: 50-200ml......... 10/22/93
Solution.
Medical Analysis Systems, Inc.......... Therapeutic Drug Monitoring Bottle: 20-300L.......... 10/22/93
Control 1, #1581 Bulk Solution.
Medical Analysis Systems, Inc.......... Therapeutic Drug Monitoring Bottle: 20-300L.......... 10/22/93
Control 2, #1582 Bulk Solution.
Medical Analysis Systems, Inc.......... Therapeutic Drug Monitoring Bottle: 20-300L.......... 10/22/93
Control 3, #1583 Bulk Solution.
Medical Analysis Systems, Inc.......... Therapeutic Drug Monitoring Bottle: .1-1L............ 10/22/93
Control 3, #1583P Pilot
Solution.
Medical Analysis Systems, Inc.......... Transfer Pilot Material Glass vial: 3-5ml........ 7/29/94
Calibrators; Levels 2, 3, 4, 5.
Medical Analysis Systems, Inc.......... Transfer Pilot Material Glass vial: 3-5ml........ 7/29/94
Controls; Negative QC and
Positive QC.
Medical Analysis Systems, Inc.......... Tri-Point LiquImmune Ligand Glass Bottle: 5ml; Kit: 6 10/23/91
Control, Levels 1, 2 and 3. Bottles.
Medical Analysis Systems, Inc.......... Tri-Point LiquImmune Ligand Glass Bottle: 5ml; Kit: 6 10/23/91
Control, Levels 1, 2 and 3. bottles.
Medical Analysis Systems, Inc.......... chemTRAK Liquid Unassayed Kit: 65ml Vials.......... 10/8/86
Therapeuitic Drug Control
Level 2.
[[Page 152]]
Medical Analysis Systems, Inc.......... chemTRAK Liquid Unassayed Kit: 65ml Vials.......... 10/8/86
Therapeutic Drug Control Level
3.
Medical Analysis Systems, Inc.......... chemTRAK Liquid Unassayed Kit: 65ml Vials.......... 10/8/86
Therapeutic Drug Control Level
I.
Medical Analysis Systems, Inc.......... chemTrak Liquid Unassayed...... Vial: 15ml............... 4/30/85
Meloy Labs, Inc........................ Counterelectrophoresis Plates, Plates: 10 determinations 9/5/73
G-301.
Meloy Labs, Inc........................ Immunoelectrophoresis Plates, G- Plates: 6 / unit......... 9/5/73
201.
Merck and Co., Inc..................... Amphetamine - d6 HCl, Cat. No. Ampule: 2 or 5ml......... 8/30/89
MD-3892.
Merck and Co., Inc..................... Cocaine-d3 HCl Catalog # MD- Ampule: 2 or 5ml......... 6/13/88
3677.
Merck and Co., Inc..................... Codeine - d3 H2O (N-methyl-d3) 2ml, 5ml ampule Carton: 5 9/6/88
No. MD-3776. ampules.
Merck and Co., Inc..................... Codeine-d3 Catalog # MD-3678... Ampule: 2 or 5ml......... 6/13/88
Merck and Co., Inc..................... DL-1 Phenyl-2-aminopropane 1, Ampule: 2 or 5ml......... 6/13/88
1, 2, 3, 3, 3, -d6
(Amphetamine-d6) Catalog # MD-
3682.
Merck and Co., Inc..................... DL-1 Phenyl-2- Ampule: 2 or 5ml......... 6/13/88
methylaminopropane-1, 1, 2, 3,
3, 3-d6 HCl (Methamphetamine
d6) Catalog # MD-3683.
Merck and Co., Inc..................... DL-1-Phenyl-2-aminopropane-1, 2ml, 5ml amber ampule 9/6/88
1, 2, 3, 3, 3-d6 HCL No. MD- Carton: 5 ampules.
3778.
Merck and Co., Inc..................... Ecgonine - d3 Methyl Ester HCl Ampule: 2 or 5ml......... 6/13/88
Catalog # MD- 3679.
Merck and Co., Inc..................... Methamphetamine - d9 HCl, Cat. Ampule: 2 or 5ml......... 8/30/89
No. MD-3853.
Merck and Co., Inc..................... Morphine - d3 HCl 3H20 (N- 2ml, 5ml ampule Carton: 5 9/6/88
methyl-d3) No. MD-3777. ampules.
Merck and Co., Inc..................... Morphine - d3 HCl Catalog # MD- Ampule: 2 or 5 ml........ 6/13/88
3680.
Merck and Co., Inc..................... O-Benzoylecgonine-d3 Catalog # Ampule: 2 or 5 ml........ 6/13/88
MD-3676.
Merck and Co., Inc..................... Phen-d5-cyclidine HCl Catalog # Ampule: 2 or 5 ml........ 6/13/88
MD-3681.
Microdiagnostics, Inc.................. Amphetamine Bulk Tracer........ Tube: 1ml; Bottle: 10ml, 1/17/96
100ml, 500ml.
Microdiagnostics, Inc.................. Amphetamine Enzyme Conjugate... Bottle: 10ml............. 12/24/92
Microdiagnostics, Inc.................. Benzoylecgonine Bulk Tracer.... Tube: 1ml; Bottle: 10ml, 1/17/96
100ml, 500ml.
Microdiagnostics, Inc.................. Cocaine Enzyme Conjugate....... Bottle: 10ml............. 12/24/92
Microdiagnostics, Inc.................. EIA for Amphetamine Metabolites Kit: 2 bottles........... 12/24/92
Microdiagnostics, Inc.................. EIA for Cocaine Metabolites.... Kit: 2 bottles........... 12/24/92
Microdiagnostics, Inc.................. EIA for Marijuana Metabolites.. Kit: 2 bottles........... 12/24/92
Microdiagnostics, Inc.................. EIA for Opiate Metabolites..... Kit: 2 bottles........... 12/24/92
Microdiagnostics, Inc.................. EIA for PCP Metabolites........ Kit: 2 bottles........... 12/24/92
Microdiagnostics, Inc.................. Morphine Bulk Tracer........... Tube: 1ml; Bottle: 10ml, 1/17/96
100ml, 500ml.
Microdiagnostics, Inc.................. Opiate Enzyme Conjugate........ Bottle: 10ml............. 12/24/92
Microdiagnostics, Inc.................. PCP Enzyme Conjugate........... Bottle: 10ml............. 12/24/92
Microdiagnostics, Inc.................. Phencyclidine Bulk Tracer...... Tube: 1ml; Bottle: 10ml, 1/17/96
100ml, 500ml.
Microdiagnostics, Inc.................. Positive Amphetamine Standard.. Bottle: 2ml.............. 12/24/92
Microdiagnostics, Inc.................. Positive Cocaine Standard...... Bottle: 2ml.............. 12/24/92
Microdiagnostics, Inc.................. Positive Opiate Standard....... Bottle: 2ml.............. 12/24/92
Microdiagnostics, Inc.................. Positive PCP Standard.......... Bottle: 2ml.............. 12/24/92
Microdiagnostics, Inc.................. Positive THC Standard.......... Bottle: 2ml.............. 12/24/92
Microdiagnostics, Inc.................. THC Enzyme Conjugate........... Bottle: 10ml............. 12/24/92
Microdiagnostics, Inc.................. Tetrahydrocannabinol Bulk Tube: 1ml; Bottle: 10ml, 1/17/96
Tracer. 100ml, 500ml.
Microgenics Corporation................ 4-Drug Barbiturate Spiking Carboy: 2L............... 12/1/93
Solution.
Microgenics Corporation................ 4-Drug Cutoff Bulk Calibrator.. Carboy: 6L............... 12/1/93
Microgenics Corporation................ 4-Drug High Bulk Calibrator.... Carboy: 4L............... 12/1/93
Microgenics Corporation................ 4-Drug Intermediate Bulk Carboy: 4L............... 12/1/93
Calibrator.
Microgenics Corporation................ 5-Drug Cutoff Bulk Calibrator.. Carboy: 4L............... 12/1/93
Microgenics Corporation................ Amphetamine ED Bulk Reagent.... Carboy: 25L.............. 4/13/94
Microgenics Corporation................ Amphetamine Manufacturing Bulk Carboy or Beaker: 4L..... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Amphetamine Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Amphetamine/Methamphetamine Carboy or Beaker: 4L..... 4/20/94
Bulk Manufacturing Calibrator
Open.
Microgenics Corporation................ Amphetamine/Methamphetamine Vial: 3.5 or 5.0ml....... 4/20/94
Manufacturing Calibrator Open.
Microgenics Corporation................ Amphetamines Spiking Solution.. Carboy: 2L............... 12/1/93
Microgenics Corporation................ Barbiturate Manufacturing Bulk Carboy or Beaker: 4L..... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Barbiturate Spiking Solution... Carboy: 2L............... 12/1/93
Microgenics Corporation................ Barbiturate/Benzodiazepine 200 Carboy: 4L............... 12/1/93
Cutoff Calibrator.
Microgenics Corporation................ Barbiturate/Benzodiazepine 300 Carboy: 2L............... 12/1/93
Cutoff Calibrator.
Microgenics Corporation................ Barbiturate/Benzodiazepine High Carboy: 2L............... 12/1/93
Bulk Calibrator.
[[Page 153]]
Microgenics Corporation................ Barbiturate/Benzodiazepine Carboy: 2L............... 12/1/93
Intermediate Bulk Calibrator.
Microgenics Corporation................ Barbiturates Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Benzodiazepine Ethanol Stock... Vial: 25ml............... 12/1/93
Microgenics Corporation................ Benzodiazepine Manufacturing Carboy or Beaker: 4L..... 4/20/94
Bulk Calibrators B, C, D, E,
F, G, H, I, J, K, Open.
Microgenics Corporation................ Benzodiazepine Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Benzodiazepine Spiking Solution Carboy: 2L............... 12/1/93
Microgenics Corporation................ Bulk Calibrator Solution 80ug/ Carboy: 10L.............. 11/13/90
ml, 40ug/ml.
Microgenics Corporation................ CEDAI DAU Opiate Assay Cat # 80- Kit: 4 Bottles, 500ml.... 12/1/93
3000.
Microgenics Corporation................ CEDIA DAU 4-Drug Cutoff Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU 4-Drug High Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU 4-Drug Intermediate Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU 5-Drug Cutoff Bottle: 5, 15ml.......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU Amphetamine Assay Kit: 4 Bottles........... 4/13/94
(For 85ml, 500ml).
Microgenics Corporation................ CEDIA DAU Amphetamine ED Vial: 100ml, 500ml....... 4/13/94
Reagent.
Microgenics Corporation................ CEDIA DAU Barb/Benz 200 Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU Barb/Benz 300 Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU Barb/Benz High Bottle: 10, 15ml......... 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU Barb/Benz Bottle: 10, 15ml......... 12/1/93
Intermediate Calibrator.
Microgenics Corporation................ CEDIA DAU Cocaine Assay Cat # Kit: 4 Bottles, 85ml..... 12/1/93
80-2300.
Microgenics Corporation................ CEDIA DAU Cocaine Assay Cat # Kit: 4 Bottles, 500ml.... 12/1/93
80-2400.
Microgenics Corporation................ CEDIA DAU Cocaine ED Reagent, Vial: 100ml.............. 12/1/93
Cat # 80-2300.
Microgenics Corporation................ CEDIA DAU Cocaine ED Reagent, Vial: 500ml.............. 12/1/93
Cat # 80-2400.
Microgenics Corporation................ CEDIA DAU Multi-Drug Control 2 Vials; 5ml/vial........ 5/10/94
Set, #80-0120.
Microgenics Corporation................ CEDIA DAU Multi-Level THC Assay Kit: 4 Bottles, 85ml..... 12/1/93
Cat # 80-2700.
Microgenics Corporation................ CEDIA DAU Multi-Level THC Assay Kit: 4 Bottles, 500ml.... 12/1/93
Cat # 80-2800.
Microgenics Corporation................ CEDIA DAU Multi-Level THC ED Vial: 100ml.............. 12/1/93
Reagent, Cat # 80-2700.
Microgenics Corporation................ CEDIA DAU Multi-Level THC ED Vial: 500ml.............. 12/1/93
Reagent, Cat # 80-2800.
Microgenics Corporation................ CEDIA DAU Multi-grug Control 2 Vials; 15ml/vial....... 5/10/94
Set, #80-0124.
Microgenics Corporation................ CEDIA DAU Opiate Assay Cat # 80- Kit: 4 Bottles, 85ml..... 12/1/93
2900.
Microgenics Corporation................ CEDIA DAU Opiate ED Reagent, Vial: 100ml.............. 12/1/93
Cat # 80-2900.
Microgenics Corporation................ CEDIA DAU Opiates ED Reagent, Vial: 500ml.............. 12/1/93
Cat # 80-3000.
Microgenics Corporation................ CEDIA DAU PPX/METD Cutoff Vial: 10ml............... 3/2/95
Calibrator.
Microgenics Corporation................ CEDIA DAU PPX/METD High Vial: 10ml............... 3/2/95
Calibrator.
Microgenics Corporation................ CEDIA DAU PPX/METD Intermediate Vial: 10ml............... 3/2/95
Calibrator.
Microgenics Corporation................ CEDIA DAU Specialty Control Set 2 Vials; 15ml/vial....... 5/10/94
1, #80-0121.
Microgenics Corporation................ CEDIA DAU Specialty Control Set 2 Vials; 15ml/vial....... 5/10/94
2, #80-0122.
Microgenics Corporation................ CEDIA DAU THC 100ng/ml Bottle: 15ml............. 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU THC 150ng/ml Bottle: 15ml............. 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU THC 25ng/ml Bottle: 15ml............. 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU THC 50ng/ml Bottle: 15ml............. 12/1/93
Calibrator.
Microgenics Corporation................ CEDIA DAU THC 75ng/ml Bottle: 15ml............. 12/1/93
Calibrator.
Microgenics Corporation................ Cocaine Conjugate.............. Vial: 25ml............... 12/1/93
Microgenics Corporation................ Cocaine ED Bulk Reagent........ Carboy: 25L.............. 12/1/93
Microgenics Corporation................ Cocaine Manufacturing Bulk Carboy or Beaker: 4L..... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Cocaine Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Cocaine Spiking Solution....... Carboy: 2L............... 12/1/93
Microgenics Corporation................ In-house Phenobarbital Bulk Bottle: 2L............... 11/13/90
Primary Standard 40ug/ml, 80ug/
ml.
Microgenics Corporation................ In-house Phenobarbital Primary Micro tube: 1.5ml; Box: 11/13/90
Standard 40ug/ml, 80ug/ml. 100 tubes.
Microgenics Corporation................ In-house manufacturing Bulk Bottle: 2L............... 11/13/90
Calibrator 10ug/ml, 20ug/ml,
40 ug/ml, 60ug/ml, 80ug/ml,
90ug/ml Phenobarbital.
Microgenics Corporation................ In-house manufacturing Vial: 3.5ml.............. 11/13/90
Calibrator 10ug/ml, 20ug/ml,
40ug/ml, 60ug/ml80ug/ml, 90ug/
ml Phenobarbital.
Microgenics Corporation................ Methadone Spiking Solution..... Vial: 2L................. 3/2/95
Microgenics Corporation................ Methamphetamine Conjugate...... Vial: 25ml............... 4/13/94
Microgenics Corporation................ Methamphetamine Manufacturing Carboy or Beaker: 4L..... 4/20/94
Bulk Calibrators B, C, D,
E.F.G.H, I, J, K, Open.
Microgenics Corporation................ Methamphetamine Manufacturing Vial: 3.5ml or 5.0ml..... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, Open.
Microgenics Corporation................ Microgenics CEDIA Phenobarbital Vial: 3.5ml; Kit: 2 vials 11/13/90
Assay 40ug/ml, 80ug/ml.
Microgenics Corporation................ Morphine Conjugate............. Vial: 25ml............... 12/1/93
[[Page 154]]
Microgenics Corporation................ Opiate ED Bulk Reagent......... Carboy: 25L.............. 12/1/93
Microgenics Corporation................ Opiate Manufacturing Bulk Carboy or Beaker: 4L..... 4/20/94
Calibrators E, F, G, H, I, J,
K, Open.
Microgenics Corporation................ Opiate Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators E, F, G, H, I, J,
K, Open.
Microgenics Corporation................ Opiate Spiking Solution........ Carboy: 2L............... 12/1/93
Microgenics Corporation................ PCP Spiking Solution........... Carboy: 2L............... 12/1/93
Microgenics Corporation................ PCP Stock Concentrate.......... Vial: 10ml............... 12/1/93
Microgenics Corporation................ Phencyclidine Manufacturing Carboy or Beaker: 4L..... 4/20/94
Bulk Calibrators E, F, G, H,
I, J, K, Open.
Microgenics Corporation................ Phencyclidine Manufacturing Vial: 3.5 or 5.0ml....... 4/20/94
Calibrators E, F, G, H, I, J,
K, Open.
Microgenics Corporation................ Phenobarbital Stock Solution... Flask: 100ml............. 11/13/90
Microgenics Corporation................ Propoxyphene/Methadone Cutoff Bulk: 4L................. 3/2/95
Calibrator.
Microgenics Corporation................ Propoxyphene/Methadone High Bulk: 4L................. 3/2/95
Calibrator.
Microgenics Corporation................ Propoxyphene/Methadone Bulk: 4L................. 3/2/95
Intermediate Calibrator.
Microgenics Corporation................ THC 100 Control Set............ Box: 2 Bottles; 15ml each 6/30/94
Microgenics Corporation................ THC 100 Controls (High & Low).. Bottle: 15ml............. 6/30/94
Microgenics Corporation................ THC 100 Controls (High & Low) Carboy: 150L............. 6/30/94
Bulk.
Microgenics Corporation................ THC 100ng/ml Bulk Calibrator... Carboy: 4L............... 12/1/93
Microgenics Corporation................ THC 150ng/ml Bulk Calibrator... Carboy: 4L............... 12/1/93
Microgenics Corporation................ THC 25 Control Set............. Box: 2 Bottles; 15ml each 6/30/94
Microgenics Corporation................ THC 25 Controls (High & Low)... Bottle: 15ml............. 6/30/94
Microgenics Corporation................ THC 25 Controls (High & Low) Carboy: 150L............. 6/30/94
Bulk.
Microgenics Corporation................ THC 25ng/ml Bulk Calibrator.... Carboy: 2L............... 12/1/93
Microgenics Corporation................ THC 50 Control Set............. Box: 2 Bottles; 15ml each 6/30/94
Microgenics Corporation................ THC 50 Controls (High & Low)... Bottle: 15ml............. 6/30/94
Microgenics Corporation................ THC 50 Controls (High & Low) Carboy: 150L............. 6/30/94
Bulk.
Microgenics Corporation................ THC 50ng/ml Bulk Calibrator.... Carboy: 4L............... 12/1/93
Microgenics Corporation................ THC 75ng/ml Bulk Calibrator.... Carboy: 1L............... 12/1/93
Microgenics Corporation................ THC Conjugate.................. Vial: 25ml............... 12/1/93
Microgenics Corporation................ THC ED Bulk Reagent............ Carboy: 25L.............. 12/1/93
Microgenics Corporation................ THC Manufacturing Bulk Carboy or Beaker: 4L..... 4/20/94
Calibrators B, C, D, E, F, G,
H, I, J, K, L, Open.
Microgenics Corporation................ THC Manufacturing Calibrators Vial: 3.5 or 5.0ml....... 4/20/94
B, C, D, E, F, G, H, I, J, K,
L, Open.
Micromedic Systems..................... Micromedic Neonatal T4 125I Nalgene Bottle: 4 oz..... 6/25/87
Tracer Solution.
Micromedic Systems..................... Micromedic Neonatal T4 Elution Nalgene Bottle: 2 oz..... 6/25/87
Solution.
Micromedic Systems..................... Neonatal T4 125I Tracer Vial: 30ml............... 5/21/80
Solution.
Micromedic Systems..................... Neonatal T4 Buffer Solution.... Bottle: 8ounce........... 5/21/80
Micromedic Systems..................... T3 RIA 125I Tracer Solution.... Vial: 30ml............... 12/14/76
Micromedic Systems..................... T3 RIA Buffer Solution......... High Density Polyethylene 12/14/76
Bottle: 8 ounce.
Micromedic Systems..................... T3 Uptake 125I Tracer Solution. Vial: 30ml............... 12/14/76
Micromedic Systems..................... T3 Uptake Buffer Solution...... High Density Polyethylene 12/14/76
Bottle: 8 ounce.
Micromedic Systems..................... T4 RIA 125I Tracer Solution.... Vial: 30ml............... 12/14/76
Micromedic Systems..................... T4 RIA Buffer Solution......... High Density Polyethylene 12/14/76
Bottle: 8 ounce.
Miles Inc.............................. Immuno-1 Setpoint TDM Glass Bottles: 5ml; Kit: 1/3/91
Calibrators Kit No. T03-2864 5 Bottles.
Component No. T13-2864(02-06).
Miles Inc.............................. Technicon Immuno 1 TESTpoint Glass vial; 5ml; Kit: 6 3/16/92
Ligand Controls, Kit No. T03- vials.
3393-01; Level I T13-3394-01;
Level II T13-3395-01; Level
III T13-3396-01.
Miles Inc.............................. Technicon RA Systems Set Point. Vial: 5ml Kit: 5 vials... 7/20/90
Miles Laboratories, Inc................ SERALYZER ARIS Phenobarbital Kit: 2 vials; 1ml/vial... 4/29/93
Calibrator Kit, # 6453.
Miles Laboratories, Inc................ SERALYZER ARIS Phenobarbital Kit: 4 vials; 1ml/vial... 4/29/93
Calibrator and Control Kit, #
6455T.
Miles Laboratories, Inc................ SERALYZER ARIS Phenobarbital Kit: 2 vials; 1ml/vial... 4/29/93
Control Kit, # 6454T.
Miles Laboratories, Inc................ SERALYZER ARIS Phenytoin Bulk Bulk..................... 6/15/94
Reagent Paper.
Miles Laboratories, Inc................ Seralyzer ARIS Drug Assay Vial: 1ml................ 1/17/84
Control.
Miles Laboratories, Inc................ Seralyzer ARIS Drug Assay High Vial: 0.5ml.............. 1/17/84
Calibrator.
Miles Laboratories, Inc................ Seralyzer ARIS Drug Assay Low Vial: 0.5ml.............. 1/17/84
Calibrator.
Miles Laboratories, Inc................ Seralyzer ARIS Phenytoin Bottle Containing 25 and 5/28/86
Reagent Strips. 50 Strips.
Miles Laboratories, Inc................ T-4 Buffer..................... Glass Screwtop Vial: \3/ 3/28/77
4\ ounce.
Monobind, Inc.......................... Monobind T3 Antibody Reagent... Test Tube w/Cap: 70ml.... 11/8/77
Monobind, Inc.......................... Monobind T3 Tracer Reagent..... Wheaton Glass Container: 11/8/77
55ml.
[[Page 155]]
Monobind, Inc.......................... Monobind T4 Antibody Reagent... Test Tube w/Cap: 70ml.... 11/8/77
Monobind, Inc.......................... Monobind T4 Tracer Reagent..... Wheaton Glass Container 11/8/77
55ml.
Monobind, Inc.......................... Monobind TSH Antibody Reagent.. Test Tube w/Cap: 10.5ml.. 11/8/77
Monobind, Inc.......................... Monobind TSH Non-Specific Wheaton Glass: 1.05ml.... 11/8/77
Buffer.
Monobind, Inc.......................... Monobind TSH Precipitating Plastic Container w/Cap : 11/8/77
Reagent. 105ml.
Monobind, Inc.......................... Monobind TSH Tracer Reagent.... Wheaton Glass Container 11/8/77
10.5ml.
Monobind, Inc.......................... T3 Adsorbent Reagent........... Glass Bottle: 110ml, 50ml 5/15/78
Plastic Bottle: 260ml.
Monobind, Inc.......................... T3 Uptake Tracer Reagent....... Glass Bottle: 55ml, 30ml 5/15/78
Plastic Bottle: 125ml.
Monobind, Inc.......................... TSH Radioimmunoassay Test Kit: 100 Tests........... 11/8/77
System.
Monobind, Inc.......................... Thyroxine Radioimmunoassay Test Kit: 100 Tests........... 11/8/77
System.
Monobind, Inc.......................... Triiodothyronine Kit: 100 tests........... 11/8/77
Radioimmunoassay Test System.
Monoclonal Antibodies, Inc............. Test Kit for Cocaine Kit: 50 tests............ 10/17/86
Metabolites in Urine.
Monoclonal Antibodies, Inc............. Test Kit for Opiates in Urine.. Kit: 50 tests............ 10/17/86
Monoclonal Antibodies, Inc............. Test Kit for Kit: 50 tests............ 10/17/86
Tetrahydrocannabinol (THC) in
Urine.
NSI Technology Services Corp........... Alpha, alpha-dimethyl- Amber Ampoule: 2ml....... 3/02/89
phenethylamine.
Nuclear Diagnostics, Inc............... MAAT T3 Uptake Reagent......... Bottle: 105ml, 210ml; 11/16/90
Kit: 1 bottle 210ml.
Nuclear Diagnostics, Inc............... SPINSEP-TBG Reagent Catalog No. Polypropylene Bottle: 12/15/77
17100. 105ml.
Nuclear Diagnostics, Inc............... TETRIA P.E.G. Antiserum Catalog Polypropylene Bottle: 3/10/78
No. 16100A. 55ml.
Nuclear Diagnostics, Inc............... TETRIA P.E.G. Reagent Catalog Polypropylene Bottle: 7/8/77
No. 16100. 105ml.
Nuclear Diagnostics, Inc............... TETRIA P.E.G. Reagent Catalog Polypropylene Bottle: 3/10/78
No. 16100R. 55ml.
Nuclear Diagnostics, Inc............... TRIA-P.E.G. Antiserum Catalog Polypropylene Bottle: 3/10/78
No. 12100A. 55ml.
Nuclear Diagnostics, Inc............... TRIA-P.E.G. Reagent Catalog Polypropylene Bottle: 3/10/78
No.12100R. 55ml.
OMI International Corporation.......... Compound N Solution............ Steel Drum: 55 gallon.... 10/1/75
Organon Teknika Corp................... Barbital Buffered Saline with Plastic Bottle: 1L....... 1/5/90
Azide.
Organon Teknika Corp................... Modified Barbital Buffer....... Plastic Bottle: 1L....... 1/5/90
Organon Teknika Corp................... Owren's Veronal Buffer for Bottle: 37 ml............ 5/7/80
FIBRIQUIK.
Organon Teknika Corp................... Platelin....................... Vial: 7.3ml.............. 3/13/72
Organon Teknika Corp................... Simplastin..................... Vial: 4.7ml, 7.3ml, and 3/13/72
16.5ml.
Organon Teknika Corp................... Simplastin-A................... Vial: 7.3ml.............. 3/13/72
Organon Teknika Corp................... TRIS/Barbital Buffer........... Plastic Bottle: 1L....... 1/5/90
Ortho Diagnostic Systems, Inc.......... Activated ThromboFAX No.721000. Bottle: 3.2ml............ 9/21/71
Ortho Diagnostic Systems, Inc.......... ORTHO Owren's Buffer........... Kit: 6-20 ml vials....... 8/26/88
Ortho Diagnostic Systems, Inc.......... Ortho Activated PTT Reagent.... Glass Vial: 30 5/23/83
determination size, 100.
Ortho Diagnostic Systems, Inc.......... Ortho Plasma Coagulation Glass Vial: 5ml.......... 10/25/83
Control Level I.
Ortho Diagnostic Systems, Inc.......... Ortho Plasma Coagulation Glass Vial: 5ml.......... 10/25/83
Control Level II.
Ortho-McNeil Pharmaceutical............ Codeine-N-Oxide................ Bottle: 2ml.............. 10/11/95
PB Diagnostic Systems, Inc............. Estradiol Reagent.............. 6 Vials; 1ml/vial........ 10/28/93
PB Diagnostic Systems, Inc............. Estradiol Test Module.......... Plastic plate: 1.7''x 10/28/93
.7''x 3.5''.
PB Diagnostic Systems, Inc............. OPUS Estradiol Kit............. Kit: 50 Tests............ 10/28/93
PB Diagnostic Systems, Inc............. OPUS Phenobarbital Calibrators: Vial: 2.5ml Carton: 5 8/7/90
5, 10, 20, 40, 80g/ml. vials.
PB Diagnostic Systems, Inc............. OPUS Phenobarbital Test Modules Plastic Test Module, 8/7/90
Tray: 5 modules, Carton:
50 modules.
Pacific Hemostasis..................... Barbital Buffered Saline....... Vial: 100ml.............. 5/24/84
Pacific Hemostasis..................... Barbital Buffered Saline (Bulk) Carboy: 100L............. 10/5/94
Pacific Hemostasis..................... Barbital Buffered Saline with Vial: 90ml............... 5/24/84
Heparin.
Pacific Hemostasis..................... Barbital Buffered Saline with Carboy: 100L............. 10/5/94
Heparin (Bulk).
Pacific Hemostasis..................... Barbital Buffered with Heparin. Bulk in Process.......... 1/24/95
Pacific Hemostasis..................... Diluting Fluid................. Bulk in Process.......... 1/24/95
Pacific Hemostasis..................... Diluting Fluid................. Vial: 20ml............... 5/24/84
Pacific Hemostasis..................... Diluting Fluid (Bulk).......... Carboy: 100L............. 10/5/94
Pacific Hemostasis..................... Kontact........................ Bulk in Process.......... 1/24/95
Pacific Hemostasis..................... Kontact........................ Vial: 4ml, 10ml.......... 3/22/94
[[Page 156]]
Pacific Hemostasis..................... Kontact (Bulk)................. Carboy: 200L............. 10/5/94
Pacific Hemostasis..................... Kontact Kit (10ml) Cat # 224- Kit: 10 Vials............ 3/22/94
006.
Pacific Hemostasis..................... Kontact Kit (4ml) Cat # 257-324 Kit: 10 Vials............ 3/22/94
Pantex................................. Immuno T3 Kit: (1)L- Kit Containing Bottles: 1/4/79
Triiodothyronine 125I (2)1st (1)10ml (2)10ml (3)50ml
Antiserum (3)2nd Antiserum (4)5ml (5)3ml.
(4)Diluent (5)Standards.
Pantex................................. Immuno-Digoxin Kit Containing: Kit Containing Bottles: 1/4/79
(1)Digoxin 125I (2)1st (1)10ml (2)20ml (3)50ml
Antiserum (3) 2nd Antiserum (4)5ml.
(4)Diluent.
Pantex................................. Immuno-Estriol 125I Kit: 2nd Bottle: 50ml............. 1/4/79
Antiserum.
Pantex................................. Immuno-Estriol Kit: (1)Estriol Kit Containing Bottles: 1/4/79
3H RIA (2)Estriol 3H Recovery (1)10ml (2)5ml (3)10ml
(3)1st Antiserum (4)2nd (4)20ml (5)100ml (6)50ml
Antiserum (5)Diluent (6)Buffer (7)5ml.
(7)Standards.
Pantex................................. Immuno-T4 Kit: (1)Thyroxine Kit Containing Bottles: 1/4/79
125I (2)1st Antiserum (3)2nd (1)100ml, 1000ml (2)50ml
Antiserum (4)Diluent (3)100ml (4)5ml (5)3ml.
(5)Standards.
Pantex................................. Immuno-Testosterone 125I Kit: Kit Containing Bottles: 1/4/79
(1)Testosterone 125I (2)1st (1)10ml (2)10ml (3)50ml
Antiserum (3)2nd Antiserum (4)100ml (5)5ml.
(4)Diluent (5)Standards.
Pantex................................. T3 Uptake Kit: L- Bottle: 100ml, 1000ml.... 1/4/79
Triiodothyronine 125I.
Perkin-Elmer Corporation............... Amphetamine Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Perkin-Elmer Corporation............... Barbiturates Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Perkin-Elmer Corporation............... Cocaine Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Perkin-Elmer Corporation............... Methadone Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Perkin-Elmer Corporation............... Morphine Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Perkin-Elmer Corporation............... Opiates Polarization Kit: 100 tests........... 12/18/86
Fluoroimmunoassay Kit.
Princeton Separations, Inc............. Panagel 16..................... Pouch: 1 slide........... 6/29/87
Princeton Separations, Inc............. Panagel 8...................... Pouch: 1 slide........... 6/29/87
Princeton Separations, Inc............. Panagel Electrobuffer.......... Fiber Drum: 25 kg........ 6/29/87
Princeton Separations, Inc............. Panagel Electrode Buffer....... Pouch: 18.3 gms.......... 6/29/87
Princeton Separations, Inc............. Panagel LD Isoenzyme Electrode Pouch: 11.85 gms......... 6/29/87
Buffer.
Princeton Separations, Inc............. Panagel LD Isoenzyme Slide..... Pouch: 1 slide........... 6/29/87
Quality Assurance Service Corp......... Q.A. Toxicology Blood Controls. Vial: 6ml, 12ml Plastic 1/23/90
Bottle: 60ml, 90ml,
250ml, 625ml Glass
Bottle: 6ml-100ml.
Quality Assurance Service Corp......... Q.A. Toxicology Serum Controls. Vial: 6ml, 12ml Plastic 1/23/90
Bottle: 60ml, 90ml,
250ml, 625ml Glass
Bottle: 6ml-100ml.
Quality Assurance Service Corp......... Q.A. Toxicology Urine Controls. Vial: 6ml, 12ml Plastic 1/23/90
Bottle: 60ml, 90ml,
250ml, 625ml Glass
Bottle: 6ml-100ml.
Quantimetrix........................... Quantimetrix Anticonvulsant Polyethylene Dropper 4/16/86
Serum Drug Control, Liquid Bottle: 15ml.
Level II Control No. 17-0303-2.
Quantimetrix........................... Quantimetrix Antidepressant Polyethylene Dropper 4/16/86
Serum Drug Control, Liquid Bottle: 15ml.
Level I Control No. 17-0303-1.
Quantimetrix........................... Quantimetrix Antidepressant Polyethylene Dropper 4/16/86
Serum Drug Control, Liquid Bottle: 15ml.
Level I Control No. 17-0305-1.
Quantimetrix........................... Quantimetrix Antidepressant Polyethylene Dropper 4/16/86
Serum Drug Control, Liquid Bottle: 15ml.
Level II Control No. 17-0305-2.
Quantimetrix........................... Urine Drugs of Abuse Control Dropper Bottle: 15 ml.... 2/23/87
Catalog No. 12-2411-1.
Quin-Tec, Inc.......................... Additive SB-1.................. Drum: 55 gals............ 5/11/87
Quin-Tec, Inc.......................... Quin-Tec Brightener 402........ Plastic Pail: 5 gallons, 10/13/81
Plastic Drum: 55 gallons.
Quin-Tec, Inc.......................... Quin-Tec Brightener 404........ Plastic Pail: 5 gallons, 10/13/81
Plastic Drum: 55 gallons.
Radian Corporation..................... (+/-) 11-Nor-9-Carboxy-delta 9- Vial: 2ml................ 6/12/91
THC-D9 0.01mg/ml, 0.1mg/ml,
1.0mg/ml.
Radian Corporation..................... (-)-11-Nor-9-carboxy-delta-9 Vial: 2ml................ 1/25/95
THC; 1.0mg/ml, 100g/
ml.
Radian Corporation..................... 17alpha-Methyl-5alpha- Ampule: 2ml.............. 7/07/95
androstane-3alpha, 17beta-
diol, 100g/ml, 1mg/ml.
Radian Corporation..................... 17alpha-Methyl-5beta-androstane- Ampule: 2ml.............. 7/07/95
3alpha, 17beta-diol, 100g/ml, 1mg/ml.
Radian Corporation..................... 2-S Methcathinone-D5 HCl Ampule: 2ml.............. 12/22/93
100g/ml, 1.0mg/ml.
Radian Corporation..................... 2R-Cathinone HCL 100g/ Ampule: 2ml.............. 12/22/93
ml, 1.0mg/ml.
Radian Corporation..................... 2R-Cathinone-D5 HCL 100g/ml, 1.0mg/ml.
Radian Corporation..................... 2R-Methcathinone HCL 100g/ml, 1.0mg/ml.
[[Page 157]]
Radian Corporation..................... 2R-Methcathinone-D5 HCL Ampule: 2ml.............. 12/22/93
100g/ml, 1.0mg/ml.
Radian Corporation..................... 2S-Cathinone HCL 100g/ Ampule: 2ml.............. 12/22/93
ml, 1.0mg/ml.
Radian Corporation..................... 2S-Cathinone-D5 HCL 100g/ml, 1.0mg/ml.
Radian Corporation..................... 2S-Methcathinone HCL 100g/ml, 1.0mg/ml.
Radian Corporation..................... 3'-Hydroxystanozolol-D3; Ampule: 2ml.............. 6/06/94
100g/ml, 1.0mg/ml.
Radian Corporation..................... 3'-Hydroxystanozolol; 100g/ml, 1.0mg/ml.
Radian Corporation..................... 3, 4-Methylenedioxy-amphetamine- 2 ml amber ampule........ 10/19/88
D5 0.1 mg/ml.
Radian Corporation..................... 3, 4-Methylenedioxy-amphetamine- 2 ml amber ampule........ 10/19/88
D5 1.0 mg/ml.
Radian Corporation..................... 3, 4-Methylenedioxy- 2 ml amber ampule........ 10/19/88
methamphetamine-D5 0.1 mg/ml.
Radian Corporation..................... 3, 4-Methylenedioxy- 2 ml amber ampule........ 10/19/88
methamphetamine-D5 1.0 mg/ml.
Radian Corporation..................... 3, 4-Methylenedioxyamphetamine Amber glass ampule: 2ml.. 1/12/89
0.1, 1.0 mg/ml.
Radian Corporation..................... 3, 4- Amber glass ampule: 2ml.. 1/12/89
Methylenedioxymethamphetamine
0.1, 1.0 mg/ml.
Radian Corporation..................... 4-Methylaminorex 100g/ Ampule: 2ml.............. 1/29/93
ml, 1.0mg/ml.
Radian Corporation..................... 4-Methylaminorex-D5 100g/ml, 1.0mg/ml.
Radian Corporation..................... 6-Acetylmorphine............... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... 6-Acetylmorphine-D3............ Ampule: 2 ml............. 12/4/87
Radian Corporation..................... 6-Acetylmorphine-D6; 100g/ml, 1.0mg/ml.
Radian Corporation..................... 6beta-Hydroxyfluoxymesterone, Ampule: 2ml.............. 7/7/95
100g/ml, 1mg/ml.
Radian Corporation..................... 6beta-Hydroxymethandienone, Ampule: 2ml.............. 7/7/95
100g/ml, 1mg/ml.
Radian Corporation..................... 9-Carboxy-11-nor-Delta-9- Ampule: 2 ml............. 12/4/87
Tetrahydrocannabinol-D3.
Radian Corporation..................... 9-Carboxy-11-nor-delta-9-THC Amber glass ampule: 2ml.. 1/12/89
0.1, 1.0 mg/ml.
Radian Corporation..................... Alpha-Hydroxyalprazolam 0.1 mg/ Vial: 2ml................ 6/12/91
ml, 1.0 mg/ml.
Radian Corporation..................... Alpha-Hydroxyalprazolam-D5 0.1 Vial: 2ml................ 6/12/91
mg/ml, 1.0 mg/ml.
Radian Corporation..................... Alpha-Hydroxytriazolam 0.1mg/ Ampule: 2ml.............. 4/27/92
ml, 1.0mg/ml.
Radian Corporation..................... Alpha-Hydroxytriazolam-D4, Ampule: 2ml.............. 4/27/92
0.1mg/ml, 1.0mg/ml.
Radian Corporation..................... Alprazolam 0.1mg/ml, 1.0mg/ml.. Ampule: 2ml.............. 11/5/90
Radian Corporation..................... Alprazolam-D5 0.1mg/ml, 1.0mg/ Ampule: 2ml.............. 11/5/90
ml.
Radian Corporation..................... Amobarbital 0.1mg/ml, 1.0mg/ml. Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Amphetamine-D3 0.1 mg/ml....... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... Anhydroecgonine 100g/ Ampule: 2ml.............. 1/29/93
ml, 1.0mg/ml.
Radian Corporation..................... Anhydroecgonine HCL, 100g/ml, 1mg/ml.
Radian Corporation..................... Anhydroecgonine methyl ester, Ampule: 2ml.............. 7/7/95
100g/ml, 1mg/ml.
Radian Corporation..................... Anhydroecgonine-D3 100g/ml, 1.0mg/ml.
Radian Corporation..................... Benzoylecgonine................ Ampule: 2ml.............. 12/4/87
Radian Corporation..................... Benzoylecgonine isopropyl Ampule: 2ml.............. 7/7/95
ester, 100g/ml, 1mg/
ml.
Radian Corporation..................... Benzoylecgonine-D3............. Ampule: 2ml.............. 12/4/87
Radian Corporation..................... Bromazepam; 1.0mg/ml, 100g/ml.
Radian Corporation..................... Buprenorphine 0.1.............. Ampule: 2ml.............. 2/1/91
Radian Corporation..................... Buprenorphine-D4 0.1 mg/ml..... Ampule: 2ml.............. 2/1/91
Radian Corporation..................... Chlordiazepoxide 100g/ Ampule: 2ml.............. 12/22/93
ml, 1.0mg/ml.
Radian Corporation..................... Clobazam, 100g/ml, 1mg/ Ampule: 2ml.............. 7/7/95
ml.
Radian Corporation..................... Clonazepam-D4; 1.0mg/ml, Vial: 2ml................ 1/25/95
100g/ml.
Radian Corporation..................... Cocaethylene 0.1mg/ml, 1.0mg/ml Ampule: 2ml.............. 12/13/90
Radian Corporation..................... Cocaethylene-D3................ Ampule: 2ml.............. 12/13/90
Radian Corporation..................... Cocaethylene-D8 100g/ Ampule: 2ml.............. 12/22/93
ml, 1.0mg/ml.
Radian Corporation..................... Cocaine 0.1, 1.0 mg/ml......... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Cocaine-D3..................... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... Codeine........................ Ampule: 2 ml............. 3/9/88
Radian Corporation..................... Codeine-D3..................... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... D-Amphetamine 0.1, 1.0 mg/ml... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... D-Methamphetamine 0.1 mg/ml, Vial: 2ml................ 6/12/91
1.0 mg/ml.
Radian Corporation..................... D-Propoxyphene 0.1, 1.0 mg/ml.. Amber glass ampule: 2ml.. 4/27/92
Radian Corporation..................... D-Propoxyphene 0.1mg/ml, 1.0mg/ Ampule: 2ml.............. 4/27/92
ml.
Radian Corporation..................... DL-3, 4-MDEA 100g/ml, Ampule: 2ml.............. 12/22/93
1.0mg/ml.
Radian Corporation..................... DL-3, 4-MDEA-D5 100g/ Ampule: 2ml.............. 12/22/93
ml, 1.0mg/ml.
Radian Corporation..................... DL-Amphetamine 0.1, 1.0 mg/ml.. Ampule: 2ml.............. 12/4/87
Radian Corporation..................... DL-Amphetamine-D11, 0.1mg/ml, Ampule: 2ml.............. 4/27/92
1.0mg/ml.
Radian Corporation..................... DL-Amphetamine-D3 0.1, 1.0 mg/ Ampule: 2ml.............. 12/4/87
ml.
Radian Corporation..................... DL-Amphetamine-D5 (SC) 0.1, 1.0 Ampule: 2ml.............. 12/4/87
mg/ml.
Radian Corporation..................... DL-Amphetamine-D5 0.1, 1.0 mg/ Ampule: 2 ml............. 12/4/87
ml.
Radian Corporation..................... DL-Amphetamine-D5 0.1, 1.0 mg/ Ampule: 2ml.............. 12/4/87
ml.
Radian Corporation..................... DL-Amphetamine-D8, 0.1mg/ml, Ampule: 2ml.............. 4/27/92
1.0mg/ml.
Radian Corporation..................... DL-MDEA-D6; 1.0mg/ml, 100g/ml.
Radian Corporation..................... DL-Methamphetamine 0.1, 1.0 mg/ Amber glass ampule: 2ml.. 1/12/89
ml.
Radian Corporation..................... DL-Methamphetamine-D11 0.1mg/ Ampule: 2ml.............. 6/16/93
ml, 1.0mg/ml.
Radian Corporation..................... DL-Methamphetamine-D5 0.1, 1.0 Ampule: 2 ml............. 12/4/87
mg/ml.
Radian Corporation..................... DL-Methamphetamine-D8 (Phenyl- Ampule: 2ml.............. 4/6/93
D5 & N-Methyl-D3) 100g/ml, 1.0mg/ml.
Radian Corporation..................... DL-Methamphetamine-D8 0.1 mg/ml Ampule: 2ml.............. 12/4/87
Radian Corporation..................... DL-Methamphetamine-D8, 0.1mg/ Ampule: 2ml.............. 4/27/92
ml, 1.0mg/ml.
Radian Corporation..................... DL-Propoxyphene-D5 0.1, 1.0 mg/ 2 ml amber ampule........ 10/19/88
ml.
Radian Corporation..................... Delta-9-Tetrahydrocannabinol Amber glass ampule: 2ml.. 1/12/89
0.1, 1.0 mg/ml.
[[Page 158]]
Radian Corporation..................... Delta-9-Tetrahydrocannabinol-D3 Ampule: 2 ml............. 12/4/87
Radian Corporation..................... Diazepam 0.1, 1.0 mg/ml........ Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Diazepam-D5 0.1 mg/ml.......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Diazepam-D5 1.0 mg/ml.......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Ecgonine 0.1 mg/ml, 1.0 mg/ml.. Vial: 2ml................ 6/12/91
Radian Corporation..................... Ecgonine Methyl Ester 0.1, 1.0 Amber glass ampule: 2ml.. 1/12/89
mg/ml.
Radian Corporation..................... Ecgonine Methyl Ester-D3 0.1 mg/ 2 ml amber ampule........ 10/19/88
ml.
Radian Corporation..................... Ecgonine Methyl Ester-D3 1.0 mg/ 2 ml amber ampule........ 10/19/88
ml.
Radian Corporation..................... Ecgonine ethyl ester, 100ug/ml, Ampule: 2ml.............. 7/7/95
1mg/ml.
Radian Corporation..................... Ecgonine-D3 0.1 mg/ml, 1.0 mg/ Vial: 2ml................ 6/12/91
ml.
Radian Corporation..................... Estazolam; 1.0mg/ml, 100ug/ml.. Vial: 2ml................ 1/25/95
Radian Corporation..................... Fentanyl....................... Ampule: 2ml.............. 1/2/91
Radian Corporation..................... Fentanyl-D5.................... Ampule: 2ml.............. 1/2/91
Radian Corporation..................... Flunitrazepam; 1.0mg/ml, 100ug/ Vial: 2ml................ 1/25/95
ml.
Radian Corporation..................... Fluoxymesterone, 100ug/ml, 1mg/ Ampule: 2ml.............. 7/7/95
ml.
Radian Corporation..................... Flurazepam 0.1mg/ml, 1.0mg/ml.. Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Heroin-D3; 1.0mg/ml, 100ug/ml.. Vial: 2ml................ 1/25/95
Radian Corporation..................... Heroin-D6; 1.0mg/ml, 100ug/ml.. Vial: 2ml................ 1/25/95
Radian Corporation..................... Heroin-D9; 1.0mg/ml, 100ug/ml.. Vial: 2ml................ 1/25/95
Radian Corporation..................... Heroin; 1.0mg/ml, 100ug/ml..... Ampule: 2ml.............. 8/23/94
Radian Corporation..................... Hexobarbital; 1.0mg/ml, 100ug/ Ampule: 2ml.............. 8/23/94
ml.
Radian Corporation..................... Hydrocodone-D3 0.1 mg/ml....... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Hydrocodone-D3 1.0 mg/ml....... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Hydrocodone 0.1, 1.0 mg/ml..... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Hydromorphone-D3 0.1 mg/ml..... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Hydromorphone-D3 1.0 mg/ml..... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Hydromorphone 0.1, 1.0 mg/ml... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Ibogaine 100ug/ml, 1.0mg/ml.... Ampule: 2ml.............. 12/22/93
Radian Corporation..................... Ibogaine-D3 100ug/ml, 1.0mg/ml. Ampule: 2ml.............. 12/22/93
Radian Corporation..................... Lorazepam 0.1mg/ml, 1.0mg/ml... Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Lorazepam glucuronide, 50ug/ml, Ampule: 2ml.............. 7/7/95
100ug/ml, 1mg/ml.
Radian Corporation..................... Lorazepam-D4, 0.1mg/ml, 1.0mg/ Ampule: 2ml.............. 4/27/92
ml.
Radian Corporation..................... Lormetazepam, 100ug/ml, 1mg/ml. Ampule: 2ml.............. 7/7/95
Radian Corporation..................... Meperidine 0.1mg/ml, 1.0mg/ml.. Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Meperidine 0.1mg/ml, 1.0mg/ml.. Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Meprobamate 0.1mg/ml, 1.0mg/ml. Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Mescaline 100ug/ml, 1.0mg/ml... Ampule: 2ml.............. 1/29/93
Radian Corporation..................... Mescaline-D9 100ug/ml, 1.0mg/ml Ampule: 2ml.............. 1/29/93
Radian Corporation..................... Methadone-D5 0.1 mg/ml......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Methadone-D5 1.0 mg/ml......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Methadone 0.1, 1.0 mg/ml....... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Methandienone, 100ug/ml, 1mg/ml Ampule: 2ml.............. 7/7/95
Radian Corporation..................... Methaqualone-D4 0.1 mg/ml...... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Methaqualone-D4 1.0 mg/ml...... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Methaqualone 0.1, 1.0 mg/ml.... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Methcathinone 100ug/ml, 1.0mg/ Ampule: 2ml.............. 1/29/93
ml.
Radian Corporation..................... Methcathinone-D5 100ug/ml, Ampule: 2ml.............. 1/29/93
1.0mg/ml.
Radian Corporation..................... Methenolone, 100ug/ml, 1mg/ml.. Ampule: 2ml.............. 7/7/95
Radian Corporation..................... Method 8270 Supplemental Stock Vial: 2ml................ 1/25/95
Standard--2000ug/ml.
Radian Corporation..................... Methohexital 0.1mg/ml, 1.0mg/ml Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Methohexital-D5; 1.0mg/ml, Ampule: 2ml.............. 8/23/94
100ug/ml.
Radian Corporation..................... Methylphenidate 0.1mg/ml, 1.0mg/ Ampule: 2ml.............. 4/27/92
ml.
Radian Corporation..................... Methylphenidate HCL, 100ug/ml, Ampule: 2ml.............. 7/7/95
1mg/ml.
Radian Corporation..................... Methyltestosterone; 1.0mg/ml, Vial: 2ml................ 1/25/95
100ug/ml.
Radian Corporation..................... Midazolam; 1.0mg/ml, 100ug/ml.. Vial: 2ml................ 1/25/95
Radian Corporation..................... Morphine....................... Ampule: 2 ml............. 3/9/88
Radian Corporation..................... Morphine-3-Beta-D-glucuronide Ampule: 2ml.............. 2/1/91
0.1, 1.0mg/ml.
Radian Corporation..................... Morphine-3-Beta-D-glucuronide- Ampule: 2ml.............. 2/1/91
D3 0.1, 1.0mg/ml.
Radian Corporation..................... Morphine-D3.................... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... N-Ethylamphetamine; 1.0mg/ml, Vial: 2ml................ 1/25/95
100ug/ml.
Radian Corporation..................... Nitrazepam 0.1 mg/ml, 1.0 mg/ml Ampule: 2ml.............. 9/17/90
Radian Corporation..................... Nitrazepam-D5 0.1 mg/ml, 1.0 mg/ Ampule: 2ml.............. 9/17/90
ml.
Radian Corporation..................... Norbenzoylecgonine, 100ug/ml, Ampule: 2ml.............. 7/7/95
1mg/ml.
Radian Corporation..................... Norcocaethylene, 100ug/ml, 1mg/ Ampule: 2ml.............. 7/7/95
ml.
Radian Corporation..................... Norcocaine 0.1 mg/ml, 1.0 mg/ml Vial: 2ml................ 6/12/91
Radian Corporation..................... Norcocaine-D8 100ug/ml, 1.0mg/ Ampule: 2ml.............. 12/22/93
ml.
Radian Corporation..................... Nordiazepam-D5 0.1 mg/ml....... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Nordiazepam-D5 1.0 mg/ml....... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Nordiazepam 0.1, 1.0 mg/ml..... Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Norethandrolone, 100ug/ml, 1mg/ Ampule: 2ml.............. 7/7/95
ml.
Radian Corporation..................... Noroxycodone 0.1mg/ml, 1.0mg/ml Ampule: 2ml.............. 6/16/93
[[Page 159]]
Radian Corporation..................... Noroxymorphone 100ug/ml, 1.0mg/ Ampule: 2ml.............. 6/16/93
ml.
Radian Corporation..................... Oxazepam-D5 0.1 mg/ml.......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Oxazepam-D5 1.0 mg/ml.......... 2 ml amber ampule........ 10/19/88
Radian Corporation..................... Oxazepam-3-Beta-D-Glucuronide- Ampule: 2ml.............. 4/25/94
D5; 100ug/ml, 1.0mg/ml.
Radian Corporation..................... Oxazepam 0.1, 1.0 mg/ml........ Amber glass ampule: 2ml.. 1/12/89
Radian Corporation..................... Oxazepam-3-Beta-D-Glucuronide; Ampule: 2ml.............. 4/25/94
100ug/ml, 1.0mg/ml.
Radian Corporation..................... Oxycodone-D6 0.1mg/ml, 1.0mg/ml Ampule: 2ml.............. 6/16/93
Radian Corporation..................... Pentobarbital 0.1 mg/ml, 1.0 mg/ Ampule: 2ml.............. 9/24/90
ml.
Radian Corporation..................... Pentobarbital-D5 0.1 mg/ml, 1.0 Ampule: 2ml.............. 9/24/90
mg/ml.
Radian Corporation..................... Phencyclidine 0.1 mg/ml, 1.0 mg/ Amber glass ampule: 2ml.. 1/12/89
ml.
Radian Corporation..................... Phencyclidine-D5............... Ampule: 2 ml............. 12/4/87
Radian Corporation..................... Phenobarbital 0.1 mg/ml, 1.0 mg/ Amber glass ampule: 2ml.. 1/12/89
ml.
Radian Corporation..................... Phenobarbital-D5 0.1 mg/ml, 1.0 Ampule: 2 ml............. 12/4/87
mg/ml.
Radian Corporation..................... Phentermine-D3; 1.0mg/ml, 100ug/ Vial: 2ml................ 1/25/95
ml.
Radian Corporation..................... Phentermine; 1.0mg/ml, 100ug/ml Vial: 2ml................ 1/25/95
Radian Corporation..................... Prazepam 100ug/ml, 1.0mg/ml.... Ampule: 2ml.............. 1/29/93
Radian Corporation..................... Prazepam-D5 100ug/ml, 1.0mg/ml. Ampule: 2ml.............. 1/29/93
Radian Corporation..................... Quazepam; 1.0mg/ml, 100ug/ml... Vial: 2ml................ 1/25/95
Radian Corporation..................... Stanozolol-D3; 100ug/ml, 1.omg/ Ampule: 2ml.............. 6/6/94
ml.
Radian Corporation..................... Stanozolol; 100ug/ml, 1.omg/ml. Ampule: 2ml.............. 6/6/94
Radian Corporation..................... Temazepam 0.1 mg/ml, 1.0 mg/ml. Ampule: 2ml.............. 9/17/90
Radian Corporation..................... Temazepam-D5 0.1 mg/ml, 1.0 mg/ Ampule: 2ml.............. 9/17/90
ml.
Radian Corporation..................... Triazolam 0.1mg/ml, 1.0mg/ml... Ampule: 2ml.............. 4/27/92
Radian Corporation..................... Triazolam-D4 0.1mg/ml, 1.0mg/ml Ampule: 2ml.............. 4/27/92
Radian Corporation..................... alpha-Hydroxyalprazolam Ampule: 2ml.............. 7/7/95
glucuronide, 50ug/ml, 100ug/
ml, 1mg/ml.
Radian Corporation..................... alpha-Hydroxymidazolam, 100ug/ Ampule: 2ml.............. 7/7/95
ml, 1mg/ml.
Radian Corporation..................... alpha-Hydroxytriazolam Ampule: 2ml.............. 7/7/95
glucuronide, 50ug/ml, 100ug/
ml, 1mg/ml.
Radian Corporation..................... m-Hydroxybenzoylecgonine; 1.0mg/ Vial: 2ml................ 1/25/95
ml, 100ug/ml.
Research Diagnostics................... 3H Alfentanil.................. Vial: 0.5ml.............. 6/15/89
Research Diagnostics................... 3H Fentanyl.................... Vial: 0.5ml.............. 6/15/89
Research Diagnostics................... 3H Sufentanil.................. Vial: 0.5ml.............. 6/15/89
Research Diagnostics................... Alfentanil Radioimmunoassay.... Kit: 200 tests........... 6/15/89
Research Diagnostics................... Alfentanil Radioimmunoassay.... Kit: 200 tests........... 6/15/89
Research Diagnostics................... Fentanyl Analogs Reference Amber Ampule: 1 ml, 10/17/89
Standards for Drug Analysis. Plastic Shell: 5
ampules, Kit: 2 shells
(10 ampules).
Research Diagnostics................... Fentanyl Radioimmunoassay...... Kit: 200 tests........... 6/15/89
Research Diagnostics................... Sufentanil Radioimmunoassay.... Kit: 200 tests........... 6/15/89
Research Triangle Institute............ 11-Nor-9-carboxy-delta-9 THC Kit Containing: 18-21ml 10/26/81
Blood Standards Kit. Ampuls; 1-5ml Ampul.
Research Triangle Institute............ 11-Nor-9-carboxy-delta-9 THC Kit Containing: 18-21ml 10/26/81
Plasma Standards Kit. Ampuls; 1-5ml Ampul.
Research Triangle Institute............ Delta-9 THC Blood Standards Kit Kit Containing: 16-2ml 10/26/81
Ampuls; 1-5ml Ampul.
Research Triangle Institute............ Delta-9 THC Plasma Standards Kit Containing: 16-2ml 11/2/81
Kit. Ampuls; 1-5ml Ampul.
Research Triangle Institute............ Iodine Kit for Radioimmunoassay Kit Containing: 26-1ml 10/26/81
of 11-Nor-9-carboxy-delta-9 Ampuls; 2-20ml Vials; 2-
THC in Blood. 250ml Bottles.
Research Triangle Institute............ Iodine Kit for Radioimmunoassay Kit Containing: 24-1ml 10/26/81
of 11-Nor-9-carboxy-delta-9 Ampuls; 2-20ml Vials; 2-
THC in Plasma. 250ml Bottles.
Research Triangle Institute............ Iodine Kit for Radioimmunoassay Kit Containing: 20-1ml 10/20/80
of Delta-9 THC. Ampules; 2-20ml Vials; 2-
250ml Bottles.
Research Triangle Institute............ Iodine Kit for Radioimmunoassay Kit Containing: 22-1ml 7/10/81
of Delta-9 THC in Blood. Ampules; 2-20ml Vials; 2-
250ml Bottles.
Research Triangle Institute............ Tritium Kit for Kit Containing: 20-1ml 6/27/80
Radioimmunoassay of Delta-9 Ampules; 2- 20ml Vials;
THC. 2- 250ml Bottles.
Restek Corp............................ Alprazolam..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Amobarbital.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Amphetamine.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Aprobarbital................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Barbital....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Benzoylecgonine................ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Benzphetamine.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Bromazepam..................... Ampule: 2ml.............. 1/8/93
[[Page 160]]
Restek Corp............................ Butabarbital................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Butalbital..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Cannabidiol delta-8............ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Cannabinol..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Chlordiazepoxide............... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Clobazam....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Clonazepam..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Cocaethylene................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Cocaine........................ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Codeine........................ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Desmethyl Diazepam............. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Diacetylmorphine............... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Diazepam....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ EPA Exempt Mix #1.............. Ampule: 1.25ml........... 3/18/94
Restek Corp............................ EPA Exempt Mix #2.............. Ampule: 1.25ml........... 3/18/94
Restek Corp............................ EPA Exempt Mix #3.............. Ampule: 1.25ml........... 3/18/94
Restek Corp............................ Ecgonine....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Ecgonine methyl ester.......... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Fenfluramine................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Fentanyl....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Flunitrazepam.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Flurazepam..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Glutethimide................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Hexobarbital................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Hydrocodone.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Levorphanol.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Lorazepam...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Medazepam...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Meperidine..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Mephobarbital.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Meprobamate.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Methadone...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Methamphetamine................ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Methohexital................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Methyprylon.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Morphine....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Nitrazepam..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Oxazepam....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Oxycodone...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Pentazocine.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Pentobarbital.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Phencyclidine.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Phendimetrazine................ Ampule: 2ml.............. 1/8/93
Restek Corp............................ Phenmetrazine.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Phenobarbital.................. Ampule: 2ml.............. 1/8/93
Restek Corp............................ Phentermine.................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Prazepam....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Propoxyphene................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Secobarbital................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Talbutal....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Temazepam...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Tetrahydrocannabinol 11-nor Ampule: 2ml.............. 1/8/93
delta-9-THC-carboxylic acid.
Restek Corp............................ Tetrahydrocannabinol delta-9... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Thebaine....................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Thiamylal...................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Thiopental..................... Ampule: 2ml.............. 1/8/93
Restek Corp............................ Triazolam...................... Ampule: 2ml.............. 1/8/93
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Amphetamine.
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Barbiturate.
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Cannabinoids.
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Cocaine Metabolite.
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for LSD (Lysergic Acid
Diethylamide).
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 vials............. 5/27/92
for Methamphetamine (High
Specificity).
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Morphine.
[[Page 161]]
Roche Diagnostic Systems, Inc.......... Abuscreen Calibration Standard Kit: 2 Vials............. 10/12/87
for Phencyclidine (PCP).
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Bottle: 4.5L............. 3/31/94
Benzoylecgonine Microparticle
Reagent.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Calibration Kit: 8 vials............. 5/18/92
Pack.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Calibrator Pack: 6 vials............ 5/18/92
Level 3.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Cannabinoids Bottle: 4.5L............. 3/31/94
Microparticle Reagent.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Opiates Bottle: 4.5L............. 3/31/94
Microparticle Reagent.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE Positive Pack: 6 vials............ 5/18/92
Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE THC Positive Kit: 6 vials; 4ml/vial... 3/22/93
Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE for Cocaine Kit: 100, 1000, 8000 3/19/91
Metabolite. Tests.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE for Opiates... Kit: 100, 1000, 8000 3/19/91
Tests.
Roche Diagnostic Systems, Inc.......... Abuscreen ONLINE for THC....... Vial: 100, 1000, 8000 3/19/91
Tests.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Amphetamine... Kit: 50 tests, 100 tests. 3/14/88
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Amphetamine Vial: 4 ml............... 3/14/88
Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Barbiturate... Kit: 50 tests, 100 tests. 3/14/88
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Barbiturates Vial: 4 ml............... 3/14/88
Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Kit: 50 Tests, 100 Tests. 5/3/91
Benzodiazepines.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Cocaine Kit: 50 tests, 100 tests. 3/14/88
Metabolite.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Cocaine Vial: 4 ml............... 3/14/88
Metabolite Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Methadone..... Kits: 50, 100 Tests...... 9/8/93
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Morphine...... Kits: 50 tests, 100 tests 3/14/88
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Morphine Vial: 4 ml............... 3/14/88
Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Multianalyte Kit: 1 Vial, 8ml......... 9/18/95
Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Phencyclidine Kit: 50 tests, 100 tests. 11/22/89
(PCP).
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK Phencyclidine Vial: 4 ml............... 11/22/89
(PCP) Positive Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK THC (100ng/ml) Kit: 50 tests, 100 tests. 3/14/88
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK THC (50ng/ml). Kit: 50 Tests, 100 Tests. 5/3/91
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK THC Positive Vial: 4 ML............... 3/14/88
Control.
Roche Diagnostic Systems, Inc.......... Abuscreen ONTRAK for Vial: 4ml................ 3/22/93
Benzodiazepines Positive
Control.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 9/13/85
Amphetamine High Specificity. tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 2/15/83
Barbiturates. tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 3/6/87
Benzodiazepines. tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 Tests 2, 500 8/14/81
Cannabinoids. Tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 Tests, 2500 2/15/83
Cocaine Metabolite. Tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 1/28/86
LSD (Lysergic Acid tests.
Diethylamide).
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 3/1/89
Methamphetamine High tests.
Specificity.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 2/15/83
Methaqualone. tests.
[[Page 162]]
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 2/15/83
Morphine. tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Radioimmunoassay for Kit: 100 tests, 2500 2/15/83
Phencyclidine (PCP). tests.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for Amphetamine.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for Barbiturate.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for
Cannabinoids.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for Cocaine
Metabolite.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for LSD
(Lysergic Acid Diethylamide).
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 vials, 100ml each. 5/27/92
and Calibrator for
Methamphetamine (High
Specificity).
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for Morphine.
Roche Diagnostic Systems, Inc.......... Abuscreen Reference Controls Kit: 3 Vials, 100ml each. 10/12/87
and Calibrator for
Phencyclidine (PCP).
Roche Diagnostic Systems, Inc.......... Abuscreenm ONTRAK Methadone Vial: 4ml................ 9/08/93
Positive Reference Control.
Roche Diagnostic Systems, Inc.......... CAL PACK Abuscreen ONLINE THC Kit: 4 vials............. 9/11/91
Calibration Pack.
Roche Diagnostic Systems, Inc.......... COBAS FP Phenobarbital Kit: 6 Vials............. 11/13/84
Calibrators.
Roche Diagnostic Systems, Inc.......... COBAS FP Reagents for Kit: 100 tests........... 11/13/84
Phenobarbital.
Roche Diagnostic Systems, Inc.......... COBAS FP TDM Controls.......... Kit: 6 Vials............. 11/13/84
Roche Diagnostic Systems, Inc.......... COBAS INTEGRA Cassette for Kit: 3 Vials............. 9/27/95
Cannabinoids.
Roche Diagnostic Systems, Inc.......... COBAS INTEGRA Cassette for Kit: 3 Vials............. 9/27/95
Cocaine Metabolite.
Roche Diagnostic Systems, Inc.......... COBAS INTEGRA Cassette for Kit: 3 Vials............. 9/27/95
Opiates.
Roche Diagnostic Systems, Inc.......... Immunizing Preparation No. 1, Vial: 10, 20, 50, or 1/25/83
2, 3, 4, 5, 6, 7, or 8. 100ml.
Roche Diagnostic Systems, Inc.......... Immunizing Preparation No. 9... Vial: 10ml, 20ml, 50ml, 7/24/84
or 100ml.
Roche Diagnostic Systems, Inc.......... Immunizing Preparation No. 9A.. Vial: 10ml, 20ml, 50ml, 7/24/84
or 100ml.
Roche Diagnostic Systems, Inc.......... Immunizing Preparation No.10... Vial: 10ml, 20ml, 50ml, 4/2/86
or 100ml.
Roche Diagnostic Systems, Inc.......... Immunizing Preparation No.10A.. Vial: 10ml, 20ml, 50ml, 4/2/86
or 100ml.
Roche Diagnostic Systems, Inc.......... Immunizing Preparations No. 1A, Vial: 10ml, 20ml, 50ml, 7/12/83
2A, 3A, 4A, 5A, 6A, 7A, or 8A. or 100ml.
Roche Diagnostic Systems, Inc.......... OnTrak TesTcup Positive Control Box: 6 Vials............. 9/25/95
Rowley Biochemical Institute, Inc...... Aldehyde Fuchsin Solution...... Bottle: Pint, Quart, 2/2/84
Gallon.
Rowley Biochemical Institute, Inc...... Aldehyde Thionin Solution...... Bottle: Pint, Quart, 2/2/84
Gallon.
Rowley Biochemical Institute, Inc...... Mayer's Hematoxylin Solution... Bottle: Pint, Quart, 2/2/84
Gallon.
Schering Corp.......................... Hepaquik....................... Vial: 9 Dram and Plate... 7/16/72
Serex Inc.............................. Benzoylecgonine Positive Bottle: 1 ml............. 12/16/89
Control.
Serex Inc.............................. Benzoylecgonine Standards...... Bottle: 1 ml............. 12/16/89
Serex Inc.............................. CoMA EIA for Cocaine Metabolite Kit: 96 tests, 2 Bottles: 10/17/89
5 ml ea., Assay Plate:
96 wells.
Serex Inc.............................. Cocaine Metabolite Standards Kit: 3 bottles--100 12/16/89
and Controls Kit. Assays.
Serex, Inc............................. Automates CoMA Cocaine Kit: 3 Bottles; 50, 1000 7/22/92
Metabolite Assay. Tests.
Serex, Inc............................. Automates CoMA Cocaine Bottle: 12.5ml, 50ml..... 7/22/92
Metabolite Assay Reagent B.
Serex, Inc............................. Automates CoMA High Calibrator. Vial: 5ml................ 7/22/92
Serex, Inc............................. Automates CoMA Plus Cocaine Kit: 3 Bottles; 50, 1000 7/22/92
Metabolite Assay. Tests.
Serex. Inc............................. Automates CoMA Low Calibrator.. Vial: 5ml................ 7/22/92
[[Page 163]]
Serex. Inc............................. Automates CoMA Plus Cocaine Bottle: 12, 5ml, 50ml.... 7/22/92
Metabolite Assay Reagent B.
Serono Diagnostics, Inc................ rT3 Barbital Buffer............ Glass Vial: 120ml........ 10/26/84
Serono Diagnostics, Inc................ rT3-125I....................... Glass Vial: 13ml......... 10/26/84
Serono Diagnostics, Inc................ rT3-Antiserum.................. Glass Vial: 13ml......... 10/26/84
Sherwood Medical Company............... Lancer Fibrinogen Kit...................... 4/17/75
Determination, Reagent Kit
Catalog No. 8889-007608.
Sigma Chemical Co...................... (+)Deoxyephedrine-d5 HCl #D- Ampule: 2ml.............. 8/28/90
5914.
Sigma Chemical Co...................... (+/-)-(2 Ampule: 1ml.............. 7/30/92
Methylamino)propiophenone
Hydrochloride.
Sigma Chemical Co...................... (+/-) 2, 5-Dimethoxy-4-bromo- Ampule: 2ml.............. 9/25/91
amphetamine Hydrobromide, D-
7633.
Sigma Chemical Co...................... (+/-) 2, 5-Dimethoxy-4-methyl- Ampule: 2ml.............. 9/25/91
amphetamine HCl, D-7883.
Sigma Chemical Co...................... (+/-) Deoxyephedrine HCl, D- Ampule: 2ml.............. 9/25/91
7508.
Sigma Chemical Co...................... (-) Deoxyephedrine, D-7258..... Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... 1-Dehydrotestosterone, Product Ampule: 2ml.............. 1/30/92
#D5791.
Sigma Chemical Co...................... 1-Tetrahydrocannabinol, Product Vial: 1ml................ 5/11/81
No. T4764.
Sigma Chemical Co...................... 11-Hydroxy-delta 9 Ampule: 2ml.............. 11/6/91
Tetrahydrocannabinol Cat. No.
H3879.
Sigma Chemical Co...................... 11-nor-delta-9- Glass Ampule: 2 ml....... 6/29/89
Tetrahyrocannabinol, 9-
carboxylic .05 mg/ml acid, No.
N-5642.
Sigma Chemical Co...................... 11-nor-delta-9THC-9-Carboxylic Ampule: 2ml.............. 8/28/90
Acid #N-6893.
Sigma Chemical Co...................... 11Beta-Hydroxytestosterone, H- Vial: 2ml................ 2/04/94
4646.
Sigma Chemical Co...................... 17alpha-Methyltestosterone, Ampule: 2ml.............. 1/30/92
Product #M8783.
Sigma Chemical Co...................... 19-Nortesterone 17- Ampule: 1ml.............. 7/30/92
Phenylpropionate, N 2771.
Sigma Chemical Co...................... 19-Nortesterone 17-Propionate, Ampule: 1ml.............. 7/30/92
N 2896.
Sigma Chemical Co...................... 19-Nortestosterone 17- Ampule: 1ml.............. 7/30/92
Decanoate, N 3021.
Sigma Chemical Co...................... 19-Nortestosterone, Product Ampule: 2ml.............. 1/30/92
#N1269.
Sigma Chemical Co...................... 3,4 Glass Ampule: 2 ml....... 6/29/89
Methylenedioxymethamphetamine
1 mg/ml, No. M-5029.
Sigma Chemical Co...................... 3,4-Methylenedioxyamphetamine, Glass Ampule: 2ml........ 6/6/89
No. M-3272.
Sigma Chemical Co...................... 3-Methylfentanyl HCl, M-6255... Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... 5,5-Diallylbarbituric Acid, Sealed Ampule: 1ml....... 6/30/77
Product No. D-6013.
Sigma Chemical Co...................... 5-Alpha-Androstan-17beta-ol-3- Ampule: 1ml.............. 7/30/92
one Benzoate, A 9768.
Sigma Chemical Co...................... 5-Androstene-3Beta, 17Beta- Ampule: 2ml.............. 1/30/92
Diol, Product #A0684.
Sigma Chemical Co...................... 6-Tetrahydrocannabinol, Product Vial: 1ml................ 5/11/81
No. T-4889.
Sigma Chemical Co...................... AST Reagent A, Stock No. 56-2.. Vial: 10ml............... 6/27/79
Sigma Chemical Co...................... Acid Hematoxylin Solution, No. Bulk: 1000L.............. 5/04/93
285-2.
Sigma Chemical Co...................... Acid Hematoxylin Solution, Bottle: 25ml, 100ml...... 8/6/73
No.285-2.
Sigma Chemical Co...................... Adenosine Phosphate Substrate, Bottle: 4 ounce.......... 7/25/83
Product No. 675-1.
Sigma Chemical Co...................... Allylcyclopentylbarbituric Acid Sealed Ampule: 1ml....... 4/10/85
(A-7787).
Sigma Chemical Co...................... Allylisobutylbarbituric Acid (A- Sealed Ampule: 1ml....... 4/10/85
1038).
Sigma Chemical Co...................... Alpha-Ethyltryptamine Acetate, Vial: 2ml................ 2/4/94
Product #E1392.
Sigma Chemical Co...................... Alphaprodine Hydrochloride (A- Ampule: 1ml.............. 8/27/84
1537).
Sigma Chemical Co...................... Alphenal (A-1163).............. Ampule: 1ml.............. 4/10/85
Sigma Chemical Co...................... Alprazolam .25 mg/ml, No. A- Glass Ampule: 2 ml....... 6/29/89
5052.
Sigma Chemical Co...................... Alprazolam-d5 #A-7055.......... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Ammonia Reagent , Stock No. 170- Vial: 10ml............... 2/17/77
10.
Sigma Chemical Co...................... Ammonia Reagent Kit: Stock No. Kit: 10 Vials............ 2/17/77
170-10.
Sigma Chemical Co...................... Ammonia Reagent Stock No. 170- Vial: 30ml............... 12/13/77
10.
Sigma Chemical Co...................... Ammonia in Plasma Kit.......... Kit: 100 tests, 30 tests. 12/13/77
Sigma Chemical Co...................... Amobarbital , Product No. A- Sealed Ampule: 1ml....... 6/30/77
5142.
Sigma Chemical Co...................... Amobarbital Sodium Salt, Ampule: 1ml.............. 5/13/93
Product No. A-7441.
Sigma Chemical Co...................... Antibody Sensitized Sheep Vials: 2ml and 5X 2ml.... 4/2/86
Erythrocytes (EA7S).
Sigma Chemical Co...................... Aprobarbital, Product No. A- Sealed Ampule: 1ml....... 6/30/77
7023.
Sigma Chemical Co...................... Barbital Buffer, Product No. B- Polyethylene Vial: 30ml.. 5/11/77
6632.
Sigma Chemical Co...................... Barbital Buffer 5X Concentrate Bottle: 200ml............ 11/14/91
Electrophoresis Reagent Cat.
No. B-3506.
Sigma Chemical Co...................... Barbital Buffer with Albumin Vial: 20ml............... 7/11/80
Stock No. 880-3.
Sigma Chemical Co...................... Barbital, Product No. B-8632... Sealed Ampule: 1ml....... 6/30/77
Sigma Chemical Co...................... Benzoylecgonine 1 mg/ml, No. B- Glass Ampule: 2 ml....... 6/29/89
8900.
Sigma Chemical Co...................... Benzoylecgonine-d3 #B-3277..... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Benzphetamine Hydrochloride, Sealed Ampule: 1ml....... 6/8/84
Product No. B-8765.
Sigma Chemical Co...................... Bolasterone, Product #B3404.... Ampule: 1ml.............. 1/30/92
Sigma Chemical Co...................... Bromazepam #B-5402............. Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Bufotenine Monooxalate, Product Sealed Ampule: 1ml....... 6/30/77
No. B-8757.
Sigma Chemical Co...................... Buprenorphine Hydrochloride.... Vial: 2ml................ 9/12/94
Sigma Chemical Co...................... Butabarbital , Product No. B- Sealed Ampule: 1ml....... 6/30/77
8882.
Sigma Chemical Co...................... Butalbital, Product No. B-5514. Sealed Ampule: 1ml....... 9/19/83
Sigma Chemical Co...................... Butethal (B-7516).............. Ampule: 1ml.............. 9/5/85
Sigma Chemical Co...................... Cannabidiol, Product No. C-6395 Vial: 1ml................ 5/11/81
Sigma Chemical Co...................... Cannabinol, Product No. C-6520. Vial: 1ml................ 5/11/81
[[Page 164]]
Sigma Chemical Co...................... Chloral Hydrate , Product No. C- Sealed Ampule: 1ml....... 6/30/77
6516.
Sigma Chemical Co...................... Chloral Hydrate, Product #C9954 Ampule: 1ml.............. 5/10/95
Sigma Chemical Co...................... Chlorazepam Dipotassium Salt, Ampule: 1ml.............. 5/24/85
(C-9531).
Sigma Chemical Co...................... Chlordiazepoxide (C-4782)...... Ampule: 1ml.............. 9/5/85
Sigma Chemical Co...................... Chlordiazepoxide Hydrochloride Ampule: 2ml.............. 6/26/90
Acetonitrile Drug Standard #C-
9547.
Sigma Chemical Co...................... Chlordiazepoxide-d5 #C-5047.... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Clobazam, No. C-6667........... Glass Ampule: 2ml........ 6/6/89
Sigma Chemical Co...................... Clonazepam, Product No. C-4404. Sealed Ampule: 1ml....... 6/8/84
Sigma Chemical Co...................... Cocaethylene, #C-8205.......... Ampule: 1ml.............. 10/9/95
Sigma Chemical Co...................... Cocaethylene, C-7313........... Vial: 2ml................ 2/4/94
Sigma Chemical Co...................... Cocaethylene-D5, #C-7073....... Ampule: 1ml.............. 10/9/95
Sigma Chemical Co...................... Cocaine Hydrochloride Product Sealed Ampule: 1ml....... 9/19/83
No. C-1528.
Sigma Chemical Co...................... Cocaine-d3 #C-3547............. Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Codeine-d3 HCl #C-3672......... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Codeine, Product No. C-1653.... Sealed Ampule: 1ml....... 9/19/83
Sigma Chemical Co...................... D-Amphetamine Sulfate, Product Vial: 1ml................ 5/11/81
No. A-3278.
Sigma Chemical Co...................... D-Propoxyphene Hydrochloride, P- Ampule: 1ml.............. 9/27/84
1550.
Sigma Chemical Co...................... DL-Amphetamine HCL , Product Sealed Ampule: 1ml....... 6/30/77
No. A-5017.
Sigma Chemical Co...................... Delorazepam #D-5789............ Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Desmethyldiazepam 1 mg/ml, No. Glass Ampule: 2 ml....... 6/29/89
D-3162.
Sigma Chemical Co...................... Desmethyldiazepam-d5 #D-6039... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Diazepam, Product No. D-9900... Sealed Ampule: 1ml....... 6/8/84
Sigma Chemical Co...................... Diazepam-d5 #D-5664............ Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Diethylpropion Hydrochloride, Sealed Ampule: 1ml....... 9/19/83
Product No. D-7274.
Sigma Chemical Co...................... Diphenoxylate HCL, Product Ampule: 1ml.............. 9/5/85
#D0780.
Sigma Chemical Co...................... Drug Standard Mix 1, D-3155.... Ampule: 2ml.............. 4/18/86
Sigma Chemical Co...................... Drug Standard Mix 2, D-3030.... Ampule: 2ml.............. 4/18/86
Sigma Chemical Co...................... Ecgonine Hydrochloride 1 mg/ml, Glass Ampule: 2 ml....... 6/29/89
No. E-9762.
Sigma Chemical Co...................... Ecgonine-d3 HCl #E-2014........ Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Ecgonine-d3 Methyl Ester HCl #E- Ampule: 2ml.............. 8/28/90
2139.
Sigma Chemical Co...................... Estazolam #E-1139.............. Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Ethinamate (E-8508)............ Ampule: 1ml.............. 4/10/85
Sigma Chemical Co...................... Ethylmorphine, E-3377.......... Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... Fencamfamine Hydrochloride..... Vial: 2ml................ 9/12/94
Sigma Chemical Co...................... Fenfluramine Hydrochloride, Sealed Ampule: 1ml....... 9/19/83
Product No. F-1884.
Sigma Chemical Co...................... Fenproporex Hydrochloride, No. Glass Ampule: 2ml........ 6/6/89
F-7261.
Sigma Chemical Co...................... Fentanyl Citrate, No. F-5886... Glass Ampule: 2 ml....... 6/6/89
Sigma Chemical Co...................... Fentanyl-d5 Citrate #F-2520.... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Flunitrazepam No. F-8763....... Vial: 1 ml............... 6/30/87
Sigma Chemical Co...................... Fluoxymesterone, Product #F6891 Ampule: 2ml.............. 1/30/92
Sigma Chemical Co...................... Flurazepam Dihydrochloride Vial: 1 ml............... 10/20/89
Product #F9134.
Sigma Chemical Co...................... Gelatin Veronal Buffer (GVB2+) Vial: 50 ml, 250ml....... 9/15/86
No. G-6514.
Sigma Chemical Co...................... Glutethimide, Product No. G- Sealed Ampule: 1 ml...... 6/30/77
3134.
Sigma Chemical Co...................... Glycerophosphate Substrate, Bottle: 4 ounce.......... 7/25/83
Product No. 675-2.
Sigma Chemical Co...................... Heroin Hydrochloride .1 mg/ml, Glass Ampule: 2 ml....... 6/29/89
No. H-5144.
Sigma Chemical Co...................... Hexobarbital, Product No. H- Sealed Ampule: 1 ml...... 6/30/77
2007.
Sigma Chemical Co...................... Hydrocodone Bitartrate, No. H- Glass Ampule: 2 ml....... 6/6/89
2269.
Sigma Chemical Co...................... Hydromorphone Hydrochloride No. Vial: 1 ml............... 6/30/87
H-7141.
Sigma Chemical Co...................... Hydroxytestosterone, Product Vial: 0.5 ml............. 5/10/95
#H9901.
Sigma Chemical Co...................... Ibogaine HCL, Product No. I- Sealed Ampule: 1 ml...... 6/30/77
4630.
Sigma Chemical Co...................... LDH Electrophoresis Buffer, Bottle: 30 ml............ 1/4/77
Stock No. 705-1.
Sigma Chemical Co...................... LDH-P Reagent No. 125-100...... Vial: 100 ml............. 5/29/73
Sigma Chemical Co...................... Levorphanol Tartrate 1 mg/ml, Glass Ampule: 2 ml....... 6/29/89
No. L-0896.
Sigma Chemical Co...................... Lorazepam (L-0140)............. Ampule: 1 ml............. 5/24/85
Sigma Chemical Co...................... Lormetazepam, No. 8145......... Glass Ampule: 2 ml....... 6/6/89
Sigma Chemical Co...................... Lysergic Acid , Product No. L- Sealed Ampule: 1 ml...... 6/30/77
5881.
Sigma Chemical Co...................... Lysergic Acid Diethylamide #L- Ampule: 2 ml............. 8/28/90
8147.
Sigma Chemical Co...................... Lysergic Acid Diethylamide, Ampule: 1 ml............. 8/17/94
Drug Standard No. L-5406.
Sigma Chemical Co...................... Mayer's Hematoxylin Solution, Bottle: 3 ml, 6 ml, 25 8/6/73
MHS-1, MHS-16, MHS-32, MHS-80, ml, 100 ml, 225 ml, 500
MHS-128. ml, 1.0L, 2.5L, 4.0L.
Sigma Chemical Co...................... Mayer's Hematoxylin Solution, Bulk: 1000L.............. 5/4/93
No. MHS-1.
Sigma Chemical Co...................... Mebutamate (M-3772)............ Ampule: 1 ml............. 9/5/85
Sigma Chemical Co...................... Medazepam (M-7646)............. Ampule: 1 ml............. 5/24/85
Sigma Chemical Co...................... Meperidine Hydrochloride (M- Ampule: 1 ml............. 8/27/84
1020).
Sigma Chemical Co...................... Mephobarbital, Product No. M- Vial: 1 ml............... 5/11/81
3514.
Sigma Chemical Co...................... Meprobamate (M-0271)........... Ampule: 1 ml............. 5/24/85
Sigma Chemical Co...................... Mescaline HC1 , Product No. M- Sealed Ampule: 1 ml...... 6/30/77
5153.
Sigma Chemical Co...................... Mesterolone, Product #M8283.... Ampule: 2 ml............. 1/30/92
Sigma Chemical Co...................... Methadone Hydrochloride, Sealed Ampule: 1 ml...... 9/19/83
Product No. M-3268.
[[Page 165]]
Sigma Chemical Co...................... Methadone-d3 #M-4781........... Ampule: 2 ml............. 8/28/90
Sigma Chemical Co...................... Methamphetamine HC1 , Product Sealed Ampule: 1 ml...... 6/30/77
No. M-5260.
Sigma Chemical Co...................... Methandrostenolone, Product Ampule: 2 ml............. 1/30/92
#M6910.
Sigma Chemical Co...................... Methaqualone Hydrochloride, Sealed Ampule: 1 ml...... 9/19/83
Product No. M-3393.
Sigma Chemical Co...................... Methaqualone-d4 #M-5406........ Ampule: 2 ml............. 8/28/90
Sigma Chemical Co...................... Methylphenidate Hydrochloride Ampule: 1 ml............. 10/31/84
(M-1145).
Sigma Chemical Co...................... Methyprylon, Product No. M-1769 Sealed Ampule: 1 ml...... 6/8/84
Sigma Chemical Co...................... Morphine Sulfate, No. M-9524... Glass Ampule: 2 ml....... 6/6/89
Sigma Chemical Co...................... Morphine-3-B-D Glucuronide, Ampule: 1 ml............. 10/21/82
Product No. M-4266.
Sigma Chemical Co...................... Morphine-d3 HCl, M-6380........ Ampule: 2 ml............. 9/25/91
Sigma Chemical Co...................... N, N-Diethyltryptamine, Product Vial: 1 ml............... 5/11/81
No. D-0392.
Sigma Chemical Co...................... N, N-Dimethyltryptamine, Sealed Ampule: 1 ml...... 6/30/77
Product No. D-6263.
Sigma Chemical Co...................... Nalorphine Hydrochloride....... Ampule: 1 ml............. 8/27/84
Sigma Chemical Co...................... Nitrazepam, N-3397............. Ampule: 1 ml............. 9/8/93
Sigma Chemical Co...................... Norcodeine Hydrochloride, No. N- Glass Ampule: 2 ml....... 6/6/89
3017.
Sigma Chemical Co...................... Normorphine HCl #N-7393........ Ampule: 2 ml............. 8/28/90
Sigma Chemical Co...................... Noroxymorphone #N-7018......... Ampule: 2 ml............. 8/28/90
Sigma Chemical Co...................... Owren's Buffer, No. 05880...... Bottle: 500 ml; Vial: 20 4/5/89
ml; Box: 5vials.
Sigma Chemical Co...................... Oxazepam, No. O-1755........... Vial: 1 ml............... 6/30/87
Sigma Chemical Co...................... Oxazepam-d5 #O-1381............ Ampule: 2 ml............. 8/28/90
Sigma Chemical Co...................... Oxazolam, No. O-8005........... Glass Ampule: 2 ml....... 6/6/89
Sigma Chemical Co...................... Oxycodone Hydrochloride, Sealed Ampule: 1 ml...... 9/19/83
Product No. O-2628.
Sigma Chemical Co...................... Oxymetholone, Product #O4006... Ampule: 2 ml............. 1/30/92
Sigma Chemical Co...................... Paraldehyde, Product No. P-3778 Ampule: 1 ml............. 10/21/82
Sigma Chemical Co...................... Pemoline, Product No. P-3518... Sealed Ampule: 1 ml...... 6/30/77
Sigma Chemical Co...................... Pentazocine Hydrochloride, Sealed Ampule: 1 ml...... 9/19/83
Product No. P-7530.
Sigma Chemical Co...................... Pentobarbital, Product No. P- Sealed Ampule: 1ml....... 6/30/77
3393.
Sigma Chemical Co...................... Phencyclidine HCL, Product Vial: 1 ml............... 6/30/87
#P7043.
Sigma Chemical Co...................... Phencyclidine-d5 HCl #P-6054... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Phendimetrazine Bitartrate, Vial: 1ml................ 5/11/81
Product #P3524.
Sigma Chemical Co...................... Phenobarbital FPIA Calibrator Kit: 6 vials............. 11/21/89
Set Cat. No. P9051.
Sigma Chemical Co...................... Phenobarbital FPIA Calibrator: Vial: 2.5 ml............. 11/21/89
A-No.P8301, B-No.P8426, C-
No.P8551, D-No.P8676, E-
No.P8801, F-No.P8926.
Sigma Chemical Co...................... Phenobarbital Primary Stock Bottle: 10, 5, 1L, 500, 2/1/91
Solution No. Z-5419. 100ml.
Sigma Chemical Co...................... Phenobarbital Prod. No.P-3643.. Sealed Ampule: 1ml....... 6/30/77
Sigma Chemical Co...................... Phentermine Hydrochloride, Sealed Ampule: 1ml....... 9/19/83
Product No. P-7655.
Sigma Chemical Co...................... Phenylacetone, Product #P3958.. Ampule: 1ml.............. 5/10/95
Sigma Chemical Co...................... Phenylacetone, Product No. P- Vial: 1ml................ 5/11/81
2024.
Sigma Chemical Co...................... Prazepam, No. P-7168........... Vial: 1 ml............... 6/30/87
Sigma Chemical Co...................... Psilocin #P-4054............... Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... SIA Cocaine Metabolites........ Kit: 96 Tests............ 7/11/91
Sigma Chemical Co...................... SIA Conjugate Cocaine Bottle: 75ml............. 7/11/91
Metabolites.
Sigma Chemical Co...................... SIA Positive Reference Cocaine Vial: 1ml................ 7/11/91
Metabolites.
Sigma Chemical Co...................... Secobarbital, Product No. S- Sealed Ampule: 1ml....... 6/30/77
4006.
Sigma Chemical Co...................... Secobarbital-d5, S-4628........ Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... Stanozolol, Product #S7649..... Ampule: 2ml.............. 1/30/92
Sigma Chemical Co...................... Stanozolol-d3, Product #S7774.. Ampule: 2ml.............. 1/30/92
Sigma Chemical Co...................... Temazepam, No. T-4903.......... Vial: 1 ml............... 6/30/87
Sigma Chemical Co...................... Tenocyclidine HCl, T-3507...... Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... Testosterone 17beta-Cypionate, Ampule: 1ml.............. 7/30/92
T 3415.
Sigma Chemical Co...................... Testosterone Acetate, Product Ampule: 2ml.............. 1/30/92
#T5661.
Sigma Chemical Co...................... Testosterone Benzoate, Product Ampule: 2ml.............. 1/30/92
#T1913.
Sigma Chemical Co...................... Testosterone Enanthate, T 3540. Ampule: 1ml.............. 7/30/92
Sigma Chemical Co...................... Testosterone Propionate, T 3665 Ampule: 1ml.............. 7/30/92
Sigma Chemical Co...................... Testosterone, Product #T5411... Ampule: 2ml.............. 1/30/92
Sigma Chemical Co...................... Testosterone-d3, Product #T5536 Ampule: 2ml.............. 1/30/92
Sigma Chemical Co...................... Thebaine, Product No. T-5270... Sealed Ampule: 1ml....... 9/19/83
Sigma Chemical Co...................... Thiamylal Sodium, Product No. T- Sealed Ampule: 1ml....... 6/8/84
6896.
Sigma Chemical Co...................... Thiopental (T-1022)............ Ampule: 1ml.............. 8/27/84
Sigma Chemical Co...................... Triazolam #T-7658.............. Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... Trizma-Barbital Buffer, Stock Bottle: 30ml............. 1/4/77
No. 710-1.
Sigma Chemical Co...................... Tropacocaine HCL, Product Vial: 1ml................ 5/11/81
#T4576.
Sigma Chemical Co...................... Z9999, Field Test Sample Vial: 400ml.............. 3/14/91
PSEUDOnarcotics Marihuana
Formulation.
Sigma Chemical Co...................... d-Amphetamine-d3 Sulfate #A- Ampule: 2ml.............. 8/28/90
7180.
Sigma Chemical Co...................... d-Lysergic Acid Cat. No. L-9752 Ampule: 2ml.............. 11/6/91
Sigma Chemical Co...................... d-Propoxyphene-d7 HCl #P-4179.. Ampule: 2ml.............. 8/28/90
Sigma Chemical Co...................... delta-9-tetrahydrocannabinol-d3 Ampule: 2ml.............. 8/28/90
#T-8783.
Sigma Chemical Co...................... dl-Amphetamine, A-2262......... Ampule: 2ml.............. 9/25/91
[[Page 166]]
Sigma Chemical Co...................... l-Amphetamine, A-9136.......... Ampule: 2ml.............. 9/25/91
Sigma Chemical Co...................... p-Methoxyamphetamine HCl #M- Ampule: 2ml.............. 8/28/90
4656.
Sigma Diagnostics...................... Amelung Systems Buffer......... Box: 6 Vials; Bottle: 2/8/96
25ml.
Sigma Diagnostics...................... CA System Buffer............... Bottle: 500ml............ 9/9/93
Smart Chemical Co...................... Regal 180XL.................... Plastic Drum: 55 gallon.. 6/12/86
SmithKline Beecham..................... Benzo/PCP QC................... Bottle: 10ml............. 7/31/95
SmithKline Beecham..................... GC/MS 1........................ Bottle: 50ml............. 7/31/95
SmithKline Beecham..................... NIDA LODQC..................... Bottle: 50ml............. 7/31/95
SmithKline Beecham..................... SAP LODQC...................... Bottle: 50ml............. 7/31/95
SmithKline Beecham..................... SB50N.......................... Bottle: 10, 25, 50ml..... 7/31/95
SmithKline Beecham..................... SB50P.......................... Bottle: 10, 25, 50ml..... 7/31/95
SmithKline Beecham..................... Urine Drug Standards Pool A, B, Bottle: 25ml............. 7/31/95
C, D, E, F, G.
SolarCare Technology Corporation....... Benzoylecgonine Cutoff Vial: 4ml................ 6/5/90
Calibrator.
SolarCare Technology Corporation....... Benzoylecgonine Negative Vial: 4ml................ 6/5/90
Control.
SolarCare Technology Corporation....... Benzoylecgonine Positive Vial: 4ml................ 6/5/90
Control.
SolarCare Technology Corporation....... Cocaine Cutoff Calibrator...... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... Cocaine EIA.................... Kit: 3 vials............. 6/5/90
SolarCare Technology Corporation....... Cocaine Metabolite EIA......... Kit: 30 vials............ 6/5/90
SolarCare Technology Corporation....... Cocaine Negative Control....... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... Cocaine Positive Control....... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... LSD Cutoff Calibrator.......... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... LSD EIA........................ Kit: 3 vials............. 6/5/90
SolarCare Technology Corporation....... LSD Negative Control........... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... LSD Positive Control........... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... Low Level Benzodiazepine Kit: 3 vials............. 6/5/90
(Triazolam) EIA.
SolarCare Technology Corporation....... Triazolam Cutoff Control....... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... Triazolam Negative Control..... Vial: 4ml................ 6/5/90
SolarCare Technology Corporation....... Triazolam Positive Control..... Vial: 4ml................ 6/5/90
Supelco, Inc........................... Gamma-DEX Programmed Column Ampule: 1ml.............. 9/15/95
Test Mix.
Supelco, Inc........................... Alk Mix No. 04-9210............ Vial: 1ml................ 8/28/73
Supelco, Inc........................... Amobarbital, No. 04-9170....... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Amph. Mix Catalog No. 4-9205... Glass Ampule: 2ml........ 6/9/86
Supelco, Inc........................... Amphetamine No. 04-9165........ Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Anticonvulsant Mixture No. 1; Glass Serum Bottle: 50ml. 6/16/77
No. 04-9202.
Supelco, Inc........................... Antiepileptic Calibration Kit: 3 Ampules........... 5/21/80
Standard Kit, No. 4-9259.
Supelco, Inc........................... Antiepileptic Calibration Glass Ampule: 5ml........ 5/21/80
Standards, Nos. 4-9256, 4-
9257, 4-9258.
Supelco, Inc........................... Appendix IX Contract Mix 3..... Ampule: 2ml.............. 12/22/94
Supelco, Inc........................... Aprobarbital No. 04-9171....... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Barb. Mix 1, Catalog No. 4-9200 Glass Ampule: 2ml........ 6/9/86
Supelco, Inc........................... Barb. Mix 2, Catalog No. 4-9201 Glass Ampule: 2ml........ 6/9/86
Supelco, Inc........................... Barbital, Catalog No. 4-9279... Glass Ampule: 10ml....... 6/9/86
Supelco, Inc........................... Barbiturates Test Mix Catalog Ampule: 2 ml............. 2/25/87
No. 4-9295.
Supelco, Inc........................... Cannabidiol, No. 04-9221....... Ampule: 1ml.............. 11/27/74
Supelco, Inc........................... Cannabinol, No. 04-9235........ Ampule: 1ml.............. 11/27/74
Supelco, Inc........................... Chloral Hydrate Kit, Product # Kit: 19 Vials; 2ml each.. 9/6/94
4-8112.
Supelco, Inc........................... Chloral Hydrate, Product # 4- Ampule: 2ml.............. 9/15/95
7335.
Supelco, Inc........................... Cocaine, No. 04-9188........... 1000 mcg /Glass Ampule... 6/5/75
Supelco, Inc........................... Codeine No. 04-9161............ Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Custom Appendix IX Mix-3, Ampule: 10ml............. 4/6/95
Product # 86-8043.
Supelco, Inc........................... Cyclobarbital No. 04-9175...... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Delta-1 THC, No. 04-9237....... Ampule: 1ml.............. 11/27/74
Supelco, Inc........................... Delta-6 THC, No. 04-9238....... Ampule: 1ml.............. 11/27/74
Supelco, Inc........................... Dextroamphetamine, No. 4-9185.. Glass Ampule: 1ml........ 5/21/80
Supelco, Inc........................... EPA 8270 Base/Neutrals Mix B, Vial: 2ml................ 8/31/94
Product # 4-8195.
Supelco, Inc........................... Glutethimide No. 04-9173....... Ampule: 1ml.............. 12/22/72
[[Page 167]]
Supelco, Inc........................... Heroin No. 04-9162............. Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Hexobarbital No. 04-9177....... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Mephobarbital No. 04-9178...... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Meprobamate, No. 4-9184........ Glass Ampule: 1ml........ 5/21/80
Supelco, Inc........................... Methadone No. 04-9163.......... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Methamphetamine No. 04-9168.... Ampule: 1ml.............. 12/22/72
Supelco, Inc........................... Methaqualone, No. 04-9183...... 1000 mcg /Glass Ampule... 6/5/75
Supelco, Inc........................... Morphine No. 04-9160........... Glass Ampule: 1000mcg.... 3/8/78
Supelco, Inc........................... NET Appendix IX Mix-3, Product Ampule: 2ml.............. 5/3/95
# 86-8-58.
Supelco, Inc........................... Pentobarbital No. 04-9179...... Glass Ampule: 1000mcg.... 3/8/78
Supelco, Inc........................... Phenobarbital No. 04-9181...... Glass Ampule: 1000mcg.... 3/8/78
Supelco, Inc........................... Psilocybin, No. 04-9191........ 1000 mcg /Glass Ampule... 6/5/75
Supelco, Inc........................... Secobarbital No. 04-9180....... Glass Ampule: 1000mcg.... 3/8/78
Supelco, Inc........................... alpha, alpha- Ampule: 2ml.............. 2/7/95
Dimethylphenethylamine.
Supelco, Inc........................... alpha, alpha- Vial: 2ml................ 8/31/94
Dimethylphenethylamine,
Product # 4-8377.
Sure-Tech Diagnostic Associates, Inc... 3, 4-Methylenedioxyamphetamine Vial: 20ml............... 4/24/92
in Urine Matrix; Prod 928.
Sure-Tech Diagnostic Associates, Inc... 3, 4- Vial: 20ml............... 4/24/92
Methylenedioxymethylamphetamin
e in Urine Matrix; Prod 929.
Sure-Tech Diagnostic Associates, Inc... Alprazolam in Urine Matrix; Vial: 20ml............... 4/24/92
Prod. 920.
Sure-Tech Diagnostic Associates, Inc... Codeine in Urine Matrix; Prod Vial: 20ml............... 4/24/92
924.
Sure-Tech Diagnostic Associates, Inc... D-Methamphetamine/D-Amphetamine Vial: 20ml............... 4/24/92
in Urine Matrix; Prod 926.
Sure-Tech Diagnostic Associates, Inc... D-Propoxyphene in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 936.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Vial: 4ml Kit: 1 vial.... 5/11/90
(Blind Sample) Positive
Amphetamine Kit No. ST 904,
Vial No. 904-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Kit: 2 vials............. 5/11/90
(Blind Sample) Positive
Cocaine & Marijuana Kit No. ST
903.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Vial: 4ml Kit: 1 vial.... 5/11/90
(Blind Sample) Positive
Cocaine, Kit No. ST 901, Vial
No. 901-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Vial: 4ml Kit: 1 vial.... 5/11/90
(Blind Sample) Positive
Marijuana, Kit No. ST 902,
Vial No. 902-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Vial: 4ml Kit: 1 vial.... 5/11/90
(Blind Sample) Positive
Opiates Kit No. ST 905, Vial
No. 905-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse Urine Control Vial: 4ml Kit: 1 vial.... 5/11/90
(Blind Sample) Positive
Phencyclidine Kit No. ST 906,
Vial No. 906-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml; Box: 1 vial.. 9/13/90
(Blind Samples) positive
Codeine No. 907-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml; Box: 1 vial.. 9/13/90
(Blind Samples) positive
Methadone No. 908-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml; Box: 1 vial.. 9/13/90
(Blind Samples) positive
Methamphetamine No. 909-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml, Box: 1 vial.. 9/13/90
(Blind Samples) positive
Methaqualone No. 913-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml, Box: 1 vial.. 9/13/90
(Blind Samples) positive
Oxazepam No. 910-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml, Box: 1 vial.. 9/13/90
(Blind Samples) positive
Propoxyphene No. 911-P.
Sure-Tech Diagnostic Associates, Inc... Drugs of Abuse: Urine Controls Vial: 20ml, Box: 1 vial.. 9/13/90
(Blind Samples) positive
Secobarbital No. 912-P.
Sure-Tech Diagnostic Associates, Inc... Meperidine in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 930.
Sure-Tech Diagnostic Associates, Inc... Methadone in Urine Matrix; Prod Vial: 20ml............... 4/24/92
925.
Sure-Tech Diagnostic Associates, Inc... Methaqualone in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 927.
Sure-Tech Diagnostic Associates, Inc... Morphine-3-Glucuronide in Urine Vial: 20ml............... 4/24/92
Matrix; Prod 931.
Sure-Tech Diagnostic Associates, Inc... Nordiazepam in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 932.
Sure-Tech Diagnostic Associates, Inc... Normeperidine in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 933.
Sure-Tech Diagnostic Associates, Inc... Oxazepam in Urine Matrix; Prod Vial: 20ml............... 4/24/92
934.
Sure-Tech Diagnostic Associates, Inc... Phencyclidine in Urine Matrix; Vial: 20 ml.............. 4/24/92
Prod 935.
Sure-Tech Diagnostic Associates, Inc... Secobarbital in Urine Matrix; Vial: 20ml............... 4/24/92
Prod 937.
[[Page 168]]
Sure-Tech Diagnostic Associates, Inc... Temazepam in Urine Matrix; Prod Vial: 20ml............... 4/24/92
938.
Sure-Tech Diagnostic Associates, Inc... Triazolam in Urine Matrix; Prod Vial: 20ml............... 4/24/92
939.
Sure-Tech Diagnostics Associates, Inc.. 9-Carboxyl-11 Nor-A-9-THC in Vial: 20ml............... 4/24/92
Urine Matrix; Prod 923.
Sure-Tech Diagnostics Associates, Inc.. Benzoylecgonine in Urine Vial: 20ml............... 4/24/92
Matrix; Prod 922.
Sure-Tech Diagnostics Associates, Inc.. D-Amphetamine in Urine Matrix; Vial: 20ml............... 4/24/92
Prod. 921.
Syva Co................................ AccuLevel Phenobarbital Test Flask: 50ml.............. 10/31/85
Control Stock Solution.
Syva Co................................ AccuLevel Phenobarbital Test (1) Glass Vial: 6ml; (2) 1/24/86
Kit (Catalog No. 10C019) Glass Vial: 9ml, 12
Contains: (1) AccuLevel Vials per test kit.
Phenobarbital Control (2)
AccuLevel Reagent I.
Syva Co................................ Advance T-3 Uptake Assay....... Kit: 100 tests........... 5/11/82
Syva Co................................ Advance Thyroxin Assay......... Kit: 100 tests........... 5/11/82
Syva Co................................ Antiepileptic Drug Control..... Vial: 10ml , Lyophilized. 8/27/74
Syva Co................................ EMIT 2000 Phenobarbital Bulk Bottle: 1000ml........... 7/14/94
Reagent 1.
Syva Co................................ EMIT 2000 Phenobarbital Bulk Bottle: 200ml............ 2/22/93
Reagent B.
Syva Co................................ EMIT 2000 Phenobarbital Bottle: 3ml.............. 7/14/94
Calibrators 5, 10, 20, 40 and
80.
Syva Co................................ EMIT IIC Cannabinoid Assay Bottle: 500ml............ 12/15/93
Reagent 2.
Syva Co................................ EMIT IIC Cannabinoid Assay..... Kit: 2 Bottles........... 12/15/93
Syva Co................................ EMIT IIC Phencyclidine Assay... Kit: 2 Bottles........... 12/15/93
Syva Co................................ EMIT IIC Phencyclidine Assay Bottle: 500ml............ 12/15/93
Reagent 2.
Syva Co................................ EMIT Thyroxine Assay, Cat. No. Glass Bottle: 4oz., Kit: 1/23/89
6J909. 500 Assays.
Syva Co................................ Emit 2000 Phenobarbital Assay Kit: 1 cassette; 8/5/91
(Convenience Pack). Cassette: 11ml.
Syva Co................................ Emit 2000 Phenobarbital Assay; Kit: 1 bottle; Bottle: 8/5/91
Enzyme Reagent 2. 15ml.
Syva Co................................ Emit 2000 Phenobarbital Bulk Bottle: 200ml............ 6/9/93
Reagent.
Syva Co................................ Emit 2000 Phenobarbital Kit: 5 vials............. 8/5/91
Calibrators (5, 10, 20, 40,
80).
Syva Co................................ Emit 700 Amphetamine Assay Bottle: 180ml............ 10/12/84
Catalog No. 3C919.
Syva Co................................ Emit 700 Barbiturate Assay Bottle: 180ml............ 10/12/84
Catalog No.3D919.
Syva Co................................ Emit 700 Benzodiazepine Assay Glass Bottle: 180ml, Kit: 2/21/89
Reagent 2. 2 bottles.
Syva Co................................ Emit 700 Calibrator A Catalog Bottle: 3ml.............. 10/5/84
No. 3A919.
Syva Co................................ Emit 700 Calibrator B Catalog Bottle: 3ml.............. 10/5/84
No. 3A969.
Syva Co................................ Emit 700 Cannabinoid (100) Bottle: 180ml............ 10/12/84
Assay Catalog No. 3M919.
Syva Co................................ Emit 700 Cannabinoid (100) Bottle: 3ml.............. 10/9/84
Calibrator Catalog No. 3M969.
Syva Co................................ Emit 700 Cannabinoid (20) Plastic Bottle: 180ml.... 9/15/86
Assay, Catalog No. 3M959.
Syva Co................................ Emit 700 Cannabinoid 100ng Bottle: 3ml.............. 7/31/89
Assay, Positive Control.
Syva Co................................ Emit 700 Cannabinoid 20ng Assay Glass Bottle: 5ml, Kit: 2 2/21/89
Calibrator. bottles.
Syva Co................................ Emit 700 Cannabinoid 20ng Assay Glass Bottle: 5ml, Kit: 2 2/21/89
Control Set-Positive Control. bottles.
Syva Co................................ Emit 700 Cannabinoid Control 2 Bottles: 3ml........... 10/9/84
Set Catalog No. 3M989.
Syva Co................................ Emit 700 Cocaine Metabolite Bottle: 180ml............ 10/12/84
Assay Catalog No. 3H919.
Syva Co................................ Emit 700 Control Set A Catalog 2 Bottles: 3ml........... 10/9/84
No. 3A939.
Syva Co................................ Emit 700 Control Set B Catalog 2 Bottles: 3ml........... 10/9/84
No. 3A989.
Syva Co................................ Emit 700 Methaqualone Assay Bottle: 180ml............ 10/19/84
Catalog No. 3Q919.
Syva Co................................ Emit 700 Opiate Assay Catalog Bottle: 180ml............ 10/12/84
No.3B919.
Syva Co................................ Emit 700 Phencyclidine Assay Bottle: 180ml............ 10/12/84
Catalog No. 3J919.
Syva Co................................ Emit AED-No. 1 Calibrator...... Vial: 3ml , Lyophilized.. 8/27/74
Syva Co................................ Emit AED-No. 2 Calibrator...... Vial: 3ml , Lyophilized.. 8/27/74
Syva Co................................ Emit AED-No. 3 Calibrator...... Vial: 3ml , Lyophilized.. 8/27/74
Syva Co................................ Emit AED-No. 4 Calibrator...... Vial: 3ml , Lyophilized.. 8/27/74
Syva Co................................ Emit AED-No. 5 Calibrator...... Vial: 3ml , Lyophilized.. 8/27/74
Syva Co................................ Emit Amphetamine Bulk Powder Bottle: 1000ml........... 10/4/89
Reagent 2.
Syva Co................................ Emit Amphetamine Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
Syva Co................................ Emit Amphetamine Bulk Reagent B Glass bottle: 1000ml..... 12/5/90
Syva Co................................ Emit Barbiturate Bulk Powder Bottle: 1000ml........... 10/4/89
Reagent 2.
Syva Co................................ Emit Barbiturate Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
[[Page 169]]
Syva Co................................ Emit Barbiturate Bulk Reagent B Glass Bottle: 1000ml..... 12/5/90
Syva Co................................ Emit Benzodiazepine Bulk Powder Bottle: 1000ml........... 10/4/89
Reagent 2.
Syva Co................................ Emit Benzodiazepine Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
Syva Co................................ Emit Benzodiazepine Bulk Glass Bottle: 1000ml..... 12/5/90
Reagent B.
Syva Co................................ Emit Calibrator B Level 1 Vial: 5ml, 25ml.......... 6/19/91
(cutoff).
Syva Co................................ Emit Calibrator B Level 2 Vial: 5ml, 25ml.......... 6/19/91
(high).
Syva Co................................ Emit Cannabinoid (100) Bulk Bottle: 1000ml........... 10/4/89
Powder Reagent 2.
Syva Co................................ Emit Cannabinoid (100) Bulk Bottle: 4 oz............. 4/20/90
Powder Reagent 2 Satellite.
Syva Co................................ Emit Cannabinoid Bulk Reagent B Glass bottle: 1000ml..... 12/5/90
Syva Co................................ Emit Cocaine Metabolite Bulk Bottle: 1000ml........... 10/4/89
Powder Reagent 2.
Syva Co................................ Emit Cocaine Metabolite Bulk Bottle: 4 oz............. 4/20/90
Powder Reagent 2 Satellite.
Syva Co................................ Emit Cocaine Metabolite Bulk Glass Bottle: 1000ml..... 12/5/90
Reagent B.
Syva Co................................ Emit Convenience Pack Plastic Cassette: 100 11/23/87
Phenobarbital Assay: Catalog tests.
No. 5D009.
Syva Co................................ Emit Convenience Pack: T-Uptake Kit: 100 Tests Ea. Kit- 5/9/88
Assay (Thyroid Hormone Binding Plastic Cassette: 16 ml.
Ratio).
Syva Co................................ Emit Convenience Pack: Plastic Cassette: 8ml, 2/22/89
Thyroxine Assay Enzyme Reagent Kit: 100 Assays.
B.
Syva Co................................ Emit Delta 9 Cannabinoid 100 ng/ Vial: 3ml................ 8/22/89
ml Calibrator/Control.
Syva Co................................ Emit Delta 9 Cannabinoid 20 ng/ Vial: 3ml................ 8/22/89
ml Calibrator/Control.
Syva Co................................ Emit Delta 9 Cannabinoid 400 ng/ Vial: 3ml................ 8/22/89
ml Calibrator/Control.
Syva Co................................ Emit Delta 9 Cannabinoid 50 ng/ Vial: 3ml................ 8/22/89
ml Calibrator/Control.
Syva Co................................ Emit HVA Amphetamine Assay Kit: 2500 Assays......... 6/30/88
Catalog No. 3C619.
Syva Co................................ Emit HVA Barbiturate Assay Kit: 2500 Assays......... 6/30/88
Catalog No. 3D619.
Syva Co................................ Emit HVA Calibrator Kit Catalog Kit: 500 Tests Each Kit - 5/10/88
No. 3A619. 2 Glass Bottles 100 ml.
Syva Co................................ Emit HVA Cannabinoid 100 ng Kit: 2 Bottles, 50 ml ea. 7/15/88
Assay Control Kit, Catalog No.
3M739.
Syva Co................................ Emit HVA Cannabinoid 100 ng. Kit: 3 Bottles 50 ml ea.. 7/15/88
Assay Calibrator Kit, Catalog
No. 3M729.
Syva Co................................ Emit HVA Cannabinoid 100 ng. Kit: 2500 Assays......... 7/15/88
Assay Kit, Catalog No. 3M719.
Syva Co................................ Emit HVA Cocaine Metabolite Bottle: 125 ml........... 5/10/88
Assay Catalog No. 3H619.
Syva Co................................ Emit HVA Control Kit Catalog Kit: 500 Tests Each Kit-2 5/10/88
No. 3A629. Glass Bottles--100ml.
Syva Co................................ Emit HVA Opiate Assay Catalog Bottle: 125ml............ 5/10/88
No. 3B619.
Syva Co................................ Emit HVA Phencyclidine Assay Bottle: 125ml............ 5/19/88
Catalog No. 3J619.
Syva Co................................ Emit II Barbiturate Assay...... Kit: 100ml, 500ml Bottle: 6/29/90
4oz, 500ml.
Syva Co................................ Emit II Calibrator A Level 1 Vial: 10ml, 50ml......... 6/29/90
(Cutoff).
Syva Co................................ Emit II Calibrator A Level 2 Vial: 10ml, 50ml......... 6/29/90
(high).
Syva Co................................ Emit II Cannabinoid 20ng, 50ng, Bottle: 4oz, 500ml; Kit: 10/12/90
100ng Assay. 100ml, 500ml.
Syva Co................................ Emit II Cocaine Metabolite Kit: 100ml, 500ml Bottle: 6/29/90
Assay. 4oz, 500ml.
Syva Co................................ Emit II Delta 9 Cannabinoid Vial: 10ml, 50ml......... 10/12/90
20ng/ml, 50ng/ml, 100ng/ml,
200ng/ml, Calibrator/Control.
Syva Co................................ Emit II Methadone Assay........ Kit: 2 vials............. 1/26/93
Syva Co................................ Emit II Methadone Assay Reagent Bottle: 100ml, 500ml..... 1/26/93
2.
Syva Co................................ Emit II Methaqualone Assay..... Kit: 2 vials............. 1/26/93
Syva Co................................ Emit II Methaqualone Assay Bottle: 100ml, 500ml..... 1/26/93
Reagent 2.
Syva Co................................ Emit II Monoclonal Amphetamine/ Kit: 2 vials............. 1/26/93
Methamphetamine Assay.
Syva Co................................ Emit II Monoclonal Amphetamine/ Vial: 100ml, 500ml....... 1/26/93
Methamphetamine Assay Enzyme
Reagent 2.
Syva Co................................ Emit II Opiate Assay........... Kit: 100ml, 500ml Bottle: 6/29/90
4oz, 500ml.
Syva Co................................ Emit II Phencyclidine Assay.... Bottle: 4oz, 500ml; Kit: 10/26/90
100ml, 500ml.
Syva Co................................ Emit IIC Barbiturate Assay..... Kit: 2 Vials............. 1/6/94
Syva Co................................ Emit IIC Barbiturate Enzyme Vial: 500ml.............. 1/6/94
Reagent 2.
Syva Co................................ Emit IIC Calibrators 0, 1, 2, Vial: 10ml............... 1/6/94
3, 4, 5.
Syva Co................................ Emit IIC Opiate Assay.......... Kit: 2 Vials............. 1/6/94
Syva Co................................ Emit IIC Opiate Enzyme Reagent Vial: 500ml.............. 1/6/94
2.
Syva Co................................ Emit Methadone Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent 2.
Syva Co................................ Emit Methadone Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
Syva Co................................ Emit Methadone Bulk Reagent.... Bottle: 1000ml........... 6/7/93
Syva Co................................ Emit Methaqualone Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent 2.
Syva Co................................ Emit Methaqualone Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
Syva Co................................ Emit Opiate Bulk Powder Reagent Bottle: 1000 ml.......... 10/4/89
2.
[[Page 170]]
Syva Co................................ Emit Opiate Bulk Powder Reagent Bottle: 4 oz............. 4/20/90
2 Satellite.
Syva Co................................ Emit Opiate Bulk Reagent B..... Glass bottle: 1000ml..... 12/5/90
Syva Co................................ Emit Phencyclidine Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent 2.
Syva Co................................ Emit Phencyclidine Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent 2 Satellite.
Syva Co................................ Emit Phencyclidine Bulk Reagent Glass Bottle: 1000ml..... 12/5/90
B.
Syva Co................................ Emit Phenobarbital Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent B.
Syva Co................................ Emit Phenobarbital Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent B Satellite.
Syva Co................................ Emit Phenobarbital Enzyme Vial: 6 ml , Lyophilized. 8/27/74
Reagent B.
Syva Co................................ Emit Qst Phenobarbital Bulk Steel Drum: 7 gallon..... 6/5/86
Powder Reagent.
Syva Co................................ Emit Qst Primidone Assay Glass Vial: 6ml, 50 Vials/ 11/12/85
Catalog No. 60819. Kit.
Syva Co................................ Emit Serum Barbiturate-Enzyme Bottle: 3ml.............. 5/22/79
Reagent B.
Syva Co................................ Emit T-Uptake Assay............ Bottle: 4 oz., 1L, Kit: 5/25/89
500 tests, 5000 tests.
Syva Co................................ Emit T-Uptake Assay (Thyroid Polyethylene Bottle: 4 oz 2/29/88
Hormone Binding Ratio) Catalog
No. 6J519.
Syva Co................................ Emit T-Uptake Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent A.
Syva Co................................ Emit T-Uptake Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent A Satellite.
Syva Co................................ Emit THC 50/100ng Assay........ Kit; 2vials, 500ml each.. 10/11/93
Syva Co................................ Emit THC Calibrators; 0ng/mlk, Vial: 10ml............... 10/11/93
50ng/ml, 100ng/ml, 200ng/ml.
Syva Co................................ Emit THC Controls; Levels I, Vial: 10ml............... 10/11/93
II, III, IV.
Syva Co................................ Emit Thyroxine Assay........... Glass Bottle: 8 oz., 1L, 5/25/89
Kit: 1300 tests, 5000
tests.
Syva Co................................ Emit Thyroxine Bulk Powder Bottle: 1000 ml.......... 10/4/89
Reagent B.
Syva Co................................ Emit Thyroxine Bulk Powder Bottle: 4 oz............. 4/20/90
Reagent B Satellite.
Syva Co................................ Emit Tox Serum Benzodiazepine Bottle: 3ml.............. 2/1/79
Assay Kit Containing: Emit
Enzyme Reagent B.
Syva Co................................ Emit d.a.u. Amphetamine Assay Kit: 100 tests, 1000 9/27/84
Catalog Nos. 3C019, 3C119. tests.
Syva Co................................ Emit d.a.u. Amphetamine Class Glass Vial: 5ml.......... 1/30/89
Low Calibrator, Cat. No. 3C179.
Syva Co................................ Emit d.a.u. Amphetamine Class Glass Vial: 5ml.......... 1/30/89
Medium Calibrator, Cat. No.
3C189.
Syva Co................................ Emit d.a.u. Barbiturate Assay Kit: 100 tests, 1000 9/27/84
Catalog Nos. 3D019, 3D119. tests.
Syva Co................................ Emit d.a.u. Benzodiazepine Kit: 100 tests, 1000 9/27/84
Assay Catalog Nos. 3F019, tests.
3F119.
Syva Co................................ Emit d.a.u. Cannabinoid 100 ng Kit: 1000 tests.......... 9/12/86
Assay, Catalog No. 3M119.
Syva Co................................ Emit d.a.u. Cannabinoid 100ng Kit: 3 vials............. 7/31/89
Assay Calibrator.
Syva Co................................ Emit d.a.u. Cannabinoid 100ng Vial: 3ml................ 7/31/89
Assay Low Calibrator.
Syva Co................................ Emit d.a.u. Cannabinoid 100ng Vial: 3ml................ 7/31/89
Assay Medium Calibrator.
Syva Co................................ Emit d.a.u. Cannabinoid 20ng Kit: 100 tests........... 2/10/86
Assay Catalog No. 3M619.
Syva Co................................ Emit d.a.u. Cannabinoid 20ng Vial: 10ml Lyophilized 2/10/86
Enzyme Reagent B. Powder.
Syva Co................................ Emit d.a.u. Cannabinoid 50 ng Vial: 5 ml............... 6/1/88
Assay Calibrators, Low And
Medium: Cat. No. 3M509.
Syva Co................................ Emit d.a.u. Cannabinoid 50 ng Kit: 100 tests........... 6/1/88
Assay: Cat. No. 3M519.
Syva Co................................ Emit d.a.u. Cannabinoid Assay Kit: 100 tests........... 9/24/84
Catalog No. 3M019.
Syva Co................................ Emit d.a.u. Cannabinoid Urine Kit: 3 Vials, 3ml Each... 1/3/80
Calibrator Set.
Syva Co................................ Emit d.a.u. Cocaine Metabolite Kit: 100 tests, 1000 9/27/84
Assay Catalog Nos. 3H019, tests.
3H119.
Syva Co................................ Emit d.a.u. Low Calibrator A... Bottle: 5ml.............. 7/20/84
Syva Co................................ Emit d.a.u. Low Calibrator A... Vial: 5 ml............... 6/30/89
Syva Co................................ Emit d.a.u. Low Calibrator A, 5 ml vial................ 10/6/88
Catalog No. 3C579.
Syva Co................................ Emit d.a.u. Low Calibrator B... Bottle: 5ml.............. 8/3/84
Syva Co................................ Emit d.a.u. Medium Calibrator A Bottle: 5ml.............. 7/20/84
Syva Co................................ Emit d.a.u. Medium Calibrator A Vial: 5 ml............... 6/30/89
Syva Co................................ Emit d.a.u. Medium Calibrator 5 ml vial................ 10/6/88
A, Catalog No. 3C569.
Syva Co................................ Emit d.a.u. Medium Calibrator B Bottle: 5ml.............. 8/3/84
Syva Co................................ Emit d.a.u. Methadone Assay Kit: 100 tests, 1000 10/5/84
Catalog Nos. 3E019, 3E119. tests.
Syva Co................................ Emit d.a.u. Monoclonal Kit: 100 tests, 1000 10/6/88
Amphetamine/Methamphetamine tests.
Assay, Catalog No3C549 100
tests, 3C559 1000 tests.
Syva Co................................ Emit d.a.u. Opiate Assay Kit: 100 tests, 1000 9/27/84
Catalog Nos. 3B019, 3B119. tests.
Syva Co................................ Emit d.a.u. Phencyclidine Assay Bottle: 6ml.............. 2/1/79
Kit Containing: (1)Emit
Phencyclidine Enzyme Reagent B.
[[Page 171]]
Syva Co................................ Emit-Qst Phenobarbital Assay, Kit: 50 Vials............ 1/18/84
Catalog Number 6D819.
Syva Co................................ Emit-Tox Serum Barbiturate Kit: 50 tests............ 5/22/79
Assay.
Syva Co................................ Emit-Tox Serum Calibrators; Low Bottle: 3ml.............. 2/1/79
and Medium.
Syva Co................................ Emit-d.a.u. Methaqualone Assay. Kit: 100 tests........... 4/27/82
Syva Co................................ Emit-st Amphetamine Assay...... Vial: 3ml, 80 vials/kit.. 10/3/80
Syva Co................................ Emit-st Barbiturate Assay...... Vial: 3ml, 80 vials/kit.. 10/3/80
Syva Co................................ Emit-st Benzodiazepine Assay... Vial: 3ml, 80 vials/kit.. 10/3/80
Syva Co................................ Emit-st Cannabinoid Assay Vial: 6ml, 80 Vials/Kit.. 9/27/84
Catalog No. 3M319.
Syva Co................................ Emit-st Cannabinoid Calibrator. Vial: 3ml, 2 vials/kit... 7/10/81
Syva Co................................ Emit-st Cannabinoid Controls... Vial: 3ml, 2 vials/kit... 7/10/81
Syva Co................................ Emit-st Opiate Assay........... Kit: 3ml, 80 vials/kit... 10/3/80
Syva Co................................ Emit-st Phencyclidine Assay.... Vial: 3ml, 80 vials/kit.. 1/7/81
Syva Co................................ Emit-st Serum Barbiturate Assay Vial: 3ml, 80 vials/kit.. 2/16/81
Syva Co................................ Emit-st Serum Benzodiazepine Vial: 3ml, 80 vials/kit.. 2/16/81
Assay.
Syva Co................................ Emit-st Serum Calibrator....... Vial: 3ml................ 2/16/81
Syva Co................................ Emit-st Serum Controls......... Vial: 3ml, 2 vials/kit... 2/16/81
Syva Co................................ Emit-st Serum Phencyclidine Vial: 3ml, 80 vials/kit.. 2/16/81
Assay.
Syva Co................................ Emit-st Urine Calibrator A..... Vial: 1ml, 3 vials/kit... 10/3/80
Syva Co................................ Emit-st Urine Cocaine Vial: 3 ml, 80 Vials/Kit. 3/16/82
Metabolite Assay.
Syva Co................................ Emit-st Urine Controls A....... Vial: 1ml, 6 vials/kit... 10/3/80
Syva Co................................ Emit-st Urine Methadone Assay.. Vial: 3ml , 80 vials/kit. 3/22/82
Syva Co................................ Emit-st Urine Methaqualone Kit: 80 Vials............ 4/27/82
Assay.
Syva Co................................ Emit-st Urine Methaqualone Vial: 3ml................ 4/27/82
Calibrator.
Syva Co................................ Emit-st Urine Methaqualone Vial: 3ml................ 4/27/82
Controls.
Syva Co................................ IL test AED Calibrator 1....... Vial: 5 ml............... 4/6/90
Syva Co................................ IL test AED Calibrator 2....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test AED Calibrator 3....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test AED Calibrator 4....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test AED Calibrator 5....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test Cannabinoid 100ng, Vial: 5ml................ 4/6/90
400ng calibrator.
Syva Co................................ IL test set A calibrator....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test set A control.......... Vial: 5ml................ 4/6/90
Syva Co................................ IL test set B calibrator....... Vial: 5ml................ 4/6/90
Syva Co................................ IL test set B control.......... Vial: 5ml................ 4/6/90
Syva Co................................ Vista Thyroxine Uptake Reagent Cartridge: 4ml........... 1/22/93
Cartridge.
Syva Co................................ Vista Triiodothyronine (T3) Cartridge: 2.02 ml....... 9/11/92
Reagent Cartridge.
Tempil Division. Big Three Industries, Tempilaq Striped Mylar......... Plastic Sheet: 6 by 12 9/22/76
Inc. in. 50 sheets per
envelope.
The Binding Site, Inc.................. I.F.E. Buffer.................. Plastic Bottle: 125ml.... 12/5/91
The Binding Site, Inc.................. Immunofixation Kit............. Kit: 125ml Plastic Bottle 12/5/91
The Theta Corp......................... Allobarbital No.FP305.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Amobarbital No. FP313.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Amphetamine No. FP604.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Anileridine No. FP203.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Aprobarbital No. FP306......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Barbital No.FP314.............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Benzoylecgonine FP-1001........ Vial: 2 ml............... 1/24/87
The Theta Corp......................... Butabarbital No. FP315......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Butalbital No. FP307........... Vial: 2ml................ 4/10/73
The Theta Corp......................... Chloral Betaine No. FP502...... Vial: 2ml................ 4/10/73
The Theta Corp......................... Chloral Hydrate No. FP501...... Vial: 2ml................ 4/10/73
The Theta Corp......................... Cocaine No. FP601.............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Codeine No. FP102.............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Cyclobarbital No. FP308........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Dihydrocodeine No. FP108....... Vial: 2ml................ 4/10/73
The Theta Corp......................... Diphenoxylate No. FP205........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Ethchlorvynol No. FP508........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Ethylmorphine No. FP106........ Vial: 2ml................ 4/10/73
The Theta Corp......................... FP207.......................... Vial: 2ml................ 9/4/80
The Theta Corp......................... FP210.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP214.......................... Vial: 2ml................ 4/10/84
The Theta Corp......................... FP327.......................... Vial: 2ml................ 4/10/84
The Theta Corp......................... FP405.......................... Vial: 2ml................ 3/8/79
The Theta Corp......................... FP411.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP412.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP416.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP512.......................... Vial: 2ml................ 3/8/79
The Theta Corp......................... FP513.......................... Vial: 2ml................ 3/8/79
The Theta Corp......................... FP514.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP515.......................... Vial: 2ml................ 3/8/79
The Theta Corp......................... FP556.......................... Vial: 2ml................ 4/10/84
[[Page 172]]
The Theta Corp......................... FP601A......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP607.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... FP609.......................... Vial: 2ml................ 5/15/84
The Theta Corp......................... Fentanyl No. FP211............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Glutethimide No. FP404......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Heptabarbital No. FP309........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Hexabarbital No. FP303......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Hydrocodone No. FP107.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Hydromorphone No. FP103........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Levorphanol No. FP208.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Marker Mixture No. FPM-104..... Vial: 2ml................ 4/10/73
The Theta Corp......................... Marker Mixture No. FPM-201..... Vial: 2ml................ 4/10/73
The Theta Corp......................... Meperidine No.FP201............ Vial: 2ml................ 4/10/73
The Theta Corp......................... Mephobarbital No. FP301........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Meprobamate No. FP402.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Methadone No. FP206............ Vial: 2ml................ 4/10/73
The Theta Corp......................... Methamphetamine No. FP603...... Vial: 2ml................ 4/10/73
The Theta Corp......................... Metharbital No. FP302.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Methohexital No. FP304......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Methylphenidate No. FP605...... Vial: 2ml................ 4/10/73
The Theta Corp......................... Monthly Urine Test No. FPM-103. Vial: 2ml................ 4/10/73
The Theta Corp......................... Morphine No. FP101............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Oxycodone No. FP109............ Vial: 2ml................ 4/10/73
The Theta Corp......................... Oxymorphone No. FP104.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Paraldehyde No.FP506........... Vial: 2ml................ 4/10/73
The Theta Corp......................... Pentobarbital No. FP318........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Phenazocine No. FP213.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Phenmetrazine No. FP606........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Phenobarbital No. FP320........ Vial: 2ml................ 4/10/73
The Theta Corp......................... Piminodine No. FP202........... Vial: 2ml................ 4/10/73
The Theta Corp......................... Probarbital No. FP319.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Secobarbital No. FP310......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Talbutal No. FP311............. Vial: 2ml................ 4/10/73
The Theta Corp......................... Test Mixture SM No. 1.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SM No. 2.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SM No. 3.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SM No. 4.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SP No. 1.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SP No. 2.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SP No. 3.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture SP No. 4.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture TM No. 1.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Test Mixture TM No. 2.......... Vial: 2ml................ 6/19/74
The Theta Corp......................... Thiamylal No. FP322............ Vial: 2ml................ 4/10/73
The Theta Corp......................... Thiopental No. FP321........... Vial: 2ml................ 4/10/73
The Theta Corp......................... Vinbarbital No. FP312.......... Vial: 2ml................ 4/10/73
The Theta Corp......................... Weekly Urine Test (FDA) No. FPM- Vial: 2ml................ 4/10/73
101.
The Theta Corp......................... Weekly Urine Test (States) No. Vial: 2ml................ 4/10/73
FPM-102.
The Upjohn Company..................... DDHQ Spent Oxidant............. Fiber Drum: 30 Gallons... 12/19/94
Toxi-Lab, Inc.......................... Proficiency Sample............. Plastic bottle containing 6/22/82
40 ml.
Toxi-Lab, Inc.......................... Special Toxi-Discs............. Plastic vial or bottle 3/30/77
containing 50 Standard
Discs.
Toxi-Lab, Inc.......................... Supplemental Standard Toxi- Plastic vial containing 6/15/88
Discs No. SD-4 Catalog No. 234. 50 Standard Discs.
Toxi-Lab, Inc.......................... Supplemental Standard Toxi- Plastic vial containing 6/15/88
Discs No. SD-5 Catalog No. 235. 50 Standard Discs.
Toxi-Lab, Inc.......................... Supplemental Standard Toxi- Plastic vial containing 6/15/88
Discs No. SD-6 Catalog No. 236. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Control................... Plastic bottle containing 3/30/77
50 ml.
Toxi-Lab, Inc.......................... Toxi-Control THC............... Plastic bottle containing 10/5/83
50 ml.
Toxi-Lab, Inc.......................... Toxi-Disc A Series............. Plastic vial containing 5/6/75
50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Disc B Series............. Plastic vial containing 5/6/75
50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No 3 Plastic vial containing 6/15/88
Catalog No. 131C. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 1 Plastic vial containing 6/15/88
Catalog No. 131A. 50 Standard Discs.
[[Page 173]]
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 10 Plastic vial containing 6/15/88
Catalog No. 131K. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 11, Plastic vial containing 6/15/88
Catalog No. 131L. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 12 Plastic vial containing 6/15/88
Catalog No. 131M. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 2 Plastic vial containing 6/15/88
Catalog No. 131B. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 5 Plastic vial containing 6/15/88
Catalog No. 131E. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs Library II, No. 8 Plastic vial containing 6/15/88
Catalog No. 131H. 50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Discs THC................. Plastic vial containing 10/5/83
50 Standard Discs.
Toxi-Lab, Inc.......................... Toxi-Grams..................... Glass jar containing 50 9/24/80
or 100 Chromatograms.
Toxi-Lab, Inc.......................... Toxi-Lab Cannabinoid (THC) Kit: 50 tests............ 10/5/83
Screen.
Tudor Laboratories, Inc................ FPIA Phenobarbital Kit--Cat. Kit: 100 tests........... 11/27/89
No. 105.
Tudor Laboratories, Inc................ Phenobarbital Calibrator Kit Kit: 6 vials............. 11/27/89
Cat. No. 205.
Tudor Laboratories, Inc................ Phenobarbital Calibrators B, C, Vial: 4.0 ml............. 11/27/89
D, E, F.
Universal Reagents, Inc................ Drug Monitoring & Toxicology Bottle: 10ml............. 10/9/90
No. DM 90-5, DM-62.
Utak Laboratories...................... Toxicology Control-High Range Bottle: 10ml............. 4/14/80
Anticonvulsants No. 71910.
Utak Laboratories...................... Toxicology Control-High Range Bottle: 10ml............. 4/14/80
Barbiturates No. 71916.
Utak Laboratories...................... Toxicology Control-High Range Bottle: 10ml............. 4/14/80
Hypnotic Plus Acetaminophem,
No. 71918.
Utak Laboratories...................... Toxicology Control-High Range Bottle: 10ml............. 4/14/80
Hypnotic Plus Salicylate, No.
71920.
Utak Laboratories...................... Toxicology Control-Mid Range Bottle: 10ml............. 4/14/80
Anticonvulsants No. 71911.
Utak Laboratories...................... Toxicology Control-Mid Range Bottle: 10ml............. 4/14/80
Barbiturates No. 71917.
Utak Laboratories...................... Toxicology Control-Mid Range Bottle: 10ml............. 4/14/80
Hypnotic Plus Acetaminophem,
No. 71919.
Utak Laboratories...................... Toxicology Control-Mid Range Bottle: 10ml............. 4/14/80
Hypnotic Plus Salicylate, No.
71921.
Utak Laboratories...................... Toxicology Serum Control Dried Bottle: 10ml............. 7/29/82
#88112.
Utak Laboratories...................... Toxicology Serum Control Dried Bottle: 10ml............. 7/29/82
#88113.
Utak Laboratories...................... Toxicology Serum Control Dried Bottle: 10ml............. 7/29/82
#88120.
Utak Laboratories...................... Toxicology Serum Control-Dried In Bottles............... 5/24/76
Catalog Nos. 44610, 44612,
44632, 44635, 44636, 44637,
44642, 44645, 44646, 44647,
44658.
Utak Laboratories...................... Toxicology Urine Control Dried Bottle: 20ml............. 7/29/82
#88100.
Utak Laboratories...................... Toxicology Urine Control Dried Bottle: 10ml............. 7/29/82
#88121.
Utak Laboratories...................... Toxicology Urine Control-Dried Bottle: 1 oz............. 5/24/76
Catalog Nos. 44650, 44651,
44652, 44653.
Ventrex Laboratories, Inc.............. PTH Antiserum.................. Vial: 5ml................ 4/12/90
Ventrex Laboratories, Inc.............. PTH Assay Buffer............... Vial: 10ml............... 4/12/90
Ventrex Laboratories, Inc.............. PTH Omega Radioimmunoassay Kit. Kit: 60 tests............ 4/12/90
Ventrex Laboratories, Inc.............. PTH Second Antibody............ Vial: 10ml............... 4/12/90
Ventrex Laboratories, Inc.............. PTH Tracer Buffer.............. Vial: 5 ml............... 4/12/90
Wien Laboratories, Inc................. 3H Dihydrotestosterone Cat. No. Vial: 5.5ml.............. 2/21/91
D-1916.
Wien Laboratories, Inc................. 3H Epi-Testosterone Cat. No. T- Vial: 5.5ml.............. 2/21/91
1028.
Wien Laboratories, Inc................. 3H Testosterone Cat. No. T-3027 Vial: 5.5ml.............. 2/21/91
Wien Laboratories, Inc................. ANS Buffer pH 8.6 Catalog No. T- Plastic Bottle: 100ml.... 5/14/75
5144.
Wien Laboratories, Inc................. Buffer Reagent pH 8.6 Catalog Bottle: 4oz.............. 12/22/72
No. T-5065.
Wien Laboratories, Inc................. Coated Charcoal Suspension No. Bottle: 4oz.............. 12/22/72
T-5077.
Wien Laboratories, Inc................. Dihydrotestosterone Standard Vial: 5.5ml.............. 2/21/91
1ng/ml Cat. No. D-1928.
Wien Laboratories, Inc................. Epi-Testosterone Standard, 10ng/ Vial: 5.5ml.............. 2/21/91
ml Cat. No. T-1016.
Wien Laboratories, Inc................. Epi-Testosterone Test Set Cat. Kit: 2 Bottles........... 2/21/91
No. TS-1010.
Wien Laboratories, Inc................. Methamphetamine: HRP EIA Vial: 5ml, 10ml.......... 6/25/90
Conjugate.
Wien Laboratories, Inc................. T3 Buffer Reagent Catalog No. T- Plastic Vial: 20ml....... 9/13/78
5156.
Wien Laboratories, Inc................. Testosterone Standard, 10ng/ml Vial: 5.5ml.............. 2/21/91
Cat. No. T-3039.
Wien Laboratories, Inc................. Testosterone Test Set Cat. No. Kit: 2 Bottles........... 2/21/91
TS-333.
Windsor Laboratories, Inc.............. Calibrators FPR Phenobarbital.. Kit: 6 Vials............. 10/30/86
Windsor Laboratories, Inc.............. Phenobarbital Fluorescence Kit: 100 tests........... 11/20/86
Polarization Immunoassay Kit.
----------------------------------------------------------------------------------------------------------------
[[Page 174]]
(j) The following substances are designated as exempt chemical
preparations for the purposes set forth in this section.
(1) Chloral. When packaged in a sealed, oxygen-free environment,
under nitrogen pressure, safeguarded against exposure to the air.(2)
EmitR Phenobarbital Enzyme Reagent B. In one liter quantities each
with a 5 ml. retention sample for repackaging as an exempt chemical
preparation only.
[38 FR 8255, Mar. 30, 1973]
Editorial Note: For Federal Register citations affecting
Sec. 1308.24, see the List of CFR Sections Affected in the Finding Aids
section of this volume.
Excluded Veterinary Anabolic Steroid Implant Products
Sec. 1308.25 Exclusion of a veterinary anabolic steroid implant product; application.
(a) Any person seeking to have any anabolic steroid product, which
is expressly intended for administration through implants to cattle or
other nonhuman species and which has been approved by the Secretary of
Health and Human Services for such administration, identified as being
excluded from any schedule, pursuant to section 102(41)(B)(i) of the Act
(21 U.S.C. 802(41)(B)(i)), may apply to the Administrator, Drug
Enforcement Administration, Department of Justice, Washington, DC 20537.
(b) An application for any exclusion under this section shall be
submitted in triplicate and contain the following information:
(1) The name and address of the applicant;
(2) The name of the product;
(3) The chemical structural formula or description for any anabolic
steroid contained in the product;
(4) A complete description of dosage and quantitative composition of
the dosage form;.
(5) The conditions of use including whether or not Federal law
restricts this product to use by or on the order of a licensed
veterinarian;
(6) A description of the delivery system in which the dosage form
will be distributed with sufficient detail to identify the product (e.g.
20 cartridge brown plastic belt);
(7) The label and labeling of the immediate container and the
commercial containers, if any, of the product;.
(8) The name and address of the manufacturer of the dosage form if
different from that of the applicant; and
(9) Evidence that the product has been approved by the Secretary of
Health and Human Services for administration through implant to cattle
or other nonhuman species.
(c) Within a reasonable period of time after the receipt of an
application for an exclusion under this section, the Administrator shall
notify the applicant of his acceptance or nonacceptance of the
application, and if not accepted, the reason therefore. The
Administrator need not accept an application for filing if any of the
requirements prescribed in paragraph (b) of this section is lacking or
is not set forth as to be readily understood. The applicant may amend
the application to meet the requirements of paragraph (b) of this
section. If the application is accepted for filing, the Administrator
shall issue and have published in the Federal Register his order on the
application, which shall include a reference to the legal authority
under which the order is issued and the findings of fact and conclusions
of law upon which the order is based. This order shall specify the date
on which it will take effect. The Administrator shall permit any
interested person to file written comments on or objections to the order
within 60 days of the date of publication in the Federal Register. If
any such comments or objections raise significant issues regarding any
finding of fact or conclusion of law upon which the order is based, the
Administrator shall immediately suspend the effectiveness of the order
until he may reconsider the application in light of the comments and
objections filed. Thereafter, the Administrator shall reinstate, revoke,
or amend his original order as he determines appropriate.
(d) The Administrator may at any time revoke or modify any
designation of excluded status granted pursuant to this section by
following the procedures set forth in paragraph (c) of this section for
handling an application for
[[Page 175]]
an exclusion which has been accepted for filing.
[56 FR 42936, Aug. 30, 1991]
Sec. 1308.26 Excluded veterinary anabolic steroid implant products.
(a) The following anabolic steroid-containing products which are
expressly intended for administration through implants to cattle or
other nonhuman species and which as been approved by the Secretary of
Health and Human Services for such administration are excluded from all
schedules pursuant to section 102(41)(B)(i) of the Act (21 U.S.C.
802(41)(B)(i):
Table of Excluded Veterinary Anabolic Steroid Implant Products
--------------------------------------------------------------------------------------------------------------------------------------------------------
Trade name Company NDC code Delivery system Ingredients Quantity
--------------------------------------------------------------------------------------------------------------------------------------------------------
F-TO............................... Animal Health Div. 0009-3351-02 20 implant cartridge testosterone 200 mg/implant
Upjohn International, belt 8 pellets/ propionate oestradiol 20 mg/implant.
Kalamazoo, MI. implant. benzoate.
Finaplix-H......................... Hoechst-Roussel, Agri- 12799-807-10 10 implant cartridge trenbolone acetate.... 200 mg/implant
Vet Co., Somerville, 10 pellets/implant. (20 mg/pellet).
NJ.
Finaplix-S......................... Hoechst-Roussel, Agri- 12799-807-07 10 implant cartridge 7 trenbolone acetate.... 140 mg/implant
Vet Co., Somerville, pellets/implant. (20 mg/pellet).
NJ.
Heifer-oid......................... Anchor Division, single & 20 implant testosterone 200 mg/implant
Boehringer Ingelheim, cartridge belts 8 propionate estradiol 20mg/implant.
St. Joseph, MO. pellets/implant. benzoate.
Heifer-oid......................... Bio-Ceutic Division, 20 implant cartridge testosterone 200 mg/implant
Boehringer Ingelheim, belt 8 pellets/ propionate estradiol 20 mg/implant.
St. Joseph, MO. implant. benzoate.
Heifer-oid......................... Ivy Laboratories, single & 20 implant testosterone 200 mg/implant
Inc., Overland Park cartridge belts. propionate. (25 mg/pellet).
KS.
............... 8 pellets/implant..... estradiol benzoate.... 20 mg/implant
(2.5 mg/pellet).
ImplusTM-H......................... The Upjohn Company, 0009-0434-01 20 implant belt 8 testosterone 200 mg/implant, 20 mg/
Kalamazoo, MI. pellets/implant. propionate estradiol implant
benzoate.
Revalor-s.......................... Hoechst-Roussel, Agri- 12799-809-07 10 implant cartridge 6 trenbolone acetate.... 120 mg/implant
Vet Co., Somerville, pellets/implant. (20 mg/pellet).
NJ.
estradiol............. 24 mg/implant
(4 mg/pellet).
Synovex H.......................... Syntex Laboratories, 10 implant clip 8 testosterone 200 mg/implant
Palo Alto, CA. pellets/implant. propionate. (25 mg/pellet).
estradiol benzoate.... 20 mg/implant
(2.5 mg/pellet).
--------------------------------------------------------------------------------------------------------------------------------------------------------
(b) In accordance with section 102(41)(B)(ii) of the Act (21 U.S.C.
802(41)(B)(ii)) if any person prescribes, dispenses, or distributes a
product listed in paragraph (a) of this section for human use, such
person shall be considered to have prescribed, dispensed, or distributed
an anabolic steroid within the meaning of section 102(41)(A) of the Act
(21 U.S.C. 802(41)(A)).
[56 FR 42936, Aug. 30, 1991, as amended at 57 FR 19534, May 7, 1992; 58
FR 15088, Mar. 19, 1993]
Exempted Prescription Products
Sec. 1308.31 Application for exemption of a nonnarcotic prescription product.
(a) Any person seeking to have any compound, mixture, or preparation
containing any nonnarcotic controlled substance listed in
Sec. 1308.12(e), or in Sec. 1308.13 (b) or (c), or in Sec. 1308.14, or
in Sec. 1308.15, exempted from application of all or any part of the Act
pursuant to section 201(g)(3)(A), of the Act (21 U.S.C. 811(g)(3)(A).
may apply to the Administrator, Drug Enforcement Administration,
Washington, DC 20537, for such exemption.
[[Page 176]]
(b) An application for an exemption under this section shall contain
the following information:
(1) The complete quantitative composition of the dosage form.
(2) Description of the unit dosage form together with complete
labeling.
(3) A summary of the pharmacology of the product including animal
investigations and clinical evaluations and studies, with emphasis on
the psychic and/or physiological dependence liability (this must be done
for each of the active ingredients separately and for the combination
product).
(4) Details of synergisms and antagonisms among ingredients.
(5) Deterrent effects of the noncontrolled ingredients.
(6) Complete copies of all literature in support of claims.
(7) Reported instances of abuse.
(8) Reported and anticipated adverse effects.
(9) Number of dosage units produced for the past 2 years.
(c) Within a reasonable period of time after the receipt of an
application for an exemption under this section, the Administrator shall
notify the applicant of his acceptance or non-acceptance of the
application, and if not accepted, the reason therefor. The Administrator
need not accept an application for filing if any of the requirements
prescribed in paragraph (b) of this section is lacking or is not set
forth so as to be readily understood. If the applicant desires, he may
amend the application to meet the requirements of paragraph (b) of this
section. If accepted for filing, the Administrator shall publish in the
Federal Register general notice of this proposed rulemaking in granting
or denying the application. Such notice shall include a reference to the
legal authority under which the rule is proposed, a statement of the
proposed rule granting or denying an exemption, and, in the discretion
of the Administrator, a summary of the subjects and issues involved. The
Administrator shall permit any interested person to file written
comments on or objections to the proposal and shall designate in the
notice of proposed rule making the time during which such filings may be
made. After consideration of the application and any comments on or
objections to his proposed rulemaking, the Administrator shall issue and
publish in the Federal Register his final order on the application,
which shall set forth the findings of fact and conclusions of law upon
which the order is based. This order shall specify the date on which it
shall take effect, which shall not be less than 30 days from the date of
publication in the Federal Register unless the Administrator finds that
conditions of public health or safety necessitate an earlier effective
date, in which event the Administrator shall specify in the order his
findings as to such conditions.
(d) The Administrator may revoke any exemption granted pursuant to
section 201(g)(3)(A) of the Act (21 U.S.C. 811(g)(3)(A)) by following
the procedures set forth in paragraph (c) of this section for handling
an application for an exemption which has been accepted for filing.
[38 FR 8254, Mar. 30, 1973. Redesignated at 38 FR 26609, Sept. 24, 1973,
as amended at 44 FR 18968, Mar. 30, 1979; 52 FR 9803, Mar. 27, 1987]
Sec. 1308.32 Exempted prescription products.
The following compounds, mixtures, or preparations which contain a
non-narcotic controlled substance listed in Sec. 1308.12(e) or in
Sec. 1308.13(b) or (c) or in Sec. 1308.14 or in Sec. 1308.15 listed in
the Table of Exempted Prescription Products have been exempted by the
Adminsitrator from the application of sections 302 through 305, 307
through 309, 1002 through 1004 of the Act (21 U.S.C. 822-825, 827-829,
and 952-954) and Secs. 1301.24, 1301.31, 1301.32, and Secs. 1301.71
through 1301.76 of this chapter for administrative purposes only. Except
that those products containing butalbital shall not be exempt from the
requirements of 21 U.S.C. 952-954 concerning importation, exportation,
transshipment and in-transit shipment of controlled substances. Any
deviation from the quantitative composition of any of the listed drugs
shall require a petition of exemption in order for the product to be
exempted.
[[Page 177]]
Exempted Prescription Products
Explanation of Column Headings and Abbreviations
Company/Trade Name. Self explanatory.
NDC Code. Refers to the specific National Drug Code listing for the
particular formulated product.
Form. Refers to the type of dosage formulation:
CA=capsule
DP=drops
EL=elixir
EC=enteric coated capsule
ET=enteric coated tablet
LQ=liquid
SS=suspension
SU=suppository
TB=tablet
WA=wafer
XC=sustained release capsule
XT=sustained release tablet
Controlled Substance (mg or mg/ml). Refers to the type and amount of
controlled substance present in the mixture. If the dosage formulation
is solid (CA, EC, ET, SU, TB, WA, XC, or XT), the amount shown is
milligrams per dosage unit. If the dosage formulation is liquid (DP, EL,
LQ, or SS), the amount shown is milligrams per milliliter.
Table of Exempt Prescription Products
----------------------------------------------------------------------------------------------------------------
Controlled (mg or
Company Trade Name NDC Code Form Substance mg/ml)
----------------------------------------------------------------------------------------------------------------
Adria Laboratories............. Axotal............ 00013-1301 TB Butalbital....... 50.00
Alpha Scriptics Inc............ Butacet Capsules.. 53121-0133 CA Butalbital....... 50.00
American Urologicals Inc....... Butace............ 00539-0906 CA Butalbital....... 50.00
Apotheca....................... Theophen.......... 12634-0101 TB Phenobarbital.... 8.00
Arco Pharmaceuthcals........... Arco-Lase Plus.... 00275-0045 TB Phenobarbital.... 8.00
Arlo Interamerican............. Espasmotex........ 11475-0835 TB Phenobarbital.... 20.00
Ascher and Co.................. Anaspaz PB........ 00225-0300 TB Phenobarbital.... 15.00
Ascot Pharmaceuticals.......... Antispasmodic 47679-0158 TB Phenobarbital.... 16.20
Tablets.
Ascot Pharmaceuticals.......... Chlordiazepoxide 47679-0268 CA Chlordiazepoxide 5.00
Hydrochloride + HCl.
Clidinium Bromide.
Ayerst Laboratories............ PMB-200........... 00046-0880 TB Meprobamate...... 200.00
Ayerst Laboratories............ PMB-400........... 00046-0881 TB Meprobamate...... 400.00
Barre Drug Co.................. Barophen.......... 00472-0981 EL Phenobarbital.... 3.24
Barre Drug Co.................. Isolate Compound.. 00472-0929 EL Phenobarbital.... 0.40
Baucum Laboratories Inc........ Butalbital, 54696-0513 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
Beecham Laboratories........... Hybephen.......... 00029-2360 TB Phenobarbital.... 15.00
Bioline Labs Inc............... Anti-Spas Elixir.. 00719-4090 EL Phenobarbital.... 3.24
Bioline Labs Inc............... Anti-Spas Tablets. 00719-1091 TB Phenobarbital.... 16.20
Bioline Labs Inc............... Bel-Phen-Ergot-S 00719-1686 TB Phenobarbital.... 40.00
Tablets.
Bioline Labs Inc............... Chlordinium....... 00719-1208 CA Chlordiazepoxide 5.00
HCl.
Blaine Co...................... Spaslin........... 00165-0029 TB Phenobarbital.... 16.20
Blansett Pharm Co.............. Anolor 300 51674-0009 CA Butalbital....... 50.00
Capsules.
Bock Pharmacal Co.............. Broncholate....... 00563-0277 CA Phenobarbital.... 8.00
Bowman Pharmaceutical.......... Private Formula No 00252-3095 TB Phenobarbital 15.00
3095. Sodium.
Breon Labs..................... Isuprel Compound.. 00057-0874 EL Phenobarbital.... 0.40
Caldwell & Bloor Co............ Hyosital White.... 00361-2131 TB Phenobarbital.... 16.20
Carnrick Labs Inc.............. Phrenilin......... 00086-0050 TB Butalbital....... 50.00
Carnrick Labs Inc.............. Phrenilin Forte... 00086-0056 CA Butalbital....... 50.00
Carpenter Pharmacal Co......... ALAGESIC Tablets.. 55726-0300 TB Butalbital....... 50.00
Chelsea Laboratories........... Chlordiazepoxide 46193-0948 CA Chlordiazepoxide 5.00
with Clidinium HCl.
Bromide.
Columbia Drug Co............... Isopap Capsules... 11735-0400 CA Butalbital....... 50.00
Consolidated Midland........... Bellalphen........ 00223-0425 TB Phenobarbital.... 16.20
Dorasol Laboratories........... Donalixir......... 00471-0095 EL Phenobarbital.... 3.24
Dunhall Pharmacal Inc.......... Triaprin.......... 00217-2811 CA Butalbital....... 50.00
Econolab....................... Micomp-PB Tablets. 55053-0525 TB Pentobarbital 30.00
Sodium.
Equipharm Corp................. EQUI-CET Tablets.. 57779-0111 TB Butalbital....... 50.00
Everett Laboratories Inc....... Repan Capsules.... 00642-0163 CA Butalbital....... 50.00
Everett Laboratories Inc....... Repan Tablets..... 00642-0162 TB Butalbital....... 50.00
Forest Pharmacal Inc........... Acetaminophen 325 00456-0674 TB Butalbital....... 50.00
mg/Butalbital 50
mg.
Forest Pharmacal Inc........... Acetaminophen 500 00456-0671 TB Butalbital....... 50.00
mg/Butalbital 50
mg.
Forest Pharmacal Inc........... Bancap............ 00456-0546 CA Butalbital....... 50.00
Forest Pharmacal Inc........... ESGIC-PLUS........ 00456-0678 TB Butalbital....... 50.00
Forest Pharmacal Inc........... Esgic Capsules.... 00456-0631 CA Butalbital....... 50.00
Forest Pharmacal Inc........... Esgic Tablets..... 00456-0630 TB Butalbital....... 50.00
Forest Pharmacal Inc........... G.B.S............. 00456-0281 TB Phenobarbital.... 8.00
Forest Pharmacal Inc........... Soniphen.......... 00456-0429 ET Phenobarbital.... 16.00
Gen-King Products.............. Antispasmodic..... 03547-0777 TB Phenobarbital.... 16.20
Genetco Inc.................... Butalbital, 00302-0490 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
[[Page 178]]
Genetco Inc.................... Butalbital, Apap 00302-0490 TB Butalbital....... 50.00
and Caffeine.
Geneva Generics................ Phenobarbital, 00781-1701 TB Phenobarbital.... 40.00
Ergotamine and
Belladonna
Tablets.
Geriatric Pharmacal Corp....... Bilezyme Plus..... 00249-1112 TB Phenobarbital.... 8.00
Geriatric Pharmacal Corp....... Gustase Plus...... 00249-1121 TB Phenobarbital.... 8.00
Glenlawn Laboratories.......... Chlordinium 00580-0084 CA Chlordiazepoxide 5.00
Sealets. HCl.
Goldline Laboratories.......... Antispasmodic 00182-0686 EL Phenobarbital.... 3.24
Elixir.
Goldline Laboratories.......... Antispasmodic 00182-0129 TB Phenobarbital.... 16.20
Tablets.
Goldline Laboratories.......... Bel-phen-ergot s 00182-1847 TB Phenobarbital.... 40.00
Tablets.
Goldline Laboratories.......... Butalbital, APAP 00182-1274 TB Butalbital....... 50.00
and Caffeine
Tablets.
Goldline Laboratories.......... C.D.P. Plus 00182-1856 CA Chlordiazepoxide 5.00
Capsules. HCl.
H.L. Moore Drug Exchange....... Antispasmodic 00839-5055 TB Phenobarbital.... 16.00
Tablets.
H.L. Moore Drug Exchange....... Bellamor Tablets.. 00839-7370 TB Phenobarbital.... 40.00
H.L. Moore Drug Exchange....... Theophenyllin..... 00839-5111 TB Phenobarbital.... 8.00
Halsey Drug Co Inc............. Blue Cross 00879-0567 TB Butalbital....... 50.00
Butalbital, APAP
and Caffeine
Tablets.
Halsey Drug Co Inc............. Butalbital and 00879-0543 TB Butalbital....... 50.00
Acetaminophen
Tablets.
Halsey Drug Co Inc............. Clinoxide......... 00879-0501 CA Chlordiazepoxide 5.00
HCl.
Halsey Drug Co Inc............. Susano............ 00879-0059 EL Phenobarbital.... 3.24
Halsey Drug Co Inc............. Susano............ 00879-0058 TB Phenobarbital.... 16.20
Horizon Products Co............ Spastrin Tablets.. 54580-0124 TB Phenobarbital.... 40.00
Hyrex Pharmaceutical........... Panzyme........... 00314-0310 TB Phenobarbital.... 8.10
Hyrex Pharmaceutical........... Two-Dyne Revised.. 00314-2229 TB Butalbital....... 50.00
Interstate Drug Exchange....... IDE-Cet Tablets... 00814-3820 TB Butalbital....... 50.00
Interstate Drug Exchange....... Spastolate........ 00814-7088 TB Phenobarbital.... 16.20
Intetlab....................... CON-TEN........... 11584-1029 CA Butalbital....... 50.00
Kaiser Foundation Hosp......... Belladonna 00179-0045 EL Phenobarbital.... 3.24
Alkaloids with
Phenobarbital.
Keene Pharmacal Inc............ Endolar........... 00588-7777 CA Butalbital....... 50.00
Knoll Pharmaceutical........... Quadrinal 00044-4580 SS Phenobarbital.... 2.40
Suspension.
Knoll Pharmaceutical........... Quadrinal Tablets. 00044-4520 TB Phenobarbital.... 24.00
Kraft Pharmacal Co Inc......... Digestokraft...... 00796-0237 TB Butabarbital 8.00
Sodium.
Kremers Urban Co............... Levsin with 00091-4530 EL Phenobarbital.... 3.00
Phenobarbital
Elixir.
Kremers Urban Co............... Levsin with 00091-3534 TB Phenobarbital.... 15.00
Phenobarbital
Tablets.
Kremers Urban Co............... Levsin-PB......... 00091-4536 DP Phenobarbital.... 15.00
Kremers Urban Co............... Levsinex with 00091-3539 XC Phenobarbital.... 45.00
Phenobarbital.
Landry Pharmacal Inc........... Febridyne Plain 05383-0001 CA Butalbital....... 50.00
Capsules.
Lanpar Co...................... PB Phe-Bell....... 12908-7006 TB Phenobarbital.... 16.20
Lasalle Laboratories........... Pacaps Modified 48534-0884 CA Butalbital....... 50.00
Formula.
Lemmon Pharmacal Co............ Donphen........... 00093-0205 TB Phenobarbital.... 15.00
Life Laboratories.............. Belladonna 00737-1283 EL Phenobarbital.... 3.00
Alkaloids with
Phenobarbital.
Lunsco Inc..................... Pacaps Capsules... 10892-0116 CA Butalbital....... 50.00
Major Pharmacal Corp........... Bellamine Tablets. 00904-2548 TB Phenobarbital.... 40.00
Major Pharmacal Corp........... Cafatine-PB 00904-1750 TB Pentobarbital 30.00
Tablets. Sodium.
Major Pharmacal Corp........... Fabophen Tablets.. 00904-3280 TB Butalbital....... 50.00
Mallard Inc.................... Anoquan Modified 00166-0881 CA Butalbital....... 50.00
Formula.
Mallard Inc.................... Malatal........... 00166-0748 TB Phenobarbital.... 16.20
Marlop Pharmacal Inc........... Broncomar......... 12939-0128 EL Butabarbital..... 1.00
Marlop Pharmacal Inc........... Dolmar............ 12939-0812 CA Butalbital....... 50.00
Marnel Pharmacal Inc........... Margesic Capsules. 00682-0804 CA Butalbital....... 50.00
Martec Pharmacal Inc........... Butalbital, 52555-0079 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
Mayrand Pharmacal Inc.......... B-A-C Tablets..... 00259-1256 TB Butalbital....... 50.00
Mayrand Pharmacal Inc.......... Sedapap-10 Tablets 00259-1278 TB Butalbital....... 50.00
Mead Johnson Pharmacal......... Quibron Plus 00087-0518 CA Butabarbital..... 20.00
Capsules.
Mead Johnson Pharmacal......... Quibron Plus 00087-0511 EL Butabarbital..... 1.33
Elixir.
Medco Supply Co................ Phenobarbital & 00764-2057 TB Phenobarbital.... 16.20
Hyoscyamine
Sulfate.
[[Page 179]]
Mikart Inc..................... Butalbital and 46672-0099 TB Butalbital....... 50.00
Acetaminophen
Tablets 50/325.
Mikart Inc..................... Butalbital and 46672-0098 TB Butalbital....... 50.00
Acetaminophen
Tablets 50/650.
Mikart Inc..................... Butalbital, 46672-0228 CA Butalbital....... 50.00
Acetaminophen and
Caffeine Capsules.
Mikart Inc..................... Butalbital, 46672-0053 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
Mikart Inc..................... Butalbital, 46672-0059 TB Butalbital....... 50.00
Acetaminophen,
and Caffeine
Tablets.
Nejo Pharmaceutical............ Spasmalones....... 00653-0002 TB Phenobarbital.... 16.00
Parke-Davis & Co............... Dilantin with 00071-0531 CA Phenobarbital.... 32.00
Phenobarbital 1/2.
Parke-Davis & Co............... Dilantin with 00071-0375 CA Phenobarbital.... 16.00
Phenobarbital 1/4.
Parke-Davis & Co............... Tedral SA......... 00071-0231 XT Phenobarbital.... 25.00
Parmed Pharmaceutical.......... Sedapar Elixir.... 00349-4100 EL Phenobarbital.... 3.24
Parmed Pharmaceutical.......... Sedapar Tablets... 00349-2355 TB Phenobarbital.... 16.20
Pasadena Research.............. Seds.............. 00418-4072 TB Phenobarbital.... 16.20
Pharmaceutical Basics Inc...... Antispasmodic 00832-8009 EL Phenobarbital.... 3.24
Elixir.
Pharmaceutical Basics Inc...... Butalbital, 00832-1102 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
Pharmaceutical Basics Inc...... Clinibrax Capsules 00832-1054 CA Chlordiazepoxide 5.00
HCl.
Poythress & Co Inc............. Antrocol.......... 00095-0041 CA Phenobarbital.... 16.00
Poythress & Co Inc............. Antrocol Elixir... 00095-0042 EL Phenobarbital.... 3.00
Poythress & Co Inc............. Antrocol Tablets.. 00095-0040 TB Phenobarbital.... 16.00
Poythress & Co Inc............. Mudrane........... 00095-0050 TB Phenobarbital.... 8.00
Poythress & Co Inc............. Mudrane GG Elixir. 00095-0053 EL Phenobarbital.... 0.50
Poythress & Co Inc............. Mudrane GG Tablets 00095-0051 TB Phenobarbital.... 8.00
Private Formula Inc............ Sangesic.......... 00511-1627 TB Butalbital....... 30.00
Qualitest Products Inc......... Butalbital, 52446-0544 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
Qualitest Products Inc......... Chlordiazepoxide 52446-0096 CA Chlordiazepoxide 5.00
HCl 5 mg and HCl.
Clidinium Br 2.5
mg.
Redi-Med....................... Butalbital 53506-0103 CA Butalbital....... 50.00
Compound Capsules.
Rexar Pharmacal Corp........... Rexatal Tablets... 00478-5477 TB Phenobarbital.... 16.52
Richlyn Laboratories........... Aminophylline & 00115-2156 ET Phenobarbital.... 15.00
Phenobarbital.
Richlyn Laboratories........... Aminophylline & 00115-2154 TB Phenobarbital.... 15.00
Phenobarbital
Tablets.
Richlyn Laboratories........... Bellophen......... 00115-2400 TB Phenobarbital.... 16.20
Richlyn Laboratories........... Spasmolin......... 00115-4652 TB Phenobarbital.... 15.00
Robins A H Co Inc.............. Donnatal Capsules. 00031-4207 CA Phenobarbital.... 16.20
Robins A H Co Inc.............. Donnatal Elixir... 00031-4221 EL Phenobarbital.... 3.24
Robins A H Co Inc.............. Donnatal Extentabs 00031-4235 XT Phenobarbital.... 48.60
Robins A H Co Inc.............. Donnatal No 2..... 00031-4264 TB Phenobarbital.... 32.40
Robins A H Co Inc.............. Donnatal Tablets.. 00031-4250 TB Phenobarbital.... 16.20
Robins A H Co Inc.............. Donnazyme......... 00031-4649 ET Phenobarbital.... 8.10
Roche Labs..................... Librax............ 00140-0007 CA Chlordiazepoxide 5.00
HCl.
Roche Labs..................... Menrium 10-4...... 00140-0025 TB Chlordiazepoxide. 10.00
Roche Labs..................... Menrium 5-2....... 00140-0023 TB Chlordiazepoxide. 5.00
Roche Labs..................... Menrium 5-4....... 00140-0024 TB Chlordiazepoxide. 5.00
Rondex Laboratories............ Antispasmodic..... 00367-4118 TB Phenobarbital.... 16.20
Rotex Pharmacal Inc............ Rogesic Capsules.. 31190-0008 CA Butalbital....... 50.00
Ruckstuhl Co................... Sedarex No 3...... 00144-1575 TB Phenobarbital.... 16.20
Rugby Laboratories Inc......... Clindex........... 00536-3490 CA Chlordiazepoxide 5.00
HCl.
Rugby Laboratories Inc......... Ergocaff-PB 00536-3801 TB Pentobarbital 30.00
Tablets. Sodium.
Rugby Laboratories Inc......... Hyosophen Capsules 00536-3926 CA Phenobarbital.... 16.00
Rugby Laboratories Inc......... Hyosophen Tablets. 00536-3920 TB Phenobarbital.... 16.20
Rugby Laboratories Inc......... ISOCET Tablets.... 00536-3951 TB Butalbital....... 50.00
Rugby Laboratories Inc......... Phenerbel-S 00536-4234 TB Phenobarbital.... 40.00
Tablets.
Rugby Laboratories Inc......... Theodrine Tablets. 00536-4648 TB Phenobarbital.... 8.00
Russ Pharmacal Inc............. FEMCET Capsules... 50474-0703 CA Butalbital....... 50.00
Sandoz Pharmacal Corp.......... Belladenal........ 00078-0028 TB Phenobarbital.... 50.00
Sandoz Pharmacal Corp.......... Belladenal-S...... 00078-0027 XT Phenobarbital.... 50.00
Sandoz Pharmacal Corp.......... Bellergal-S....... 00078-0031 XT Phenobarbital.... 40.00
Sandoz Pharmacal Corp.......... Cafergot P-B 00078-0035 SU Pentobarbital.... 60.00
Suppository.
[[Page 180]]
Sandoz Pharmacal Corp.......... Cafergot P-B 00078-0036 TB Pentobarbital 30.00
Tablets. Sodium.
Sandoz Pharmacal Corp.......... Fioricet.......... 00078-0084 CA Butalbital....... 50.00
Schein Henry Inc............... Antispasmodic..... 00364-0020 TB Phenobarbital.... 16.00
Schein Henry Inc............... Antispasmodic 00364-7002 EL Phenobarbital.... 3.20
Elixir.
Schein Henry Inc............... Isolate Compound 00364-7029 EL Phenobarbital.... 0.40
Elixir.
Schein Henry Inc............... T-E-P............. 00364-0266 TB Phenobarbital.... 8.10
Shoals Pharmacal Co............ Tencet............ 47649-0370 TB Butalbital....... 50.00
Shoals Pharmacal Co............ Tencet Capsules... 47649-0560 CA Butalbital....... 50.00
Stewart-Jackson Pharmacal...... Ezol.............. 45985-0578 CA Butalbital....... 50.00
Stuart Pharmaceutical.......... Kinesed........... 00038-0220 TB Phenobarbital.... 16.00
Superpharm Laboratories........ Chlordiazepoxide 57247-1003 CA Chlordiazepoxide 5.00
HCl & Clidinium HCl.
Br.
Towne Paulsen & Co............. T. E. P........... 00157-0980 TB Phenobarbital.... 8.00
Trimen Labs.................... Amaphen Capsules 11311-0954 CA Butalbital....... 50.00
(reformulated).
Truxton C O Inc................ Atropine Sulfate 00463-6035 TB Phenobarbital.... 15.00
with
Phenobarbital.
Truxton C O Inc................ Ephedrine with 00463-6086 TB Phenobarbital.... 15.00
Phenobarbital.
Truxton C O Inc................ Spastemms Elixir.. 00463-9023 EL Phenobarbital.... 3.24
Truxton C O Inc................ Spastemms Tablets. 00463-6181 TB Phenobarbital.... 15.00
U.S. Pharmaceuticals Inc....... Medigesic Tablets. 52747-0311 TB Butalbital....... 50.00
UAD Laboratories Inc........... Bucet Capsules.... 00785-2307 CA Butalbital....... 50.00
UAD Laboratories Inc........... Bucet Tablets..... 00785-2307 TB Butalbital....... 50.00
UAD Laboratories Inc........... Triad............. 00785-2306 TB Butalbital....... 50.00
UAD Laboratories Inc........... Triad Capsules.... 00785-2305 CA Butalbital....... 50.00
UDL Laboratories............... Belladonna 51079-0168 TB Phenobarbital.... 16.20
Alkaloids with
Phenobarbital.
United Research Labs Inc....... Bel-Tabs.......... 00677-1171 TB Phenobarbital.... 40.00
University of Iowa............. Bladder Mixture 11326-1624 LQ Phenobarbital.... 2.92
Plus
Phenobarbital.
Vale Chemical Co............... Alkaloids of 00377-0527 TB Phenobarbital.... 16.20
Belladonna and
Phenobarbital.
Vale Chemical Co............... Antispas.......... 00377-0622 TB Phenobarbital.... 16.20
Vale Chemical Co............... Barbeloid 00377-0365 TB Phenobarbital.... 16.20
(Revised) Green.
Vale Chemical Co............... Barbeloid Yellow.. 00377-0498 TB Phenobarbital.... 16.20
Vale Chemical Co............... Charspast......... 00377-0500 TB Phenobarbital.... 16.20
Vale Chemical Co............... Digestokraft...... 00377-0460 TB Butabarbital 8.00
Sodium.
Vale Chemical Co............... Ephedrine & Sodium 00377-0109 TB Phenobarbital 16.20
Phenobarbital. Sodium.
Vale Chemical Co............... Panzyme........... 00377-0491 TB Phenobarbital.... 8.10
Vale Chemical Co............... Pulsaphen......... 00377-0652 TB Phenobarbital.... 15.00
Vale Chemical Co............... Truxaphen......... 00377-0541 TB Phenobarbital.... 16.20
Vale Chemical Co............... Wescophen S-II.... 00377-0628 TB Phenobarbital.... 30.00
Vale Chemical Co............... Wesmatic Forte.... 00377-0426 TB Phenobarbital.... 8.10
Vitarine Pharmacal Inc......... E-Caff PB Tablets. 00185-0982 TB Pentobarbital.... 30.00
Vortech Pharmacal Co........... Donna-Sed......... 00298-5054 EL Phenobarbital.... 3.24
Vortech Pharmacal Co........... Hypnaldyne........ 00298-1778 TB Phenobarbital.... 16.20
Vortech Pharmacal Co........... Isophed........... 00298-5680 LQ Phenobarbital.... 0.40
Vortech Pharmacal Co........... Phedral C. T...... 00298-1173 TB Phenobarbital.... 8.10
W.E. Hauck Inc................. G-1 Capsules...... 43797-0244 CA Butalbital....... 50.00
Wallace Laboratories........... Barbidonna Elixir. 00037-0305 EL Phenobarbital.... 3.20
Wallace Laboratories........... Barbidonna No 2... 00037-0311 TB Phenobarbital.... 32.00
Wallace Laboratories........... Barbidonna Tablets 00037-0301 TB Phenobarbital.... 16.00
Wallace Laboratories........... Butibel Elixir.... 00037-0044 EL Butabarbital 3.00
Sodium.
Wallace Laboratories........... Butibel Tablets... 00037-0046 TB Butabarbital 15.00
Sodium.
Wallace Laboratories........... Lufyllin-EPG 00037-0565 EL Phenobarbital.... 1.60
Elixir.
Wallace Laboratories........... Lufyllin-EPG 00037-0561 TB Phenobarbital.... 16.00
Tablets.
Wallace Laboratories........... Milprem-200....... 00037-5501 TB Meprobamate...... 200.00
Wallace Laboratories........... Milprem-400....... 00037-5401 TB Meprobamate...... 400.00
Wesley Pharmacal Co............ Hytrophen......... 00917-0244 TB Phenobarbital.... 16.20
Wesley Pharmacal Co............ Pulsaphen Gray.... 00917-0113 TB Phenobarbital.... 15.00
Wesley Pharmacal Co............ Wescophen-S....... 00917-0135 TB Phenobarbital.... 30.00
Wesley Pharmacal Co............ Wesmatic Forte.... 00917-0845 TB Phenobarbital.... 8.00
West-ward Inc.................. Belladonna 00143-1140 TB Phenobarbital.... 16.20
Alkaloids &
Phenobarbital.
West-ward Inc.................. Butalbital with 00143-1787 TB Butalbital....... 50.00
Acetaminophen and
Caffeine Tablets.
West-ward Inc.................. Theophylline 00143-1695 TB Phenobarbital.... 8.00
Ephedrine &
Phenobarbital.
[[Page 181]]
Winthrop Labs.................. Isuprel........... 00024-0874 EL Phenobarbital.... 0.40
Zenith Labs Inc................ Azpan............. 00172-3747 TB Phenobarbital.... 8.00
----------------------------------------------------------------------------------------------------------------
[52 FR 9803, Mar. 27, 1987, as amended at 53 FR 10861, April 1, 1988; 54
FR 11520, Mar. 21, 1989; 55 FR 9114, Mar. 12, 1990; 57 FR 23301, June 3,
1992]
Exempt Anabolic Steroid Products
Sec. 1308.33 Exemption of certain anabolic steroid products; application.
(a) The Administrator, upon the recommendation of the Secretary of
Health and Human Services, may, by regulation, exempt from the
application of all or any part of the Act any compound, mixture, or
preparation containing an anabolic steroid as defined in Sec. 1308.02
if, because of its concentration, preparation, mixture or delivery
system, it has no significant potential for abuse (Pub. L. 101-647
section 1903(a)).
(b) Any person seeking to have any compound, mixture, or preparation
containing an anabolic steroid as defined in Sec. 1308.02 exempted from
the application of all or any part of the Act, pursuant to paragraph (a)
of this section, may apply to the Administrator, Drug Enforcement
Administration, Department of Justice, Washington, DC 20537.
(c) An application for an exemption under this section shall be
submitted in triplicate and contain the following information:
(1) The name and address of the applicant;
(2) The name of the product;
(3) The chemical structural formula or description for any anabolic
steroid contained in the product;
(4) The complete description of dosage and quantitative composition
of the dosage form;
(5) A description of the delivery system, if applicable;
(6) The indications and conditions for use in which species,
including whether or not this product is a prescription drug;
(7) Information to facilitate identification of the dosage form,
such as shape, color, coating, and scoring;
(8) The label and labeling of the immediate container and the
commercial containers, if any, of the product;
(9) The units in which the dosage form is ordinarily available; and
(10) The facts which the applicant believes justify:
(i) A determination that the product has no significant potential
for abuse and
(ii) a granting of an exemption under this section.
(d) Within a reasonable period of time after the receipt of the
application for an exemption under this section, the Administrator shall
notify the applicant of his acceptance or nonacceptance of the
application, and if not accepted, the reason therefor. The Administrator
need not accept an application for filing if any of the requirements
prescribed in paragraph (c) of this section is lacking or is not set
forth so as to be readily understood. The applicant may amend the
application to meet the requirements of paragraph (c) of this section.
If accepted for filing, the Administrator will request from the
Secretary for Health and Human Services his recommendation, as to
whether such product which contains an anabolic steroid should be
considered for exemption from certain portions of the Controlled
Substances Act. On receipt of the recommendation of the Secretary, the
Administrator shall make a determination as to whether the evidence
submitted or otherwise available sufficiently establishes that the
product possesses no significant potential for abuse. The Administrator
shall issue and publish in the Federal Register his order on the
application, which shall include a reference to the legal authority
under which the order is issued, and the findings of fact and
conclusions of law upon which the order is based. This order shall
specify
[[Page 182]]
the date on which it will take effect. The Administrator shall permit
any interested person to file written comments on or objections to the
order within 60 days of the date of publication of his order in the
Federal Register. If any such comments or objections raise significant
issues regarding any finding of fact or conclusion of law upon which the
order is based, the Administrator shall immediately suspend the
effectiveness of the order until he may reconsider the application in
light of the comments and objections filed. Thereafter, the
Administrator shall reinstate, revoke, or amend his original order as he
determines appropriate.
(e) The Administrator may revoke any exemption granted pursuant to
section 1903(a) of Public Law 101-647 by following the procedures set
forth in paragraph (d) of this section for handling an application for
an exemption which has been accepted for filing.
[56 FR 42936, Aug. 30, 1991; 57 FR 10815, Mar. 31, 1992]
Sec. 1308.34 Exempt anabolic steroid products.
The following anabolic steroid containing compounds, mixtures, or
preparations have been exempted by the Administrator from application of
sections 302 through 309 and 1002 through 1004 of the Act (21 U.S.C.
822-829 and 952-954) and Secs. 1301.24, 1301.31, 1301.32, and 1301.71
through 1301.76 of this chapter for administrative purposes only:
Table of Exempt Anabolic Steroid Products
----------------------------------------------------------------------------------------------------------------
Trade name Company NDC No. Form Ingredients Quantity
----------------------------------------------------------------------------------------------------------------
Androgyn L.A................. Forest 0456-1005........ Vial....... Testosterone 90 mg/ml
Pharmaceuticals enanthate. 4 mg/ml
, St. Louis, MO. Estradiol
valerate.
Andro-Estro 90-4............. Rugby 0536-1605........ Vial....... Testosterone 90 mg/ml
Laboratories, enanthate. 4 mg/ml
Rockville Estradiol
Centre, NY. valerate.
depANDROGYN.................. Forest 0456-1020........ Vial....... Testosterone 50 mg/ml
Pharmaceuticals cypionate. 2 mg/ml
, St. Louis, MO. Estradiol
cypionate.
DEPO-T.E..................... Quality Research 52765-257........ Vial....... Testosterone 50 mg/ml
Pharm., Carmel, cypionate. 2 mg/ml
IN. Estradiol
cypionate.
depTESTROGEN................. Martica 51698-257........ Vial....... Testosterone 50 mg/ml
Pharmaceuticals cypionate. 2 mg/ml
, Phoenix, AZ. Estradiol
cypionate.
Duomone...................... Wintec 52047-360........ Vial....... Testosterone 90 mg/ml
Pharmaceutical, enanthate. 4 mg/ml
Pacific, MO. Estradiol
valerate.
DURATESTRIN.................. W.E. Hauck, 43797-016........ Vial....... Testosterone 50 mg/ml
Alpharetta, GA. cypionate. 2 mg/ml
Estradiol
cypionate.
DUO-SPAN II.................. Primedics 0684-0102........ Vial....... Testosterone 50 mg/ml
Laboratories, cyplonate. 2 mg/ml
Gardena, CA. Esterified
cypionate.
Estratest.................... Solvay 0032-1026........ TB......... Esterified 1.25 mg
Pharmaceuticals estrogens. 2.5 mg
, Marletta, GA. Methyltestoster
one.
Estratest HS................. Solvay 0032-1023........ TB......... Esterified 0.625 mg
Pharmaceuticals estrogens. 1.25 mg
, Marletta, GA. Methyltestoster
one.
PAN ESTRA TEST............... Pan American 0525-0175........ Vial....... Testosterone 50 mg/ml
Labs, cypionate. 2 mg/ml
Covington, LA. Estradiol
cypionate.
Premarin with Ayerst Labs. 0046-0879........ TB......... Conjugated 1.25 mg
Methyltestosterone. Inc., New York, estrogens. 10.0 mg
NY. Methyltestoster
one.
Premarin with Ayerst Labs. 0046-0878........ TB......... Conjugated 0.625 mg
Methyltestosterone. Inc., New York, estrogens. 5.0 mg
NY. Methyltestoster
one.
Synovex H Pellets in process. Syntex Animal ................. Drum....... Testosterone 25 mg.
Health, Palo propionate. 2.5 mg.
Alto, CA. Estradiol
benzoate.
Synovex H Pellets in process Syntex Animal ................. Drum....... Testosterone 10 parts.
granulation. Health, Palo propionate. 1 part.
Alto, CA. Estradiol
benzoate.
TEST-ESTRO Cypionates........ Rugby 0536-9470........ Vial....... Testosterone 50 mg/ml
Laboratories, cypionate. 2 mg/ml
Rockville Estradiol
Centre, NY. cypionate.
Testagen..................... Clint 55553-257........ Vial....... Testosterone 50 mg/ml.
Pharmaceuticals cypionate. 2 mg/ml.
, Nashville, TN. Estradiol
cypionate.
Testosterone Cyp 50 Estradiol I.D.E.- 0814-7737........ Vial....... Testosterone 50 mg/ml
Cyp 2. Interstate, cypionate. 2 mg/ml
Amityville, NY. Estradiol
cypionate.
[[Page 183]]
Testosterone Cypionate-- Best Generics, 54274-530........ Vial....... Testosterone 50 mg/ml
Estradiol Cypionate No. Miami cypionate. 2 mg/ml
Injection. Beach, FL. Estradiol
cypionate.
Testosterone Cypionate-- Goldline Labs, 0182-3069........ Vial....... Testosterone 50 mg/ml.
Estradiol Cypionate Ft. Lauderdale, cypionate. 2 mg/ml.
Injection. FL. Estradiol
cypionate.
Testosterone Cypionate-- Schein 0364-6611........ Vial....... Testosterone 50 mg/ml
Estradiol Cypionate Pharmaceuticals cypionate. 2 mg/ml
Injection. , Port Estradiol
Washington, NY. cypionate.
Testosterone Cypionate-- Steris Labs. 0402-0257........ Vial....... Testosterone 50 mg/ml
Estradiol Cypionate Inc., Phoenix, cypionate. 2 mg/ml
Injection. AZ. Estradiol
cypionate.
Testosterone Cypionate-- The Upjohn Co., 0009-0253........ Vial....... Testosterone 50 mg/ml.
Estradiol Cypionate Kalamazoo, MI. cypionate. 2 mg/ml.
Injection. Estradiol
cypionate.
Testosterone Enanthate-- Goldline Labs, 0182-3073........ Vial....... Testosterone 90 mg/ml.
Estradiol Valerate Injection. Ft. Lauderdale, enanthate. 4 mg/ml.
FL. Estradiol
valerate.
Testosterone Enanthate-- Schein 0364-6618........ Vial....... Testosterone 90 mg/ml
Estradiol Valerate Injection. Pharmaceuticals enanthate. 4 mg/ml
, Port Estradiol
Washington, NY. valerate.
Testosterone Enanthate-- Steris Labs. 0402-0360........ Vial....... Testosterone 90 mg/ml
Estradiol Valerate Injection. Inc., Phoenix, enanthate. 4 mg/ml
AZ. Estradiol
valerate.
Tilapia Sex Reversal Feed Zeigler ................. Plastic Methyltestoster 60 mg/1 kg.
(Investigational). Brothers, Inc., Bags. one fish feed.
Gardners, PA.
----------------------------------------------------------------------------------------------------------------
[56 FR 42937, Aug. 30, 1991, as amended at 57 FR 55091, Nov. 24, 1992;
58 FR 16773, Mar. 31, 1993; 58 FR 34708, June 29, 1993]
Hearings
Sec. 1308.41 Hearings generally.
In any case where the Administrator shall hold a hearing on the
issuance, amendment, or repeal of rules pursuant to section 201 of the
Act, the procedures for such hearing and accompanying proceedings shall
be governed generally by the rulemaking procedures set forth in the
Administrative Procedure Act (5 U.S.C. 551-559) and specifically by
section 201 of the Act (21 U.S.C. 811), by Secs. 1308.42-1308.51, and by
Secs. 1316.41-1316.67 of this chapter.
Sec. 1308.42 Purpose of hearing.
If requested by any interested person after proceedings are
initiated pursuant to Sec. 1308.44, the Administrator shall hold a
hearing for the purpose of receiving factual evidence and expert opinion
regarding the issues involved in the issuance, amendment or repeal of a
rule issuable pursuant to section 201(a) of the Act (21 U.S.C. 811(a)).
Extensive argument should not be offered into evidence but rather
presented in opening or closing statements of counsel or in memoranda or
proposed findings of fact and conclusions of law.
Sec. 1308.43 Waiver or modification of Rules.
The Administrator or the presiding officer (with respect to matters
pending before him) may modify or waive any rule in this part by notice
in advance of the hearing, if he determines that no party in the hearing
will be unduly prejudiced and the ends of justice will thereby be
served. Such notice of modification or waiver shall be made a part of
the record of the hearing.
Sec. 1308.44 Initiation of proceedings for rulemaking.
(a) Any interested person may submit a petition to initiate
proceedings for the issuance, amendment, or repeal of any rule or
regulation issuable pursuant to the provisions of section 201 of the
Act.
(b) Petitions shall be submitted in quintuplicate to the
Administrator in the following form:
_______________________________________________________________________
(Date)
Administrator, Drug Enforcement
Administration
Department of Justice,
Washington, DC 20537.
[[Page 184]]
Dear Sir: The undersigned --------------- hereby petitions the
Administrator to initiate proceedings for the issuance (amendment or
repeal) of a rule or regulation pursuant to section 201 of the
Controlled Substances Act.
Attached hereto and constituting a part of this petition are the
following:
(A) The proposed rule in the form proposed by the petitioner. (If
the petitioner seeks the amendment or repeal of an existing rule, the
existing rule, together with a reference to the section in the Code of
Federal Regulations where it appears, should be included.)
(B) A statement of the grounds which the petitioner relies for the
issuance (amendment or repeal) of the rule. (Such grounds shall include
a reasonably concise statement of the facts relied upon by the
petitioner, including a summary of any relevant medical or scientific
evidence known to the petitioner.)
All notices to be sent regarding this petition should be addressed
to:
_______________________________________________________________________
(Name)
_______________________________________________________________________
(Street Address)
_______________________________________________________________________
(City and State)
Respectfully yours,
_______________________________________________________________________
(Signature of petitioner)
(c) Within a reasonable period of time after the receipt of a
petition, the Administrator shall notify the petitioner of his
acceptance or nonacceptance of the petition, and if not accepted, the
reason therefor. The Administrator need not accept a petition for filing
if any of the requirements prescribed in paragraph (b) of this section
is lacking or is not set forth so as to be readily understood. If the
petitioner desires, he may amend the petition to meet the requirements
of paragraph (b) of this section. If accepted for filing, a petition may
be denied by the Administrator within a reasonable period of time
thereafter if he finds the grounds upon which the petitioner relies are
not sufficient to justify the initiation of proceedings.
(d) The Administrator shall, before initiating proceedings for the
issuance, amendment, or repeal of any rule either to control a drug or
other substance, or to transfer a drug or other substance from one
schedule to another, or to remove a drug or other substance entirely
from the schedules, and after gathering the necessary data, request from
the Secretary a scientific and medical evaluation and the Secretary's
recommendations as to whether such drug or other substance should be so
controlled, transferred, or removed as a controlled substance. The
recommendations of the Secretary to the Administrator shall be binding
on the Administrator as to such scientific and medical matters, and if
the Secretary recommends that a drug or other substance not be
controlled, the Administrator shall not control that drug or other
substance.
(e) If the Administrator determines that the scientific and medical
evaluation and recommendations of the Secretary and all other relevant
data constitute substantial evidence of potential for abuse such as to
warrant control or additional control over the drug or other substance,
or substantial evidence that the drug or other substances should be
subjected to lesser control or removed entirely from the schedules, he
shall initiate proceedings for control, transfer, or removal as the case
may be.
(f) If and when the Administrator determines to initiate
proceedings, he shall publish in the Federal Register general notice of
any proposed rule making to issue, amend, or repeal any rule pursuant to
section 201 of the Act. Such published notice shall include a statement
of the time, place, and nature of any hearings on the proposal in the
event a hearing is requested pursuant to Sec. 1308.45. Such hearings may
not be commenced until after the expiration of at least 30 days from the
date the general notice is published in the Federal Register. Such
published notice shall also include a reference to the legal authority
under which the rule is proposed, a statement of the proposed rule, and,
in the discretion of the Administrator, a summary of the subjects and
issues involved.
(g) The Administrator may permit any interested persons to file
written comments on or objections to the proposal and shall designate in
the notice of proposed rule making the time during which such filings
may be made.
[[Page 185]]
Sec. 1308.45 Request for hearing or appearance; waiver.
(a) Any interested person desiring a hearing on a proposed
rulemaking, shall, within 30 days after the date of publication of
notice of the proposed rulemaking in the Federal Register, file with the
Administrator a written request for a hearing in the form prescribed in
Sec. 1316.47 of this chapter.
(b) Any interested person desiring to participate in a hearing
pursuant to Sec. 1308.41 shall, within 30 days after the date of
publication of the notice of hearing in the Federal Register, file with
the Administrator a written notice of his intention to participate in
such hearing in the form prescribed in Sec. 1316.48 of this chapter. Any
person filing a request for a hearing need not also file a notice of
appearance; the request for a hearing shall be deemed to be a notice of
appearance.
(c) Any interested person may, within the period permitted for
filing a request for a hearing, file with the Administrator a waiver of
an opportunity for a hearing or to participate in a hearing, together
with a written statement regarding his position on the matters of fact
and law involved in such hearing. Such statement, if admissible, shall
be made a part of the record and shall be considered in light of the
lack of opportunity for cross-examination in determining the weight to
be attached to matters of fact asserted therein.
(d) If any interested person fails to file a request for a hearing;
or if he so files and fails to appear at the hearing, he shall be deemed
to have waived his opportunity for the hearing or to participate in the
hearing, unless he shows good cause for such failure.
(e) If all interested persons waive or are deemed to waive their
opportunity for the hearing or to participate in the hearing, the
Administrator may cancel the hearing, if scheduled, and issue his final
order pursuant to Sec. 1308.48 without a hearing.
Sec. 1308.46 Burden of proof.
At any hearing, the proponent for the issuance, amendment, or repeal
of any rule or regulation shall have the burden of proof.
Sec. 1308.47 Time and place of hearing.
The hearing will commence at the place and time designated in the
notice of proposed rulemaking published in the Federal Register but
thereafter it may be moved to a different place and may be continued
from day to day or recessed to a later day without notice other than
announcement thereof by the presiding officer at the hearing.
Sec. 1308.48 Final order.
As soon as practicable after the presiding officer has certified the
record to the Administrator, the Administrator shall cause to be
published in the Federal Register his order in the proceeding, which
shall set forth the final rule and the findings of fact and conclusions
of law upon which the rule is based. This order shall specify the date
on which it shall take effect, which shall not be less than 30 days from
the date of publication in the Federal Register unless the Administrator
finds that conditions of public health or safety necessitate an earlier
effective date, in which event the Administrator shall specify in the
order his findings as to such conditions.